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Abstract 
 
 
A number of stereoselective syntheses have been investigated employing the 
ability of a furanyl ether chiral centre to epimerise under acidic conditions, 
therefore allowing the more stable diastereoisomer to preferentially form under 
thermodynamic control. As the furanyl group is able to undergo a number of 
synthetically useful transformations (e.g. Diels-Alder reactions, hydrogenations, 
oxidative cleavage, Achmatowicz oxidation, etc.) these syntheses represent a 
highly useful pathway to important moieties in a number of biologically active and 
pharmaceutically interesting molecules. 
 
Previous work within the group has investigated utilising the acid-catalysed 
epimerisation of furanyl ether chiral centres on conformationally well-defined 
scaffolds. This has been demonstrated in the synthesis of 2,6-disubstituted 
tetrahydropyrans, 2,6-disubstituted piperidines and also in spiroketals. In all cases 
high levels of stereocontrol were observed.  
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Attention was focused on the stereoselective synthesis of 2,4-disubstituted and 
2,4,5-trisubstituted tetrahydropyrans starting from ‘stereorandom’ precursors. In all 
cases high levels of stereocontrol were observed, going from an approximately 1:1 
diastereomeric mixture of the corresponding diol or triol to ratios exceeding 10:1 in 
the case of the disubstituted tetrahydropyrans and to ratios exceeding 15:1:0.9:0 
in the case of the trisubstituted tetrahydropyrans. This is due to the rapid 
epimerisation of the furanyl chiral centre allowing the substituents to adopt the 
thermodynamically favoured equatorial position on a chair conformation.  
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1. Introduction 
1.1. Biologically Active Compounds 
There are a plethora of compounds that demonstrate biological activity, whether 
beneficial or adverse, on living matter. A large number of these are natural 
products or their analogues,1 and they can vary greatly in their bioactive properties 
amongst structurally related compounds or even amongst enantiomers.2 This is 
due to the importance of the three dimensional, spatial orientation when the 
compound interacts with biological systems.3 
 
Throughout human history people have utilised traditional folk remedies and 
passed the knowledge of this down to their descendants.4 A classic example of 
this is in the case of aspirin. Aspirin is synthesised from salicylic acid, which is an 
active ingredient of analgesic herbal remedies, including willow bark, which the 
ancient Egyptians and Romans consumed to relieve aches and pains.5 Although in 
many cases we now know the active ingredient of these remedies, there are far 
more cases where the compound responsible for the biological effect is not yet 
known. This is unsurprising based on the high levels of structural diversity seen 
throughout the natural world in these biologically active compounds. 
 
Structural diversity stems from numerous variations that can be seen amongst 
functional groups; the spatial arrangement of atoms; variation in scaffolds present 
in the compound and the variation of structural groups present about a common 
backbone.3 
08	Fall	
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This chemical diversity has led to natural products being a driving force behind 
pharmaceutical discovery.6 Of the commercial drugs currently available 70% are 
derivatives of compounds isolated from nature that have exhibited biological 
activity.7  
 
These extremely useful compounds come from a wide variety of sources (such as 
plants, fungi, marine sponges, etc.) and include the tetrahydropyran containing 
compound bryostatin 1 (1), which inhibits tumour growth and angiogenesis (the 
formation of new blood vessels from already pre-existing ones).7 Bryostatin 1 (1) is 
often used in conjunction with paclitaxel (Taxol®) (2) as an anticancer treatment;8 
however, paclitaxel is an effective anticancer agent in its own right and works by 
promoting tubulin polymerisation and the stabilisation of microtubules.9 This 
interrupts cell division and promotes apoptosis (cell death). 
 
Figure 1.1: Structures of bryostatin 1 and paclitaxel (Taxol®). 
  
Although natural products are often bioactive and have an array of potential uses, 
there are a number of disadvantages associated with them. The major 
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disadvantage is the extraction and isolation can be difficult and tedious.10 In some 
cases the compounds are present in sufficiently high abundances within the 
biological material, or possess suitable chemical properties (for example the 
basicity of alkaloids) that isolation can be achieved via distillation or 
recrystallisation. This is the case for strychnine (3), a highly poisonous compound 
that has previously been used in pest management. Strychnine can be easily 
isolated from Nux vomica seeds by grinding, as each one of the seeds can contain 
up to 3% of the natural product.11 
 
 
 
 
 
 
 
Figure 1.2: Structure of strychnine. 
 
In many other cases the quantity of the desired natural product within the 
biological material is so small that various chromatographic methods need to be 
used instead.12 This is the case with the compound paclitaxel (2), which is 
extracted from the Pacific Yew. The bark of three mature trees yields one gram of 
paclitaxel; however worldwide demand in 2009 was for 250 kilograms.13 This is 
one of the reasons that stereoselective synthetic pathways to biologically active 
compounds are of such great importance.1 Current synthesis of paclitaxel is 
achieved through the derivatisation of a similar compound that is much more 
readily available from the English Yew14 but, despite this, stereoselective 
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synthesis is still important as it allows for the development of new and effective 
methodologies; grants material for research purposes that may be difficult to 
obtain in such quantities via extraction and it can also allow access to other, often 
simpler, derivatives that may possess higher levels of activity, or may be easier to 
synthesise and therefore be more viable for commercial synthesis. This was seen 
in the case of eribulin, a simplified derivative of the natural product halichondrin B; 
that is both totally synthetic and also complex, containing a number of 
stereocentres (see section 1.1.1.) 
 
Stereoselective synthesis is extremely important and different stereoisomers of a 
compound may have vastly different effects. This was demonstrated in 1957 when 
an anti-emetic drug known as thalidomide was sold as a racemate and marketed 
as being suitable for pregnant women.15 The (R)-(+)-isomer (4a) did have this 
effect; however, the (S)-(-)-isomer (4b) possessed significant teratogenic activity. 
In other words, it could significantly disturb the development of an embryo or 
foetus, resulting in birth defects.16 It was also discovered that the (R)-isomer is 
racemised within the body.  
 
 
 
 
 
 
Figure 1.3: Both enantiomers of thalidomide. Image adapted from reference 17. 
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This worldwide disaster led to pharmaceutical companies being required to 
investigate the biological activity and effects of single enantiomers and highlights 
why stereoselective synthesis is so important. 
 
1.1.1. Selected Natural Products 
This section will focus on selected tetrahydropyran-containing natural products, 
their biological activity and the key step in their synthesis. Other synthetic methods 
will be covered later in this thesis (see section 1.2.). 
1.1.1.1. Eribulin 
In 1986 eight antitumour compounds were isolated from Halichondria okadai,18 a 
marine sponge that can be found, widely distributed, about the Pacific coast of 
Japan.19 One of these compounds was halichondrin B (5). In 1992 the Kishi group 
published the total synthesis of this molecule,20 which possesses 32 
stereocentres, meaning that it can adopt over four billion different stereoisomers.21 
The longest linear sequence in this synthesis was 47 steps, but in total the 
synthesis was 90 steps and therefore impractical in terms of drug development22 
despite tests revealing that it possesses potent antimitotic and antitumour 
activities.23 
 
 
 
 
 
 
Figure 1.4: Structure of Halichondrin B. 
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Eisai (a Japanese pharmaceutical company) collaborated with Kishi in order to 
explore the structure-activity relationships of halichondrin B (5) and it was found 
that the macrocyclic ketone structure is the key to the antitumour properties of the 
molecule. This work led to the development of the chemically and biologically 
optimised totally synthetic drug derived from halichondrin B (5) known as eribulin 
(6) (commercially called Halaven®).24 This compound shows anticancer activity 
against a number of human cancer lines including breast cancer, lymphoma and 
prostrate cancer.25 
 
 
 
 
 
 
 
 
Figure 1.5: Eribulin – a compound that possesses nineteen stereogenic centres.26 
 
Eribulin (6) is a derivative of an intermediate from the total synthesis of compound 
5 by Kishi and co-workers and was found to be moderately more active than its 
parent compound.23 In 2010 Halaven® was approved as a drug treatment for 
metastatic breast cancer.27 Metastasis refers to tumour migration. Hence 
metastatic breast cancer is an advanced form of breast cancer where the tumours 
are migrating to other organs. Approximately 10 – 15% of patients will develop this 
advanced form within three years of the original diagnosis.28 The following year 
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(2011), Halaven® was entered into new trials for the treatment of non-small cell 
lung cancer and prostrate cancer. These trials are still ongoing.29 
 
The commercial synthetic route to eribulin was 62 steps but, in 2015, seven steps 
were added to this in order to reduce the cost and waste of the synthesis by 80% 
by removing the need for column chromatography.21  
 
The reaction scheme followed for the synthesis of eribulin was the same as the 
initial synthetic route followed to synthesise halichondrin B (5) and featured a 
Nozaki-Hiyama-Kishi coupling as one of the key steps. The reaction involves 
coupling of an alkenyl halide and an aldehyde in order to generate an alcohol, as 
shown in scheme 1.1. It is quite similar to the magnesium (0)-catalysed Barbier-
type reaction but the Nozaki-Hiyama-Kishi (NHK) coupling doesn’t use magnesium 
and so can tolerate ketones and esters in the presence of the aldehyde. In other 
words the NHK reaction tolerates a broader range of functionalities. 
 
The NHK reaction was first reported in 1977 stating only the need for chromium (II) 
chloride. Concurrently, in 1986, both Kishi30 and Nozaki31 reported that the 
effectiveness of the reaction was dependent on the source and batch of the 
chromium (II) chloride used. The reason for this was found to be that the effective 
batches possessed a trace quantity (~ 0.5 mol%) of NiCl2 and the effectiveness of 
this reaction was dependent on this. The NHK reaction uses a substoichiometric 
quantity of NiCl2 and this is needed in conjunction with stoichiometric quantities of 
CrCl2.32 
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Scheme 1.1: Catalytic pathway for the Nozaki-Hiyama-Kishi coupling. Adapted from reference 31. 
 
The NHK coupling reaction, shown in scheme 1.2, produced the secondary 
alcohol (15) in a 3:1 mixture showing that the reaction proceeds with some level of 
stereocontrol. The major stereoisomer that formed matched the desired 
stereochemistry needed for the tetrahydropyran formation seen in the next step. 
The tetrahydropyran was formed via an intramolecular Williamson ether synthesis 
with inversion of stereochemistry at CX.  
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Scheme 1.2: Tetrahydropyran ring formation in the total synthesis of eribulin. Adapted from 
reference 26. 
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1.1.1.2. (−)-Centrolobine 
Diarylheptanoid compounds that contain a tetrahydropyran ring have been shown 
to exhibit a variety of biological activities. One of these compounds is  
(−)-centrolobine (19).  
 
 
 
 
Figure 1.6: Structure of (−)-centrolobine. 
 
This compound was isolated in 1964 from the heartwood of Centrolobium 
robustum and the stem of Brosnium potabile, both from the Amazonian 
rainforest.33 It has been shown to possess antibacterial activity, anti-inflammatory 
activity34 and it also demonstrates activity against Leishmania amazonensis 
promatigotes, a parasite associated with leishmaniasis. 
 
Leishmaniasis is a parasitic disease whose vector is the sandfly. In the human 
host the Leishmania protozoa attacks the body’s spongiform organs (particularly 
the liver and the spleen).35 The parasite can also attack the skin in cutaneous 
leishmaniasis. This gives rise to nodules and ulcers on the skin and symptoms are 
akin to leprosy.36 
 
The treatment for this disease over the past 80 years has been through the use of 
pentavalent antimonials (e.g. Sb(V) N-methyl-D-glucamine complexes); however 
O
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they have now been linked to both cardiac and renal toxicity. Hence new 
alternatives are required.35 
 
Centrolobine was first isolated in 1964 and successfully synthesised in 1965 as a 
mixture of stereoisomers.37 Despite this success the first asymmetric synthesis of 
(−)-centrolobine (19) was not achieved until 2002.38 This asymmetric synthesis 
(see Scheme 1.3) relied on the formation of a hydroxyketone (28) that could then 
cyclise to form the tetrahydropyran (29). The hydroxyketone was synthesised via 
the reduction of the corresponding β-ketosulfoxide (23) and the stereoselectivity is 
achieved due to the presence of the chiral sulfoxide and the use of zinc bromide 
as a complexing agent allowing for the directed complexation of 
diisobutylaluminium hydride (DIBAL-H) (24). The hydride is then intramolecularly 
transferred. The stereochemistry is a result of the aromatic group located on the 
sulfoxide group hindering the bromine-directed approach of DIBAL-H from one 
direction. This effect was described in 1990 by Solladié-Cavallo and co-workers 
using a catalytic quantity of zinc chloride.39 Upon obtaining the secondary alcohol 
(25) it can then be converted to the Weinreb amide (26) before being reacted with 
p-methoxyphenylmagnesium bromide (27) to generate the desired hydroxyketone.  
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Scheme 1.3: Synthesis of hydroxyketone for use in the synthesis of (−)-centrolobine. Adapted from 
reference 38. 
 
Upon obtaining hydroxyketone (28) the tetrahydropyran ring (29) could then be 
forged through treatment with an excess of triethylsilane and one equivalent of 
trimethylsilyl trifluoromethanesulfonate, as shown in scheme 1.4. The reaction 
proceeded at 0°C and, in 15 minutes, produced an 81% yield. 
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Scheme 1.4: Construction of the tetrahydropyran ring in the asymmetric synthesis of (−)-
centrolobine. Adapted from reference 38. 
 
1.1.1.3. Bryostatin 1 
The family of compounds known as the bryostatins were first isolated from Bugula 
neritina in 196840 but it wasn’t until 1982 that the structure of bryostatin 1 (1) was 
reported41 as a multiringed macrocyclic lactone – the structure of bryostatin 1 is 
shown in Figure 1.1. 
 
Bryostatin 1 (1) possesses a variety of biological activities. It is a modulator of 
protein kinase C (a protein involved in the regulation of cell differentiation and cell 
proliferation); it has demonstrated usefulness in the treatment of Alzheimer’s 
disease; in combinational therapy it could be used in a treatment against HIV27 
and it possesses antitumour properties. It’s antitumour properties derive from the 
molecule’s ability to: 
1. Trigger the development of specific cytotoxic T-lymphocytes. 
2. Activate and induce the proliferation of both T- and B-cells. 
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3. Stimulate T-cells to generate a number of cytokines, which includes IFN-γ 
and IL-2, two cytokines that have shown antitumour effects.42 
 
Although bryostatin 1 (1) has entered clinical trials with these properties, testing 
has not yet been completed. Bryostatin 1 (1) has also entered trials as a 
combinational therapy with paclitaxel (Taxol®) (2).8  
 
In 2011, three new bryostatin total syntheses were reported in the literature with 
the shortest being 36 steps. One of these was the first synthesis of bryostatin 1 by 
Keck and co-workers in 58 steps.43 The ability of chemists to synthesise these 
compounds in an efficient and low cost manner has led to the current push on the 
synthesis of these compounds and their analogues to generate more practical and 
effective drug candidates. 
 
Efficient and stereoselective routes to the fragments of natural products is one way 
that this can be achieved, which is why stereoselective synthesis of 
tetrahydropyrans is so important and has been something that has been 
previously investigated by the group. 
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1.2. Tetrahydropyrans 
The tetrahydropyran moiety is classed as a privileged scaffold and the function of 
the compounds it is found in are vastly different, depending on the array of 
functional groups located about the scaffold and their stereochemistry. 
 
Examples (shown in Figure 1.7) include thyrensol A (30), thyrensol B (31), (+)-
phorboxazoles A (32) and B (33), as well as leucascandrolide A (34). Thyrensols A 
(30) and B (31) were isolated from the red algae Laurencia viridis and possess 
cytotoxic activity against a number of human breast cancer cell lines.7 Both (+)-
phorboxazole A (32) and (+)-phorboxazole B (33) are isolated from marine 
sponges (Phorbas sp.). They posses antibiotic and antifungal activity, along with 
possessing great cytotoxicity against a number of human cell lines. Their 
cytotoxicity is so great that it puts them in the same category as the halichondrin 
compounds (see section 1.1.1.) and the spongistatins.44 Leucascandrolide A (34) 
possesses potent antifungal activity, inhibiting the growth of Candida albicans, a 
fungus known for causing yeast infections in humans. This tetrahydropyran-
containing compound was isolated from the marine sponge Leucascandra 
caveolata.45 
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Figure 1.7: Examples of biologically active, tetrahydropyran-containing natural products. 
 
Another common privileged scaffold is the piperidine motif. Entities possessing this 
structure are currently important targets in pharmaceutical research.46 Since 1993 
there have been four commercial drugs developed that contain this moiety.47 
1. Donepezil (35) (Aricept™) – an acetyl cholinesterase inhibitor that is used 
in the treatment of Alzheimer’s disease. 
2. Naratriptan (36) (Amerge™ and Naramig™) – used in the treatment of 
migraines. 
3. Risperidone (37) (Risperdal™) – used in the treatment of schizophrenia. 
4. Sertindole (38) (Serdolect™ and Serlect™) – used in the treatment of 
schizophrenia. 
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Figure 1.8: Pharmaceuticals developed since 1993 that contain the piperidine moiety. Adapted 
from reference 47. 
 
Whether looking at tetrahydropyrans or piperidines, the importance of 
stereochemistry cannot be denied. Due to this, new stereoselective synthetic 
methods are of great importance. 
 
A number of strategies have been developed in the stereoselective synthesis of 
tetrahydropyrans. Some of the more commonly used techniques include: the Prins 
cyclisation, oxy-Michael reaction and the hetero-Diels-Alder reaction. 
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1.2.1. Strategies used in the Stereoselective Synthesis of 
Tetrahydropyrans 
1.2.1.1. Tetrahydropyran Synthesis – Prins Cyclisation 
The Prins cyclisation is a method that can synthesise functionalised oxygen-
containing heterocycles such as tetrahydropyrans, dihydropyrans and 
tetrahydropyranones. The reaction is acid catalysed, under thermodynamic control 
and takes place between an aldehyde and a homoallylic alcohol.48 In terms of 
tetrahydropyran synthesis it is one of the most versatile methods available.49 
 
Kriewitz performed the initial work investigating the condensation of alkenes with 
aldehydes in 1899.50 From this work he discovered that unsaturated alcohols 
could be produced upon heating paraformaldehyde with pinene (a bicyclic 
monoterpene). Prins began a comprehensive study of the reactions between 
formaldehyde and various alkenes and this work was reported in 1919.51 
 
 
 
 
 
 
 
 
Scheme 1.5: Initial studies leading to the development of the Prins cyclisation. Adapted from 
reference 51. 
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When first investigated, the reaction used sulfuric acid and heating, giving a 
number of unwanted side products. Since the discovery of the reaction and its 
application to the synthesis of tetrahydropyrans an array of Brønsted and Lewis 
acid catalysts have been tested and successfully applied.52 
 
 The Prins cyclisation generates, in situ, an oxocarbenium ion (47). After 
computational studies by Alder53 it was found that this ion preferentially adopts the 
E-geometry.48 The oxocarbenium ion undergoes an intramolecular cyclisation that 
produces the ring structure with substituents located in the equatorial positions. A 
nucleophile can be used to trap the carbocation formed giving the tetrahydropyran 
product.54  
 
 
 
 
 
 
 
 
Scheme 1.6: Generalised Prins cyclisation. Adapted from reference 51. 
 
Despite its synthetic usefulness there are a number of limitations to the Prins 
cyclisation: 
1. A stoichiometric quantity of the acid is needed.49 
2. Generally a halide is used to trap the carbocation. 
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3. If an electron-rich aromatic ring is seen adjacent to the alcohol then the 
reaction suffers from solvolysis of the alcohol, a number of side products 
are seen and the competing oxonia-Cope rearrangement is seen.55 
The competing oxonia-Cope rearrangement is one of the biggest problems seen 
when using the Prins cyclisation. 
 
Typically the oxonia-Cope rearrangement is seen when there is an electron-rich 
aromatic ring present in the homoallylic alcohol. This is because the electron-
donating ability of the ring provides stability to the carbocation that forms through 
conjugation.56 When the aromatic ring possesses electron withdrawing 
substituents then this is not the case and the oxonia-Cope product is not seen.54 
 
Whether the oxonia-Cope rearrangement occurs or not the oxocarbenium ion is 
able to proceed to the desired tetrahydropyran (54), but if the [3+3]-oxonia-Cope 
rearrangement has taken place then loss of absolute stereochemistry is seen. This 
means that when the tetrahydropyran is formed it is a mixture of stereoisomers 
due to racemisation seen with the oxonia-Cope intermediate.57 As well as 
proceeding to the tetrahydropyran, the rearranged oxonia-Cope ion can fragment 
in an allyl transfer process giving a new aldehyde (56) and a new homoallylic 
alcohol (57). This newly formed homoallylic alcohol can react with the initial 
aldehyde (10) to give a symmetrical tetrahydropyran (58), which was not desired. 
The nucleophile used (in this case Cl-) can also react with the carbocation forming 
the side product 53.51 
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Scheme 1.7: Prins cyclisation where an electron-rich aromatic ring is adjacent to the alcohol. The 
competing oxonia-Cope rearrangement is shown also. Adapted from reference 59. 
 
The Prins cyclisation has received much attention in the literature and one area of 
research that has been focused on is methods by which the competing oxonia-
Cope rearrangement can be minimised. Rychnovsky reported on one such 
development in 2002. This involved cyclisation of an α-acetoxy ether using a 
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temperature was also used for this reaction and, based on the Maxwell-Boltzmann 
distribution, this may have contributed to the suppression of the competing 
reaction. 
 
 
 
 
Scheme 1.8: Rychnovsky’s tetrahydropyran formation from the corresponding α-acetoxy ether. 
The competing oxonia-Cope rearrangement is minimised due to the rapid rate of the reaction when 
employing SnBr4 as the Lewis acid. Adapted from reference 55. 
 
Many of the developments of this reaction have focused on looking at different 
catalysts which can be used (e.g. iodine).58 One particularly effective class of 
catalysts were the indium halides.51 This was first developed to synthesise 4-halo 
tetrahydropyrans in good yield. It was taken further by Loh by including another 
halogen atom in the starting compound. This allowed the synthesis of 2,4,5,6-
tetrasubstituted tetrahydropyrans where positions 4 and 5 both have halo-
substituents.59 
 
 
 
 
 
Scheme 1.9: Loh’s indium-catalysed formation of 2,4,5,6-tetrasubstituted tetrahydropyrans. 
Adapted from reference 59. 
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Loh discovered that by controlling the geometric configuration of the γ-brominated 
homoallylic alcohol, the stereochemistry at the C5 position (bearing a bromine 
substituent) in the tetrahydropyran could be effectively manipulated. The two R 
groups present maintained a cis-relationship and in both cases were located in the 
equatorial positions, as was the bromine substituent in the C4 position.59 This is 
shown in Scheme 1.10.  
 
Scheme 1.10: Mechanism explaining the stereochemical outcome seen in Loh’s formation of 
2,4,5,6-tetrasubstituted tetrahydropyrans. Adapted from reference 59.  
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quantity of an alternate stereoisomer was seen that possessed the trifluoroacetoxy 
group in the axial position (8:1 major:minor ratio).62 
 
Scheme 1.11: Maier’s synthesis of the neopeltolide macrolactone utilising the Prins cyclisation. 
Adapted from reference 61. 
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reaction (reaction of an oxygen nucleophile with a conjugate acceptor system) is 
now garnering more interest and has shown to be a useful technique in the 
synthesis of functionalised tetrahydropyrans. 
 
There are two main drawbacks to oxy-Michael additions. The first is the 
reversibility when the oxygen nucleophile adds to the conjugate acceptor. The 
second is the low reactivity of the oxygen nucleophile. In order to increase the 
nucleophilicity the alcohol can be deprotonated by a strong base (such as 
potassium tert-butoxide).64 Another way to overcome this issue is to activate the 
conjugate acceptor system using a Brønsted or Lewis acid or by use of a transition 
metal complex.65 In some cases these conditions are incompatible with other 
functionalities located within the compound. Another drawback to this reaction is 
that a pre-existing chiral centre is required, but the use of a transition metal 
catalyst is such an effective technique in the production of chiral alcohols, that this 
drawback is generally overcome.66 
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Scheme 1.12: Generalised oxy-Michael addition. Top – Intermolecular, acyclic example. Bottom – 
Intramolecular, cyclic example. 
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two partially negatively charge oxygen atoms.67 This work has been supported by 
White when using the oxy-Michael addition68 and also by Martín.69 
 
The transition state seen with (E)-double bond geometry favours the ester 
substituent being located in the axial position. This is because it allows for 
chelation with the metal ion. If the (E)-double bond is located in the equatorial 
position then the partially negative carbonyl oxygen is unable to chelate to the 
metal due to distance. This favours the trans-tetrahydropyran. The transition state 
with (Z)-double bond geometry favours the equatorial position as it allows 
chelation for the metal that is not seen if the (Z)-double bond is located in the axial 
position. This is demonstrated in Figure 1.9. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Transition states showing how double bond geometry affects the stereochemical 
outcome of the oxy-Michael reaction. Adapted from reference 70. 
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As shown in Scheme 1.12 it is possible to use the potent nucleophilicity of the 
enolates formed via this reaction in additional reactions with suitable electrophiles 
in a domino process. One way of doing this, which was exploited by Menche and 
Wang in 2012, is to combine the oxy-Michael reaction with a Tsuji-Trost coupling 
(the allylation of nucleophiles with allylic compounds, catalysed by palladium).71 
This is an effective process to synthesise highly functionalised tetrahydropyrans 
from homoallylic alcohols. The palladium catalyst can form a π-allyl complex (90). 
This generates an electrophile that is able to react with the previously generated 
enolate via an intramolecular allylic substitution reaction. 
 
 
 
 
 
 
 
 
 
 
Scheme 1.13: Combining the oxy-Michael addition and the Tsuji-Trost coupling. Adapted from 
reference 65.  
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Michael reaction under basic conditions a 1:1 mixture of diastereoisomers was 
seen varying at the C43 position. This comes from the fact that the double bond 
geometry in the tetrahydropyran precursor was in the (E)-geometry as shown in 
Figure 1.9. The tetrahydropyran diastereoisomer mixture was allowed to 
equilibrate under basic conditions and, after twenty hours, the all-equatorial 
substituted tetrahydropyran was seen in a 95:5 diastereomeric ratio.74 
 
Scheme 1.14: Use of the oxy-Michael reaction in the synthesis of a tetrahydropyran in the EF 
segment of spongistatin 1. Adapted from references 74 and 75. 
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is the hetero-Diels-Alder (HDA) reaction.77 This allows the construction of 
heterocycles and is one way to construct substituted tetrahydropyrans.78 
 
In 1982, Danishefsky and co-workers extended the scope of the HDA to include 
unactivated aldehyde heterodienophiles through the use of a Lewis acid catalyst.79 
Since then the reaction has garnered much attention because it provides an easy 
route to the synthesis of dihydropyrans and pyranone products. These are 
important intermediates in the synthesis of a range of multi-substituted 
tetrahydropyrans. The Lewis acid catalyst binds to the carbonyl group of the 
aldehyde and lowers the energy level of the lowest unoccupied molecular orbital 
(LUMO) accounting for the enhancement to the reaction rate.80  
 
Metal ions can also play a part in affecting the stereochemical outcome of the 
product due to chelation. By including MgBr2 (0.2 eqv.) Luger and co-workers were 
able to product the trans pyranone (101) instead of the cis pyranone (99) that was 
seen as the major product under thermal conditions.81 
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Scheme 1.15: Metal chelation affecting the stereochemical outcome of the HDA reaction. Adapted 
from reference 81. 
 
This is because the exo-transition state is less hindered than the endo-transition 
state. The endo-transition state exhibits an unfavourable interaction between one 
of the bromine atoms and the carbon skeleton of the diene. 
 
  
 
 
 
 
 
 
Figure 1.10: Exo and endo transition states of Luger’s hetero-Diels-Alder reaction. Adapted from 
reference 81. 
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When an activated diene is used in the HDA reaction, such as the Danishefsky-
type dienes (102), then the reaction may proceed through one of two routes. The 
route that is followed is dependent on the chiral Lewis acid catalyst that has been 
employed. These two routes are the Mukaiyama-Aldol pathway and the Diels-
Alder pathway. The Mukaiyama-Aldol intermediate (103) is able to undertake a 
ring closure to give the HDA-adduct 104. 
 
Scheme 1.16: An activated diene being used in the HDA reaction – both reaction pathways are 
shown. Adapted from reference 82. 
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The Jacobsen group have reported HDA reactions using less nucleophilic dienes 
and unactivated carbonyl compounds, therefore giving the reaction greater scope. 
This is done using a chromium (III) catalyst such as the tridentate Schiff base 
chromium (III) complex 106.83 
 
 
 
 
 
 
 
 
 
 
Scheme 1.17: Jacobsen’s development to HDA reactions using a tridentate Schiff base chromium 
(III) complex. Adapted from reference 109. 
 
This has not been the only catalyst developed for the HDA reactions. Another 
catalyst is the copper BOX-complex 109.  
 
 
 
 
 
Figure 1.11: Copper BOX-complex catalyst. Adapted from reference 84. 
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This catalyst was used in a HDA reaction that was part of the synthesis of one of 
the rings located in the shellfish toxin (+)-azaspiracid. The HDA produced the 
dihydropyran, which was reduced to the corresponding tetrahydropyran (113).8 
 
Scheme 1.18: A HDA reaction employed in the synthesis of (+)-azaspiracid. Adapted from 
references 85 and 86. 
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Scheme 1.19: Generalised Pd(0) catalysed ring closure. Adapted from reference 87. 
 
Work of this type (i.e. forming tetrahydropyrans through a Pd (0) catalysed 
reaction) was initially completed by Trost in 1988.88 This work made use of allyl 
acetates that possessed a remote vicinal diol (117). This was subjected to the 
cyclisation conditions and the work focused on the ring size that would 
preferentially form. The stereochemical aspects were not explored.  
 
Scheme 1.20: Trost’s work on palladium-catalysed chemoselective cyclic ether formation. Adapted 
from reference 88. 
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In 2008 the reaction shown in Scheme 1.19 was also catalysed using a gold 
catalyst by Aponick.89 Gold has only recently begun to be used as it was 
previously assumed to be inert.90 However Au(I) catalysts can co-ordinate to C-C 
π-bonds, activating them towards nucleophilic attack.91 
 
Gold catalysts can also be used in the synthesis of tetrahydropyrans and 
piperidines from homopropargylic ethers (119). This synthesis combines two gold-
catalysed transformations.90 The homopropargylic ether (119) undergoes a gold-
catalysed addition of water, followed by the elimination of methanol. The 
intramolecular 1,4-addition that follows involving the alcohol or amine is also gold-
catalysed. 
 
Scheme 1.21: Gold-catalysed reaction of homopropargylic ethers. Adapted from reference 90. 
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Palladium (II) compounds form pyrans differently than Pd (0) and other related 
catalysts. The Pd (II) compound co-ordinates to the carbon-carbon double bond 
forming a π-complex. The electrophilic nature of Pd (II) means that there is a 
decrease in electron density about the alkene bond allowing it to be attacked by a 
nucleophile.92 
 
Uenishi employed this in the total synthesis of (-)-laulimalide (127).93 When it 
came to forming the pyran ring both Pd (0) and Pd (II) complexes were tested (on 
slightly altered starting materials). In both cases the stereoselectivity of the 
reaction matched but the reaction using Pd (II) gave a higher yield – 89% rather 
than 59%. The stereoselectivity when using Pd (II) comes from the possibility of 
nucleophilic attack from either the re or si face. 
 
Scheme 1.22: (-)-laulimalide synthesis utilising palladium (II). Adapted from reference 95. 
PMBO
O
O
OH
H
H
HO
123
PdCl2
21
O
OHPd
H
Cl Cl
re face
attack
si face
attack
124
- PdCl2
- H2O
- PdCl2
- H2O
89%
re face
attack
si face
attack
O
H
O
H
Not observed
125
126
19 steps
12%
OH H
OH
O
OO
OH
O
H
127
(-)-laulimalide
		
Introduction	–	Tetrahydropyrans	 		 	
38	
The palladium π-complex forms on the same face as the hydroxyl group located 
on C21. An internal syn-SN2’-type reaction then takes place with the nucleophilic 
hydroxyl group attacking from the same side of the complex (in the case of 124 on 
the si face). If the C21 hydroxyl group is located in front of the plane of the 
molecule, the complex will form on the other side of the molecule from that shown 
in 124, and so the nucleophilic hydroxyl group will attack from the re-face. In that 
scenario only stereoisomer 125 is observed.93  
 
1.2.1.5. Tetrahydropyran Synthesis – Ring Closing Metathesis 
Ring closing metathesis (RCM) is a widely used tool in the formation of carbon-
carbon bonds. It is a technique that has been used in the construction of 
tetrahydropyrans and piperidines.94 This is due to the mild conditions the reaction 
requires, high product yields, stereochemistry retention and excellent 
compatibilities with a range of functionalities. During the reaction the stereocentres 
do not change and this gives rise to the retention of stereochemistry. This means 
that the stereochemistry seen in the starting material is seen in the product.95 The 
drawback to this is that the stereochemistry needs to be installed before the 
reaction takes place. Another is that the product of the RCM reaction is the 
dihydropyran and so a further reduction step is required in order to generate the 
tetrahydropyran moiety.96 
 
There are two classes of RCM reactions that can be used in the synthesis of these 
heterocycles. Class I consists of the ring closure of an ether that possesses an 
allylic or homoallylic functionality. This gives rise to the 3,4-dihydropyran, which 
can then be reduced to construct the desired tetrahydropyran.  
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Class II RCM reactions involve the ring closure of a homoallylic acrylate to 
generate the unsaturated lactone. This can then be further functionalised to a 
substituted tetrahydropyran. Molybdenum and ruthenium catalysts are commonly 
used in these reactions. The most common are Grubbs’ catalysts, either first or 
second generation.96 
 
It is known in the class I reaction that olefin isomerisation/migration is possible. 
This affects the product distribution and reduces the overall yield of the desired 
compound. The unwanted isomers are also typically very difficult to remove using 
standard purification methods. The isomerisation is seen due to decomposition of 
the ruthenium metathesis catalyst to a ruthenium hydride species.  
 
Grubbs explored compounds that could be added to the reaction that prevented 
the undesired isomerisation but that did not affect the metathesis reaction itself.97 
The most effective compound found to prevent this isomerisation was 1,4-
benzoquinone. This works by being reduced, by the ruthenium hydride species, to 
the corresponding hydroquinone. 
  
 
 
  
 
 
 
Scheme 1.23: Two classes of ring closing metathesis reactions. Adapted from reference 96. 
R1 O R2
RCM
R1 O R2
reduction
R1 O R2
Class I
R1 O O
RCM
R1 O O
1) reduction
2) reductive
alkylation/
acetylation
R1 O R2
Class II
128 129 130
130131 132
		
Introduction	–	Tetrahydropyrans	 		 	
40	
Crimmins reported on the enantioselective total synthesis of the microbial 
metabolite known as SCH 351448 (136) in 2006.98 One of the key steps in this 
synthesis relied on a class I RCM reaction. In the presence of Grubbs II catalyst 
and dioxenone (134), the acyclic polyene monomer precursor 133 undergoes a 
double RCM/cross metathesis tandem reaction and this proceeds with an 88% 
yield. 
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Scheme 1.24: Enantioselective synthesis of SCH 351448 using a double RCM/cross metathesis 
tandem reaction. Adapted from reference 98. 
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1.2.1.6. Tetrahydropyran Synthesis – Other 
It is possible to synthesise tetrahydropyrans through the use of nucleophilic 
epoxide opening using an intramolecular hydroxyl group. The regioselectivity of 
this reaction is highly dependent on the stereochemistry of the epoxide and 
whether adjacent substituents possess a π-system or not, and so whether the exo 
or endo product is favoured. The epoxide needed for these reactions can be 
generated in several different ways, one being the Sharpless asymmetric 
epoxidation reaction.  
 
In the case of δ-hydroxy-trans-epoxides, tetrahydropyran formation is favoured 
over the formation of the seven-membered oxepane regardless of the nature of 
the substituents. If the corresponding cis-epoxide is reacted and an adjacent 
substituent possesses a π-system then preferential oxepane generation is seen. 
With no π-system the major product is the tetrahydropyran. A similar situation is 
seen with the γ-hydroxy epoxides. The cis-epoxide favours the formation of the 
five-membered tetrahydrofuran regardless of the nature of the substituents. The 
trans-epoxide sees tetrahydropyran formation with an adjacent π-system present 
(see Scheme 1.26) but if it is not then tetrahydrofuran formation is seen.96 
 
The reasoning for this is that the adjacent π-orbital allows for stabilisation of the δ+ 
charge and so favours the endo pathway over the exo route. If this stabilisation 
isn’t present then the endo pathway is not the favoured route.99 
 
 
 
		
Introduction	–	Tetrahydropyrans	 		 	
43	
 
 
 
  
Scheme 1.25: Nucleophilic epoxide opening to form the saturated heterocycle. Adapted from 
reference 99. 
 
 
 
 
 
 
 
 
 
Scheme 1.26: Stabilisation of the endo pathway with an adjacent π-system. Adapted from 
reference 99. 
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construct a tetrahydropyran ring that showed promise as a precursor to bryostatin 
1 (1). The reaction was a 6-exo-tet ring-closure.100 
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Scheme 1.27: Epoxide opening utilised in the synthesis of a bryostatin 1 (1) precursor. Adapted 
from reference 100. 
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1.3. Previous Work and Aims 
1.3.1. Previous Work by the Group 
Furan is a five-membered, aromatic heterocycle; however, furan will undergo 
transformations that lead to its dearomatisation relatively easily. The reasoning 
behind this is that although furan exhibits some level of aromatic stabilisation (with 
a resonance energy of ~70 kJmol-1), it is significantly less than is seen in benzene 
(151 kJmol-1) and is also less than is seen in both pyrrole and thiophene – other 
five-membered, aromatic heterocycles.101 This means that furan is synthetically 
very useful as it can undergo a variety of transformations. Examples include a 
Diels-Alder reaction,102 Piancatelli reaction103 or the Achmatowicz oxidation.104 The 
electron-rich nature of the furanyl group (due to the lone pair of electrons present 
on the oxygen atom) means that it is able to stabilise cations that are adjacent to 
the group. Under acidic conditions the group has used this stabilising effect to 
facilitate the epimerisation of an adjacent ether chiral centre. 
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Scheme 1.28: Examples of furanyl compounds undergoing: a) a Diels-Alder reaction; b) Piancatelli 
reaction; c) an Achmatowicz oxidation 
 
The use of the 2-furanyl group to facilitate the acid catalysed cyclisation and 
subsequent epimerisation was a technique that was applied in a number of 
syntheses by the group. The electron-rich furanyl group that can stabilise the 
cation on the adjacent chiral centre facilitates this epimerisation. 
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Scheme 1.29: Cyclisation method employed by the group. 
 
Under acidic conditions the hydroxyl group adjacent to the furanyl group can be 
lost due to the stabilisation offered by the electron-rich furanyl group. The 
remaining hydroxyl group is then able to cyclise around to form the 
tetrahydropyran ring. In order to adopt the lowest energy conformation the 
tetrahydropyran ring will be found as a chair conformation. Assuming that the R 
group is locked in the equatorial position, preventing ring flipping, then the furanyl 
group can be located in either the equatorial position or the axial position. 
However, under these conditions the cyclisation step is reversible and it is 
possible, over time, for epimerisation to occur at this chiral centre allowing the 
more stable product (the equatorially substituted product) to form in a greater ratio 
over time. 
 
One of the ways this methodology has been utilised by the group is in the 
synthesis of 2,6-disubstituted tetrahydropyrans.105 
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Scheme 1.30: Previously completed synthesis of 2,6-disubstituted tetrahydropyrans by the group. 
Adapted from reference 105. 
 
The major stereoisomer (172a) seen from this previous synthesis was the syn-
disubstituted tetrahydropyran. This possessed both substituents in the equatorial 
position and was the thermodynamically preferred product. In order to 
demonstrate the effectiveness of this method and how it could be useful in other 
syntheses the major diastereoisomer (172a) was taken on to synthesise the civet 
cat compound (+)-2-((2S, 6S)-6-methyltetrahydro-2H-pyran-2-yl)acetic acid (176). 
In this synthesis the furanyl group was transformed via RuCl3 catalysed oxidative 
cleavage. 
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Scheme 1.31: Synthesis of the civet cat compound. Adapted from reference 105. 
 
This methodology has also been used in the synthesis of nitrogen heterocycles in 
the form of 2,6-disubstituted piperidines. The nitrogen atom in this heterocycle was 
protected using a tosyl group. Literature suggested that when an electron-
withdrawing group is located on the nitrogen atom, pseudoallylic strain dominated 
and caused the formation of the diaxial product.106 This effect was indeed seen 
during the course of these experiments, probably due to the nitrogen atom’s lone 
pair of electrons delocalising into the electron-withdrawing tosyl group. This 
resulted in a more planar arrangement with the two substituents in the 2 and 6 
positions being located axially, minimising steric hindrance with the bulky tosyl 
group.107  
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Scheme 1.32: Previously completed synthesis of 2,6-disubstituted piperidines by the group. 
Adapted from reference 107. 
 
The mechanism for the cyclisation and epimerisation in the piperidine synthesis is 
very similar to that seen for the 2,6-disubstituted tetrahydropyrans. Again the 
cyclisation step, under these acidic conditions, is reversible and this allows, over 
time, the furanyl group to facilitate the equilibration of the adjacent tosylamide 
chiral centre. 
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Scheme 1.33: Mechanism for the cyclisation and epimerisation of 2,6-disubstituted piperidines. 
 
With both the tetrahydropyran synthesis and the piperidine synthesis, the 
stereoselectivity is achieved through the epimerisation of the furanyl chiral centre 
and both are under thermodynamic control as the more stable product is the one 
that forms preferentially over time. This is achieved due to the reversibility of the 
cyclisation step through a reversible elimination-addition mechanism. 
 
 
 
 
 
Scheme 1.34: Elimination-addition mechanism in the synthesis of spiroketals by the group. 
 
This elimination-addition mechanism is something that was seen in the 2006 and 
2007 reported synthesis of spiroketals by the group. Again this was completed 
using the epimerisable nature of the furanyl chiral centre.108 The stereoelectronic 
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properties of spiroketals leads to their strong conformation preferences and this 
has given rise to their use as a scaffold in diastereoselective synthesis. The 
thermodynamically more stable isomer possesses substituents in the equatorial 
positions and a double anomeric effect is also seen in the compound. From this 
work diastereomeric ratios exceeding 98:2 were seen, favouring the compound 
that possessed a double anomeric effect and had all substituents located in 
equatorial positions (185). 
  
Scheme 1.35: Previous synthesis of spiroketals completed by the group. Adapted from reference 
108. 
 
Again to demonstrate the effectiveness of this method and its ability to be useful in 
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1.3.2. Aims 
• Development of the stereoselective synthesis of tetrahydropyrans through 
the use of an epimerisable furanyl chiral centre. This could be done in a 
number of ways:  
v Movement of the non-furanyl substituent. 
v Increase the number of substituents. 
• Development of a synthetic route to an organometallic coupling compound 
that could provide an alternative route to tetrahydropyrans, piperidines, 6,6-
spiroketals and 6,6-azaspiroketals. 
• Development of a functional continuous flow system in order to complete a 
number of reactions, where both the reaction step and the subsequent 
aqueous work-up is completed in flow. The resulting organic solution 
obtained would ideally comprise of only solvent and the desired product. 
This is something that is currently receiving much attention and is a very 
topical area of research. 
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2. Results and Discussion 
2.1. Working Towards the Synthesis of Azaspiroketals 
The first project that was undertaken looked at developing the spiroketal synthesis 
that had previously been completed within the group.108 The idea being to develop 
this methodology further and to construct a 6,6-azaspiroketal. 
 
In previous syntheses the stereocontrol that was achieved when constructing the 
spiroketal was very high and possessed both substituents in the equatorial 
position, whilst also exhibiting a double anomeric effect as shown in Scheme 1.35  
(Introduction). This was the expected result due to substituents generally favouring 
the equatorial position as the lowest energy conformation and also with the 
favoured lowest energy conformation of the 6,6-spiroketal possessing a double 
anomeric effect.109  
 
As demonstrated in previous work this was reliant on the epimerisation of the 
furanyl ether chiral centre over time to adopt the most favourable conformation via 
an elimination-addition mechanism as shown in Scheme 1.34 (Introduction). 
Despite the preference for the equatorial position when a ring has adopted a chair 
conformation, during the stereoselective synthesis of 2,6-disubstituted piperidines 
it was seen that substituents had a preference for the axial positions due to a 
steric clash with the bulky tosyl group that was bonded to the nitrogen atom in the 
heterocycle.107 
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Combining these previous works suggested that the synthesis of this compound 
could provide some interesting stereochemical results. Would the final product 
possess the double anomeric effect with substituents in the equatorial position 
(188b)? Would the furanyl group be in the equatorial location and the alkyl group 
on the piperidine ring be located in the axial position (188c)?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Theorised potential outcomes of the 6,6-aza-spiroketal formation. 
 
It wasn’t certain that the anomeric effect involving the nitrogen’s atom lone pair 
would be seen. This is because of the delocalisation of the nitrogen’s lone pair into 
the tosyl protecting group, meaning that it wouldn’t be available for use in the 
anomeric effect. Research into the literature showed that a tosyl-protected 
piperidine ring with a methoxy substituent in the 2-position had been synthesised 
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by Shono in 1984110 and also by Somfai in 1992.111 In both cases the 
stereochemistry of this compound is not discussed and it is difficult to determine 
the stereochemistry based on the NMR data provided.  
 
A literature search for similar 6,6-azaspiroketals yielded a paper by Sinibaldi and 
Canet from 2005.112 They synthesised a boc-protected 6,6-azaspiroketal with 
hydroxymethyl and ether substituents on the carbon adjacent to the oxygen atom 
and nitrogen atom respectively. Based on theoretical calculations the major 
diastereoisomer was reported as having a double anomeric effect, two equatorial 
substituents and the boc group in a pseudo-axial position. Further NMR 
experiments were conducted and nOe results obtained confirm the conformation 
of the spiro ring system.  
 
This could mean that, unlike in the piperidine synthesis performed by the O’Brien 
group, that a diequatorial product with a double anomeric effect would be seen in 
the aza-spiroketal product 188. However the difference between the boc and tosyl 
protecting groups could show that the stereochemical outcome could be 
influenced by the protecting group, something that could be exploited in 
stereoselective syntheses. 
		
Results	and	Discussion	–	Working	Towards	the	Synthesis	of	Azaspiroketals	 		 	
57	
 
Scheme 2.1: Retrosynthetic analysis to the 6,6-azaspiroketal 
 
The aza-spiroketal 188b could be synthesised from the commercially available, 
racemic piperidine (193). This was tosylated using p-toluenesulfonyl chloride, 
along with triethylamine and 4-aminodimethylpyridine (DMAP). This proved an 
effective reaction that yielded a crystalline product. The tosylated piperidine (194) 
was then oxidised using sodium periodate and a ruthenium catalyst using 
methodology that has been described previously in the synthesis of this compound 
by Occhiato as shown in scheme 2.2.113 
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Scheme 2.2: Tosylation and oxidation of starting piperidines. 
 
At this step of the reaction column chromatography using silica gel was required in 
order to purify the cyclic amide 191. This is because the ruthenium chloride 
catalysed oxidation did not go to completion even after six days. This gave rise to 
reaction yields of 33 – 41%. NMR analysis showed that some of the material that 
was obtained off the column was the unreacted tosylated piperidine. In an effort to 
increase the reaction yield the material was subjected to the reaction conditions 
again and was then again purified by column chromatography. These efforts 
increased the overall yield to 69%. 
 
Completing the reaction pathway using 2-methylpiperidine (193) would yield a 6,6-
azapiroketal where the methyl group is adjacent to the tosyl-protected nitrogen 
atom in the ring. In the group’s previous synthesis of 2,6-disubstituted piperidines 
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the methyl group ended up in an axial position and it was thought that this could 
happen here; however, were the methyl group to be located in an alternative 
position then A1,3-strain may not be an issue. This could mean that the methyl 
group would be located in the equatorial position. In an attempt to explore this 
possibility these two steps were completed starting from the commercially 
available 4-methylpiperidine (195) and the tosylation step was completed with the 
commercially available 3-methylpiperidine (198). These two compounds were not 
taken further along the synthetic pathway due to issues that were identified with 
the progression of tosylated lactam 191. 
 
Scheme 2.3: Attempted coupling of alkyne 192 with piperidinone 191 and subsequent 
deprotection. 
 
The next step in the reaction pathway was to couple the cyclised amide 191 to 
alkyne 192 in order to incorporate the furanyl chiral centre, as shown in Scheme 
2.3. This was based on a similar step from the diastereoselective synthesis of 
spiroketals reported in 2007 by the group114 and some of alkyne 192 had 
previously been synthesised and stored in the freezer. 1H-NMR analysis showed 
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that the compound hadn’t degraded and was still pure, meaning it was suitable to 
use in this project. An alternative product was formed during the course of this 
coupling reaction and, based on spectroscopic data gathered, the putative 
structure of 201 was proposed. 
 
Entry Solvent Base used Temperature Time Result 
1 THF 1.1 eqv. n-
BuLi 
−78°C 2 days Unsuccessful 
2 THF 1.5 eqv. n-
BuLi 
−78°C 2 days Unsuccessful 
3 THF over 
CaH2 
1.5 eqv. n-
BuLi 
−78°C 2 hours 191 consumed – 
possibly 201 
formed 
4 THF over 
CaH2 
1.5 eqv. n-
BuLi 
−78°C to 
−15°C 
2 hours 191 consumed – 
potentially 
successful 
Table 2.1: Summary of coupling conditions used with the tosylated piperidinone 191 and furanyl 
alkyne 192. 
 
A number of attempts were made to synthesise compound 200 and the conditions 
tested are summarised in Table 2.1. The material produced from entry 4 was 
analysed and this showed a more promising result than had been seen before. In 
the group’s previous synthesis of spiroketals the furanyl alkyne (186) underwent a 
coupling reaction, hydrogenation, deprotection and cyclisation without any 
purification107 and it is this that encouraged the tentative progression of this 
coupled material without further purification. 
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The next step of the reaction attempted the deprotection of the hydroxyl group. 
This was achieved using tetrabutylammonium fluoride (TBAF). This is the most 
commonly used method to deprotect silyl ethers and has been used in numerous 
syntheses.115 This is due to it being a fluoride source that is readily soluble in 
organic solvents and the conditions required for this deprotection means that many 
other functionalities are not affected. The crude yield over these two steps was 
29%.  
 
Scheme 2.4: Hydrogenation and cyclisation steps required to complete the 6,6-azaspiroketal 
synthesis. 
 
Hydrogenation of the C-C triple bond to a C-C single bond was attempted on the 
crude material obtained after the deprotection. This was done using a Pd/C 
catalyst, allowing for complete reduction of the alkyne functionality to the saturated 
alkane. The alkene was not observed as it was also hydrogenated under these 
conditions.116  
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Upon completion of the reaction and subsequent work-up the crude material was 
immediately subjected to acidic conditions in d-chloroform in order to affect the 
spiro-fused product; however the NMR spectra were not consistent with the 
desired product. After one day no change was seen in terms of approaching an 
aza-spiroketal but the material started to degrade and data suggested that the 
azaspiroketal had not been successfully synthesised. 
 
Concurrent work within the group on similar systems suggested that the 
hydrogenation reaction was highly dependent on timing. In these studies it was 
found that, following alkyne hydrogenation, the furanyl group itself was also being 
hydrogenated at a significant rate. 
 
Due to the problems encountered with the hydrogenation step it was considered 
for use in flow chemistry (see section 2.6.). In flow chemistry it is far easier to 
control the contact time between the solution and the hydrogen gas. This means 
that the contact time can be far more finely tuned and hopefully will allow for the 
hydrogenation of the alkyne bond without affecting the furanyl group. This reaction 
has not yet been completed but is an avenue of investigation that will be explored 
in the future. At the same time as investigating this reaction, work began exploring 
the development of a 4-furanyl-4-hydroxyorganometallic coupling partner based on 
work done by Katritzky that would allow an alternate route for tetrahydropyran and 
piperidine synthesis. Focus shifted onto the development of this coupling partner 
due to its possible versatility and use in a number of potential future projects and 
so the aza-spiroketal synthesis has yet to be investigated further. 
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2.2. Development of a 4-furanyl-4-hydroxy-
Organometallic Coupling Partner 
Organometallic reagents are versatile and powerful tools in synthetic organic 
chemistry,117 which are commonly used in reactions with carbonyl compounds 
(including lactones).118 When adding to aldehydes and ketones the carbonyl group 
is transformed to a hydroxyl group. Esters are also commonly used with 
organometallic coupling partners (with this there is the possibility of double 
addition) as are imines.119 There are two issues seen when using imines in these 
reactions. The first is that imines (and carbonyl compounds) can enolise, or 
undergo a reduction in the presence of a Grignard reagent, rather than the desired 
nucleophilic addition. 
 
Work on the competing reactions in a carbonyl system were examined by Mosher 
and Cowan in 1962.120 The presence of an acidic proton on the α-carbon means 
that the basic Grignard reagent can remove it to generate the enolate anion (from 
carbonyls) or the aza-enolate anion (from imines). Hydrolysis of this anion 
regenerates the original starting ketone. The nucleophilic addition reaction is 
usually the more rapid reaction but this competing process can still be seen. If the 
Grignard reagent possesses a β-hydrogen then it is able to act as a reducing 
agent in a competing process to the desired nucleophilic addition. This reduces 
the carbonyl to the corresponding alcohol or the imine to the corresponding amine 
whilst the Grignard reagent forms an alkene (205).120 This is known as the 
Meerwein-Pondorff-Verley reduction,121 though typically it is achieved with an 
aluminium catalyst.122 
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Scheme 2.5: Reduction reaction that can be seen competing with the nucleophilic addition of a 
Grignard reagent when a β-hydrogen is present on the Grignard reagent.   
 
Another issue seen when using imines is the poor electrophilicity of the carbon in 
the C=N bond. Due to this the electrophilicity often needs to be increased for these 
reactions and this can be achieved through the alkylation, acylation, oxidation or 
sulfonylation of the nitrogen atom.123 The activating group can then be cleaved 
after the reaction has taken place to garner the free amine. Another route to 
achieve this is to activate the imine through co-ordination with a Lewis acid.124 
 
The idea behind this project was to use the knowledge of these reactions involving 
organometallic reagents and use them to synthesise a diol or hydroxylamine 
through reactions with lactones, ketones, aldehydes and sulfonylated imines. 
These could then, under acidic conditions, cyclise to produce the corresponding 
heterocycle. To ensure stereoselectivity the organometallic compound that was 
envisioned would contain a furanyl chiral centre, adjacent to one of the hydroxyl 
groups that would participate in the cyclisation, and this could epimerise under the 
acidic conditions, hopefully giving high levels of stereoselectivity. The 
organometallic reagent would therefore be utilised, as the key component, in a 
number of syntheses (see Scheme 2.6). 
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Scheme 2.6: Potential uses for the organometallic coupling partner. ‘P’ refers to a protecting 
group. 
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The synthetic route designed for the synthesis of this Grignard reagent began with 
commercially available 5-methylfurfural (222). The plan was to convert the 
aldehyde to a ketone using a masked acyl anion approach – an umpolung 
approach. The conversion of aldehydes to ketones via this method is something 
that has been explored by Katritzky and co-workers. They showed that 
benzotriazole is useful as an effective activating and leaving group.125 An 
umpolung route utilising cyanohydrins could also be considered in the future.126 
 
 
 
 
 
 
Scheme 2.7: Reaction of 5-methylfurfural (222) to yield the benzotriazole adduct 225. 
 
Katritzky had used furfural as one of the aldehydes and he reported that the 
compound was easily converted to the corresponding benzotriazole adduct in 
three hours stirring at room temperature. Katritzky also reported on a number of 
substituted benzaldehydes and how, unlike the five-membered heterocyclic 
compounds, these were stirred for three hours and then refluxed for ten hours.  
 
Entry Aldehyde Time Temperature Result 
Reported Furfural 3 hours rtp Successful 
1 5-methylfurfural 5 hours rtp No reaction 
2 5-methylfurfural 15 hours Reflux 3:1 mixture of product 
and impurity 226 
Table 2.2: Reaction conditions used to obtain benzotriazole adduct 225. 
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Figure 2.2: Theorised acetal impurity formed during the formation of benzotriazole adduct 269. 
 
Benzotriazole adduct 225 proved to be unstable with regards to column 
chromatography, heat and deuterated chloroform. Due to the inability to purify this 
material via column chromatography, an alternative approach was sought. 
Dissolving the crude product in petroleum ether yielded a solution that contained 
compound 225 along with a crystalline material. Upon further investigation this 
was found to be benzotriazole (223). The trace quantity of triethyl orthoformate 
(224) that was also present in the solution was taken through to the next stage of 
the synthetic pathway. 
 
The next stage of using this umpolung approach was to use a strong base in order 
to deprotonate the benzotriazole adduct 225 and react this with a relevant 
electrophile before hydrolysis of the hemiaminal to reveal the carbonyl group. 
 
Scheme 2.8: Formation of bromoketone 229. 
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Deprotonation was achieved through the use of n-butyl lithium solution (2.5 M in 
hexanes) and the electrophile used was 1,3-dibromopropane (227). This 
incorporated the correct number of carbon atoms to synthesise a six membered 
heterocycle after the Grignard coupling reaction. It also incorporated a bromine 
atom that could be used to form the Grignard reagent. 
 
Hydrolysis of the hemiaminal to reveal the carbonyl group was achieved under 
acidic conditions. Initially hydrochloric acid was used to achieve this 
transformation. Unfortunately after column chromatography no fractions 
corresponded to ketone 229. The crude 1H-NMR spectrum of this material showed 
the presence of benzotriazole, triethyl orthoformate, ethanol and a compound that 
contained an aldehyde peak, which may have been 5-methylfurfural. 
 
Due to the lack of success upon using hydrochloric acid an alternative was tested. 
Polymer-supported sulfonic acid offered both a slightly weaker acid and also a 
greatly simplified work-up procedure. Intermediate 228 was dissolved in a 4:1 
mixture of THF and water, to which the polymer-supported acid was added. After 
two hours the reaction had gone to completion. The crude 1H-NMR showed the 
desired compound with benzotriazole present and the trace of triethyl orthoformate 
that had been brought through. After purification, ketone 229 was obtained in 73% 
yield. 
 
Once the ketone had been successfully synthesised the next step was reduction to 
the alcohol, followed by protection of the hydroxyl group. A variety of reducing 
agents are available for this transformation, along with a multitude of protecting 
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groups. Initially the reduction was trialed with sodium borohydride.127 This reaction 
was successful but gave low yields. 
 
Despite this enough material was amassed to test protecting the alcohol. The 
protection method chosen was to form the tert-butyldimethylsilyl ether. This was 
selected because: it is stable to a variety of conditions, including those of Grignard 
formation and because it can easily be removed.128 
 
Initially the conditions used for this reaction matched those of Corey in 1972, using 
imidazole to increase the rate of reaction. The imidazole reacts with the silyl 
reagent to produce a more reactive compound, (in this case tert-butyldimethylsilyl 
imidazole), which then reacts with the alcohol.129 However, substoichiometric 
quantities of 4-dimethylaminopyridine (DMAP) were required for a successful 
reaction in seven hours, rather than two days without. 
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Scheme 2.9: Formation of tert-butyldimethylsilyl imidazole and the subsequent protection of an 
alcohol. Adapted from reference 129. 
 
Both of these steps gave low yielding results. Evidence from spectroscopic data 
implied that a side reaction was occurring during the reduction step, where the 
alkoxide that formed, engaged in an intramolecular 5-exo-tet ring closure resulting 
in product 235. Evidence suggested that this was a volatile compound and it could 
easily be removed. This compound was synthesised by Harwood and Robertson 
in 1987, through the cyclisation of 4-(2-furanyl)-1-butanol and derivatives in DDQ 
and dioxane (no spectroscopic data was provided).130  
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Scheme 2.10: Potential mechanism for the theorised impurity seen during the reduction of 
bromoketone 229. 
 
Due to the low yields seen alternative approaches were examined. DIBAL-H (24) 
and Red-Al (sodium bis(2-methoxyethoxy)aluminium hydride) were tested. 
 
Entry Reducing 
agent 
Solvent Temperature Time Result 
1 NaBH4 MeOH −15 °C 1 hour 20% yield 
2 DIBAL-H THF −78 °C 7 hours 58% yield 
3 Red-Al THF −78 °C 10 mins Taken through crude 
Table 2.3: Reduction reactions tested with bromoketone 229. 
 
These gave low to moderate yields and the material was protected in the manner 
described previously to look at the yields over two steps. One pot reactions were 
also tested and the results are summarised in Scheme 2.11. 
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Scheme 2.11: Summary of reactions tested to obtain the TBS-protected alcohol 237. 
  
Due to consecutively low yields seen regardless of reducing agent, an alternative 
protecting group was reviewed. The incorporation of a methyl-protecting group, 
producing the corresponding methyl ether, was investigated. The reaction was 
completed using methanol and polymer-supported sulfonic acid. This reaction 
proved unsuccessful and one possibility was that methanol was being eliminated 
from the desired product, resulting in compound 239. 
 
 
 
 
229
NaBH4, MeOH,
0°C - rt
30 mins, 33%
TBS-Cl, DMAP,
imidazole,
THF, 7 hours, 
22%
DIBAL-H (24),
THF, −78°C,
1 hour 
then imidazole,
DMAP, TBS-Cl,
0°C, 3 days, 14%
Red-Al, 
THF,
−78°C
10 mins,
TBS-Cl, DMAP
imidazole, THF,
7 hours,
17% over 2 steps
Red-Al, THF
−78°C, 4 hours
then imidazole,
DMAP, TBS-Cl,
0°C, 3 days,
24%
O
Br
O
236
OH
Br
O
237
OTBS
Br
O
236
OH
Br
O
237
OTBS
Br
O
		
Results	and	Discussion	–	Development	of	a	4-furanyl-4-hydroxy	Organometallic	Coupling	Partner	 		 	
73	
 
 
 
 
 
 
 
 
 
Scheme 2.12: Attempted conversion of a hydroxyl group to a methoxy group under acidic 
conditions. 
 
At this point in time other protecting groups were not looked at, but rather the 
protected material 237 that had been successfully synthesised was used in an 
attempt to form a Grignard reagent and coupled with a commercially available 
aldehyde. 
 
Grignard formation is a well-known and widely utilised tool and it has been 
proposed that it is a non-chain radical reaction. The theorised mechanism is 
initiated through a single electron transfer from the exposed magnesium surface to 
the organic halide. This yields a radical anion that is associated with the radical 
cation of the surface magnesium. The magnesium acts as a Lewis acid and it is 
able to co-ordinate and add stabilisation to the complex.131 
 
Iodine is known to be a catalyst in the formation of Grignard reagents. One thought 
behind this is that the iodine cleans the surface of the magnesium. Another theory 
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is that the iodine forms magnesium (I) iodide in situ and this is the catalytic species 
of the reaction.132 Much investigation has occurred to determine the mechanism of 
this proposed catalysed reaction and the currently accepted mechanism is shown 
in Scheme 2.13.  
 
 
 
 
 
Scheme 2.13: Formation of Grignard reagent utilising an iodine catalyst. 
 
Grignard formation was attempted with an iodine catalyst and after this, an attempt 
was made to couple the subsequent Grignard reagent with octyl aldehyde (240). 
After one day no reaction was seen and this may be due to the small scale that the 
reaction was attempted on as Grignard reactions are well-known for being low-
yielding and difficult to complete.132 
 
Scheme 2.14: Attempted Grignard coupling. 
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was increased to 7% but this is still quite low and alternative routes to suitable 
Grignard reagents could be developed. 
 
It was thought that one of the reasons for the low yield seen was the possibility of 
an intramolecular reaction to forge the tetrahydrofuran 235. One of the methods by 
which that could be avoided was to not have the halide atom present at the start of 
the reaction pathway and instead make use of an Appel-type reaction to 
incorporate this functionality from the alcohol precursor.  
 
The advantage to this new route was that all of the steps involved were similar to 
well-known reactions that produced high yields, theoretically allowing easy access 
to a large quantity of material to convert to the Grignard reagent. The halide also 
wouldn’t be introduced to the molecule until the free alcohol was protected, 
meaning that cyclisation of the compound should not be seen. 
 
Scheme 2.15: Retrosynthesis of 4-furanyl-4-methoxybutyl iodide. 
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The first step in this pathway involved a reaction between 2-methylfuran (245) and 
γ-butyrolactone (246). The 2-methylfuran was purified prior to any reaction 
occurring.  
 
Scheme 2.16: Procedure followed to achieve 250. 
 
The idea behind the reaction was to lithiate the 2-methylfuran (245) at the 5-
position then allowing it to react with γ-butyrolactone (246), opening the lactone 
ring and producing the furanyl ketone 244. There was some literature basis for this 
reaction. In 2006 Guo reacted furan with γ-butyrolactone in 74% yield133 and in 
2007 the Nicolaou group reported this reaction in the synthesis of a ring system of 
maitotoxin in a 58% yield.134 In both these cases an unsubstituted furanyl 
compound had been used; however Nicolaou had performed the same reaction 
with a substituted furan and an acyclic compound possessing a C=O bond. This 
gave a 91% yield and demonstrated that a substituent in the 2-position would not 
hinder the reaction. Further research into the literature demonstrated that there 
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were a large number of C-2 substituted furans that had been lithiated at the 
relatively acidic C-5 position using both n-butyl lithium solution or lithium 
diisopropyl amide.135 
 
Upon completion of the reaction, it was apparent that an impurity was present 
alongside the desired compound. Spectroscopic data was gathered on the 
impurity and this led to the belief that the compound was the cyclised form, 2-(5-
methylfuran-2-yl)tetrahydrofuran-2-ol (247). Both compounds demonstrated good 
stability and it was decided to take the crude mixture through the next two steps 
and then purify, to allow for an easier separation. 
 
With the furanyl ketone in hand attention turned to protecting the primary alcohol. 
This is because in the coming steps the ketone will be reduced to the secondary 
alcohol and protected in the form of a methyl ether. The protection of the primary 
alcohol needed to happen before this, due to selectivity issues that would be seen 
if this were not done. 
 
Protection of the primary alcohol was achieved using benzoyl chloride and DMAP. 
Compounds 244 and 247 were both protected and taken through to the next step 
crude. This was because only the desired compound 248 would be reduced to the 
alcohol, greatly simplifying the separation of these two compounds. 
 
The reduction was completed using sodium borohydride and went to completion 
within forty minutes. Purification by column chromatography removed the cyclised 
impurity (249), though this was not successfully isolated meaning that the identity 
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of this compound is not definite. The yield of pure desired material at the end of 
this reaction was 8% over three steps. However, approximately half of the 
potential yield was lost to the cyclic impurity. 
 
As this step was at the start of the synthesis pathway, it meant that the initial 
reactions could be conducted on a larger scale, to accumulate more material due 
to the low yield. The three reactions were repeated on a four times larger scale 
and this gave a 15% yield over the three steps. A third batch of material was 
brought through also giving a 15% yield over three steps. This is likely due to 
becoming more familiar with the column conditions and the relevant work-ups.  
 
One potential change that could be attempted in the future is completing the 
reduction reaction using DIBAL-H. In the previously attempted Grignard reagent 
synthesis DIBAL-H (24) gave a higher yield than use of sodium borohydride and it 
would be interesting to see whether that would be mirrored in this synthesis; 
however the potential difficulty of removing the DIBAL-H by-products may mean 
that this is not an effective route after all.  
 
 
 
 
Scheme 2.17: Conversion of the hydroxyl group to the methyl ether. 
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butyldimethylsilyl ether again but conversion to the methyl ether was completed in 
less than a day and did not require any substantial work-up or purification because 
polymer supported sulfonic acid was used and this polymer could just be filtered 
off at the end of the reaction. The use of these polymer-supported compounds in 
organic synthesis is something that is becoming increasing popular and due to the 
ease of work-up it is easy to see why this is the case.136 
 
The reaction was completed in 5 hours and provided pure 251 after filtering the 
polymer-supported acid. All three batches of material were brought through this 
step. 
 
 
 
 
Scheme 2.18: Removal of benzoate ester through base hydrolysis. 
 
The benzoate ester was cleaved using alkaline hydrolysis. Once all the material 
had undergone this process, the Appel-type reaction was investigated, in order to 
convert the primary alcohol in 243 to the iodide 242. 
 
 
 
 
Scheme 2.19: Conversion of primary alcohol 243 to the corresponding iodide 242. 
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The Appel-type reaction uses triphenylphosphine (252), typically with a 
tetrahalomethane (such as CCl4); however the reaction can be performed using 
iodine rather than tetraiodomethane. Triphenyphosphine oxide (260) is a by-
product of this reaction and it is the production of this strong P=O bond that drives 
the reaction to completion.  
 
The reaction conditions followed are based on work completed by Garegg and 
Samuelsson in 1980.137 They looked at the conversion of hydroxyl-groups into 
iodo-groups in carbohydrates that were achieved with an inversion of 
configuration. The paper also puts forward a theorised mechanism that imidazole 
is not only present to neutralise the iodic acid that forms but to form a reactive 
intermediate with the triphenylphosphine (252).  The mechanism for this 
transformation, along with the generally accepted mechanism for an Appel-type 
reaction is shown in Scheme 2.20.  
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Scheme 2.20: Mechanism for the Appel-type reaction. On the left is how imidazole can form a 
reactive intermediate phosphine species. 
 
Due to the wide-ranging uses of organic halides the Appel reaction and Appel-type 
reactions have received much interest with a lot of effort being invested into 
making the reaction more efficient. One method has been to deviate away from 
the Appel-reaction and to investigate reactions that perform the same 
transformation but without the production of such high levels of undesired material 
(the triphenylphosphine oxide). Another method has been to look at recycling the 
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phosphine oxide by-product, meaning that it can be used to regenerate the active 
species. 
 
In 2014 the Denton group reported their advancement in regards to this 
reaction.132 Rather than using triphenylphosphine and tetrahalomethane the group 
looked at using polystyrene bound phosphine oxide (262). Using the 
corresponding oxalyl halide it is possible to convert the phosphine oxide to the 
halophosphonium salt (263). This meant that when the phosphine oxide is 
regenerated by the end of the reaction it could be recycled under the reaction 
conditions and there is no need for a difficult reductive step as is seen with 
previous examples using a supported or polymeric phosphorus reagent. As an 
added benefit the only by-products of converting the bound phosphine oxide to the 
halophosphonium salt are carbon monoxide and carbon dioxide. 
 
 
 
 
 
 
 
 
Scheme 2.21: The Denton group’s use of polystyrene-bound phosphine oxide in the Appel-type 
reaction. Adapted from reference 138. 
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the material needed to be purified by column chromatography before the pure 
iodide was obtained. Despite this the yield of the reaction was 57%. Unfortunately 
iodo-compound 242 wasn’t very stable and the material decomposed overnight 
even after being stored in the freezer. Because of this the remaining material was 
kept as the furanyl alcohol 243 as this had shown no signs of decomposition and 
will be brought through to the iodide (242) as needed.  
 
One of changes that had been made to the Grignard reagent in this synthetic 
pathway compared to the previously attempted Grignard reagent is that this would 
form the magnesium iodide rather than the magnesium bromide. This was done 
despite bromide Grignard reagents being more widely available and generally 
being thought of as being easier to handle.139 The reasoning behind this was that it 
is easier to form the Grignard reagent from the iodide compared to the bromide. 
This is based on the bond strength. The carbon-iodide bond is weaker than the 
carbon-bromide bond.140 
 
Another benefit to using the iodide is that it should allow easy access to the 
lithiated species through use of tert-butyl lithium at low temperatures. This could 
then go on to be used as an organometallic reagent to couple with 
aldehydes/ketones/imines/etc. (see Scheme 2.6) or could undergo a 
transmetallation reaction. Due to the presence of the methyl group on the furanyl 
ring the t-BuLi won’t deprotonate at that site, meaning that the reaction should 
proceed without the formation of any undesired compounds. 
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The conversion of iodide 242 to the Grignard reagent was not attempted due to 
the decomposition of the synthesised material. The remaining material is still at the 
furanyl alcohol stage (243) and is stored in the freezer at −20°C and currently 
shows no signs of decomposition. This will be converted to the iodide, purified by 
column chromatography and immediately reacted to form the organometallic 
compound and will then take part in the subsequent coupling reagent at a later 
date. 	
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2.3. Stereoselective Synthesis of 4-aryl-2-furyl 
Tetrahydropyrans 
Previous work in the O’Brien group had established a stereoselective route to 2,6-
disubstituted tetrahydropyrans. The idea used in this synthesis was that the furanyl 
chiral centre would epimerise under acidic conditions to give the more stable 
configuration over time (i.e. the thermodynamic product). This concept was one 
that could be utilised in the synthesis of 2,4-disubstituted tetrahydropyrans; 
however this synthetic route would have to be different in order to garner the 
desired substitution pattern.  
 
Scheme 2.22: Conceptual idea for the synthesis of 2,4-disubstituted tetrahydropyrans. 
 
The conceptual idea of this synthesis was the development of a 1,5-diol 
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acidic conditions and, using the existing, non-epimerisable centre at the 4-position 
of the tetrahydropyran, provide stereoselectivity under thermodynamic control. The 
reaction would therefore ideally afford a preferred product diastereoisomer from a 
stereorandom mixture of diols. In theory the favoured tetrahydropyran 
diastereomer would place both substituents in the equatorial position on the chair 
conformation (269). The inclusion of the furanyl group is advantageous as it both 
facilitates the acid catalysed epimerisation allowing the stereoselectivity and also 
sets the molecule up for an array of possible future transformations (as highlighted 
in Scheme 1.28). 
 
Scheme 2.23: Retrosynthetic analysis of 2,4-disubstituted tetrahydropyrans. 
 
The first step in this synthetic route was to synthesise a series of chalcones (272a-
q) that could be taken through a number of steps to yield the tetrahydropyran 
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(274) or 5-methyl-2-acetylfuran (275). This reaction was completed in methanol 
and base catalysed by employing 5% sodium hydroxide solution.  
 
The Claisen-Schmidt condensation is catalysed by base due to the acidic nature of 
the α-hydrogens of the enolisable carbonyl compound (i.e. 274 or 275 in this 
case). The nucleophilic enolate ion that forms can then add to the second carbonyl 
compound, which possesses electrophilic reactivity.143 The initial product of this 
reaction is the β-hydroxycarbonyl compound. This reaction is reversible but under 
these reaction conditions a subsequent E1cb reaction can be seen producing the 
α,β-unsaturated compound. This elimination of water shifts the position of 
equilibria and favours product formation.144 
 
Pivalaldehyde was also used to incorporate the tert-butyl functionality and furfural 
and 2-methylfurfural were used to introduce a second furanyl group. These were 
potentially interesting compounds that did not possess the enolisable proton on 
the α-carbon, meaning they were suitable for this reaction. The yields seen from 
this ranged from low to very high and this was dependent on which aldehyde was 
employed. The substituted benzaldehydes all gave yields that exceeded 70%. It 
was when using alternative aldehydes that the lower yields were seen. In the 
cases where pivalaldehyde was used this is likely due to the loss of the highly 
conjugated system that is seen when substituted benzaldehydes are used.  
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Scheme 2.24: Chalcone formation via a Claisen-Schmidt condensation. 
 
Entry Compound R1 R2 Yielda 
1 272a C6H5 H 80% 
2 272b 4-C6H4-Cl H 85% 
3 272c 4-C6H4-OMe H 72% 
4 272d 4-C6H4-CH3 H 82% 
5 272e 3,4-C6H3-(OMe)2 H 75% 
6 272f 4-C6H4-Br H 95% 
7 272g 2,4,5-C6H2-(OMe)3 H 77% 
8 272h 4-C6H4-Br Me 80% 
9 272i C6H5 Me 71% 
10 272j 4-C6H4-CH3 Me 71% 
11 272k 4-C6H4-Cl Me 85% 
12 272l Tert-butyl H 20% 
13 272m Furan H 15% 
14 272n Furan Me 51% 
15 272o Methylfuran H 62% 
16 272p Methylfuran Me 62% 
17 272q 2-C6H4-Cl H 68% 
a: Isolated yield after purification either via recrystallisation from hot ethanol or via column chromatography. 
Compounds 272a-e and 272q were synthesised by Dr O’Brien. 
Table 2.4: Chalcones produced for the synthesis of 2,4-disubstituted tetrahydropyrans. 
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All chalcones were purified by recrystallisation from hot ethanol, except 
compounds 272l and 272q, which did not recrystallise and so were purified via 
column chromatography using dichloromethane as the solvent. Due to the low 
yields for 272l-p seen, it was only 272a-k that were taken through to the 
tetrahydropyran product. 272q was taken through the synthetic route; however 
issues were seen throughout the process in terms of successful purification and so 
the use of this compound was limited. 
 
The next step of the reaction sequence involved a Michael addition of dimethyl 
malonate (276) to the chalcones to yield the relevant keto-diesters (271a-k).  
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Scheme 2.25: Michael addition of dimethyl malonate using sodium hydride. 
 
Entry Compound R1 R2 Yielda 
1 271a H H 60% 
2 271b 4-Cl H N/A* 
3 271c 4-OMe H 49% 
4 271d 4-CH3 H 59% 
5 271e 3,4-OMe H N/A* 
6 271f 4-Br H N/A* 
7 271g 2,4,5-OMe H N/A* 
8 271h 4-Br Me N/A* 
9 271i H Me N/A* 
10 271j 4-CH3 Me N/A* 
11 271k 4-Cl Me N/A* 
a: Isolated yields after purification via column chromatography. 
*: These compounds were not purified at this stage but rather taken through the next stage of the reaction and a yield 
calculated over both steps then. 
271g was synthesised by Dr O’Brien. 
 
Table 2.5: Michael addition products from the synthesis of 2,4-disubstituted tetrahydropyrans. 
 
O
O
R2
R1
O
O O
OO
O
R2
R1
O
O O
O
276
272a-k
271a-k
Sodium hydride,
THF, -18°C,
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Michael addition reactions are facile and occur where a nucleophilic species adds 
across an activated, electrophilic alkene/alkyne. The reaction is base facilitated. In 
the example shown in Scheme 2.25 the base deprotonates the dimethyl malonate 
to generate the enolate anion and this reacts with the chalcone in a conjugate 
addition reaction. Upon workup a proton is transferred to generate the keto-diester 
271. The nucleophile attacks at the β-carbon because there is a preference for 
1,4-conjugate addition compared to a 1,2-conjugate addition.145 This preference 
for attack at the β-carbon can also be explained by the “hard and soft acids and 
bases principle” (HSAB principle). This principle was propounded in 1963 by 
Pearson146 and classifies chemical species as either hard or soft. Hard species 
possess small atomic radii, high effective nuclear charges and low polarisability. 
The reverse is true for soft species. The HSAB principle states that acids show a 
greater affinity for bases of the same class and a hard-soft combination is 
destabilised.147 In the case detailed in Scheme 2.26 the organic donor atom is the 
carbon atom, which is a soft base. This is because the electron density is spread 
out, meaning that there is less electrostatic stabilisation. Based on the HSAB 
principle this soft base will attack preferentially at the soft acid site in the chalcone 
compound over the hard species (soft species = C-C double bond; hard species = 
carbonyl group). 
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Scheme 2.26: Mechanism of the conjugate addition of dimethyl malonate to the starting chalcones 
(272a-k). 
 
Though this reaction went to completion and yielded the desired keto-diester there 
was always the issue of mineral oil being present in the NMR spectra. This came 
from the sodium hydride and analysis using TLC showed that the mineral oil eluted 
very closely to the desired product despite a number of solvents being tested. 
Excess dimethyl malonate was also present at the end of the reaction. Rather than 
purify the crude material at this stage it was taken through a Krapcho 
decarboxylation to yield the keto-ester.  
 
Although this method was successful and was used in the initial synthesis of these 
compounds the residual presence of mineral oil was always noted. Column 
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chromatography was always an option to purify this material, but it would be 
preferential to avoid this, especially on larger scales, to minimise the cost and time 
of the synthetic route. Due to this an alternative method for the Michael addition 
was sought.  
 
With this in mind methodologies within the literature were examined and a method 
described by Rosnati and co-workers in a 1981 paper seemed promising.148 The 
paper described the reactions of phenolic Michael donors with α-bromo Michael 
acceptors using potassium carbonate. This is something that has also been 
achieved under solvent free conditions using a technique known as high-speed 
vibration milling (within the reaction vessel is placed a number of stainless steel 
balls and these are vigorously agitated).149 Due to a lack of the necessary 
machinery it was not possible to utilise a high-speed vibration milling method; 
however this did show that the reaction being attempted with very similar starting 
compounds was possible.  
 
Scheme 2.27: Conjugate addition using potassium carbonate. 
 
Rosnati’s methodology was applied on the scaled up conjugate additions and 
proved very effective. Initially compounds were purified by column 
O
O
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R1
O
O O
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chromatography and all yields exceeded 65%. However, column chromatography 
proved unnecessary as the excess dimethyl malonate would undergo the Krapcho 
decarboxylation in the next step of the reaction sequence, yielding the volatile 
product methyl acetate. This compound would be far easier to remove and 
wouldn’t necessitate column chromatography. The Krapcho decarboxylation was 
used to remove one of the ester functionalities from compounds 271a-k, yielding 
the keto-ester product (270a-k). 
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Scheme 2.28: Krapcho decarboxylation of keto-diesters. 
 
Entry Compound R1 R2 Yielda 
1 270a H H 46% 
2 270b 4-Cl H 6%* 
3 270c 4-OMe H 10% 
4 270d 4-CH3 H 29% 
5 270e 3,4-OMe H 14%* 
6 270f 4-Br H 12%* 
7 270g 2,4,5-OMe H 45%* 
8 270h 4-Br Me 25% 
9 270i H Me 16%* 
10 270j 4-CH3 Me 15%* 
11 270k 4-Cl Me 13%* 
a: Isolated yields after purification via column chromatography. 
*: Yields calculated are over two steps – the Michael addition and the Krapcho decarboxylation. 
270g was synthesised by Dr O’Brien. 
 
Table 2.6: Krapcho decarboxylation products from the 2,4-disubstituted tetrahydropyran synthesis. 
 
MeO O
OO
OMeO
R2
R1
MeO O
OO
R2
R1
5:1 DMSO:H2O,
40 eqv. LiCl, 110°C,
5 days, 
46%
271a-k
270a-k
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In 1967, Krapcho reported on a novel synthetic procedure that transformed 
geminal dicarbethoxy compounds into the corresponding ethyl ester.150 This was 
achieved using sodium cyanide in dimethyl sulfoxide (DMSO) and heating to 
reflux. The reaction gave good yields, though in one example stated the product 
yield was 25%; however they recovered a yield of 60% for the starting material. 
 
Despite the usefulness and efficiency of this reaction, alternatives to sodium 
cyanide were investigated.  In 1973, Krapcho detailed a reaction to convert 
geminal diesters to the corresponding ester using sodium chloride in wet 
DMSO.151 This removed the need for sodium cyanide and replaced it with an 
alternative that was easy-to-handle and cheap. In all cases the yields reported 
were above 85% but the amount of water added to wet the DMSO varied 
depending on the substrate. This averaged out at around 2 moles of water per 
mole of diester.  
 
 
 
  
 
 
 
 
 
Scheme 2.29: Mechanism of the Krapcho decarboxylation reaction using a chloride anion and 
271a as substrate examples. 
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When using a chloride salt with a diester (271a) the chloride anion attacks the 
alkyl group of one of the esters in a SN2 reaction to yield the intermediate 279. As 
this is a SN2 reaction larger ester groups can affect the rate of reaction. The 
methyl ester proceeds relatively rapidly as it is a relatively small group, whereas a 
bulkier substituent would decrease the rate of reaction. Intermediate 279 then 
loses a molecule of carbon dioxide to yield the enolate anion 280 that is 
protonated by water to yield the desired product (270a-k).152 
 
A series of chloride salts and solvent systems were tested for use in the Krapcho 
decarboxylation.  
 
Entry Solvent System Salt Result 
1 DMSO 1:1 NaCl:LiCl 21% over 2 steps 
2 DMSO NaCl No reaction 
3 DMSO LiCl 35% over 2 steps 
4 5:1 DMSO:H2O NaCl No reaction 
5 5:1 DMSO:H2O LiCl 45% over 2 steps 
Table 2.7: Solvent systems and salts tested for the Krapcho decarboxylation. 
 
After the Krapcho decarboxylation, an average yield of 26% was seen. This yield 
was over two steps (malonate addition and subsequent decarboxylation), but this 
was still relatively low. The key reason for the low yields being seen was based on 
one of the impurities seen from the Krapcho reaction. Upon purification by column 
chromatography the main impurity seen from this reaction was isolated. This 
impurity was isolated in yields of about 25% and 1H-NMR analysis showed that 
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this was the corresponding chalcone. Crude 1H-NMR after the Krapcho reaction 
had taken place showed ratios of 3:1 and in some cases 3:2 of desired product 
and chalcone.  
 
Due to the chalcone being reformed in such high yields an alternative route was 
investigated. The first step in this alternative pathway was to convert the diester 
271a to the corresponding diacid 281. This was achieved using base hydrolysis 
with 1M potassium hydroxide, followed by acidification with HCl. This reaction 
went in a moderate yield of 44%. This compound was then heated in DMSO for 12 
hours to lose a molecule of carbon dioxide. This should have yielded the 
carboxylic acid 282 that in theory could then have been taken to the next step of 
the synthetic route and reduced to the 1,5-diol; however the 1H-NMR of this 
material showed the presence of the original starting chalcone and also seemed to 
have degraded as a number of impurities were seen by 1H-NMR and TLC. 
Coupled with this was the fact that the impure material obtained at the end of this 
two-step reaction process was only a 19% yield, one that was lower than seen in 
the original Krapcho decarboxylation step. 
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Scheme 2.30: Route investigated as an alternative to the Krapcho decarboxylation step. 
 
Due to this no alternative route was used; rather all the keto-diesters (271a-k) 
were transformed to the corresponding keto-ester (270a-k) using the Krapcho 
decarboxylation method and the recovered chalcone material was stored and 
recycled. 
 
Upon obtaining the purified keto-ester the aim was to convert this to the 
corresponding 1,5-diol in the penultimate step of the reaction sequence. 
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Scheme 2.31: Lithium aluminium hydride reduction of keto-esters to form the 1,5-diol moieties. 
 
Entry Compound R1 R2 Yielda d.r. 
1 266a H H 99% 1.43 : 1 
2 266b 4-Cl H 99% 1.33 : 1 
3 266c 4-OMe H 96% 1.33 : 1 
4 266d 4-CH3 H 40% 1.33 : 1 
5 266e 3,4-OMe H 41% 1.25 : 1 
6 266f 4-Br H 91% 1.32 : 1 
7 266g 2,4,5-OMe H 97% 1.54 : 1 
8 266h 4-Br Me 28% 1.42 : 1 
9 266i H Me 73% 1.42 : 1 
10 266j 4-CH3 Me 99% 1.42 : 1 
11 266k 4-Cl Me 69% 1.33 : 1 
a: Isolated yields after purification via column chromatography. 
266g was synthesised by Dr O’Brien. 
 
Table 2.8: Diols synthesised along the synthetic route to 2,4-disubstituted tetrahydropyrans. 
 
MeO
O O
O
R2
R1
OH OH
O
R2
R1
LiAlH4, THF,
−15°C - rt, 
20 mins, 
99%
270a-k syn/anti-266a-k
d.r. ≈ 1:1
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This was accomplished through the use of lithium aluminium hydride (LiAlH4) and, 
in the majority of cases, this proved to be a very effective reduction method 
resulting in yields exceeding 90%. Despite the success of this step, issues were 
encountered when there was a bromine substituent on the aromatic phenyl ring as 
an impurity was being seen in the 1H-NMR spectrum. 
 
The similarity in peak pattern suggested that the impurity was a related compound 
and when compared to compound 266a the minor compound matched exactly. 
This suggested that during the reduction of the keto-ester the aryl bromide had 
also been reduced. This effect is something that was reported in 1948 by Johnson, 
Blizzard and Carhart when using tetrahydrofuran or diethyl ether as the solvent 
system for the reaction with alkyl halides. They refluxed the reaction mixture and 
this resulted in the hydrogenolysed product.153 This area received further interest 
in 1969 when Brown and Krishnamurthy looked at the reaction with aryl 
bromides.154 They found similar effects during the course of the reaction; however 
there was no need for heat. Brown went on further to test the reaction rates using 
differing alkyl and aryl halides. Some trends were seen during the course of this 
investigation. The rate of reaction with primary halides was more rapid than with 
secondary halides153 and the highest rate of reaction was seen with aryl iodides, 
followed by aryl bromides, then aryl chlorides and a slow rate was seen with aryl 
fluorides.154  
 
This explained why, in the reduction of the keto-esters to the corresponding diols, 
this effect had only been seen with the 4-bromo substituted phenyl rings and not 
the 4-chloro examples. In order to overcome this the reaction was ran for only 10 
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minutes in these cases and this proved successful as none of compound 266a 
was seen and the yields obtained were comparable with the other diols.  
 
An alternative route was found where sodium borohydride was the reducing agent. 
In 1963, Brown reported on the reduction of esters using sodium borohydride.155 
This reaction took place in refluxing methanol and the reaction was reported as 
vigorous. Further developments led to the reaction being completing in refluxing 
THF, with a small quantity of methanol being added dropwise.156 This reaction 
proved to be very effective; however it showed no obvious advantages over the 
use of lithium aluminium hydride. 
 
The final step in this reaction sequence was to cyclise the diol under acidic 
conditions in order to obtain the 2,4-disubstituted tetrahydropyrans.  
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Scheme 2.32: Cyclisation of 1,5-diols under acidic conditions to forge the 2,4-disubstituted 
tetrahydropyran structure. 
 
Entry Compound R1 R2 d.r. Yielda 
1 269a H H 22:1 73% 
2 269b 4-Cl H 19:1 23% 
3 269c 4-OMe H 10:1 59% 
4 269d 4-CH3 H 20:1 83% 
5 269e 3,4-OMe H 15:1 82% 
6 269f 4-Br H 10:1 96% 
7 269g 2,4,5-OMe H 25:1 93% 
8 269h 4-Br Me 22:1 70% 
9 269i H Me 20:1 83% 
10 269j 4-CH3 Me 15:1 85% 
11 269k 4-Cl Me 10:1 68% 
a: Isolated yields after purification via column chromatography after using the crude 1 H-NMR to determine the d.r. 
269g was synthesised by Dr O’Brien. 
 
Table 2.9: 2,4-disubstituted tetrahydropyrans synthesised and their respective diastereomeric 
ratios. 
OH OH
O
R2
R1
O O R2
R1
H
SO3H
MeCN, rt, 1 hr
96%
266a-k
269a-k
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A series of acids were tested for this reaction and in these seven test cases the 
reaction was ran in deuterated acetonitrile in order to allow the real-time analysis 
of the reaction by 1H-NMR. After 10 minutes the reaction was analysed to 
determine whether the reaction was occurring or not. If successful, the reaction 
was left for one hour to allow for epimerisation.  
 
Entry Acid Time Result and Purification 
1 Catalytic quantity of p-
toluenesulfonic acid 
1 hour Successful reaction. Purified 
using a silica plug 
2 1 drop of acetic acid 10 mins No reaction 
3 6 drops of acetic acid 10 mins No reaction 
4 1 drop of trifluoroacetic acid 
(TFA) 
1 hour Successful reaction. Purified 
by column chromatography 
5 Catalytic quantity of polymer-
supported sulfonic acid 
1 hour Successful reaction. Filtered 
6 5 drops of 1:1 acetic acid:TFA 10 mins No reaction 
7 5 drops of 1:6 acetic acid:TFA 1 hour Successful reaction. Purified 
by column chromatography 
Table 2.10: Acids tested for use in the cyclisation of 1,5-diols to the corresponding 
tetrahydropyrans. 
 
Upon evaluation of these acids it was decided to use the polystyrene-supported 
sulfonic acid (entry 5). This was mainly because of the ease of work-up. Filtering 
and washing the beads meant that very little material was lost and so very high 
yields of the tetrahydropyran product could be obtained. These yields were higher 
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than those obtained from other methods that had been ran through a column or 
plug in order to remove the acid.  
 
After finding a suitable acid catalyst for the reaction the cyclisation of the 1,5-diols 
(266a-k) began. The test reactions had been run for up to 1 hour and showed a 
high ratio in favour of one diasteroisomer over the other. In order to show that the 
reaction was epimerising over time, rather than the final ratio being produced 
immediately, the reaction was monitored by 1H-NMR at set intervals. The reaction 
was analysed after ten minutes, twenty-five minutes and forty-five minutes. An 
added benefit to using the polymer-supported sulfonic acid was that monitoring the 
reaction at certain times was easily achieved as the acid was filtered off, the 
analysis was performed and then the acid was again added to the reaction mixture 
under identical conditions. 
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Figure 2.3: 1H-NMR spectra of the cyclisation of 266a to 269a. The reaction was monitored after 
10 minutes, 25 minutes and 45 minutes. Integrations of the two key peaks show the change in ratio 
of the two diastereoisomers seen over time. 
 
Figure 2.3 shows the three spectra obtained over the course of converting 266a 
into 269a under acidic conditions. After 10 minutes, the initial cyclisation reaction 
had only just gone to completion and this is shown in the ratio of diastereoisomers. 
In the minor diastereomer, that which possesses the aryl ring in the equatorial 
position and the furanyl ring in the axial position the proton at the furanyl chiral 
centre is easily identifiable at around 5 ppm. In the major diastereoisomer, that 
which possesses both the aryl ring and the furanyl ring in the equatorial positions 
Equatorial proton 
at the furanyl 
chiral centre. 
Axial proton 
at the furanyl 
chiral centre. 
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the proton at the furanyl chiral centre is slightly lower at around 4.5 ppm. After ten 
minutes the ratio of these two peaks is about 2:1 in favour of the diequatorial 
compound.   
 
After a further 15 minutes has elapsed this ratio has increased to 16:1 and after a 
total time of 45 minutes this ratio has reached 22:1 in favour of the diequatorial 
compound.  
 
Figure 2.4: Expanded spectra for the cyclisation of 266a to 269a. 
 
This increase in diastereomeric ratio shows that the epimerisation of the furanyl 
chiral centre occurs under acidic conditions and, under thermodynamic control, 
allows the emergence of one diastereomer over the other as the major product of 
the reaction. This epimerisation is able to occur because of the cyclisation step 
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being reversible under these conditions and because of the electron-rich nature of 
the furanyl group.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.33: Mechanism for the cyclisation of 1,5-diol 266a to the corresponding 
tetrahydropyran. 
 
The electron-rich nature of the furanyl group facilitates the elimination of water 
under the acidic conditions of the reaction. This generates the oxonium ion 267a 
where the remaining hydroxyl group can attack the carbon-carbon double bond 
and form the tetrahydropyran product. The reversibility of this reaction means that 
over time the diequatorial 269a is favoured due to the stability of having both 
substituents in an equatorial position. 
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In order to prove beyond any doubt that the epimerisation is facilitated by the 
acidic conditions of the reaction, diol 266a was cyclised under basic conditions. 
This prevents epimerisation and means that both diastereoisomers of the alcohol 
are cyclised, giving both diastereoisomers of the tetrahydropyran product. This 
would also allow the production of significant amounts of the minor 
diastereoisomer to obtain clear NMR data. This NMR data could then be 
compared to the NMR spectra obtained from the acid-catalysed cyclisation and 
peaks could then be assigned. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.34: Cyclisation of a 1,5-diol under basic conditions. 
OH OH
O
THF, NaH, 
TsCl, 2 hrs
266a
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This was achieved in a one-pot reaction using sodium hydride and tosyl chloride in 
THF. Both 268a and 269a were obtained in an approximately 1:1 ratio, and this 
showed that epimerisation of the furanyl chiral centre only occurred under acidic 
conditions. Careful column chromatography yielded a small quantity of pure 268a, 
a small quantity of 269a and a substantial quantity of the mixed fractions. 
 
After characterisation, 268a was subjected to the established acidic conditions of 
the cyclisation reaction. This allowed epimerisation and the 1:1 mixture of 
tetrahydropyran diastereomers increased to reach ratios that had been seen 
previously (i.e. 22:1 in favour of the diequatorial compound). 
 
The final stage of investigation into the disubstituted tetrahydropyrans that had 
been produced was to unambiguously determine the stereochemistry of the two 
diastereoisomers produced. Previously the assignments had been made based on 
the NMR coupling constants and the chemical shifts seen in the 1H-NMR 
spectrum. From the tosylation-cyclisation both stereoisomers could be analysed by 
nuclear Overhauser effect spectroscopy (NOESY). The nuclear Overhauser effect 
(nOe) allows information to be garnered on which protons are spatially close 
together.157  
 
The NOESY spectrum of the major diastereoisomer formed shows several nOe 
enhancements. These match the idea of a diequatorial compound because the 
axial hydrogens shown in Figure 2.5 would be close in space. There is also an 
nOe enhancement between the axial and equatorial hydrogen on C-6 (shown in 
red). 
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Figure 2.5: 2D-NOESY spectrum of tetrahydropyran 269a. 
 
In comparison to this the NOESY spectrum of the minor diastereoisomer seen in 
the cyclisation of diol 266a shows only one nOe enhancement and that is for the 
axial and equatorial protons shown in fuchsia. The furanyl group in this compound 
is axial, rather than equatorial and the equatorial proton is at too great a distance 
for a nOe enhancement to be seen. This lack of an observation does not prove the 
stereochemistry beyond any doubt but combined with the J-values obtained from 
the 1H-NMR the evidence does suggest that this is the case.  
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A change in the puckering of the ring from this adjustment in substituent position 
may be the cause of seeing no nOe between the axial proton on C-6 and the axial 
proton on C-4. This change in puckering may slightly adjust the distance between 
these two protons and, as the cross relaxation is dependent on distance to the 
power of six, a very small adjustment can have quite a large effect.  
 
 
 
 
 
Figure 2.6: 2D-NOESY spectrum of tetrahydropyran 268a. 
 
Although this evidence was very compelling, efforts were made to generate a 
crystalline disubstituted tetrahydropyran as this could be used to obtain an X-ray 
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crystal structure of the major diastereoisomer. Initially this was the reason why the 
4-bromo substituted examples 269f and 269h were synthesised; however these 
did not yield the desired crystals. Fortuitously after being stored in the freezer for a 
substantial period of time the dimethoxy substituted compound 269e yielded a 
crystalline product. This was sent to National Crystallography Service at the 
University of Southampton and an X-ray crystal structure was obtained (shown in 
Figure 2.7).  
 
Figure 2.7: X-ray crystal structure of 269e. This confirms that the major diastereoisomer seen from 
the cyclisation reaction is the diequatorial compound. 
 
When the 2,4,5-trimethoxy compound 269g was successfully synthesised this too 
proved to be a crystalline structure. 
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Figure 2.8: X-ray crystal structure of the trimethoxy 2,4-disubstituted tetrahydropyran 269g. 
 
This shows that the major diastereoisomer from the acid cyclisation of diols 269a-k 
is the diequatorial compound. The tetrahydropyran ring is in the chair conformation 
and the furanyl substituent along with the substituted phenyl ring, are both located 
in the equatorial positions.  
 
The aim of this investigation was to develop a methodology that could be used to 
synthesise 2,4-disubstituted tetrahydropyrans stereoselectively but could then be 
taken on further and used in further syntheses. In order to test this the furanyl 
group was oxidatively cleaved159 (as seen in previous work by the group in the 
synthesis of compound 173 in Scheme 1.31). The resulting carboxylic acid 285 
was then reduced to the corresponding terminal alcohol 286.  
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Scheme 2.35: Conversion of the furanyl substituent to the corresponding terminal alcohol. 
 
The furanyl group was oxidatively cleaved with sodium periodate and a ruthenium 
(III) chloride catalyst. The carboxylic acid from this reaction was obtained after one 
hour and was taken through the next step without purification. The removal of the 
carbonyl group proceeded in 30 minutes and, after purification by column 
chromatography, the pure alcohol 286 was obtained in a 21% over two steps.  
 
The oxidative cleavage involves ruthenium (III) chloride with a co-oxidant of 
sodium periodate. This generates ruthenium (VIII) oxide, which catalyses the 
reaction. This is used alongside a ternary solvent system that is made up of 
acetonitrile, water and typically carbon tetrachloride.158 This allows oxidative 
cleavage to the carboxylic acid in good yields and when there is a stereogenic 
centre at the α-position to the carbonyl group the reaction proceeds without 
epimerisation.159 This was an important consideration for this reaction so that the 
stereoselectivity from the cyclisation was not lost.  
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Reduction of the carboxylic acid was achieved using borane. This was selected for 
use as the transformation would readily occur under mild conditions and without 
affecting the remainder of the compound.160 
 
This two-step conversion was completed without optimisation and therefore this 
reaction yield could very probably be increased; however it does show that the 
disubstituted tetrahydropyrans can be taken through further steps and this allows 
the methodology to be used in synthesis of more biologically active and 
pharmaceutically interesting compounds.  
 
When developing this synthesis it was thought that the malonate addition product 
could also be used to synthesise the corresponding triols. These could then be 
cyclised and be used to synthesise 2,4,5-trisubstituted tetrahydropyrans. If 
successful, this would demonstrate double diastereoselectivity. The 2,4-
disubstituted tetrahydropyran pathway was followed first to ascertain if the single 
diastereoselectivity would be achieved as imagined, before progressing to the 
more complex scenario. 
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2.4. Stereoselective Synthesis of 4-aryl-2-furyl-5-
hydroxymethyl Tetrahydropyrans 
The idea of synthesising 2,4,5-trisubstituted tetrahydropyrans came from the idea 
of utilising double diastereoselectivity. This would mean that a single, defined 
chiral centre would control the formation of two new chiral centres, rather than a 
single chiral centre as seen in the synthesis of 2,4-disubstituted tetrahydropyrans. 
The other advantage to this project was that it could be completed in a short space 
of time, as the synthetic pathway required branched from the pathway used for the 
disubstituted compounds after the successful synthesis of the keto-diester. These 
could be reduced, resulting in the corresponding triol that would then cyclise under 
acidic conditions to yield the 2,4,5-trisusbtituted tetrahydropyrans. 
 
If successful then it was theorised that the stereoselectivity would come about 
from two sources. The first, as seen in the 2,4-disubstituted tetrahydropyrans, 
would arise from the ability of the furanyl chiral centre to epimerise under acidic 
conditions and the reversibility of the cyclisation reaction under these conditions, 
meaning that the thermodynamic product could form over time, giving a greater 
ratio in favour of the more stable compound.  
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Scheme 2.36: Theorised formation of 2,4,5-trisubstituted tetrahydropyrans. 
 
As shown in Scheme 2.36 there are two terminal hydroxyl groups in the triol 
compounds. Under acidic conditions the cyclisation mechanism is very similar to 
that of Scheme 2.33 with an additional hydroxymethyl substituent. However, when 
cyclised either of these two hydroxyl groups (either the one in red or the one in 
blue) can be the one that cyclises to produce the tetrahydropyran ring. Due to the 
reversibility of the cyclisation reaction it was hypothesised that over time there 
would be a shift to favour the hydroxyl group that places the remaining 
hydroxymethyl group, when in the tetrahydropyran product, in the equatorial 
position. This, coupled with the ability of the furanyl group to epimerise under the 
reaction conditions, would theoretically produce the triequatorial tetrahdyropyran 
as the thermodynamically more stable product, and therefore this was 
hypothesised to be the major product of the reaction.  
 
The keto-diester that was being used as the starting material was generally the 
same material that was used for the Krapcho decarboxylation in the previous 
synthesis. In some cases more material needed to be synthesised and this was 
easily achieved from the remaining chalcone material and use of the potassium 
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carbonate facilitated conjugate addition reaction described previously. All material 
was purified before being reduced. 
 
 
 
 
 
Scheme 2.37: Lithium aluminium hydride reduction of keto diesters (271a-k) to the corresponding 
triol (287a-k). 
 
Entry Compound R1 R2 Yielda d.r. 
1 287a H H Crude 1.25 : 1 
2 287b 4-Cl H 47% N/A 
3 287c 4-OMe H 33% 1.67 : 1 
4 287d 4-CH3 H 27% 1.33 : 1 
5 287e 3,4-OMe H 15% 1 : 1 
6 287f 4-Br H 35% 1 : 1.25 
7 287g 2,4,5-OMe H 65% 2 : 1 
8 287h 4-Br Me 28% 1.67 : 1 
9 287i H Me 35% 2 : 1 
10 287j 4-CH3 Me 31% 1.67 : 1 
11 287k 4-Cl Me 37% 1.67 : 1 
a: Isolated yields after purification via column chromatography. 
Compound 287g was synthesised by Dr O’Brien. 
 
Table 2.11: Triols synthesised during the route to achieve 2,4,5-trisubstituted tetrahydropyrans. 
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Reduction to the triols was achieved using lithium aluminium hydride, as described 
in the previous synthesis. The Fieser method161 was investigated as an 
appropriate work-up technique; however this showed no obvious advantage in 
yield or time over an aqueous work-up. Another alternative approach would be the 
use of Rochelle’s salt (sodium potassium tartrate);162 however this can take up to 
twelve hours to complete and so was not investigated at this time. 
 
There was a moment of serendipity during the triol synthesis. When left overnight 
the diastereomers of triol 287b separated. One was a crystalline material, whilst 
the other remained as an oil. After a number of recrystallisations the 
diastereomers were fully separated and an X-ray crystal structure was obtained on 
the crystalline product to determine its stereochemistry. Through the process of 
elimination this gave the stereochemistry of the diastereomer that was an oil. 
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Figure 2.9: X-ray crystal structure of the crystalline para-chloro triol 287b.  
 
The final stage in the synthesis of the 2,4,5-trisubstituted tetrahydropyrans was to 
cyclise the triol compound under acidic conditions in order to establish the 
stereoselectivity of the reaction. Previously the acid cyclisation step had been 
completed using polymer-supported sulfonic acid in acetonitrile. Due to the 
effectiveness of this method it was applied to this cyclisation as well.  
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Scheme 2.38: Cyclisation of triols 287a-k to yield the 2,4,5-trisubstituted tetrahydropyrans 288a-k. 
 
Entry Compound R1 R2 d.r. Yielda 
1 288a H H 12:1 23% 
2 288b 4-Cl H 17:1:1:0 89% 
3 288c 4-OMe H 18:1 87% 
4 288d 4-CH3 H 13:1 95% 
5 288e 3,4-OMe H 19:1 89% 
6 288f 4-Br H 10:1 86% 
7 288g 2,4,5-OMe H 20:1 96% 
8 288h 4-Br Me 12:1 63% 
9 288i H Me 12:1 84% 
10 288j 4-CH3 Me 13:1 75% 
11 288k 4-Cl Me 10:1 83% 
a: Isolated yields after purification via column chromatography. The yield for 288a is over two steps. 
Compound 288g was synthesised by Dr O’Brien. 
 
Table 2.12: 2,4,5-trisubstituted tetrahydropyrans synthesised and the diastereomeric ratios 
obtained. Note that for 288b the ratios of all four diastereoisomers can be given. In the other cases 
only the major and minor ratios can accurately be given. 
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d.r. ~ 1.67 : 1 d.r. > 10 :1
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What needed to be examined was whether the timings of the reaction needed to 
be adjusted to allow time for the compound to epimerise. This could easily be 
achieved as the polymer-supported acid could easily be filtered off, thereby 
removing the acid source and allowing for 1H-NMR analysis without affecting the 
material that was not part of the NMR sample.  
 
The reaction mixture was analysed at various times: 15 minutes after addition of 
acid, 25 minutes after, 40 minutes after, 3 hours after and 2 days after. Even after 
15 minutes there was no triol present in the reaction mixture; however the ratio of 
the two major diastereoisomers seen within the spectrum was relatively low (3:1). 
Over time the ratio of these two diastereoisomers increased to a ratio of 13:1 after 
3 hours and then to 24:1 after two days. Due to this the cyclisation reactions were 
left under acidic conditions for one day to yield a highly enriched mixture in favour 
of one diastereoisomer.  
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Figure 2.10: 1H-NMR comparison for the cyclisation of triol 287a over a period of two days. 
 
In the NMR spectrum only two diastereoisomers can clearly be seen. This was 
surprising as there was a potential four diastereoisomers that could be formed 
from this reaction (as shown in Figure 2.11).  
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Figure 2.11: The four diastereoisomers of 2,4,5-trisubstituted tetrahydropyran 288a. 
 
In an attempt to determine the diastereoisomers present from the cyclisation 
reaction an effort was made to obtain sufficient quantities of the minor 
diastereoisomers for spectroscopic analysis.  
 
A 2D-NOESY spectrum was obtained on 288d in an attempt to determine the 
stereochemistry of the product. This showed peaks between the C-2 proton, the C-
4 proton, the C-6 axial proton and one of the C-3 protons. Coupled with the J-
values obtained this suggested that the major diastereoisomer was the 
triequatorial compound. 
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Figure 2.12: NOESY spectrum seen from the diastereomeric mixture produced from cyclisation of 
triol 287d. 
 
Although this information was extremely useful it did not provide information about 
the stereochemistry of the remaining three diastereoisomers. Obtaining these 
other three stereoisomers would allow for structural determination. Even obtaining 
some of the minor compounds would allow for greater structural determination by 
elimination. Previously, in the case of the 2,4-disubstituted tetrahydropyrans, this 
was achieved through the tosylation-cyclisation of the precursor followed by 
careful column chromatography in order to separate the diastereoisomers. 
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The base-promoted cyclisation was attempted using tosyl chloride and sodium 
hydride as had been achieved previously. This would theoretically cyclise the triol 
without allowing epimerisation and would also mean that the hydroxymethyl group 
would not be the terminal alcohol but would instead be a tosyl-protected alcohol. 
Obtaining the pure diastereoisomers via this method proved unsuccessful, 
probably due to the small scale the reaction was completed on. 
   
 
 
 
 
 
Scheme 2.39: Attempted base cyclisation of 287b. 
 
The fortuitous separation of the two para-chloro triol (287b) diastereoisomers 
suggested an interesting strategy to access significant quantities of the minor 
cyclisation diastereoisomers. This would involve the mono tert-butyldiphenylsilyl 
(TBDPS) protection of one of the primary hydroxyl groups followed by the 
separation of the two stereoisomers formed. This would give four diastereoisomers 
that could then be cyclised under acidic conditions (290a-d). Two of these four 
diastereoisomers would give a mixture of two of the cyclised diastereoisomers 
whilst the other two would give a mixture of the remaining two cyclised 
diastereoisomers. This would be achieved as one of the hydroxyl groups would be 
locked by the TBDPS protecting group, therefore preventing it from taking part in 
the cyclisation. The acidic conditions would still allow the furanyl group to 
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epimerise but that would be the only epimerisation seen. Once these mixtures of 
diastereoisomers were obtained then NMR experiments could be conducted on 
each pair and the resulting spectra could be compared to the spectrum obtained 
when the cyclisation of triol 287b was performed. Dr O’Brien carried out the 
synthesis for this work. 
 
Both para-chloro triol diastereoisomers were individually dissolved in 
dichloromethane and to this was added the TBDPS-chloride and DMAP. From 
these reactions a mixture of both mono-protected compounds were obtained 
alongside a trace amount of the bis-protected compound. In no case was 
protection of the furanyl secondary alcohol seen. Repeated careful 
chromatography separated these two reaction mixtures into the four mono-
protected diastereoisomers (290a-d). These were then each individually cyclised 
using the established acidic conditions. 
 
The mixtures of 291a+b and 291c+d were both deprotected through the use of 
tetrabutylammonium fluoride (TBAF). This removed the TBDPS protecting group 
but did not affect the stereochemistry of the compounds meaning that all four 
diastereoisomers of the tetrahydropyran 288b were obtained. The syn,anti and 
anti,anti 288b compounds were those that could easily be seen in the original 
NMR spectrum when 287b was cyclised under acidic conditions. From comparing 
the NMR spectra it was also possible to see that in the original NMR spectrum the 
syn,syn 288b compound was also present; however none of the anti,syn 
compound was seen (see Figure 2.11). 
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Scheme 2.40: A summary of how all para-chloro trisubstituted tetrahydropyran diastereoisomers 
were obtained. 
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The reasoning behind this is that when the TBDPS-diols 290a and 290c were 
cyclised under acidic conditions, the tetrahydropyrans that were produced 
(291c+d) were in a ratio of 8:1, where the major diastereoisomer was that which 
placed the phenyl group and the furanyl group in the equatorial position whilst the 
hydroxymethyl group was in the axial orientation. Due to this selectivity it stands to 
reason that the anti,syn configuration is not seen in the NMR spectrum when the 
reaction is conducted under acidic conditions with triol 287b; assuming that the 
selectivity seen originally is the same as the selectivity seen when completing the 
reaction with the presence of the TBDPS-groups. 
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Figure 2.13: NMR overlay between 5.25 ppm and 2.25 ppm. Top – syn,syn-288b and anti,syn-
288b, Middle – syn,anti-288b and anti,anti-288b. Bottom – Cyclisation of 287b under standard 
acidic conditions. 
 
The NMR spectra in Figure 2.13 show the mixtures obtained from the TBDPS-
protection methodology and also the acid-catalysed cyclisation and epimerisation 
of the triol. This shows that more than two diastereoisomers are present in the final 
mixture. 
 
If the syn,syn 288b and anti,syn 288b mixture is placed under the same acidic 
conditions as used in the cyclisation step then epimerisation is able to occur and 
this results in the mixture going to the same ratio as was initially seen favouring 
the syn,anti 288b compound as the major diastereoisomer. Likewise if the syn,anti 
288b and anti,anti 288b mixture is placed under the same acidic conditions as 
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used in the cyclisation step then epimerisation also occurs. This increases the 
ratio in favour of the syn,anti 288b compound and also shows a trace amount of 
syn,syn 288b in the spectrum. 
 
After this work it was possible to state with confidence the double 
diastereoselectivity of this reaction. Only three of the possible four 
diastereoisomers were seen once the reaction had gone to completion and been 
given time to epimerise. This can only confidently be stated with the para-chloro 
example though as none of the remaining triols were separated and taken through 
these steps. 
 
Although NMR data gave a clear indication of which stereoisomer was favoured 
the aim was to unambiguously determine this and again the answer was to obtain 
an X-ray crystal structure. Unlike previously, none of the compounds had 
spontaneously yielded crystals, even after a period of time in the freezer at 
approximately −20°C. Due to this attention turned to the dimethoxy and trimethoxy 
compounds (288e and 288g respectively). These had successfully given 
crystalline products in the 2,4-disubstituted tetrahydropyran series and it was 
hoped that this would also be the case in this series.  
 
Over the course of several days a number of solvents were used in the hope that 
the slow evaporation of the solvent would orientate the molecules in a suitable 
manner for a crystalline product to form. Unfortunately no success was seen with 
the dimethoxy substituted compound 288e; however a crystal was eventually 
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gained from the trimethoxy product 288g. This was achieved through a number of 
repetitive slow evaporations of diethyl ether at room temperature. 
 
Once the crystal had formed it was sent to the National Crystallography Service at 
the University of Southampton and an X-ray crystal structure obtained.  
 
 
Figure 2.14: X-ray crystal structure of the trimethoxy trisubstituted tetrahydropyran 288g. 
 
After successfully exploring the synthesis of both 2,4-disubstiuted and 2,4,5-
trisubstituted tetrahydropyrans an alternative strategy for double 
diastereoselection presented itself. This was to create a 2,6-disubstituted 
tetrahydropyran where both the substituents were a furanyl or 5-methylfuranyl 
group. 
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2.5. Synthesis of 4-aryl-2,6-difuranyl Tetrahydropyrans 
As previously discussed the furanyl functional group is highly versatile and is able 
to undergo a plethora of transformations allowing the further development of the 
compound, and therefore proving synthetically useful in terms of facilitating the 
synthesis of natural products or other biologically active compounds. It is this 
versatility that led to the idea of using the methodology developed in the synthesis 
of 2,4- and 2,4,5-trisubstituted tetrahydropyrans and applying it to the synthesis of 
a 2,4,6-trisubstituted tetrahydropyran where both the 2- and the 6-substitutent 
would be a furanyl group.  
 
Scheme 2.41: Retrosynthetic analysis of 4-aryl-2,6-difuranyl tetrahydropyrans. The hypothetical 
triequatorial compound is depicted. 
 
Not only would this be interesting due to the potential that the molecule would 
have in terms of use in future syntheses but as the cyclisation would again be 
occurring under acidic conditions then in theory high levels of stereoselectivity 
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would be seen based on the ability of the furanyl chiral centre to epimerise. This 
has already been seen in previous examples and the results suggested that the 
stereochemistry in this case would favour the triequatorial compound (292). This 
would be assumed anyway due to the increased stability when compounds are 
located in the equatorial position.  
 
Synthesis of these compounds began with the chalcones (272c, d and f). These 
underwent an addition reaction with 2-acetylfuran (274). This introduced the 
second furanyl group and was completed under identical conditions as the 
chalcone synthesis (i.e. adding 5% aqueous sodium hydroxide solution to 
methanol and refluxing the reaction mixture).  
 
Scheme 2.42: Reaction between chalcones (272c, d, and f) and 2-acetylfuran (274) to synthesise 
the difuranyl diketones (294c, d and f). 
 
As the chalcones had been synthesised on such scales previously there was no 
need to synthesise them again for this project; however as the reaction conditions 
are the same for this reaction as the aldol condensation reaction then it may have 
been possible to use double the number of equivalents of 2-acetylfuran (274) in 
O
O
R1
O
O OO
O O
R1
272c, d and f 274 294c, d and f
5% NaOH(aq), MeOH,
reflux,
5 hours, column
chromatography,
294c, R1 = 4-OMe, 41%
294d, R1 = 4-Me, 58%
294f, R1 = 4-Br, 53%
		
	 Results	and	Discussion	–	Stereoselective	Synthesis	of	4-aryl-2,6-difuranyl	Tetrahydropyrans	 		 	
136	
the initial reaction in order to synthesise the difuranyl-diketones (294). Despite not 
attempting the one-pot reaction, yields of the desired products were moderate and 
easily gave enough material in order to test the synthetic pathway.  
 
Upon obtaining the difuranyl-diketones (294) the next step was to generate the 
1,5-diol moiety. Sodium borohydride was chosen over lithium aluminum hydride, 
which was used in the previous syntheses. This meant that the work-up was 
substantially easier due to the absence of aluminium salts forming during the 
work-up procedure.  
 
Scheme 2.43: Reduction of the difuranyl diketones to the corresponding diol. 
 
The reduction went in moderate to high yields and after purification by column 
chromatography gave the desired 1,5-diols. All fractions containing any diol 
diastereoisomer were combined (as well as two fractions either way) to ensure 
that the stereoisomers were not being separated, as this would affect the 
conclusions drawn from the reaction. The 1H-NMR spectra of these compounds 
only seemed to show two diastereoisomers when three would be expected. This 
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may be due to overlap of peaks, rather than only two diastereoisomers being 
produced. 
 
Figure 2.15: Difuranyl diol stereoisomers. 293d-ii and 293d-iii are enantiomers and therefore the 
1H-NMR should be the same in both cases. This means that there are three possible 
diastereoisomers that could be seen in the diol 1H-NMR spectrum.  
 
The previous projects had already optimised the cyclisation process using 
polymer-supported sulfonic acid and so this method was again used in the 
cyclisation of the difuranyl-diols (293). The acidic conditions would allow both of 
the furanyl groups to epimerise and over time to favour the more stable 
conformation. The hypothesis going into this experiment was that both furanyl 
groups and the aryl group would be in the equatorial positions due to the 
reversibility of the cyclisation step and the resulting epimerisation under these 
conditions.  
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Scheme 2.44: Cyclisation of difuranyl diols to the corresponding 4-aryl-2.6-difuranyl trisubstituted 
tetrahydropyran. 
 
There was one main difference that was seen during the course of this reaction 
that had not been seen in the previous cases and this was that the solution 
became black in colour. This suggested some sort of decomposition or side 
reaction, which was confirmed upon analysis by TLC as several spots were 
observed. Once the reaction was filtered and purified by column chromatography 
the yields of the desired compound were low in all cases (10% - 26%).  
 
This low yield was disappointing because although there seemed to be a mixture 
of diastereoisomers that favoured one in particular, it could not be stated that the 
reaction was stereoselective as questions arose about where the other material 
was and whether selective decomposition was being seen (i.e. one 
diastereoisomer would decompose before the other under these conditions).  
 
TLC and 1H-NMR was used to monitor this reaction over a period of six days to 
investigate what was happening. These showed that the desired product was 
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being formed, alongside an unknown impurity. 1H-NMR analysis suggested that 
this impurity was an aldehyde. After one day the impurity began to decrease in 
intensity and the diastereomeric ratio of the tetrahydropyran product reached 5:1. 
After four days this ratio increased to 14:1, but evidence of decomposition was 
clearly seen in the reaction vessel.  
 
 
 
 
Figure 2.16: NMR analysis of the cyclisation reaction to yield the difuranyl tetrahydropyrans over 
the course of four days. The diastereomeric ratios of the two main diastereoisomers seen in the 
mixture are noted. Some peaks (e.g. peak above 9.0 ppm) correspond suspected aldehyde 
impurity. Fur = furanyl group. 
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As shown in Figure 2.16 not all the peaks present in the 1H-NMR spectrum 
matched those of the desired product and the related diastereoisomers. Instead 
some peaks (e.g. the peak between 9.40 ppm and 9.60 ppm) correspond to the 
unknown impurity that formed during the course of this reaction. Peaks around this 
region usually represent an aldehyde proton, but in order to gain more information 
a number of NMR experiments were ran on this compound after it was isolated by 
careful column chromatography (1H-NMR, 13C-NMR and COSY experiments were 
conducted).  
 
The 1H-NMR spectrum showed the presence of the toluene group as well as the 
presence of the furanyl groups (integration of the peaks showed both furanyl 
groups were present), showing that the unknown compound was somewhat 
related to the desired product. After numerous discussions and analysis of the 
NMR spectra a putative structure was proposed as shown below in Figure 2.17. A 
possible mechanism that would explain the formation of 295 is shown in Scheme 
2.45. The proposed mechanism involves the second furanyl group attacking the 
carbocation formed under acidic conditions to produce a favoured six-membered 
ring structure (298). This type of mechanism was not possible in previous projects. 
The reactions occur at the furanyl-2 position due to resonance providing increased 
stability and because it allows for the formation of a six-membered ring, which is 
favoured.  
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Figure 2.17: Putative structure of the by-product formed during the course of the cyclisation 
reaction. 
 
Upon observation of the other NMR spectra obtained on this compound the 
putative structure seemed more likely. The 13C-NMR showed a carbonyl group at 
201.7 ppm. The aromatic and aliphatic regions of this NMR spectrum also 
matched the putative structure. This supported the aldehyde peak seen in the 1H-
NMR at 9.57 ppm. 
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Scheme 2.45: Theorised mechanism for the formation of the aldehyde by-product 295. 
 
It was thought that the aldehyde product and the desired tetrahydropyran product 
could be in equilibrium, with the tetrahydropyran being more thermodynamically 
favourable, meaning that over time the aldehyde could be used to produce the 
tetrahydropyran product (292d). In an effort to test this theory the isolated 
aldehyde 295 was subjected to identical reaction conditions as were used in the 
cyclisation step. After three days none of the tetrahydropyran product was seen; 
however the aldehyde had been consumed. The reaction mixture had also 
become black in colour over the course of these three days. The reaction mixture 
was passed through a silica plug, which was washed repeatedly with ethyl acetate. 
The reaction material remained at the top of the silica plug suggesting that it had 
decomposed over the three days. This explained where some of the material was 
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going during the course of the cyclisation reaction where the tetrahydropyran 
product was only being obtained in a 10% yield.  
 
This idea of migration of a furanyl group is not unheard of in the literature and 
recently Li and coworkers reported on a 1,5-migration of a furanyl group;163 
however this was using a gold catalyst and the compound possessed a carbon-
carbon triple bond, neither of which were present in our reaction. Despite this, the 
mechanism they propose is very similar to that which is proposed for the formation 
of 295.  
 
Scheme 2.46: Li’s gold-catalysed furanyl migration mechanism. Adapted from reference 163. 
 
This furanyl cation intermediate is also something that has been reported by 
Hashmi in 2012.164 Again this movement of the furanyl group involved a gold 
catalyst and a carbon-carbon triple bond but the intermediate proposed is very 
similar to that proposed for the formation of aldehyde 295. This migration of 
groups is something that is commonly seen in a 1,2-aryl migration via a 
phenonium ion.165 Other aryl 1,5-migrations have been seen in the literature, 
however these do not proceed via the proposed mechanism to form 295. Instead, 
these occur through a radical mechanism, as reported in 2000166 and 2002167 by 
Struder who used this method to prepare biaryls from silyl ethers.  
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As the acid cyclisation of diols 293c, d and f were not proving fruitful the 
tosylation-cyclisation of 293c was attempted. This was performed using conditions 
matching that of the tosylation-cyclisation seen in the synthesis of the 2,4-
disubstituted tetrahydropyrans (i.e. sodium hydride with tosyl chloride).  
 
 
 
 
 
 
Scheme 2.47: Tosylation-cyclisation of difuranyl diol 293c. 
 
After the reaction was worked up the crude 1H-NMR was not clear enough to 
make out the presence of all three diastereoisomers. Hence the reaction mixture 
was subjected to column chromatography in hopes making the 1H-NMR spectrum 
clearer. This chromatography was able to separate the diastereoisomers 
somewhat; however clean separation of all three diastereoisomers was not 
achieved. 
 
The diastereoisomers that could possibly form from this reaction are shown in 
Figure 2.18. The triequatorial compound, which was thought to be the major 
diastereoisomer showed only one axial hydrogen adjacent to the furanyl group (as 
would be expected) due to the mirror plane of symmetry (seen at 4.76 ppm in the 
1H-NMR spectrum). The peaks corresponding to this compound also only showed 
one set of CH2 peaks in the 1H-NMR spectrum at 2.14 – 2.01 ppm. The remaining 
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peaks in the spectrum were minor. A minor peak at 5.28 ppm seemed to be in the 
correct area for an equatorial proton on the tetrahydropyran ring; however it was 
not possible to fully characterise all diastereoisomers.  
 
Figure 2.18: Possible diastereoisomers of tetrahydropyran compound 292c. 
 
In the enantiomeric stereoisomers the aryl chiral centre is in fact a pseudochiral 
centre. This is because, via flipping the molecule, the opposing structure maintains 
the same chirality. This is shown in Figure 2.19. 
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Figure 2.19: Pseudo-stereogenic centre that could be seen in 292c-ii and 292c-iv. 
 
The diastereomeric mixture was stored in the freezer for when this project is 
continued. A number of questions arose from this project have yet to be answered, 
including: 
• What is the effect of acid strength and solvent on the cyclisation?  
• Can the cyclisation step occur without the side reaction being seen? 
• Is the reaction stereoselective or is selective decomposition being seen? 
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This project was running alongside another and as that project seemed like it 
would be completed relatively quickly, attention was shifted to work on a 
continuous-flow synthesis system.
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2.6. Continuous-Flow Chemistry System 
2.6.1. An Introduction to Continuous-Flow Chemistry 
Flow chemistry is an emerging technique as an alternative to the more traditional 
batch protocols that are used in synthetic chemistry. In flow chemistry, starting 
materials and/or reagents are continuously pumped through a relatively small 
reaction zone. This is different to batch chemistry where all the reagents are 
added to the flask at the start of the reaction and where the relative reaction zone 
is much larger.168  
 
Although traditional batch processes are still widely used and are perfectly suitable 
for an array of synthetic processes, there are a number of advantages that are 
seen through the use of a continuous-flow system. One of the biggest advantages 
in the use of a continuous-flow system is the exceptional heat exchange efficiency. 
This suppresses the build up of heat within the reaction (and so prevents the 
formation of hot spots). This is true even in the case of rapid and highly exothermic 
reactions.169 This is achieved due to the high surface-area-to-volume ratio within 
the flow reactor and this means that any transfer of heat is far more efficient than 
is seen in a batch process. The temperature and pressure of the solvent and the 
reagents can also be manipulated in a far safer manner than in a traditional batch 
process. The temperature solvents experience can safely exceed the atmospheric 
norms within a continuous flow system through pressurising the system. This can 
safely be done, using a back-pressure regulator, due to the small volume of the 
reactor.170 The back-pressure regulator is placed downstream of the heated 
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section. This blocks any flow that does not exceed the pressure setting on the 
regulator. This means that if the pump used can pump against that pressure then 
a continuous flowing stream, kept above a set pressure, is obtained and keeps the 
superheated solvent in the liquid phase.  
 
Typically, an increase in the temperature increases the rate of reaction and the 
ability to greatly increase the temperature and pressure beyond the standard 
boiling point at atmospheric pressure theoretically should greatly increase the rate 
of reaction; however, the pump being used must be able to pump against the 
pressure formed without any damage being seen to the tubes and any connecting 
joints.   
 
The reaction within the flow reactor only occurs in a relatively small reaction zone. 
This means that only a small quantity of material is being processed at any given 
time and this offers an enhanced safety profile, especially with the use of explosive 
or hazardous reagents/intermediates. Scale up of a reaction does not affect this 
small reaction zone as the reaction is scaled up over time (i.e. the pumping time is 
increased) rather than through a scale up of dimensions (as is seen in a batch 
process). This also means that issues are not seen of a scale-variant nature in 
terms of reaction parameters. This is something that was seen in batch with the 
hydrogenation of alkynes described in section 2.1. Reaction time in that case was 
vitally important as a reaction time of greater than two minutes began to exhibit 
signs of over-hydrogenation. Upon scale up, two minutes was not enough time for 
all of the reaction to have gone to completion and yet some of the material was 
beginning to be over-hydrogenated.  
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This was possibly due to the change in surface-area-to-volume ratio. The change 
in surface-area-to-volume ratio affects the rate at which hydrogen can pass from 
the gaseous phase, through the interfacial surface, to the liquid phase to take part 
in the reaction. This is something that could be addressed through the use of a 
continuous flow system as it allows fine control of the reaction time and also gives 
a high surface-area-to-volume ratio. 
 
Although there are many advantages to the use of a continuous flow system there 
are also a number of limitations to the methodology. The key limitation seen with 
this technology is that reactions that are performed through the use of continuous 
flow need to be completely converted in the reaction zone. This is controlled by the 
flow rates and also by the path-length, as these affect the residence time. It is also 
important that the product formed during the course of the reaction does not 
precipitate in the solvent being used. This is because the precipitate can cause a 
blockage within the tubing, either preventing the continuous flow or causing the 
system to leak due to build up of pressure.168 Precipitation can be circumvented 
through the use of an alternative solvent or through adjustments to the 
concentrations used in the reaction. However, this may impact negatively upon the 
reaction chemistry itself. 
 
Any bubbles that are in the tubes or any biphasic mixtures that have been 
insufficiently mixed can also cause issues in the flow process and this is because 
they prevent the effective mixing of the streams and can result in an incomplete 
reaction. Reactor fouling and cross contamination can also be an issue in some 
systems if lines are not cleaned out upon completion of the reaction.171 
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All the above listed limitations are based on the equipment that is used for the 
continuous flow process; however, there is a limitation to using continuous flow 
itself. This is that some enantioselective reactions require an extended reaction 
time in order to achieve efficient asymmetric induction. The use of a continuous 
flow system does not easily allow for this.170  
 
Flow chemistry has been applied to a number of reactions that are traditionally 
performed using batch protocols that produce kinetically unstable intermediates 
during the course of the reaction. One of these is the Swern oxidation.  
 
The Swern oxidation is one of the most commonly used methods in order to 
convert an alcohol to a carbonyl compound. Yoshida and co-workers reported on 
this Moffatt-Swern oxidation in a continuous flow system in 2005.172 Typically this 
reaction is conducted at cryogenic temperatures (−50°C and below).  
 
The first step of the Moffatt-Swern type oxidation is activation of the DMSO (304). 
Yoshida achieved this through the use of trifluoroacetic anhydride (TFAA) (305). 
This generates an intermediate cation 306 that is stable below −30°C (hence the 
use of cryogenic temperatures); however the activation of DMSO can lead to a 
side product forming through a Pummerer rearrangement (309). The low 
temperatures also aid in minimising this side reaction.  
 
The cationic intermediate 306 can then react with the desired alcohol to obtain a 
second intermediate that can be treated with base in order to obtain the desired 
carbonyl compound (the base that is commonly used is triethylamine). Treatment 
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of the second intermediate with a base can also result in another Pummerer 
rearrangement and this again results in an undesired side product (312). The 
undesired side product from the first Pummerer rearrangement (309) is also able 
to react with the alcohol used in the reaction and generate another undesired 
compound. 
 
Scheme 2.48: Moffatt-Swern oxidation. 
S
O F3C O CF3
OO
304
305 S
OCOCF3
306
Unstable 
above −30°C
Pummerer
rearrangement S
OCOCF3
306
F3C O
O
307
H
S
F3C O
O
307
308
F3C O
O
S
309
Moffatt-Swern
oxidation
S
OCOCF3
306
R1 R2
OH
204
S
O
R2
R1
310
Pummerer
rearrangement
S
O
R2
R1
310H
B
S
R1 O
R2
311
308
SO
R1
R2
312
Moffatt-Swern
oxidation
S
O
R2
R1
310 H
B
313
R1 R2
O
202
S
O H
R2R1
F3C O
O
307
F3C O
O
307
F3C O
O
307
		
Results	and	Discussion	–	Continuous-Flow	Chemistry	System	 		 	
153	
Although this reaction requires cryogenic temperatures in batch processes a 
substantial quantity of both impurities from the reaction are formed. Yoshida 
completed this reaction with a number of alcohols using continuous flow 
technology. This was done at −20°C, 0°C and 20°C. All three of these 
temperatures are above the temperature for the long-term stability of intermediate 
306. In each case the yield of the desired carbonyl compound far exceeded the 
yield of either of the two impurities and the yield of the desired product was far 
greater than was seen when using a traditional batch approach. This is because 
the flow-rate and path-length used in the flow reaction can be completely 
controlled. Therefore the intermediate can very swiftly be generated and reacted, 
minimising the time allowed for any unwanted side reactions and enhancing the 
yield of the desired product. This speed is noted in the fact that Yoshida refers to 
this aspect of flow chemistry as “flash chemistry”. 
 
Flow chemistry is not only advantageous when reactive intermediates are 
generated but can be used with gases in order to increase the safety of the 
reaction. The use of gaseous reagents in reactions can often be dangerous due to 
the high pressures required. These gases are also very mobile and, should they 
be released into the air, can disperse very speedily. Reactions like this also tend to 
require the use of specialised, expensive equipment. These effects are intensified 
upon any scale up of the procedure. One way to counter this is through the use of 
continuous flow techniques using gas-liquid reactors. This is because they use a 
small volume reactor in order to minimise the volume of pressurised gas being 
used. This minimises the kinetic energy (and the volume of gas released) should 
the vessel rupture or the system leak. 
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One such reactor was developed by Ley and co-workers and was reported in 
2015.173 This made use of Teflon AF-2400, an amorphous co-polymer that is 
made up of fluoroethylene and perfluorodioxolane. This co-polymer is permeable 
to a number of gases; however, it remains impermeable to non-fluorinated 
solvents and a number of corrosives.  
 
The reaction vessel was developed, keeping in mind the need for control over the 
pressure of the gas being used in the reaction. This was achieved by housing the 
reagent stream in the tube of Teflon AF-2400 and surrounding this with a larger 
diameter PTFE tube filled with the reactive gas. The tubing was separated at both 
entry and exit to the reaction vessel through the use of Swagelok T pieces in order 
to allow the precise control of the pressure and flow rate, within the reaction 
vessel, of both the reagent stream and the gaseous stream. 
 
The paper reports on numerous examples of the successful use of this reaction 
vessel showcasing both its durability and variability. One such reaction that was 
tested was the Wacker oxidation using gaseous oxygen at 8-bar pressure.  
 
 
 
 
 
 
Scheme 2.49: Wacker oxidation completed in a continuous-flow system. 
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2.6.2. Developing a Continuous-Flow System for Liquid-Liquid 
Extraction 
The premise that began this project was based on gravity-based liquid-liquid 
extraction, one of the most commonly used batch protocols for both work-up and 
purification. It is achieved using inexpensive reagents and apparatus. The idea of 
incorporating this into a continuous-flow system would provide a cost-effective 
purification stage that is continually replenished. This is advantageous compared 
to commonly used supported-reagents or scavengers as these get depleted over 
time. 
 
Strategies to achieve liquid-liquid extraction in continuous-flow already exist using 
the selective wetting of materials in order to generate membranes. These are 
impermeable to aqueous solutions but permeable to organic solutions, thereby 
affording an easy separation (one such material is expanded, porous PTFE). One 
of the drawbacks to this method is that if the flow rates differ too much, or the 
combination of the flow rates is either too high or too low then inefficient 
separation of the phases can be seen.174 Another drawback to this is that the 
pressure differential across the membrane needs to be controlled so as not to 
damage the physically weak structure. 
 
An alternative to this technique is to adapt the batch protocol of gravity-based 
separations in a way that enables their use in a continuous flow system. The idea 
behind this is that the organic stream is mixed with an aqueous stream that is used 
to quench the reaction and/or extract any aqueous-soluble by-products. After 
being thoroughly mixed the biphasic mixture enters a separation chamber. Here 
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the mixture will settle out with the denser phase being at the bottom of the 
chamber and able to leave from there. The less dense phase is closer to the top 
and can be pumped out from there. By controlling the pump rate, the position of 
interface of these two phases can be managed but this requires the strict 
monitoring of that position, to ensure that the phases cannot enter the wrong 
outlets. 
 
The notion behind the system developed for this project is that the position of 
interface is tracked through the use of a ‘computer-vision’ system that monitors the 
position of a float that sits at the liquid-liquid interface. This float was made up of a 
mixture of plastics. It was formed using a 210 mg piece of a the green plunger 
from a Norm-Ject 1 mL PP/PE disposable syringe, along with a 67 mg piece of a 
green Keck clip (made of polyacetal). The material from the plunger is less dense 
than water and the material from the Keck clip is more dense than 
dichloromethane. When fused together these sit at the interface position between 
an aqueous solution and dichloromethane. As the computer ‘vision-system’ 
monitors the position of this float it feeds information back in order to affect the 
speed of the pump that is removing aqueous material from the separation 
chamber. The upper and lower bounds can be set prior to beginning a run using 
the flow system and this allows the computer to be told what parameters that the 
float needs to be kept between. The separation chamber in this apparatus was the 
barrel of a 6 mL disposable syringe and the ideal point was marked as midway. If 
the float is above the upper bound (meaning that there is more dichloromethane 
than aqueous solution) then the aqueous outflow is reduced to 0 mL min-1; at the 
ideal point then the aqueous outflow is around 1 mL min-1 and as the lower bound 
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is approached (meaning that there is more aqueous solution than 
dichloromethane) the pump speed can increase up to a maximum speed of 9.9 mL 
min-1 depending on the severity of the situation. 
 
 
 
 
 
 
 
Figure 2.20: General schematic for the gravity-based liquid-liquid separator in continuous-flow. 
Taken with permission from reference 175. 
 
The use of this continuous flow system meant that any reaction performed needed 
to meet a number of parameters: 
• The reagents and products formed from this reaction must be soluble in 
dichloromethane. Dichloromethane was chosen as the solvent because it 
is non-flammable and the system contained improvised, electronic circuits 
that could spark.  
• During the course of the reaction no precipitate should form, nor should 
any gels. 
• The aqueous phase must fully extract any reagents that had been present 
in excess as well as any side products formed during the course of the 
reaction. 
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• The reaction needed to progress to completion at room temperature as the 
necessary equipment (e.g. back-pressure regulator) for high temperature 
reactions was not available at the time. 
 
Reactions that were considered for this system were tested and optimised in 
micro-scale batch reactions and were followed by TLC every minute for ten 
minutes. The results from this were then analysed and if the reaction had gone to 
completion then the quench/extraction process was tested and after this the 
organic material was concentrated under reduced pressure and then analysed by 
1H-NMR to determine the success of the extraction. If the reaction successfully 
passed through these two stages then there was a possibility of using it in the 
continuous flow system. 
 
2.6.3. Testing Reactions for their Suitability for the Continuous-Flow 
System 
Reactions that went to completion under these micro-scale batch conditions were 
only characterised by 1H-NMR. Any reaction that was successful and used in the 
continuous-flow system would then be fully characterised. 
 
 
 
 
 
Scheme 2.50: Flow chemistry test reaction between benzaldehyde (56) and methyl carbazate 
(316). 
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The first reaction tested for its suitability was the reaction between aldehydes and 
methyl carbazate (316). This would make use of excess carbazate to react with 
the aldehyde. The carbazate compound was basic (the pKa of similar compounds 
is around 13 with phenyl hydrazinecarboxylate possessing a pKa of 13.6).176 
Because of this it was thought that the excess carbazate would be extracted 
through the use of aqueous acid. This would protonate the carbazate and the 
resulting salt would then be water-soluble and enter the aqueous phase. It was 
thought that the product resulting from this reaction would not be extracted as it 
would be less basic (due to the loss of the terminal amine) and any protonation 
would be less rapid than with the starting material. 
 
The aldehyde used for the test reaction was benzaldehyde (56). 0.5 mL of a 0.25 
M benzaldehyde solution was mixed with 0.5 mL of a 0.5 M methyl carbazate 
solution and this was monitored every minute by TLC for twenty minutes. 
Unfortunately the reaction did not go to completion in this time frame. A paper 
published in 2008 included this reaction in their synthetic pathway and they used 
an acid catalyst in this reaction.177 In an effort to replicate this, the reaction was 
repeated but using 12.5 mg of pyridinium para-toluenesulfonate (PPTS), a weak 
acid catalyst. This reaction successfully went to completion in two minutes but 
began to form a precipitate after five minutes. This was an issue as precipitation 
could cause clogging of the tubing. The precipitate that formed did not readily 
dissolve in a variety of solvents and so this issue could not be achieved through 
dilution or a solvent mixture being used. 
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In an effort to prevent precipitation the mass of the acid catalyst used was reduced 
to 2 mg. This reaction took four minutes to go to completion but no precipitate 
formed even after standing for 20 minutes. It is possible that the precipitate that 
was forming was the protonated carbazate but no spectroscopic data was 
obtained on this compound.  
 
Due to this success the work-up procedure was tested on the reaction mixture. 
The work-up was completed using 2.5 mL of 1 M phosphoric acid. The biphasic 
mixture was vigorously shaken for 30 seconds and then the organic phase was 
concentrated under reduced pressure and analysed. This showed that the reaction 
was successful and the extraction was also successful as only the desired product 
was present in the 1H-NMR spectrum. The isolated yield of this reaction was 92%.  
 
In an attempt to speed up the reaction further another reaction was set up using 
the same volumes and concentrations of benzaldehyde and methyl carbazate but 
using 4 mg of PPTS. It was hoped that this quantity of PPTS would be enough to 
increase the rate of reaction but not so much that issues of precipitation were 
seen. The reaction went to completion in 2 minutes and again no precipitate was 
seen even after 20 minutes of standing. The reaction was worked up using 1.5 mL 
of 1 M phosphoric acid and again this proved successful in extracting the excess 
reagent. This gave a 95% isolated yield.  
 
The 2008 paper by He and Lam discussed the synthesis of these compounds in a 
reaction scheme they had developed towards the synthesis of 3-substituted and 
3,3-disubstituted 1,2-dialkyl-pyrazolidine-3,5-diones. The synthesis of these 
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compounds were completed using solid supports and microwave reactors and the 
reason for their synthesis was their proven antimicrobial activity.177 The 
development of a continuous-flow synthesis of the carbazate imine, incorporating 
an inline liquid-liquid extraction, might enable a complete multistep flow synthesis 
of these interesting compounds to be realised. 
 
The hydrazone carbamates formed in the reaction between aldehydes and methyl 
carbazate do not only have a use as precursors for further reactions but phenolic 
hydrazone carbamates have been shown to possess an inhibitory effect on MIF 
tautomerase.178  
 
In a similar field, the reaction of amines and isocyanates was examined using 
benzylamine and 2-chlorophenylisocyanate.179 In this situation the amine would be 
in excess and, due to the basicity of these compounds, it was thought that 
extraction using aqueous acid would be successful. As with the previous test, it 
was theorised that the product would be less basic than the amine due to the loss 
of the free amine group.  
 
 
 
 
 
Scheme 2.51: Flow chemistry test reaction between 2-chlorophenyl isocyanate (318) and 
benzylamine (319). 
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The reaction was first set up using 1 mL of a 1 M solution of benzylamine (319) 
and 1 mL of a 0.5 M solution of 2-chlorophenyl isocyanate (318). The reaction was 
monitored every minute by TLC for 3 minutes. Analysis would have gone on for 
the full 10 minutes but after three minutes a large quantity of precipitate was seen 
in the reaction vessel. TLC analysis showed that the reaction had gone to 
completion in 1 minute. The reaction caused some initial boiling of the solvent due 
to its exothermic nature. 
 
In an attempt to prevent the formation of the precipitate the reaction was set up 
identical to the previous one but an extra 1 mL of dichloromethane was added to 
dilute the reaction mixture. The reaction went to completion in 2 minutes this time 
but a precipitate began to form after 5 minutes and by 7 minutes was at the same 
stage as the previous test.  
 
Various solvents were tested to dissolve the precipitate and the one that 
succeeded was butanol. As butanol is not miscible with water there was the 
potential to use that in the flow system if needed. However, when the reagent 
solutions were made up with butanol and the two solutions added together, no 
reaction was seen by TLC. 
 
In an attempt to encourage the reaction to proceed, but to also keep any 
precipitate from forming, the reaction was run using a 3:1 mixture of 
dichloromethane and butanol. This showed progress of the reaction but full 
consumption of the starting material was not seen after twenty minutes; however 
no precipitate formed. Butanol seemed to be a good solvent to dissolve the 
		
Results	and	Discussion	–	Continuous-Flow	Chemistry	System	 		 	
163	
precipitate but not a suitable solvent for the reaction, possible due to hydrogen-
bonding between the reagents and the solvent preventing the reaction from taking 
place. 
 
In an effort to overcome this various other solvents were tested. Toluene, acetone, 
ethyl methyl ketone, diethyl ether and diethyl carbonate were all used; however in 
all five cases a precipitate formed meaning that under these conditions the 
reaction was not suitable for use in the continuous-flow system. 
 
Rather than proceed with the successful reaction between aldehydes and methyl 
carbazate (316) this reaction was placed on hold for now. The reason for this was 
that the work up involved the use of phosphoric acid and there was concern that 
this would corrode the pump being used to remove the aqueous solution. Due to 
this concern various reactions were investigated that would use a basic work-up 
solution. 
 
The first concept tested was to perform a Pinacol coupling in continuous flow. This 
could be achieved using benzaldehyde along with titanium tetrachloride and zinc, 
to generate the low-valent titanium II species. The concern with this reaction was 
how to extract the metal reagents. Rather than attempt the reaction followed by a 
quench/extraction step, a solution of titanium tetrachloride and zinc in 
dichloromethane and tetrahydrofuran (THF) was made up and the extraction 
techniques were tested solely on this.  
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The first extraction technique attempted was the use of ethylenediamine 
tetraacetic acid disodium salt (EDTA·2Na). The aim was to produce a 2 M solution 
of this in water, however due to a solubility issue this was not achieved. Because 
of this a 0.5 M solution of EDTA·2Na in water was attempted but again this did not 
fully dissolve; however a 0.5 M solution of EDTA·2Na in 2 M sodium hydroxide 
solution was successfully made. 1 mL of this solution was added to 1 mL of the 
TiCl4/Zn solution to test the quench/extraction step but a precipitate formed 
meaning that this method wasn’t suitable for use in the flow system. 
 
Rochelle’s salt (sodium potassium tartrate) is a common metal-chelating agent 
and so it seemed plausible to make use of this during the work-up procedure. A 2 
M solution of this in water was made up and then 1 mL of the Rochelle’s salt 
quench solution was added to 1 mL of the TiCl4/Zn solution. No precipitate formed 
but the solution did become a very thick gel. Attempts to dilute this were made with 
the aim of reducing the viscosity of the gel; however these efforts were 
unsuccessful and the reaction was left for the time being. 
 
Previously work had been completed using a similar continuous flow system on 
the protection of aldehydes with 1,3-propanedithiol.180 
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Scheme 2.52: Ley and co-workers continuous-flow reaction between aldehydes and 1,3-
propanedithiol (321). 
 
One possibility was to extend this to the use of 1,2-ethanedithiol. This reaction was 
completed under the same conditions as those reported in Ley and co-workers 
2012 paper. Thiols can be extracted from the organic phase through the use of 
aqueous hydroxide solution and this was the method of extraction utilised by Ley.  
 
 
 
 
 
 
Scheme 2.53: Flow chemistry test reaction between benzaldehyde (56) and 1,2-ethanedithiol 
(323). 
 
0.5 mL of a 0.5 M solution of benzaldehyde was mixed with 0.5 mL of a 1 M 
solution of 1,2-ethanedithiol and 0.75 M solution of BF3·THF. This reaction was 
followed by TLC for ten minutes and this showed that the reaction had gone to 
completion after 1 minute. To quench and extract this reaction 1 mL of 2 M sodium 
hydroxide solution was added. This was a highly exothermic step but analysis of 
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the organic phase showed the successful purification of the desired product. The 
reaction was completed again under identical parameters but was monitored every 
10 seconds for 1 minute by TLC. This showed that the reaction went to completion 
in 20 seconds. In an attempt to further this reaction 1,2-ethanedithiol was tested 
with acetophenones and acetoacetates.  
 
 
 
 
 
Scheme 2.54: Flow chemistry test reaction between acetophenone (325) and 1,2-ethanedithiol 
(323). 
 
The reaction between acetophenone and 1,2-ethanedithiol was set up using 
identical conditions as described for the reaction between 1,2-ethanedithiol and 
benzaldehyde. This was monitored by TLC every minute for 10 minutes but by this 
time the reaction had not gone to completion. In an attempt to increase this 
reaction rate the concentrations of the starting reagents were all doubled. Hence 
0.5 mL of a 1 M solution of acetophenone and 0.5 mL of a 2 M solution of 1,2-
ethanedithiol and 1.5 M solution of BF3·THF were mixed together. This was again 
monitored every minute for 10 minutes by TLC, and again the reaction had not 
gone to completion in this time frame. Due to this the concentrations of BF3·THF 
and 1,2-ethanedithiol were again doubled. Once the reaction was set up under 
these conditions then the reaction went to completion in 1 minute. The work up 
was completed using 4 mL of 2 M sodium hydroxide solution (the volume was 
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increased due to the increased concentration of 1,2-ethanedithiol) and this proved 
successful, though again the work up proved to be exothermic. 
 
The successful conditions used in the protection of ketones was attempted with 
the protection of acetoacetates. This meant that 0.5 mL of a 1 M solution of benzyl 
acetoacetate was mixed with 0.5 mL of a 4 M solution of 1,2-ethanedithiol and a 3 
M solution of BF3·THF. The reaction was monitored every minute for ten minutes 
by TLC and this showed that the reaction had gone to completion in 1 minute. The 
quench/extraction was achieved through the use of 4 mL sodium hydroxide 
solution; however a white precipitate formed during this stage meaning that it was 
unsuitable for use in the continuous flow system. 
 
 
 
 
 
 
Scheme 2.55: Flow chemistry test reaction between carbonyl groups and ethylene glycol (335). 
 
All three of these reactions were tested with ethylene glycol rather than 1,2-
ethanedithiol, using triethyl orthoformate as a dehydrating agent; however in all of 
these cases the reaction did not go to completion within a ten-minute time frame. 
 
One more reaction was tested after this for its suitability for use in the continuous 
flow system and that was the halogenation of enaminones.  
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2.6.4. Halogenation of Enaminones in Continuous-Flow 
The success of this reaction led to its use in the continuous-flow system. Due to 
this, all products synthesised, and the corresponding starting materials were fully 
characterised. Previous products, from test reactions, were only characterised by 
1H-NMR. 
 
Enaminones are known to be active toward electrophiles and the carbon that is in 
the β-position to the nitrogen atom has been well documented in terms of its 
nucleophilicity.181 One of the reactions that is commonly seen at this site is 
halogenation. The concept of completing this reaction using continuous flow was 
an attractive one due to the reported rapid reaction rates182 and so work began 
investigating the reaction using N-bromosuccinimide (NBS) and N-iodosuccinimide 
(NIS) as the halogenating agents, which would be in excess of the enaminone.  
 
The logic behind using these compounds was that the excess reagent could be 
reduced to succinimide through use of aqueous sodium thiosulfate solution. The 
resulting succinimide could then be extracted into the mildly alkaline aqueous 
phase. Initially bromination with NBS was explored.  
 
The first step in this reaction was to synthesise some enaminones that could be 
used as test compounds. One of the key thoughts behind this synthesis was to 
begin by developing enaminones that were very unlikely to react in any other way 
other than bromination of the alkene carbon in the β-position with regards to the 
nitrogen atom. A number of enaminones that matched this criterion were 
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synthesised as well as a selection that were more synthetically interesting (e.g. 
those that possessed a chiral centre, a furanyl group or a pyridine ring).  
 
The enaminones (331a-n) were synthesised using a facile condensation reaction 
between the symmetrical diketones: dimedone (329a), cyclohexanedione (329b) 
and 2,4-pentanedione (329c). These were reacted with a series of amines (319 
and 330a-g) and in the majority of cases were recrystallised from toluene giving 
high yields of the desired compound with high levels of purity. 
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Scheme 2.56: General reaction for the formation of enaminones. 
 
 
 
Figure 2.21: Enaminones synthesised. 
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saturated ammonium chloride solution to remove the excess amine. Subsequent 
washing of the organic phase, drying over magnesium sulfate and concentration 
under reduced pressure yielded a pure compound (purity determined from 1H-
NMR analysis). 331n did not yield a solid and after an aqueous work-up with 
ammonium chloride did not yield a pure compound. 1H-NMR spectra of this 
compound showed a number of trace impurities within this compound meant that it 
would require purification before use. Due to the number of other materials to work 
with this was not a priority.  
 
 
 
 
Scheme 2.57: Bromination of enaminones using NBS. 
 
Compound 331a was used to optimise the reaction conditions using NBS. The 
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showed the presence of some succinimide still, along with the desired product and 
a trace impurity.  
 
Upon repeating the reaction using identical conditions but quenching at two 
minutes the trace impurity wasn’t present in the 1H-NMR spectrum (though 
succinimide was still an issue). This suggested that the reaction is time dependent 
and would begin to overbrominate should the reaction be left for too long. In an 
effort to test this a solution of 0.1 M 331a was mixed with 0.15 M NBS and the 
reaction was left for 2 hours. After this time had elapsed the reaction was 
quenched in the normal manner and the organic material analysed. This showed 
only the undesired product. The time dependency of this reaction made it all the 
more interesting to study and also meant that the reaction was more suitable to 
continuous flow than initially thought. 
 
The issue that remained however was the presence of the succinimide after the 
reaction. It was obvious that some succinimide was being removed into the 
aqueous phase as the integration of the CH2 peak showed fewer equivalents than 
went into the reaction. In an attempt to rectify this situation the volume of aqueous 
solution used in the quench/extraction step was increased. This had a positive 
effect in the sense that the integrated value of the succinimide CH2 peak 
decreased; however the effect was very slight. 
 
A serendipitous error of making up the aqueous solution without the presence of 
sodium bicarbonate showed that this did not have either a positive or an adverse 
effect on the removal of succinimide. This showed that the bicarbonate did not 
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generate a strong enough alkaline solution to remove the succinimide. The pKa of 
succinimide is 9.6183 and this is too high to be deprotonated by bicarbonate 
(carbonic acid), which has a pKa of 6.4. The pKa of carbonate (bicarbonate) is 10.3 
and this led to use of a stronger base to deprotonate the succinimide.  
 
A change of base from sodium bicarbonate to potassium carbonate showed a 
significant decrease in the intensity of the succinimide peak upon analysis of the 
organic material. Coupling this with the idea of using a more dilute aqueous 
solution to ensure that the aqueous phase wasn’t becoming saturated. A new 
aqueous phase was made up of 0.1 M sodium thiosulfate/potassium carbonate. 
This was used to quench/extract the reaction after two minutes had passed and 
this showed only a minor succinimide peak in the product.  
 
In all these cases the volume of the organic solution and the volume of aqueous 
solution were matched. In the next trial run the volume of the aqueous solution 
was four times greater than that of the organic solution. After shaking the biphasic 
mixture vigorously and separating the phases the organic material was dried, 
concentrated and analysed. This showed that all succinimide had been removed 
from the reaction.  
 
This success meant that the reaction could also be tested using NIS. The main 
issue seen with NIS was that it was even less soluble than NBS in 
dichloromethane. The maximum concentration of NIS obtained was 0.021 M. 
Hence 1.5 mL of 0.021 M NIS was reacted with 1 mL of 0.03 M 339a solution. This 
was monitored by TLC every minute for ten minutes. At the end of this time period 
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TLC analysis showed that the reaction had not gone to completion. In an effort to 
change this, the volume of NIS was increased (as the concentration could not be 
increased). In a second attempt the same volume of 331a solution was used but 
this was with 2.9 mL of 0.021 M NIS solution. This was again monitored by TLC 
and it was found that this reaction went to completion within 2 minutes. This was 
quenched using the potassium carbonate/sodium thiosulfate mixture and the 
succinimide was successfully extracted. Using this volume ratio with NBS rather 
than NIS resulted in the major product being the presumed overbrominated 
compound. In an effort to reduce any chance of overbromination the concentration 
of NBS and enaminone was altered. The reaction was trialed with 1 mL 0.1 M 
enaminone and 1 mL 0.106 M NBS. This reaction still went to completion in the 
same time frame and aqueous extraction was still successful using 4 mL of a 0.1 
M solution of sodium thiosulfate/potassium carbonate. 
 
A further test was performed using 1-butyl-3-methylimidazolium tribromide 
([Bmim]Br3) as the halogenating agent. This is an ionic liquid and there have been 
several reported cases where this has been used successfully in the bromination 
of phenols and activated aromatics.184 This was tested and quenched in the same 
manner as had been found to be effective for NBS. 1H-NMR analysis showed that 
the desired compound was present (after three minutes of reaction time) but that 
there was some of the imidazolium reagent present in the organic phase. This was 
put on hold for the time being and attention focused on the use of NBS as the 
halogenating agent.  
 
		
Results	and	Discussion	–	Continuous-Flow	Chemistry	System	 		 	
175	
With this information in hand the time came to introduce this reaction to the 
continuous flow system, but before this could be done, the three pumps being 
used needed to be calibrated in order to determine if their flow rates matched up 
with what was depicted on the control panel. Both the Milton Roy ConstaMetric III 
Metering pump and the LKB Bromma 2150 HPLC pump matched in terms of their 
theoretical pump speed and their actual pump speed. With the Waters 510 HPLC 
pump however this was not the case. Instead the actual pump speed was 2.08 
times faster than the indicated pump speed. 
 
Graph 2.1: Calibration of the Milton Roy ConstaMetric III Metering pump. 
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Graph 2.2: Calibration of the LKB Bromma 2150 HPLC pump. 
 
 
Graph 2.3: Calibration of the Waters 510 HPLC pump. 
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A completely linear plot was obtained with all three pumps and this meant that the 
pump settings could be adjusted to produce a flow rate of 1 mL min-1. The initial 
test of the continuous flow system was completed using enaminone 331a as the 
conditions had already been optimised in batch. The 0.10 M solution of enaminone 
331a was placed in an injection loop of 3.0 mL length whilst the 0.106 M solution 
of NBS was placed in an injection loop of 4.1 mL. The NBS was injected into the 
flow stream 20 seconds prior to the addition of the enaminone compound as this 
meant that there was a 20 second overlap at the start of the reaction and a 46 
second overlap at the end of the enaminone injection to ensure that no enaminone 
was without NBS to react with. Both the enaminone stream and the NBS reagent 
stream were pumping at 1 mL min-1. These both entered a reaction loop of 4.7 mL 
giving a reaction time of 2 minutes and 21 seconds and at the end of this loop the 
organic stream immediately encountered the aqueous stream to quench the 
reaction (running at 4 mL min-1). This biphasic mixture was passed into a mixing 
column (made up of several small PTFE coated stirrer bars that were placed in a 
glass column and stationed over a magnetic stirrer. This was set to full speed and 
enabled the rapid mixing of the two phases. After passing through this column the 
tubing continued on to a separation vessel, which was being monitored by the 
webcam system developed for this purpose (using a Python script, incorporating 
the OpenCV library).  
 
Initial tests with the webcam system showed success for the first four minutes but 
then as a more intensely coloured solution entered the separation vessel the 
webcam proved no longer able to detect the float. This issue was rectified by 
relaxing the parameters responsible for determining the hue value of the selected 
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colour (i.e. the detection was made more tolerant to the presence of other 
colours). When this was completed the experiment was repeated using identical 
conditions and proved to be far more successful. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.22: NMR spectra of the reaction product with extraction using the aqueous solution (in 
red) and without extraction (in black). Taken with permission from reference 175. 
 
In an effort to show that the succinimide was successfully being extracted by the 
aqueous solution the reaction was completed both with and without the aqueous 
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extraction. The 1H-NMR spectra of both these runs were then compared as is 
shown in Figure 2.22. The spectrum in red corresponds to the run that included 
extraction with the aqueous solution. The spectrum in black corresponds the run 
that bypassed the aqueous extraction. 
 
The yield of the brominated compound was pleasingly high and after removal of 
solvent showed very high purity, meaning there was no need for purification steps, 
something that would make this especially useful if the compound was taking part 
in a multi-step reaction using a continuous flow system. 
 
Enaminones 331a-l were reacted in the continuous flow system using NBS as the 
halogenating agent. In some cases the flow rate had to be adjusted slightly due to 
trace quantities of overbrominated product being present or due to the leftover 
presence of a trace of starting material; however in all cases the flow rate was very 
close to 1 mL min-1 (for full details please see experimental section 5.7.). Several 
flow runs were completed in each laboratory session and despite never 
dismantling the apparatus there was no cross contamination of compounds seen. 
At the end of each day distilled water was pumped through the aqueous-out pump 
to avoid the settling or build up of any particulates that had been removed. It was 
noted that the aqueous waste developed a fine yellow precipitate upon standing, 
which could perhaps be elemental sulfur from the thiosulfate. 
 
The main drawback to this set up is that if the colouration exceeds beyond the 
parameters listed or if the solutions were the same colour of the float then the 
position of the float may be lost by the system and a manual takeover needed. 
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Despite this it is possible to adjust the hue tolerances for other shades and colours 
and work would be needed to determine the most suitable one. Although this is the 
case the parameters used in this set up proved very tolerable to intense yellow 
solutions. In Figure 2.23 real time images can be seen during the bromination of 
enaminone 331i. This was one of the most intensely coloured compounds. 
Camera images (i) show the float as being magnified due to the cylindrical vessel 
whilst the processed images (ii) show (in white) what the computer programme 
identifies as possessing the correct hue. The small blue circles on the image 
represent the upper and lower bounds. These bounds are limits set by the user to 
represent the highest and lowest position that the float can reach. The system then 
utilises the position of the float in reference to these bounds to determine the 
pump speed. 
 
 
 
 
 
 
 
Figure 2.23: (i) Camera images and (ii) processed images focusing on the separating vessel at a) 
0 mins, b) 5 mins 28 secs, c) 7 mins 43 secs and d) 10 mins 17 secs. Taken with permission from 
reference 175. 
 
Currently, work is taking place introducing some of the alternative reactions tested 
to the continuous flow set up (see Figure 2.20) including the use of NIS as a 
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halogenating agent for enaminones; the reaction between aldehydes and methyl 
carbazate and the protection of aldehydes and ketones with 1,2-ethanedithiol. 
Some interest is also focused on the use of the continuous flow system in a multi-
step reaction sequence to synthesise synthetically interesting and potentially 
biologically active compounds. 
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2.7. Future Work 
Whilst progressing through these projects a number of questions and future 
possibilities have arose that could be investigated in the future. During the 
synthesis of the spiro compound the main issue seen was the hydrogenation of 
the alkyne. As described in section 2.1. Dr. Mei Shi (a visiting scholar from 
Nanjing) discovered that this was an extremely time sensitive reaction that was 
also probably dependent on the surface-area-to-volume ratio. In order to 
overcome this, one idea is to combine this project with the use of a continuous 
flow system. This would use a liquid-gas reactor and would allow for the fine 
control of the residence times where the organic solution containing the substrate 
and the catalyst would be in contact with the hydrogen gas (under pressure). This 
could then be immediately quenched and ideally undergo an extraction/purification 
step upon leaving the reaction vessel providing the desired product. Optimisation 
of the conditions within the continuous flow system would obviously require some 
work. Prior to this (and the changing of the reaction vessel) the other reactions 
would be completed (and in some cases are in the process of being completed). 
This would mean the flow system would be tested in terms of gravity-based liquid-
liquid inline extraction using both an acidic and a basic quench/extraction solution.  
 
A lot of work has been completed on the tetrahydropyran methodology over the 
course of these projects and it would be extremely interesting to apply this to 
natural product synthesis. A number of examples that could potentially be 
achieved without too much change to the method include (-)-centrolobine (19),38 
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FR901464 (333) (isolated from Pseudomonas sp.)185 or diospongin A (334), a 
natural product demonstrating anti-osteoporotic activity.186 
 
Figure 2.24: Potential natural products for future synthetic investigations. 
 
There is also the possibility of adapting this methodology in two ways. The first 
would use methyl cyanoacetate rather than dimethyl malonate (276) to incorporate 
a nitrogen atom and this could open up a pathway to the stereoselective synthesis 
of variously substituted piperidines. Another interesting possibility would be to look 
at the use of pyrrole rather than furan as the electron-rich substituent to facilitate 
epimerisation under acidic conditions. This would not only allow for the 
incorporation of nitrogen into any further transformations of the group but highly 
functionalised and substituted pyrroles can easily be synthesised through the 
Barton-Zard reaction using isocyanates and nitroalkenes.187 
 
Alongside this it would be possible to synthesise the 2,4-disubstituted 
tetrahydropyrans and the 2,4,5-trisubstituted tetrahydropyrans enantioselectively. 
This could be achieved by an asymmetric Michael reaction and a number of these 
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have been described in the literature using dimethyl malonate. One example is 
shown in work by He and co-workers using dimethyl malonate and chalcones in 
2014.188 This employs cinchona alkaloids-based bifunctional tertiary amine-
thioureas that possess multiple hydrogen-bond donors to achieve the 
enantioselectivity. 
 
I would also like to continue the development of the Grignard reagent and take the 
iodide described in Section 2.2. through to the coupling step with various 
aldehydes, imines or Elman’s sulfinamides. This could be completed either as the 
Grignard reagent or, via a transmetallation reaction, as the organozinc compound. 
I would also like to revisit the cyclisation step in the synthesis of difuranyl 
tetrahydropyrans (see Section 2.5.). This would allow the investigation of what is 
happening during the reaction (i.e. is selective decomposition being seen) whilst 
also allowing further investigation into the aldehyde produced as a side product as 
this could potentially have use in the synthesis of the corresponding 
tetrahydropyran. 
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3. Conclusions 
This thesis postulated that the previous work within the group on the acid-
catalysed stereoselective synthesis of tetrahydropyrans could be built upon and 
expanded. Initially this was to be completed by looking at the synthesis of 2,4-
disubstituted tetrahydropyrans; before observing the more interesting double 
diastereoselectivity of the 2,4,5-trisubstituted tetrahydropyrans. Another realm that 
was investigated during the course of this work was the development of a suitable 
organometallic coupling compound that could be involved in reactions with 
aldehydes, imines and sulfinamides with the aim being focused on the 
stereoselective synthesis of both tetrahydropyrans and piperidines. Finally 
investigations were conducted into the development of a continuous-flow liquid-
liquid extractor that could be used effectively with reactions to yield only the 
desired product, in other words the excess material and any by-products/impurities 
would be extracted from the product into the aqueous stream. 
 
The stereoselective synthesis of 2,4-disubstituted and 2,4,5-trisusbtituted 
tetrahydropyrans was achieved through the use of an acid catalysed cyclisation 
reaction. These reactions were both under thermodynamic control and the most 
favoured diastereoisomer was that which placed all the substituents in the 
equatorial position on a chair conformer. This stereoselectivity came from the 
reversibility of the cyclisation reaction under acidic conditions and the ability of the 
furanyl chiral centre to epimerise in this environment. Base cyclisation showed that 
these reactions needed acidic conditions in order to facilitate the epimerisation and 
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so under basic conditions no stereoselectivity in the cyclisation was observed. 
Work was also completed to enable single crystal X-ray structures to be obtained 
of the major tetrahydropyran diastereoisomer in order to confirm the 
stereochemical findings beyond any doubt. 
 
This work contributes well to the literature because this is an efficient route to 
tetrahydropyrans, an area of research that has received much attention over the 
years and an area that remains of key importance due to the number of natural 
products that possess the moiety. The review papers of Clarke and co-workers in 
2006189 and 201484 and the review by Perry, Rychnovsky and Sizemore in 201496 
all show the amount of effort and research that is going into this area and it is 
generally focused on the Prins cyclisation, hetero-Diels-Alder reaction, oxy-
Michael cyclisation and metal-catalysed cyclisation. The exploitation of the 
epimerisable nature of the furanyl group under acidic conditions has received very 
little attention outside of the group and yet has the potential to be used in 
stereoselective syntheses of natural products due to the ability of the furanyl group 
to undergo a multitude of transformations reported in the literature over the past 
century.  
 
Despite its potential uses the compound does need to be subjected to acidic 
conditions and may not be suitable for some functionalities at late stages in a total 
synthesis. Another drawback to the synthesis described in this thesis is that 
aromatic compounds are always present in the 4-position on the tetrahydropyran 
ring. This is an obvious drawback if this is an undesired group in the desired 
compound. 
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To approach the synthesis of tetrahydropyrans via an alternative route, attempts 
were made to synthesise an appropriate organometallic coupling compound that 
would introduce the furanyl chiral centre. Work was unsuccessful beginning with 
benzotriazole but more success was seen starting with γ-butyrolactone and 5-
methylfuran. This synthetic route relied on more traditional chemistry and yielded 
the iodide in a good overall yield; however the actual Grignard formation and 
reaction have yet to be properly tested. Should these steps proceed successfully 
then the route would theoretically be an efficient way to reach substituted 
tetrahydropyrans and piperidines. Again this knowledge could be used in the 
stereoselective synthesis of the tetrahydropyran moiety when engaging in the total 
synthesis of natural products/biologically active compounds; however this depends 
on whether any issues are seen in the Grignard reaction or subsequent 
cyclisation. 
 
In an area away from stereoselective synthesis this thesis has reported on the 
successful development of a continuous-flow liquid-liquid extractor that has been 
used in the bromination of enaminones, where both quenching the reaction and 
extracting the succinimide side product were completed with a suitable aqueous 
stream. Work has also been completed on the development of conditions for a 
number of other reactions that could be applied to this system and these are 
currently going to be tested, if they are not in the process of being tested already.  
 
The area of flow chemistry is receiving a lot of attention in the literature, especially 
from the Ley group in the United Kingdom. The system discussed in this thesis is 
focused on inline liquid-liquid extraction and the key concept is that it is monitored 
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via a computer system meaning that almost the entire process (excluding the 
removal of the flask containing the product and the insertion of starting materials) 
is automated and can be constructed from relatively inexpensive technologies. 
The paper reporting this information contains the details needed to set up a similar 
system and this means that other researchers can develop this technology 
themselves.  
 
Overall the original aims of this thesis have been met and the research has 
contributed knowledge to the current literature, with potential applications for future 
work as discussed throughout Section 2. Some of this work has already been 
started within the group and will be reported on in due course. 
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5. Experimental 
5.1. General Experimental Information 
Unless otherwise specified, all reagents were purchased from commercial 
suppliers (Sigma-Aldrich; Fisher Scientific – Fisher Chemical/Acros Organics; Alfa-
Aesar; TCI; VWR Chemicals) and were used as received with no further 
purification.  
 
Methanol was purchased from VWR Chemicals (UN1230 – 2.5 L). Ethanol was 
purchased from Fisher Chemical (E/0650DF/17 – 2.5 L). Dichloromethane was 
purchased from VWR Chemicals (UN1593 – 2.5 L). Toluene was purchased from 
Fisher Chemical (T/2300/17 – 2.5 L). Hexane was purchased from Sigma Aldrich 
(34859 – 2.5 L). Petroleum ether 40 - 60°C was purchased from Fisher Chemical 
(P/1440/17 – 2.5 L). Diethyl ether was purchased from Fisher Chemical 
(D/2400/17 – 2.5 L). Ethyl acetate was purchased from VWR Chemicals (UN1173 
– 2.5 L). Acetonitrile was purchased from Sigma Aldrich (34851 – 2.5 L). 
Tetrahydrofuran was purchased from Fisher Chemical (T/0701/17 – 2.5 L). 
Anhydrous tetrahydrofuran was purchased from Acros Organics (3484 50010 – 1 
L). Dimethyl sulfoxide was purchased from Alfa Aesar (A13280 – 500 g). Butan-1-
ol was purchased from Acros Organics (1076 90025 – 2.5 L). Chloroform was 
purchased from Fisher Chemicals (C/4920/17 – 2.5 L). Anhydrous 
dimethylformamide was purchased from Acros Organics (3268 70010 – 1 L). 
Transfers of anhydrous solvents were always achieved using a positive pressure 
of nitrogen gas (balloon).  
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Reactions that were being conducted under an inert atmosphere were carried out 
using a positive pressure of dry nitrogen or argon gas (either through use of a 
balloon or through use of a manifold/bubbler apparatus) and glassware for these 
reactions was dried using a heat-gun under a constant flow of the respective gas. 
Grains of calcium hydride, when used in reactions as a desiccant, were obtained 
from freshly ground chunks of the material, which was stored in an airtight 
container under nitrogen. 
 
Column chromatography was carried out using glass columns and compressed air 
at approximately 0.5 bar above ambient pressure. Silica gel used was purchased 
from Grace-Davison (Davisil LC60A 40-63 micron) or from Sigma Aldrich (Merck-
9385 grade silica). Reactions were monitored by thin layer chromatography (TLC) 
and the TLC plates used were Merck Silica-Gel 60 F254, aluminium backed, 
1.005554.0001. Visualisation of the TLC plates was achieved using a vanillin dip, 
potassium permanganate dip, iodine vapour or through use of shortwave 
ultraviolet light (254 nm).  
 
NMR spectroscopy was conducted on Bruker systems (300 MHz: Magnet – Bruker 
Spectrospin 300 MHz/52 mm, Spectrometer – Avance 300), (400 MHz: Magnet – 
Bruker Ascend 400, Spectrometer: Avance III 400). d-Chloroform was purchased 
from Cambridge Isotopes, Andover Massachusetts, USA (99.8% D, DLM-7TB-
100) and was stored over granular anhydrous potassium carbonate (approximately 
5 g was added to each bottle used). d3-Acetonitrile was purchased from Apollo 
Scientific (98.8% D) or Cambridge Isotopes (99.8% D, DLM-21). d4-Methanol was 
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purchased from Cambridge Isotopes (99.8% D, DLM-24-10). d6-Benzene was 
purchased from Sigma Aldrich (99.96% D, 241-061-8). 
 
All NMR data is quoted in parts-per-million (ppm) relative to trimethylsilane (TMS) 
at 0 ppm. 1H-NMR spectra were calibrated in reference to the residual H-solvent 
peak (CDCl3 = 7.26 ppm, CD3CN = 1.94 ppm – central peak of quintuplet, CD3OD 
= 3.31 ppm – central peak of quintuplet, C6D6 = 7.15 ppm). 13C-NMR spectra were 
calibrated in reference to the residual H-solvent peak (CDCl3 – 77.0 ppm – central 
peak of triplet, CD3CN = 1.24 ppm – central peak of septuplet, CD3OD = 49.05 
ppm, central peak of septuplet, C6D6 = 128.02 ppm – central peak of triplet).  
 
Multiplicity is denoted by: d = doublet; t = triplet; q = quartet; m = multiplet; dd = 
double doublet; etc. Coupling constants (J values) are listed in Hertz (Hz) and are 
quoted with averaging between mutually coupling protons. Protons that are 
coupled to two other non-identical protons but with identical coupling constants are 
generally referred to as double doublets rather than triplets (or apparent triplets).  
 
Assignment of peaks in the 1H-NMR spectrum was conducted using chemical-shift 
values, coupling constants, correlation spectroscopy (COSY), total correlation 
spectroscopy (TOCSY), heteronuclear multiple bond correlation (HMBC) and 
heteronuclear single quantum correlation (HSQC). For diastereomeric mixtures, 
where possible, peaks corresponding to particular diastereomers are labeled and 
unless otherwise specified the stereochemistry of each diastereomer is unknown.  
Infrared spectroscopy was carried out using a thin film (evaporated from solution) 
on a Thermo Scientific Nicolet iS10 ATR spectrometer. Mass spectrometry was 
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carried out on a Waters LCMS with electrospray ionisation and a time-of-flight 
(TOF) analyser. 
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5.2. Data for Compounds Synthesised from the 
Azaspiroketal Synthesis  
 
Synthesis of 2-methyl-1-tosylpiperidine (194) 
 
 
 
 
 
 
2-methylpiperidine (1.18 mL, 10.1 mmol, 1.00 eqv.) was dissolved in 
dichloromethane (20.0 mL). To this triethylamine (4.25 mL, 30.5 mmol, 3.02 eqv.) 
and 4-dimethylaminopyridine (65.8 mg, 0.539 mmol, 0.0539 eqv.) were added and 
the reaction mixture was cooled to 0°C. To this a solution of p-toluenesulfonyl 
chloride (2.96 g, 15.4 mmol, 1.52 eqv.) in dichloromethane (10.0 mL) was added 
dropwise over the course of one minute, whilst the reaction temperature was 
maintained at 0°C. After four hours the reaction had reached completion and 2M 
sodium hydroxide solution (20.0 mL) was added to convert the excess p-
toluenesulfonyl chloride to p-toluenesulfonic acid. This was allowed to stir for a 
further 20 minutes. The organic material was washed with 2M sodium hydroxide 
solution (50.0 mL), water (50.0 mL), 2M hydrochloric acid (50.0 mL), water (50.0 
mL) and finally brine (50.0 mL). The organic material was then dried over calcium 
carbonate before being dried under reduced pressure. The product crystallised 
giving cream crystals. 
3
2
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1
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Yield: 97% (2.47 g, 9.75 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 7.70 (J = 8.3 Hz, 
2H, d, H-7), 7.27 (J = 8.3 Hz, 2H, d, H-8), 4.29 – 4.17 (1H, m, H-6e), 3.72 – 3.67 
(1H, m, H-2), 2.97 (J = 2.5, 12.8, 13.2 Hz, 1H, ddd, H-6a), 2.41 (3H, s, H-9), 1.62 – 
1.37 (6H, m, H-3, H-4 and H-5), 1.06 (J = 6.9 Hz, 3H, d, H-1); Melting Point: 55 – 
56 °C (Literature Value: 55 °C); Data in accordance with literature values.1 
 
Synthesis of 4-methyl-1-tosylpiperidine (196) 
 
 
 
 
 
 
 
Experimental procedure followed that described for 194 using: 
4-methylpiperidine (1.20 mL, 10.1 mmol, 1.00 eqv.); triethylamine (4.20 mL, 30.1 
mmol, 2.98 eqv.); 4-dimethylaminopyridine (63.8 mg, 0.522 mmol, 0.0517 eqv.), p-
toluenesulfonyl chloride (2.96 g, 15.4 mmol, 1.52 eqv.) and DCM (30.0 mL). The 
product crystallised giving a white solid. 
 
Yield: 97% (2.51 g, 9.91 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 7.63 (J = 8.3 Hz, 
2H, d, H-5), 7.31 (J = 8.3 Hz, 2H, d, H-6), 3.73 (J = 11.3 Hz, 2H, d, H-4e), 2.43 
(3H, s, H-7), 2.23 – 2.19 (2H, m, H-4a), 1.65 – 1.21 (5H, m, H-2 and H-3), 0.90 (J = 
5.5 Hz, 3H, d, H-1); Melting Point: 83 – 84 °C; Data in accordance with literature 
values.1 
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Synthesis of 3-methyl-1-tosylpiperidine (199) 
 
 
 
 
 
 
Experimental procedure followed that described for 194 using: 
3-methylpiperidine (1.19 mL, 10.2 mmol, 1.00 eqv.); triethylamine (4.25 mL, 30.5 
mmol, 2.99 eqv.); 4-dimethylaminopyridine (79.6 mg, 0.652 mmol, 0.0639 eqv.), p-
toluenesulfonyl chloride (2.96 g, 15.5 mmol, 1.52 eqv.) and DCM (30.0 mL). The 
product crystallised giving a cream solid. 
 
Yield: 96% (2.48 g, 9.79 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 7.63 (J = 8.2 Hz, 
2H, d, H-7), 7.31 (J = 8.2 Hz, 2H, d, H-8), 3.67 – 3.58 (2H, m, H-3e and H-6e), 2.43 
(3H, s, H-9), 2.18 (J = 3.1, 11.3, 11.4 Hz, 1H, ddd, H-6a), 1.85 (J = 10.6, 10.6 Hz, 
1H, dd, H-3a), 1.82 – 1.52 (5H, m, H-2, H-4 and H-5), 0.86 (J = 6.3 Hz, 3H, d, H-1); 
Melting Point: 110 – 111 °C (Literature Value: 110 °C); Data in accordance with 
literature values.2 
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Synthesis of 6-methyl-1-tosylpiperidin-2-one (191) 
 
 
 
 
 
 
2-methyl-1-tosylpiperidine (194) (1.02 g, 4.03 mmol, 1.00 eqv.) was dissolved in 
ethyl acetate (40.0 mL). Water (20.0 mL) was added to this and the biphasic 
mixture was rapidly stirred. Sodium periodate (4.22 g, 19.7 mmol, 4.89 eqv.) was 
added and, once dissolved, ruthenium (III) chloride hydrate (10.3 mg, 0.0497 
mmol, 0.0123 eqv.) was added. After twelve hours the reaction had gone to 
completion and the aqueous phase was washed with ethyl acetate (2 × 50.0 mL). 
The combined organic phases were then washed with water (2 × 50.0 mL) and 
brine (100 mL) before being dried over magnesium sulfate and subsequently 
concentrated under reduced pressure. The crude material was then purified via 
column chromatography using a graduated solvent system reaching a 3:2 mixture 
of petroleum ether and ethyl acetate. The desired product was obtained as a 
colourless oil. 
 
Yield: 33% (357 mg, 1.34 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 7.90 (J = 8.3 Hz, 
2H, d, H-6), 7.29 (J = 8.3 Hz, 2H, d, H-7), 4.83 – 4.72 (1H, m, H-2), 2.53 – 2.29 
(5H, m, H-3e, H-5e and H-8), 1.99 – 1.76 (4H, m, H-3a, H-4 and H-5a), 1.47 (J = 6.6 
Hz, 3H, d, H-1); Data in accordance with literature values.1 
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Synthesis of 4-methyl-1-tosylpiperidin-2-one (197) 
 
 
 
 
 
 
 
Experimental procedure followed matched that described for 191 using: 
4-methyl-1-tosylpiperidine (196) (0.998 g, 3.94 mmol, 1.00 eqv.); sodium periodate 
(4.30 g, 20.1 mmol, 5.10 eqv), ruthenium (III) chloride hydrate (13.7 mg, 0.0665 
mmol, 0.0169 eqv.), water (10.0 mL) and ethyl acetate (35.0 mL). The desired 
product was obtained as a yellow/brown oil. 
 
Yield: 45% (0.475 g, 1.78 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 7.91 (J = 8.3 Hz, 
2H, d, H-6), 7.31 (J = 8.3 Hz, 2H, d, H-7), 4.14 (J = 1.8, 4.7, 12.0 Hz, 1H, ddd, H-
5e), 3.27 (J = 10.3, 12.0 Hz, 1H, dd, H-5a), 2.53 – 2.33 (5H, m, H-3e, H-4e and H-
8), 2.08 – 1.93 (1H, m, H-3a), 1.91 – 1.78 (1H, m, H-4a), 1.50 – 1.34 (1H, m, H-2), 
1.11 (J = 6.8 Hz, 3H, d, H-1); Data in accordance with literature values.1 
 
Alkyne 192 
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1H-NMR (300 MHz, CDCl3): δ 7.36 (J = 1.8 Hz, 1H, d, H-1), 6.32 (J = 1.8, 3.2 Hz, 
1H, dd, H-2), 6.26 (J = 3.2 Hz, 1H, d, H-3), 4.86 (J = 6.7 Hz, 1H, t, H-4), 2.70 (J = 
2.6, 6.7 Hz, 2H, dd, H-5), 1.97 (J = 2.6 Hz, 1H, t, H-6), 0.89 (9H, s, H-9, H-10 and 
H-11), 0.11 (3H, s, Si-Me), -0.01 (3H, s, Si-Me);  
 
Alkyne 192 (0.330 g, 1.32 mmol, 1.00 eqv.) was dissolved in tetrahydrofuran (2.23 
mL). The solution was cooled to −78°C. Once cooled, n-butyllithium solution (2.5 
M in hexanes) (0.700 mL, 1.75 mmol, 1.33 eqv.) was added dropwise over the 
course of two minutes, and the solution was then stirred for 15 minutes. After this 
the solution was warmed to −15°C and stirred for a further 45 minutes. Deuterium 
oxide (0.250 mL, 13.8 mmol, 10.5 eqv.) was added and the solution was stirred for 
one hour whilst warming to room temperature. After this, the solution was diluted 
with ethyl acetate (25.0 mL) and water (25.0 mL). Extraction was performed using 
ethyl acetate (2 × 25.0 mL). The combined organic phases were then washed with 
water (2 × 50.0 mL) and brine (50.0 mL) before being dried over magnesium 
sulfate and concentrated under reduced pressure. 
 
1H-NMR (300 MHz, CDCl3): δ 7.36 (J = 1.8 Hz, 1H, d, H-1), 6.32 (J = 1.8, 3.2 Hz, 
1H, dd, H-2), 6.25 (J = 3.2 Hz, 1H, d, H-3), 4.85 (J = 6.7 Hz, 1H, t, H-4), 2.69 (J = 
1
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2.6, 6.7 Hz, 2H, dd, H-5), 0.88 (9H, s, H-8, H-9 and H-10), 0.10 (3H, s, Si-Me), -
0.02 (3H, s, Si-Me) 
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5.3. Data from Organometallic Coupling Partner 
Synthesis 
 
Synthesis of 1-(ethoxy(5-methylfuran-2-yl)methyl)-1H-benzo[d][1,2,3]triazole (225) 
 
 
 
 
 
5-methylfurfural (222) (2.00 mL, 20.1 mmol, 1.00 eqv.) was dissolved in THF (30.0 
mL). To this was added benzotriazole (223) (6.23 g, 52.3 mmol, 2.59 eqv.), 
ethanol (2.40 mL, 41.1 mmol, 2.04 eqv.), triethyl orthoformate (224) (10.0 mL, 60.1 
mmol, 2.99 eqv.) and sulfuric acid (30.0 µL, 0.563 mmol, 0.0280 eqv.). This 
formed a creamy precipitate that dissolved upon stirring. The reaction mixture was 
stirred at reflux for 36 hours. After this, the reaction mixture was diluted with diethyl 
ether (100 mL) and water (100 mL). Extraction was completed with diethyl ether (3 
× 30.0 mL). The combined organic phases were washed with saturated sodium 
bicarbonate solution (2 × 100 mL) and water (100 mL) before being dried over 
magnesium sulfate and subsequently being concentrated under reduced pressure. 
The crude material was dissolved in petroleum ether (500 mL) and diethyl ether 
(50.0 mL). This resulted in the precipitation of excess benzotriazole and hence this 
was filtered and removed from the solution. The product was a yellow oil. 
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Yield: 61% (3.14 g, 12.2 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 8.07 – 8.04 (1H, m, 
H-10), 7.63 (J = 8.1 Hz, 1H, d, H-7), 7.44 – 7.33 (2H, m, H-8 and H-9), 7.11 (1H, s, 
H-4), 6.36 (J = 3.1 Hz, 1H, d, H-3), 5.95 (J = 3.1 Hz, 1H, dd, H-2), 3.78 – 3.65 (1H, 
m, H-5), 3.47 – 3.36 (1H, m, H-5’), 2.20 (3H, s, H-1), 1.19 (J = 7.0 Hz, 3H, t, H-6); 
Data in accordance with literature values.3 
 
Synthesis of 4-bromo-1-(5-methylfuran-2-yl)butan-1-one (229) 
 
 
 
 
1-(ethoxy(5-methylfuran-2-yl)methyl)-1H-benzo[d][1,2,3]triazole (225) (0.682 g, 
2.64 mmol, 1.00 eqv.) was dissolved in THF (15.0 mL) and the solution was 
cooled to −78°C. To this was added 1,3-dibromopropane (227) (0.410 mL, 4.04 
mmol, 1.53 eqv.) and 2.5 M n-butyl lithium solution (1.60 mL, 4.00 mmol, 1.52 
eqv.). The reaction was kept below 0°C and stirred for 2.5 hours. Once complete 
the reaction was quenched by adding water (5.00 mL) dropwise over the course of 
five minutes. The reaction mixture was then diluted with diethyl ether (150 mL) and 
washed with saturated sodium bicarbonate solution (2 × 100 mL) and water (100 
mL), before being dried over magnesium sulfate and subsequently being 
concentrated under reduced pressure. The crude material (228) was then 
dissolved in THF (10.0 mL) and water (2.50 mL) and a catalytic quantity of 
polymer-supported sulfonic acid was added. The reaction was gently stirred for 
three hours. Upon completion, the acid was filtered off and washed with THF (2 × 
10.0 mL). The combined organic material was then concentrated under reduced 
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pressure before being dissolved in petroleum ether (100 mL). This was washed 
with saturated sodium bicarbonate solution (2 × 100 mL) and water (100 mL) 
before being dried over magnesium sulfate and subsequently being concentrated 
under reduced pressure. The crude product was then purified by column 
chromatography using a graduated solvent system reaching a 9:1 mixture of 
petroleum ether and ethyl acetate. The product was a yellow oil. 
 
Yield: 45% over 2 steps (277 mg, 1.20 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 7.13 
(J = 3.5 Hz, 1H, d, H-3), 6.15 (J = 3.5 Hz, 1H, d, H-2), 3.50 (J = 6.4 Hz, 2H, t, H-6), 
2.96 (J = 7.1 Hz, 2H, t, H-4), 2.38 (3H, s, H-1), 2.30 – 2.21 (2H, m, H-5); Data in 
accordance with literature values.4 
 
Synthesis of 4-bromo-1-(5-methylfuran-2-yl)butan-1-ol (236) 
 
 
 
 
4-bromo-1-(5-methylfuran-2-yl)butan-1-one (229) (49.0 mg, 0.212 mmol, 1.00 
eqv.) was dissolved in methanol (5.00 mL) under an inert atmosphere. The 
reaction mixture was cooled to 0°C and sodium borohydride (24.3 mg, 0.642 
mmol, 3.03 eqv.) was added. The reaction was stirred for two hours and allowed to 
warm to room temperature during this time. The reaction was then quenched by 
the dropwise addition of water (5.00 mL) over the course of two minutes. After this 
the reaction mixture was diluted with ethyl acetate (50.0 mL) and water (50.0 mL). 
Extraction was completed using ethyl acetate (2 × 25.0 mL). The combined 
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organic phases were washed with saturated sodium bicarbonate solution (2 × 50.0 
mL) and water (50.0 mL) before being dried over magnesium sulfate and 
subsequently concentrated under reduced pressure. The product was a pale 
yellow oil. 
 
Yield: 33% (16.4 mg, 0.0704 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 6.12 (J = 3.1 
Hz, 1H, d, H-3), 5.90 (J = 0.9, 3.1 Hz, 1H, dd, H-2), 4.64 (J = 5.9 Hz, 1H, t, H-4), 
3.45 (J = 5.5, 6.6 Hz, 2H, dd, H-7), 2.28 (J = 0.9 Hz, 3H, d, H-1), 2.04 – 1.90 (4H, 
m, H-5 and H-6); Data in accordance with literature values.4 
 
Synthesis of (4-bromo-1-(5-methylfuran-2-yl)butoxy)(tert-butyl)dimethylsilane (237) 
 
 
 
 
 
 
4-bromo-1-(5-methylfuran-2-yl)butan-1-ol (236) (69.9 mg, 0.300 mmol, 1.00 eqv.) 
was dissolved in THF (5.00 mL). Imidazole (230) (248 mg, 3.64 mmol, 12.1 eqv.) 
and tert-butyldimethylsilyl chloride (231) (192 mg, 1.27 mmol, 4.23 eqv.) were 
added and the reaction mixture was stirred at room temperature for seven hours. 
The reaction was then diluted by adding water (20.0 mL). Extraction was achieved 
with diethyl ether (3 × 50.0 mL). The combined organic phases were washed with 
saturated sodium bicarbonate solution (50.0 mL), water (50.0 mL) and brine (50.0 
mL) before being dried over magnesium sulfate and subsequently being 
237
4
5
6O
7
Br
Si
O
2 3
1
10 12
11
8
9
		
Experimental	–	Organometallic	Coupling	Partner	Synthesis	 		 	
218	
concentrated under reduced pressure. The product was purified by column 
chromatography using a graduated solvent system reaching a 7:3 mixture of 
petroleum ether and ethyl acetate. The pure product obtained was a pale yellow 
oil. 
 
Yield: 22% (22.6 mg, 0.0651 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 6.04 (J = 3.0 
Hz, 1H, d, H-3), 5.87 (J = 3.0 Hz, 1H, d, H-2), 4.65 (J = 5.8 Hz, 1H, t, H-4), 3.42 (J 
= 3.8, 6.7 Hz, 2H, dd, H-7), 2.27 (3H, s, H-1), 2.02 – 1.85 (4H, m, H-5 and H-6), 
0.88 (9H, s, H-10, H-11 and H-12), 0.05 (3H, s, Si-Me), −0.07 (3H, s, Si-Me); 13C-
NMR: (CDCl3, 75 MHz) δ 154.7, 151.0, 106.7, 105.8, 67.8, 35.3, 33.8, 30.3, 28.9, 
25.8, 18.2, 13.5, −4.9, −5.1; IR: 𝜈 2957, 2928, 2857, 1463, 1361, 1254, 1221, 
1079, 1039, 1020, 1004, 834, 775, 442, 423; Rf (9:1 petroleum ether : ethyl 
acetate) 0.65; Mass Spectrometry: Decomposed rapidly – accurate mass unable 
to be obtained. 
 
Synthesis of 4-hydroxy-4-(5-methylfuran-2-yl)butyl benzoate (250) 
 
 
 
 
2-methylfuran (245) (10.5 mL, 117.5 mmol, 2.00 eqv.) was dissolved in THF (100 
mL) and cooled to −10°C. n-butyl lithium solution (23.5 mL, 58.8 mmol, 1.00 eqv.) 
was added and the reaction mixture was stirred for one hour at this temperature.  
Independently γ-butyrolactone (246) (5.00 mL, 65.0 mmol, 1.11 eqv.) was 
dissolved in THF (100 mL) and both reaction vessels were cooled to −78°C. Using 
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a cannula the lithiated species was transferred to the γ-butyrolactone solution. The 
reaction was allowed to warm to room temperature and was stirred at this 
temperature for 15 hours. The mixture was then diluted with diethyl ether (50.0 
mL) and water (50.0 mL). Extraction was accomplished using diethyl ether (3 × 
50.0 mL) and the combined organic phases were then washed with water (2 × 100 
mL) and brine (100 mL). The organic phase was then dried over magnesium 
sulfate and concentrated under reduced pressure. The crude material (4.50 g, 
26.8 mmol, 1.00 eqv.) was dissolved in dichloromethane (50.0 mL) under an inert 
atmosphere. 4-dimethylaminopyridine (10.5 g, 85.6 mmol, 3.19 eqv.) was added 
and the reaction cooled to −15°C before the addition of benzoyl chloride (3.80 mL, 
32.7 mmol, 1.22 eqv.). This was stirred at −15°C for five minutes. The reaction 
mixture was then diluted with diethyl ether (60.0 mL) and water (60.0 mL). 
Extraction was achieved with diethyl ether (3 × 50.0 mL). Subsequently the 
combined organic phases were washed with saturated sodium bicarbonate 
solution (2 × 100 mL) and saturated ammonium chloride solution (2 × 100 mL) 
before being dried over magnesium sulfate and then being concentrated under 
reduced pressure. The crude material (5.80 g, 21.3 mmol, 1.00 eqv.) was 
dissolved in methanol (100 mL) and cooled to −15°C. Gradually sodium 
borohydride (2.49 g, 65.8 mmol, 3.09 eqv.) was added over the course of five 
minutes. The reaction was stirred for 40 minutes and during this time the reaction 
was allowed to warm to room temperature. The reaction mixture was concentrated 
to a volume of approximately 10.0 mL before being diluted with ethyl acetate (100 
mL) and water (100 mL). Extraction was completed using ethyl acetate (3 × 60.0 
mL) and the combined organic phases were washed with brine (2 × 100 mL). The 
organic phase was then dried over magnesium sulfate and subsequently 
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concentrated under reduced pressure. The product was purified using column 
chromatography using a graduated solvent system reaching a 1:1 mixture of 
petroleum ether and diethyl ether. The pure product was an orange oil. 
 
Yield: 16% over 3 steps (2.62 g, 9.55 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 8.04 (J 
= 1.5, 7.6 Hz, 2H, td, H-8 and H-12), 7.58 – 7.52 (1H, m, H-10), 7.42 (J = 1.5, 7.6 
Hz, 2H, td, H-9 and H-11), 6.12 (J = 3.1 Hz, 1H, d, H-3), 5.89 (J = 0.9, 3.1 Hz, 1H, 
dd, H-2), 4.68 (J = 6.3 Hz, 1H, t, H-4), 4.35 (J = 6.3 Hz, 2H, t, H-7), 2.26 (J = 0.9 
Hz, 3H, d, H-1), 2.04 – 1.76 (4H, m, H-5 and H-6); 13C-NMR: (CDCl3, 75 MHz) δ 
166.6, 154.5, 151.7, 132.8, 130.2, 129.5, 128.3, 106.8, 106.0, 67.3, 64.6, 31.8, 
25.0, 13.5; IR: 𝜈 3420 (O-H), 2954, 2922, 1714 (C=O), 1451, 1385, 1315, 1271, 
1219, 1176, 1116, 1070, 1024, 998, 950, 933, 785, 709, 687; Rf (7:3 petroleum 
ether : diethyl ether): 0.32; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 
297.1103, Observed: m/z 297,1093, Difference = 3.37 ppm 
 
Synthesis of 4-methoxy-4-(5-methylfuran-2-yl)butyl benzoate (251) 
 
 
 
 
4-hydroxy-4-(5-methylfuran-2-yl)butyl benzoate (250) (2.50 g, 9.11 mmol) was 
dissolved in methanol (50.0 mL). To this solution was added Quadrapure™ 
polymer-supported sulfonic acid (0.353 g). The reaction was gently stirred for 
twelve hours. After, the reaction was filtered and the polymer beads washed with 
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methanol (3 × 10.0 mL). The organic solution was then concentrated under 
reduced pressure. The product was an orange/brown oil. 
 
Yield: 96% (2.52 g, 8.74 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 8.04 (J = 1.3, 7.6 
Hz, 2H, td, H-9 and H-13), 7.58 – 7.52 (1H, m, H-11), 7.43 (J = 1.3, 7.6 Hz, 2H, td, 
H-10 and H-12), 6.16 (J = 3.0 Hz, 1H, d, H-3), 5.91 (J = 0.9, 3.0 Hz, 1H, dd, H-2), 
4.33 (J = 6.3 Hz, 2H, t, H-4), 4.14 (J = 6.8 Hz, 1H, t, H-8), 3.26 (3H, s, H-5), 2.28 
(J = 0.9 Hz, 3H, d, H-1), 2.08 – 1.70 (4H, m, H-6 and H-7); 13C-NMR: (CDCl3, 75 
MHz) δ 166.6, 152.1, 151.7, 132.8, 130.3, 129.5, 128.3, 109.2, 105.8, 76.1, 64.6, 
56.2, 30.5, 25.1, 13.6; IR: 𝜈 2924, 2821, 1715 (C=O), 1451, 1314, 1270, 1176, 
1110, 1070, 1025, 928, 785, 709, 687, 675; Rf (1:1 petroleum ether : diethyl ether): 
0.80; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 311.1259, Observed: 
m/z 311.1232, Difference = 8.68 ppm 
 
Synthesis of 4-methoxy-4-(5-methylfuran-2-yl)butan-1-ol (243) 
 
 
 
 
4-methoxy-4-(5-methylfuran-2-yl)butyl benzoate (251) (1.90 g, 6.59 mmol) was 
dissolved in THF (24.0 mL). To this was added methanol (10.0 mL) and 20% 
sodium hydroxide (6.00 mL). The reaction mixture was rapidly stirred for one hour. 
After this the reaction mixture was diluted with diethyl ether (100 mL) and water 
(100 mL). Extraction was completed using diethyl ether (4 × 40.0 mL). The 
combined organic phases were washed with brine (3 × 100 mL) before being dried 
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over magnesium sulfate and subsequently concentrated under reduced pressure.  
The final product was an amber oil. 
 
Yield: >99% (1.21 g, 6.57 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 6.13 (J = 3.1 Hz, 
1H, d, H-3), 5.89 (J = 1.0, 3.1 Hz, 1H, dd, H-2), 4.10 (J = 6.0, 7.6 Hz, 1H, dd, H-4), 
3.62 (J = 6.3 Hz, 2H, t, H-8), 3.24 (3H, s, H-5), 2.26 (J = 1.0 Hz, 3H, d, H-1), 2.02 
– 1.80 (2H, m, H-6), 1.72 – 1.53 (2H, m, H-7); 13C-NMR: (CDCl3, 75 MHz) δ 152.9, 
152.0, 152.0, 151.9, 108.9, 107.6, 105.9, 105.7, 73.9, 68.0, 67.9, 62.5, 56.1, 50.6, 
30.7, 30.0, 29.1, 25.9, 25.5, 13.5; IR: 𝜈 3390 (O-H), 2924, 2871, 2821, 1561, 1449, 
1327, 1220, 1109, 1062, 1019, 964, 930, 783, 554, 466; Rf (1:1 petroleum ether : 
diethyl ether): 0.31; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 
207.0997, Observed: m/z 207.0992, Difference = 2.41 ppm 
 
Synthesis of 2-(4-iodo-1-methoxybutyl)-5-methylfuran (242) 
 
 
 
 
Triphenyl phosphine (252) (6.90 g, 26.3 mmol, 4.04 eqv.) was dissolved in 
dichloromethane (75.0 mL) under an inert atmosphere. To this was added 
imidazole (230) (4.61 g, 67.7 mmol, 10.4 eqv.) and iodine (2.45 g, 9.65 mmol, 1.48 
eqv.) and the mixture was stirred at room temperature for five minutes. The 
reaction mixture was then cooled to −15°C and a solution of 4-methoxy-4-(5-
methylfuran-2-yl)butan-1-ol (243) (1.20 g, 6.51 mmol, 1.00 eqv.) in 
dichloromethane (75.0 mL) was added dropwise over the course of three minutes. 
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The reaction was stirred for two hours, whilst being allowed to warm to room 
temperature. After, the mixture was diluted with water (100 mL) and diethyl ether 
(100 mL). Extraction was achieved with diethyl ether (4 × 50.0 mL). The combined 
organic phases were then washed with brine (2 × 100 mL), 30% hydrogen 
peroxide (2 × 50.0 mL), water (5 × 100 mL) and brine (100 mL) before being dried 
over magnesium sulfate. Once dried the organic solution was concentrated under 
reduced pressure. The product was purified via column chromatography using a 
graduated solvent system reaching a 1:1 mixture of petroleum ether and 
dichloromethane. The product was a yellow tinted oil. 
 
Yield: 57% (1.09 g, 3.71 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 6.14 (J = 3.1 Hz, 
1H, d, H-3), 5.90 (J = 0.7, 3.1 Hz, 1H, dd, H-2), 4.08 (J = 6.5 Hz, 1H, t, H-4), 3.28 
(3H, s, H-5), 3.17 (J = 6.2 Hz, 2H, t, H-8), 2.28 (J = 0.7 Hz, 3H, d, H-1), 2.02 – 
1.77 (4H, m, H-6 and H-7); 13C-NMR: (CDCl3, 75 MHz) δ 152.1, 151.7, 151.6, 
150.8, 125.3, 120.7, 109.1, 108.5, 107.2, 105.8, 75.4, 56.1, 36.9, 34.7, 29.8, 13.6, 
13.6, 6.5, 4.9; Rf (diethyl ether): 0.91; Mass Spectrometry: Decomposed rapidly – 
accurate mass unable to be obtained. 
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5.4. Data for Compounds Synthesised in the Formation of 
2,4-Disubstituted Tetrahydropyrans 
 
Synthesis of (E)-3-(4-bromophenyl)-1-(furan-2-yl)prop-2-en-1-one (272f) 
 
 
 
 
2-acetylfuran (274) (10.7 g, 97.2 mmol, 1.05 eqv.) was dissolved in methanol (100 
mL). 4-bromobenzaldehyde (17.1 g, 92.5 mmol, 1.00 eqv.) was added, along with 
5% aqueous sodium hydroxide solution (25.0 mL). This caused a precipitate to 
begin forming. This was stirred for 15 hours. After, the reaction was added to ice 
cold water (300 mL). This was then filtered under reduced pressure and the 
product recrystallised using ethanol. The product was a pale yellow crystalline 
solid. 
 
Yield: 95% (24.3 g, 87.7 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.79 (J = 15.8 Hz, 
1H, d, H-3), 7.66 (J = 1.7 Hz, 1H, d, H-7), 7.55 – 7.49 (4H, m, H-1 and H-2), 7.43 
(J = 15.8 Hz, 1H, d, H-4), 7.34 (J = 3.6 Hz, 1H, d, H-5), 6.60 (J = 1.7, 3.6 Hz, 1H, 
dd, H-6); Melting Point: 132 – 133 °C (Literature Value: 132 °C); Data in 
accordance with literature values.5 
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Synthesis of (E)-3-(4-bromophenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one (272h) 
 
 
 
 
Experimental procedure followed matched that described for 272f using: 
5-methyl-2-acteylfuran (275) (0.480 mL, 4.12 mmol, 1.00 eqv.), 4-
bromobenzaldehyde (0.978 g, 5.29 mmol, 1.28 eqv.), methanol (10.0 mL) and 5% 
aqueous sodium hydroxide solution (5.00 mL). The product was a pale yellow 
crystalline solid. 
 
Yield: 80% (0.965 g, 3.31 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.77 (J = 15.8 Hz, 
1H, d, H-3), 7.56 – 7.49 (4H, m, H-1 and H-2), 7.37 (J = 15.8 Hz, 1H, d, H-4), 7.27 
(J = 2.6 Hz, 1H, d, H-5), 6.23 (J = 2.6 Hz, 1H, d, H-6), 2.45 (3H, s, H-7); Melting 
Point: 159 °C (Literature Value: 159 °C); Data in accordance with literature 
values.6 
 
Synthesis of (E)-1-(5-methylfuran-2-yl)-3-phenylprop-2-en-1-one (272i) 
 
 
 
 
Experimental procedure followed matched that described for 272f using: 
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5-methyl-2-acteylfuran (275) (0.940 mL, 8.07 mmol, 1.00 eqv.), benzaldehyde 
(0.820 mL, 8.07 mmol, 1.00 eqv.), methanol (10.0 mL) and 5% aqueous sodium 
hydroxide solution (0.500 mL). The product was a pale yellow crystalline solid. 
 
Yield: 71% (1.21 g, 5.70 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.86 (J = 15.8 Hz, 
1H, d, H-4), 7.69 – 7.61 (2H, m, H-3), 7.42 – 7.40 (3H, m, H-1 and H-2), 7.39 (J = 
15.8 Hz, 1H, d, H-5), 7.28 (J = 4.0 Hz, 1H, d, H-6), 6.23 (J = 4.0 Hz, 1H, d, H-7), 
2.45 (3H, s, H-8); Melting Point: 112 °C (Literature Value: 112 – 113 °C); Data in 
accordance with literature values.7 
 
Synthesis of (E)-1-(5-methylfuran-2-yl)-3-p-tolylprop-2-en-1-one (272j) 
 
 
 
 
Experimental procedure followed matched that described for 272f using: 
5-methyl-2-acteylfuran (274)  (0.940 mL, 8.07 mmol, 1.00 eqv.), p-tolualdehyde 
(0.950 mL, 8.06 mmol, 0.999 eqv.), methanol (10.0 mL) and 5% aqueous sodium 
hydroxide solution (0.500 mL). The product a yellow crystalline material. 
 
Yield: 71% (1.29 g, 5.70 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.83 (J = 15.8 Hz, 
1H, d, H-4), 7.54 (J = 8.0 Hz, 2H, d, H-3), 7.34 (J = 15.8 Hz, 1H, d, H-5), 7.24 (J = 
3.5 Hz, 1H, d, H-6), 7.22 (J = 8.0 Hz, 2H, d, H-2), 6.21 (J = 3.5 Hz, 1H, d, H-7), 
2.44 (3H, s, H-8), 2.39 (3H, s, H-1); Melting Point: 133 – 134 °C; Rf 
(dichloromethane) 0.45; Data in accordance with literature values.8 
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Synthesis of (E)-3-(4-chlorophenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one (272k) 
 
 
 
 
Experimental procedure followed matched that described for 272f using: 
5-methyl-2-acteylfuran (275)  (0.940 mL, 8.07 mmol, 1.00 eqv.), 4-
chlorobenzaldehyde (1.23 g, 8.75 mmol, 1.08 eqv.), methanol (10.0 mL) and 5% 
aqueous sodium hydroxide solution (0.500 mL). The product was a pale yellow 
powder. 
 
Yield: 85% (1.69 g, 6.85 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.76 (J = 15.8 Hz, 
1H, d, H-3), 7.58 (J = 8.5 Hz, 2H, d, Ar-H), 7.35 (J = 15.8 Hz, 1H, d, H-4), 7.40 – 
7.34 (2H, m, Ar-H), 7.27 – 7.25 (1H, m, H-5), 6.23 (J = 3.5 Hz, 1H, d, H-6), 2.45 
(3H, s, H-7); Melting Point: 155 °C (Literature Value: 151 °C); Data in accordance 
with literature values.6 
 
Synthesis of (E)-1-(furan-2-yl)-4,4-dimethylpent-2-en-1-one (272l) 
 
 
 
Experimental procedure followed matched that described for 272f using: 
2-acetylfuran (274) (0.663 g, 6.02 mmol, 1.00 eqv.), trimethylacetylaldehyde 
(0.650 mL, 5.98 mmol, 0.993 eqv.), methanol (10.0 mL) and 5% aqueous sodium 
hydroxide solution (1.00 mL). The product was a brown oil. 
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Yield: 20% (0.213 g, 1.20 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.59 (J = 1.5 Hz, 
1H, d, H-8), 7.21 (J = 3.6 Hz, 1H, d, H-6), 7.12 (J = 15.7 Hz, 1H, d, H-4), 6.67 (J = 
15.7 Hz, 1H, d, H-5), 6.52 (J = 1.5, 3.6 Hz, 1H, dd, H-7), 1.10 (9H, s, H-1, H-2 and 
H-3); Data in accordance with literature values.9 
 
Synthesis of (E)-1,3-di(furan-2-yl)prop-2-en-1-one (272m) 
 
 
 
 
Experimental procedure followed matched that described for 272f using: 
2-acetylfuran (274) (0.545 g, 4.95 mmol, 1.08 eqv.), furaldehyde (0.380 mL, 4.59 
mmol, 1.00 eqv.), methanol (10.0 mL) and 5% aqueous sodium hydroxide solution 
(2.00 mL). The product was a cream coloured crystalline solid. 
 
Yield: 15% (0.128 g, 0.680 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.65 (J = 1.4 Hz, 
1H, d, H-8), 7.63 (J = 14.6 Hz, 1H, d, H-4), 7.53 (J = 1.6 Hz, 1H, d, H-1), 7.32 (J = 
14.6 Hz, 1H, d, H-5), 7.31 (J = 3.6 Hz, 1H, d, H-6), 6.73 (J = 3.4 Hz, 1H, d, H-3), 
6.59 (J = 1.4, 3.6 Hz, 1H, dd, H-7), 6.52 (J = 1.6, 3.4 Hz, 1H, dd, H-2); Melting 
Point: 87 °C (Literature Value: 85 – 86 °C); Data in accordance with literature 
values.10 
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Synthesis of (E)-3-(furan-2-yl)-1-(5-methylfuran-2-yl)prop-2-en-1-one (272n) 
 
 
 
 
Experimental procedure followed matched that described for 272f using: 
5-methyl-2-acetylfuran (275) (0.470 mL, 3.97 mmol, 1.00 eqv.), furaldehyde (0.350 
mL, 4.23 mmol, 1.07 eqv.), methanol (10.0 mL) and 5% aqueous sodium 
hydroxide solution (2.00 mL). The product a yellow crystalline material. 
 
Yield: 51% (0.412 g, 2.04 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.58 (J = 15.5 Hz, 
1H, d, H-4), 7.50 (J = 1.2 Hz, 1H, d, H-1), 7.24 (J = 15.5 Hz, 1H, d, H-5), 7.22 (J = 
3.4 Hz, 1H, d, H-6), 6.67 (J = 3.5 Hz, 1H, d, H-3), 6.48 (J = 3.4 Hz, 1H, d, H-7), 
6.19 (J = 1.2, 3.5 Hz, 1H, dd, H-2), 2.41 (3H, s, H-8); Melting Point: 80 – 81 °C;   
Rf (dichloromethane) 0.57; Data in accordance with literature values.7 
 
Synthesis of (E)-1-(furan-2-yl)-3-(5-methylfuran-2-yl)prop-2-en-1-one (272o)11 
 
 
 
 
Experimental procedure followed matched that described for 272f using: 
2-acetylfuran (274) (0.533 g, 4.84 mmol, 1.05 eqv.), 5-methyl-2-furaldehyde (0.460 
mL, 4.62 mmol, 1.00 eqv.), methanol (10.0 mL) and 5% aqueous sodium 
hydroxide solution (2.00 mL). The product was a pale yellow crystalline solid. 
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Yield: 62% (0.579 g, 2.86 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.64 (J = 1.7 Hz, 
1H, d, H-8), 7.57 (J = 15.8 Hz, 1H, d, H-4), 7.30 (J = 3.6 Hz, 1H, d, H-6), 7.23 (J = 
15.8 Hz, 1H, d, H-5), 6.63 (J = 3.3 Hz, 1H, d, H-3), 6.57 (J = 1.7, 3.6 Hz, 1H, dd, 
H-7), 6.13 (J = 3.3 Hz, 1H, d, H-2), 2.39 (3H, s, H-1); Melting Point: 68 – 69 °C 
(Literature Value: 69 – 70 °C); Data in accordance with literature values.11 
 
Synthesis of (E)-1,3-bis(5-methylfuran-2-yl)prop-2-en-1-one (272p) 
 
 
 
 
Experimental procedure followed matched that described for 272f using: 
5-methyl-2-acetylfuran (275) (0.480 mL, 4.06 mmol, 1.00 eqv.), 5-methyl-2-
furaldehyde (0.410 mL, 4.12 mmol, 1.01 eqv.), methanol (10.0 mL) and 5% 
aqueous sodium hydroxide solution (2.00 mL). The product was a red/brown oil. 
 
Yield: 62% (0.547 g, 2.53 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.52 (J = 15.4 Hz, 
1H, d, H-4), 7.21 (J = 3.4 Hz, 1H, d, H-6), 7.15 (J = 15.4 Hz, 1H, d, H-5), 6.58 (J = 
3.3 Hz, 1H, d, H-3), 6.18 (J = 3.4 Hz, 1H, d, H-7), 6.10 (J = 3.3 Hz, 1H, d, H-2), 
2.42 (3H, s, H-8), 2.37 (3H, s, H-1); 13C-NMR (CDCl3, 75 MHz): δ 177.1 (C=O), 
157.9, 155.7, 152.5, 150.2, 129.4, 119.1, 118.0, 117.1, 109.3, 109.1, 14.1, 14.0; 
IR: 𝜈 3116, 2923, 1651 (C=O), 1601, 1567, 1526, 1505, 1368, 1313, 1265, 1205, 
1180, 1065, 1017, 965, 784, 727, 713, 623, 540; Rf (dichloromethane) 0.33; Mass 
Spectrometry: TOF ES+: MH+: Expected: m/z 217.0865, Observed: m/z 217.0868, 
Difference = −1.38 ppm 
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Synthesis of dimethyl-2-(3-(furan-2-yl)-3-oxo-1-phenylpropyl)malonate (271a) 
 
 
 
 
 
 
Sodium hydride (60% in mineral oil) (0.210 g, 5.25 mmol, 1.90 eqv.) was 
suspended in tetrahydrofuran (14.0 mL) and cooled to −18°C. Dimethyl malonate 
(276) (0.600 mL, 5.25 mmol, 1.90 eqv.) was added dropwise over the course of 
two minutes. The reaction mixture was stirred for 15 minutes at room temperature. 
It was then again cooled to −18°C and (E)-1-(furan-2-yl)-3-phenyl-2-propen-1-one 
(272a) (0.550 g, 2.77 mmol, 1.00 eqv.) in tetrahydrofuran (5.00 mL) was added. 
The reaction was stirred at room temperature for 2.5 hours. The reaction mixture 
was then diluted with saturated ammonium chloride (20.0 mL) and diethyl ether 
(20.0 mL). Extraction was completed using diethyl ether (3 × 20.0 mL). The 
combined organic phases were then washed with saturated sodium bicarbonate (2 
× 50.0 mL), water (50.0 mL) and brine (50.0 mL). This was then dried over 
magnesium sulfate and concentrated under reduced pressure prior to analysis.  
The material was purified by column chromatography using a graduated solvent 
system reaching a 1:1 mixture of petroleum ether and diethyl ether. The purified 
product obtained was a white solid.  
 
Yield: 60% (0.548 g, 1.66 mmol); 1H-NMR (CDCl3, 300MHz): δ 7.53 (J = 1.7 Hz, 
1H, d, H-8), 7.25 – 7.17 (5H, m, H-9, H-10 and H-11), 7.15 (J = 3.6 Hz, 1H, d, H-
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6), 6.48 (J = 1.7, 3.6 Hz, 1H, dd, H-7), 4.16 (J = 4.7, 7.6, 9.7 Hz, 1H, ddd, H-4), 
3.85 (J = 9.7, 1H, d, H-3), 3.73 (3H, s, OMe), 3.50 (3H, s, OMe), 3.34 (J = 4.7, 7.6 
Hz, 2H, dd, H-5); 13C-NMR (CDCl3, 75 MHz): δ 186.4 (C=O), 168.5 (C=O), 168.0 
(C=O), 152.4, 146.3, 140.0, 128.4, 128.0, 127.1, 117.2, 112.2, 57.1, 52.6, 52.4, 
42.1, 40.5; IR: 𝜈 3126, 3098, 2958, 1724 (C=O), 1664 (C=O), 1497, 1421, 1294, 
1237, 1219, 1153, 1095, 1045, 980, 918, 860; Melting Point: 114 – 115 °C; Rf (7:3 
petroleum ether : diethyl ether) 0.27; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 353.1001, Observed: m/z 353.1017, Difference = 4.53 ppm 
 
Potassium Carbonate Method 
(E)-1-(furan-2-yl)-3-phenyl-2-propen-1-one (272a) (4.60 g, 23.2 mmol, 1.00 eqv.) 
was dissolved in methanol (100 mL). To this was added dimethyl malonate (276) 
(5.50 mL, 48.1 mmol, 2.07 eqv.) and potassium carbonate (3.58 g, 25.9 mmol, 
1.12 eqv.). The reaction was stirred at reflux for two hours. After, the reaction 
mixture was concentrated to approximately 10.0 mL, before being diluted with 
diethyl ether (50.0 mL) and water (100 mL). Extraction was achieved with diethyl 
ether (3 × 50.0 mL). The combined organic phases were washed with water (2 × 
75.0 mL) and brine (75.0 mL) before being dried over magnesium sulfate and 
concentrated under reduced pressure. The product was purified by column 
chromatography using a graduated solvent system reaching a 1:1 mixture of 
hexane and diethyl ether.  
 
Yield: 65% (5.01 g, 15.2 mmol) 
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Synthesis of dimethyl-2-(1-(4-chlorophenyl)-3-(furan-2-yl)-3-oxopropyl)malonate 
(271b) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 271a with sodium 
hydride using: 
Sodium hydride (60% in mineral oil) (0.410 g, 10.1 mmol, 4.35 eqv.), dimethyl 
malonate (276) (1.00 mL, 8.60 mmol, 3.71 eqv.), (E)-3-(4-chlorophenyl)-1-(furan-2-
yl)prop-2-en-1-one (272b) (0.549 g, 2.32 mmol, 1.00 eqv.) and THF (20.0 mL). 
The product was a yellow crystalline solid.  
 
1H-NMR (CDCl3, 300 MHz): δ 7.53 (J = 1.7 Hz, 1H, d, H-8), 7.24 – 7.21 (4H, s, H-9 
and H-10), 7.15 (J = 3.6 Hz, 1H, d, H-6), 6.49 (J = 1.7, 3.6 Hz, 1H, dd, H-7), 4.13 
(J = 4.4, 7.7, 9.7 Hz, 1H, ddd, H-4), 3.81 (J = 9.7 Hz, 1H, d, H-3), 3.73 (3H, s, 
OMe), 3.52 (3H, s, OMe), 3.32 (J = 4.4, 7.7 Hz, 2H, dd, H-5); 13C-NMR (CDCl3, 75 
MHz): δ 186.2 (C=O), 168.3 (C=O), 167.8 (C=O), 152.4, 146.4, 138.6, 133.0, 
129.5, 128.6, 117.2, 112.3, 56.9, 52.8, 52.5, 41.9, 39.9; IR: 𝜈 2956, 2923, 2853, 
1726 (C=O), 1662 (C=O), 1467, 1433, 1399, 1274, 1251, 1157, 1090, 1039, 993, 
910, 876, 831; Melting Point: 78 °C; Rf (7:3 petroleum ether : diethyl ether) 0.17; 
Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 387.0611, Observed: m/z 
387.0619, Difference = 2.07 ppm 
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Synthesis of dimethyl-2-(3-(furan-2-yl)-1-(4-methoxyphenyl)-3-oxopropyl)malonate 
(271c) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 271a with sodium 
hydride using: 
Sodium hydride (60% in mineral oil) (0.492 g, 12.3 mmol, 5.10 eqv.), dimethyl 
malonate (276) (1.05 mL, 9.14 mmol, 3.79 eqv.), (E)-1-(furan-2-yl)-3-(4-
methoxyphenyl)prop-2-en-1-one (272c) (0.543 g, 2.41 mmol, 1.00 eqv.) and THF 
(10.0 mL). The product was a pale yellow solid. 
 
Yield: 49% (0.42 g, 1.17 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.52 (J = 1.6 Hz, 
1H, d, H-8), 7.16 (J = 8.7 Hz, 2H, d, H-9), 7.14 (J = 3.5 Hz, 1H, d, H-6), 6.77 (J = 
8.7 Hz, 2H, d, H-10), 6.47 (J = 1.6, 3.5 Hz, 1H, dd, H-7), 4.10 (J = 4.7, 8.6, 9.8 Hz, 
1H, ddd, H-4), 3.80 (J = 9.8 Hz, 1H, d, H-3), 3.71 (3H, s, OMe), 3.70 (3H, s, OMe), 
3.49 (3H, s, OMe), 3.29 (J = 4.7, 9.8 Hz, 2H, dd, H-5); 13C-NMR (CDCl3, 75 MHz): 
δ 186.5 (C=O), 168.6 (C=O), 168.0 (C=O), 158.4, 152.4, 146.3, 131.9, 129.0, 
117.2, 113.7, 112.2, 57.3, 55.0, 52.6, 52.4, 42.2, 39.9; IR: 𝜈 2956, 2838, 1727 
(C=O), 1665 (C=O), 1612, 1515, 1474, 1402, 1289, 1270, 1252, 1159, 1115, 
1045, 1032, 981, 919, 861, 827, 769, 734, 598, 563, 533; Melting Point: 115 – 116 
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°C; Rf (7:3 petroleum ether : diethyl ether) 0.18; Mass Spectrometry: TOF ES+: 
MNa+: Expected: m/z 383.1107, Observed: m/z 383.1094, Difference = −3.39 ppm 
 
The experiment was later repeated and the Experimental procedure followed 
matched that described for 271a with potassium carbonate using: 
(E)-1-(furan-2-yl)-3-(4-methoxyphenyl)prop-2-en-1-one (272c) (4.77 g, 20.9 mmol, 
1.00 eqv.), dimethyl malonate (276) (5.52 mL, 48.1 mmol, 2.30 eqv.), potassium 
carbonate (2.92 g, 21.2 mmol, 1.01 eqv.) and methanol (100 mL). The material 
was taken through to the next step with no purification. 
 
Synthesis of dimethyl-2-(3-(furan-2-yl)-3-oxo-1-p-tolylpropyl)malonate (271d) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 271a with sodium 
hydride using: 
Sodium hydride (60% in mineral oil) (0.287 g, 7.07 mmol, 2.95 eqv.), dimethyl 
malonate (276) (0.860 mL, 7.52 mmol, 3.13 eqv.), (E)-1-(furan-2-yl)-3-p-tolylprop-
2-en-1-one (272d) (0.507 g, 2.40 mmol, 1.00 eqv.) and THF (10.0 mL). The 
product was a cream solid.  
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Yield: 59% (0.49 g, 1.42 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.53 (J = 1.6 Hz, 
1H, d, H-8), 7.14 (J = 3.2 Hz, 1H, d, H-6), 7.13 (J = 7.9 Hz, 2H, d, H-9), 7.04 (J = 
7.9 Hz, 2H, d, H-10), 6.48 (J = 1.6, 3.2 Hz, 1H, dd, H-7), 4.12 (J = 4.4, 6.8, 9.5 Hz, 
1H, ddd, H-4), 3.83 (J = 9.5 Hz, 1H, d, H-3), 3.73 (3H, s, OMe), 3.51 (3H, s, OMe), 
3.33 (J = 4.4, 6.8 Hz, 2H, dd, H-5), 2.26 (3H, s, H-11); 13C-NMR (CDCl3, 75 MHz): 
δ 186.6 (C=O), 168.6 (C=O), 168.1 (C=O), 152.5, 146.3, 136.9, 136.8, 129.2, 
127.8, 117.2, 112.2, 57.3, 52.7, 52.4, 42.2, 40.2, 21.0; IR: 𝜈 3126, 3097, 2948, 
1730 (C=O), 1665 (C=O), 1473, 1433, 1401, 1319, 1273, 1250, 1241, 1151, 1044, 
1022, 992, 974, 912, 820, 770, 596, 552; Melting Point: 88 – 89 °C; Rf (7:3 
petroleum ether : diethyl ether) 0.20; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 367.1158, Observed: m/z 367.1174, Difference = 4.36 ppm 
 
Synthesis of dimethyl-2-(1-(3,4-dimethoxyphenyl)-3-(furan-2-yl)-3-
oxopropyl)malonate (271e) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 316a with sodium 
hydride using: 
Sodium hydride (60% in mineral oil) (0.373 g, 9.25 mmol, 4.60 eqv.), dimethyl 
malonate (276) (1.00 mL, 8.75 mmol, 4.35 eqv.), (E)-3-(3,4-dimethoxyphenyl)-1-
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(furan-2-yl)prop-2-en-1-one (272e) (0.515 g, 2.01 mmol, 1.00 eqv.) and THF (11.5 
mL). The purified product was a yellow oil. 
 
1H-NMR (CDCl3, 300 MHz): δ 7.55 (J = 1.7 Hz, 1H, d, H-8), 7.14 (J = 3.6 Hz, 1H, 
d, H-6), 6.80 – 6.71 (3H, m, H-9, H-10 and H-11), 6.48 (J = 1.7, 3.6 Hz, 1H, dd, H-
7), 4.10 (J = 5.3, 8.9, 9.3 Hz, 1H, ddd, H-4), 3.83 (J = 9.3 Hz, 1H, d, H-3), 3.82 
(3H, s, OMe), 3.80 (3H, s, OMe), 3.73 (3H, s, OMe), 3.52 (3H, s, OMe), 3.35 (J = 
8.9, 16.4 Hz, 1H, dd, H-5), 3.26 (J = 5.3, 16.4 Hz, 1H, dd, H-5’); 13C-NMR (CDCl3, 
75 MHz): δ 186.6 (C=O), 168.6 (C=O), 168.1 (C=O), 152.5, 148.5, 147.9, 146.3, 
132.5, 119.8, 117.2, 112.2, 111.4, 110.9, 57.3, 55.8, 55.7, 52.7, 52.5, 42.1, 40.3; 
IR: 𝜈 3108, 3020, 2973, 2863, 2857, 1731 (C=O), 1651 (C=O), 1513, 1439, 1373, 
1251, 1226, 1141, 1121, 1078, 1009, 908, 875, 804, 750, 601, 587, 506; Rf (7:3 
petroleum ether : diethyl ether) 0.14; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 413.1212, Observed: m/z 413.1216, Difference = 0.97 ppm 
 
Synthesis of dimethyl-2-(1-(4-bromophenyl)-3-(furan-2-yl)-3-oxopropyl)malonate 
(271f) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 271a with sodium 
hydride using: 
O
3
O
4
OO
2
1
5
O
6 7
8
O
9
10
271f
Br
		
Experimental	–	2,4-Disubstituted	Tetrahydropyran	Synthesis	 		 	
238	
Sodium hydride (60% in mineral oil) (0.413 g, 10.3 mmol, 5.60 eqv.), dimethyl 
malonate (276) (1.20 mL, 10.5 mmol, 5.71 eqv.), (E)-3-(4-bromophenyl)-1-(furan-
2-yl)prop-2-en-1-one (272f) (0.513 g, 1.84 mmol, 1.00 eqv.) and THF (10.0 mL). 
The product was a cream coloured solid.  
 
1H-NMR (CDCl3, 300 MHz): δ 7.54 (J = 1.7 Hz, 1H, d, H-8), 7.34 (J = 8.5 Hz, 2H, 
d, H-9), 7.17 – 7.13 (J = 8.5 Hz, 2H, d, H-10), 7.15 (J = 3.6 Hz, 1H, dd, H-6), 6.46 
(J = 1.7, 3.6 Hz, 1H, dd, H-7), 4.12 (J = 4.6, 7.8, 9.0 Hz, 1H, ddd, H-4), 3.81 (J = 
9.0 Hz, 1H, d, H-3), 3.70 (3H, s, OMe), 3.49 (3H, s, OMe), 3.32 (J = 4.6, 7.8, 2H, 
dd, H-5); 13C-NMR (CDCl3, 75 MHz): δ 186.0 (C=O), 168.2 (C=O), 167.7 (C=O), 
152.2, 146.3, 139.1, 131.4, 129.8, 121.0, 117.2, 112.2, 56.7, 52.6, 52.4, 41.7, 
39.8; IR: 𝜈 3131, 2955, 2924, 2854, 1740 (C=O), 1724 (C=O), 1660, 1488, 1466, 
1397, 1306, 1253, 1217, 1065, 991, 909, 827, 765, 719, 554, 525; Melting Point: 
78 – 79 °C; Rf (7:3 petroleum ether : diethyl ether) 0.23; Mass Spectrometry: TOF 
ES+: MNa+: Expected: m/z 431.0106, Observed: m/z 431.0119, Difference = 3.02 
ppm 
 
The experiment was later repeated and the Experimental procedure followed 
matched that described for 271a with potassium carbonate using: 
(E)-3-(4-bromophenyl)-1-(furan-2-yl)prop-2-en-1-one (272f) (16.4 g, 59.2 mmol, 
1.00 eqv.), dimethyl malonate (276) (14.0 mL, 123 mmol, 2.08 eqv.), potassium 
carbonate (8.20 g, 59.3 mmol, 1.00 eqv.) and methanol (200 mL). 
 
Yield: 77% (18.7 g, 45.7 mmol) 
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Synthesis of dimethyl-2-(1-(4-bromophenyl)-3-(5-methylfuran-2-yl)-3-
oxopropyl)malonate (271h) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 271a with sodium 
hydride using: 
Sodium hydride (60% in mineral oil) (0.275 g, 7.00 mmol, 3.78 eqv.), dimethyl 
malonate (276) (0.800 mL, 7.00 mmol, 3.78 eqv.), (E)-3-(4-bromophenyl)-1-(5-
methylfuran-2-yl)prop-2-en-1-one (272h) (0.543 g, 1.85 mmol, 1.00 eqv.) and THF 
(12.0 mL). The product was a pale yellow oil. 
 
1H-NMR (CDCl3, 300 MHz): δ 7.36 (J = 8.3 Hz, 2H, d, H-9), 7.14 (J = 8.3 Hz, 2H, 
H-10) 7.07 (J = 3.4 Hz, 1H, d, H-6), 6.10 (J = 3.4 Hz, 1H, d, H-7), 4.10 (J = 4.5, 
8.0, 9.1 Hz, 1H, ddd, H-4), 3.81 (J = 9.1 Hz, 1H, d, H-3), 3.73 (3H, s, OMe), 3.52 
(3H, s, OMe), 3.24 (J = 4.5, 8.0 Hz, 2H, dd, H-5), 2.34 (3H, s, H-8); 13C-NMR 
(CDCl3, 75 MHz): δ 185.3 (C=O), 168.3 (C=O), 167.8 (C=O), 157.9, 151.1, 139.2, 
131.5, 129.9, 121.1, 119.4, 109.0, 56.8, 52.7, 52.5, 41.5, 40.2, 14.0; IR: 𝜈 2953, 
2923, 2852, 1730 (C=O), 1660 (C=O), 1514, 1488, 1433, 1241, 1159, 1074, 1038, 
1010, 826, 795, 556; Rf (7:3 petroleum ether : diethyl ether) 0.24; Mass 
Spectrometry: TOF ES+: MNa+: Expected: m/z 445.0263, Observed: m/z 
445.0278, Difference = 3.37 ppm 
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The experiment was later repeated and the Experimental procedure followed 
matched that described for 271a with potassium carbonate using: 
(E)-3-(4-bromophenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one (272h) (12.0 g, 41.2 
mmol, 1.00 eqv.), dimethyl malonate (276) (9.50 mL, 83.1 mmol, 2.02 eqv.), 
potassium carbonate (6.05 g, 43.8 mmol, 1.06 eqv.) and methanol (300 mL). 
 
Yield: 79% (13.8 g, 32.6 mmol) 
 
Synthesis of dimethyl-2-(3-(5-methylfuran-2-yl)-3-oxo-1-phenylpropyl)malonate 
(271i) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 271a with sodium 
hydride using: 
Sodium hydride (60% in mineral oil) (0.403 g, 10.0 mmol, 4.20 eqv.), dimethyl 
malonate (276) (1.10 mL, 9.62 mmol, 4.04 eqv.), (E)-1-(5-methylfuran-2-yl)-3-
phenylprop-2-en-1-one (272i) (0.504 g, 2.38 mmol, 1.00 eqv.) and THF (10.0 mL). 
The product was a white solid. 
 
1H-NMR (CDCl3, 300 MHz): δ 7.25 – 7.15 (5H, m, H-9, H-10 and H-11), 7.07 (J = 
3.5 Hz, 1H, d, H-6), 6.09 (J = 3.5 Hz, 1H, d, H-7), 4.14 (J = 4.8, 7.6, 9.7 Hz, 1H, 
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ddd, H-4), 3.86 (J = 9.7 Hz, 1H, d, H-3), 3.73 (3H, s, OMe), 3.49 (3H, s, OMe), 
3.27 (J = 4.8, 7.6 Hz, 2H, dd, H-5), 2.34 (3H, s, H-8); 13C-NMR (CDCl3, 75 MHz): δ 
185.7 (C=O), 168.6 (C=O), 168.1 (C=O), 157.7, 151.3, 140.1, 128.4, 128.1, 127.2, 
119.3, 108.9, 57.2, 52.7, 52.4, 41.9, 40.9, 14.0; IR: 𝜈 2954, 2922, 2852, 1746, 
1727, 1659, 1516, 1433, 1252, 1205, 1149, 1074, 1040, 1027, 956, 904, 788, 702, 
594, 530; Melting Point: 112 – 113 °C; Rf (7:3 petroleum ether : diethyl ether) 0.25; 
Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 367.1158, Observed: m/z 
367.1140, Difference = −4.90 ppm 
 
Synthesis of dimethyl-2-(3-(5-methylfuran-2-yl)-3-oxo-1-p-tolylpropyl)malonate 
(271j) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 271a with sodium 
hydride using: 
Sodium hydride (60% in mineral oil) (0.399 g, 10.0 mmol, 4.10 eqv.), dimethyl 
malonate (276) (1.10 mL, 9.62 mmol, 3.94 eqv.), (E)-1-(5-methylfuran-2-yl)-3-p-
tolylprop-2-en-1-one (272j) (0.552 g, 2.44 mmol, 1.00 eqv.) and THF (12.0 mL). 
The product was a pale yellow solid. 
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1H-NMR (CDCl3, 300 MHz): δ 7.13 (J = 8.1 Hz, 2H, d, H-9), 7.08 (J = 3.5 Hz, 1H, 
d, H-6), 7.04 (J = 8.1 Hz, 2H, d, H-10), 6.09 (J = 3.5 Hz, 1H, d, H-7), 4.10 (J = 6.1, 
8.0, 9.5 Hz, 1H, ddd, H-4), 3.83 (J = 9.5 Hz, 1H, d, H-3), 3.73 (3H, s, OMe), 3.51 
(3H, s, OMe), 3.25 (J = 8.0 Hz, 1H, d, H-5), 3.24 (J = 6.1 Hz, 1H, d, H-5’), 2.34 
(3H, s, H-8), 2.25 (3H, s, H-11); 13C-NMR (CDCl3, 75 MHz): δ 185.8 (C=O), 168.7 
(C=O), 168.1 (C=O), 157.7, 151.3, 137.0, 136.7, 129.1, 127.9, 119.3, 108.9, 57.3, 
52.6, 52.4, 41.9, 40.5, 21.0, 14.0; IR: 𝜈 2953, 2922, 2852, 1729 (C=O), 1660 
(C=O), 1432, 1301, 1239, 1221, 1161, 1144, 1081, 1041, 959, 906, 816, 794, 772, 
560; Melting Point: 103 – 104 °C; Rf (7:3 petroleum ether : diethyl ether) 0.23; 
Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 381.1314, Observed: m/z 
381.1311, Difference = −0.79 ppm 
 
Synthesis of dimethyl-2-(1-(4-chlorophenyl)-3-(5-methylfuran-2-yl)-3-
oxopropyl)malonate (271k) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 271a with sodium 
hydride using: 
Sodium hydride (60% in mineral oil) (0.343 g, 8.25 mmol, 3.57 eqv.), dimethyl 
malonate (276) (1.00 mL, 8.75 mmol, 3.79 eqv.), (E)-3-(4-chlorophenyl)-1-(5-
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methylfuran-2-yl)prop-2-en-1-one (272k) (0.571 g, 2.31 mmol, 1.00 eqv.) and THF 
(12.0 mL). The product was a pale orange solid. 
 
1H-NMR (CDCl3, 300 MHz): δ 7.13 (4H, s, H-9 and H-10), 7.06 (J = 3.5 Hz, 1H, d, 
H-6), 6.08 (J = 3.5 Hz, 1H, d, H-7), 4.10 (J = 4.2, 8.0, 9.7 Hz, 1H, ddd, H-4), 3.79 
(J = 9.7 Hz, 1H, d, H-3), 3.71 (3H, s, OMe), 3.49 (3H, s, OMe), 3.21 (J = 4.2, 8.0 
Hz, 2H, dd, H-5), 2.31 (3H, s, H-8); 13C-NMR (CDCl3, 75 MHz): δ 185.4 (C=O), 
168.4 (C=O), 167.9 (C=O), 157.9, 151.2, 138.7, 132.9, 129.5, 128.6, 119.4, 109.0, 
56.9, 52.8, 52.5, 41.6, 40.2, 14.1; IR: 𝜈 2954, 2938, 2876, 1728 (C=O), 1660 
(C=O), 1515, 1491, 1435, 1239, 1164, 1039, 1015, 907, 864, 795, 728, 648, 559; 
Melting Point: 88 °C; Rf (7:3 petroleum ether : diethyl ether) 0.25; Mass 
Spectrometry: TOF ES+: MH+: Expected: m/z 379.0948, Observed: m/z 379.0953, 
Difference = −1.32 ppm 
 
Synthesis of methyl-5-(furan-2-yl)-5-oxo-3-phenylpentanoate (270a) 
 
 
 
 
 
Dimethyl-2-(3-(furan-2-yl)-3-oxo-1-phenylpropyl)malonate (271a) (0.320 g, 0.969 
mmol, 1.00 eqv.) was dissolved in a 5:1 mixture of DMSO and water (5.00 mL). 
Lithium chloride (1.77 g, 38.7 mmol, 39.9 eqv.) was added and the reaction was 
stirred at reflux for 5 days. After, the reaction mixture was diluted with diethyl ether 
(30.0 mL) and water (30.0 mL). Extraction was completed using diethyl ether (3 × 
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30.0 mL) and the combined organic phases were washed with water (2 × 50.0 mL) 
and brine (50.0 mL). This was then dried over magnesium sulfate and 
concentrated under reduced pressure.  The crude material was then purified via 
column chromatography using a graduated solvent system reaching a 1:1 mixture 
of petroleum ether and diethyl ether. The product was a white solid. 
 
Yield: 46% (0.120 g, 0.441 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.51 (J = 1.7 Hz, 
1H, d, H-7), 7.28 – 7.14 (5H, m, H-8, H-9 and H-10), 7.13 (J = 3.6 Hz, 1H, d, H-5), 
6.47 (J = 1.7, 3.6 Hz, 1H, dd, H-6), 3.83 (J = 7.3, 7.3, 7.4, 7.4 Hz, 1H, dddd, H-3), 
3.55 (3H, s, H-1), 3.19 (J = 7.3 Hz, 2H, d, H-4), 2.71 (J = 7.4 Hz, 2H, d, H-2); 13C-
NMR (CDCl3, 75 MHz): δ 187.2 (C=O), 172.1 (C=O), 152.6, 146.3, 142.9, 128.5, 
127.2, 126.8, 117.1, 112.2, 51.5, 44.3, 40.4, 37.4; IR: 𝜈 3146, 3129, 3099, 3028, 
3003, 2950, 2909, 1726 (C=O), 1658 (C=O), 1566, 1465, 1429, 1396, 1287, 1245, 
1219, 1197, 1157, 1086, 1064, 1042, 1027, 986, 970, 918, 882, 778, 761, 702, 
594, 555, 493; Melting Point: 85 – 86 °C; Rf (1:1 petroleum ether : diethyl ether) 
0.31; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 295.0946, Observed: 
m/z 295.0945, Difference = −0.34 ppm 
 
Synthesis of methyl-3-(4-chlorophenyl)-5-(furan-2-yl)-5-oxopentanoate (270b) 
 
 
 
 
 
Experimental procedure followed matched that described for 270a using: 
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Dimethyl-2-(1-(4-chlorophenyl)-3-(5-methylfuran-2-yl)-3-oxopropyl)malonate 
(271b) (0.384 g, 1.04 mmol, 1.00 eqv), lithium chloride (2.40 g, 56.6 mmol, 54.4 
eqv) and DMSO (8.00 mL). The product was a white solid. 
 
Yield: 6% over two steps (0.0403 g, 0.131 mmol); 1H-NMR (CDCl3, 300 MHz): δ 
7.55 (J = 1.7 Hz, 1H, d, H-7), 7.24 (J = 8.3 Hz, 2H, d, H-9), 7.20 (J = 8.3 Hz, 2H, d, 
H-8), 7.16 (J = 3.6 Hz, 1H, d, H-5), 6.51 (J = 1.7, 3.6 Hz, 1H, dd, H-6), 3.83 (J = 
7.2, 7.2, 7.4, 7.4 Hz, 1H, dddd, H-3), 3.58 (3H, s, H-1), 3.20 (J = 7.2 Hz, 2H, d, H-
4), 2.78 (J = 7.4, 15.7 Hz, 1H, dd, H-2), 2.66 (J = 7.4, 15.7 Hz, 1H, dd, H-2’); 13C-
NMR (CDCl3, 75 MHz): δ 186.9 (C=O), 171.9 (C=O), 152.6, 146.4, 141.4, 132.5, 
128.7 (2 × C), 117.2, 112.3, 51.7, 44.1, 40.3, 36.8; IR: 𝜈 3124, 3098, 2959, 1722 
(C=O), 1662 (C=O), 1473, 1430, 1363, 1306, 1266, 1216, 1160, 1088, 1066, 
1042, 1014, 873, 827, 770, 669, 597, 537, 519, 402; Melting Point: 83 – 84 °C; Rf 
(1:1 petroleum ether : diethyl ether) 0.31; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 329.0557, Observed: m/z 329.0566, Difference = 2.74 ppm 
 
Synthesis of methyl-5-(furan-2-yl)-3-(4-methoxyphenyl)-5-oxopentanoate (270c) 
 
 
 
 
 
Experimental procedure followed matched that described for 270a using: 
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Dimethyl-2-(3-(furan-2-yl)-1-(4-methoxyphenyl)-3-oxopropyl)malonate (271c) 
(0.609 g, 1.69 mmol, 1.00 eqv.), lithium chloride (2.81 g, 66.3 mmol, 39.2 eqv.) 
and DMSO (8.00 mL). The product was an off-white coloured oil. 
 
Yield: 10% (0.0528 g, 0.175 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.54 (J = 1.4 
Hz, 1H, d, H-7), 7.19 – 7.13 (3H, m, H-5 and H-8), 6.80 (J = 8.6 Hz, 2H, d, H-9), 
6.49 (J = 1.4, 3.5 Hz, 1H, dd, H-6), 3.85 – 3.75 (1H, m, H-3), 3.75 (3H, s, H-10), 
3.57 (3H, s, H-1), 3.16 (J = 7.2 Hz, 2H, d, H-4), 2.70 (J = 7.5 Hz, 2H, d, H-2); 13C-
NMR (CDCl3, 75 MHz): δ 186.9 (C=O), 171.8 (C=O), 157.9, 152.2, 146.1, 134.6, 
127.9, 116.9, 113.5, 111.9, 54.7, 51.1, 44.1, 40.2, 36.4; IR: 𝜈 2952, 2837, 1731 
(C=O), 1670 (C=O), 1611, 1568, 1513, 1466, 1436, 1364, 1246, 1178, 1152, 
1030, 883, 830, 763, 729, 595, 557; Rf (1:1 petroleum ether : diethyl ether) 0.43; 
Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 325.1052, Observed: m/z 
325.1059, Difference = 2.15 ppm 
 
Synthesis of methyl-5-(furan-2-yl)-5-oxo-3-p-tolylpentanoate (270d) 
 
 
 
 
 
Experimental procedure followed matched that described for 270a using: 
Dimethyl-2-(3-(furan-2-yl)-3-oxo-1-p-tolylpropyl)malonate (271d) (0.200 g, 0.581 
mmol, 1.00 eqv.), lithium chloride (1.11 g, 26.2 mmol, 45.1 eqv.) and DMSO (5.00 
mL). The product was a pale yellow solid. 
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Yield: 29% (0.0586 g, 0.171 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.54 (J = 1.7 
Hz, 1H, d, H-7), 7.15 (J = 3.6 Hz, 1H, d, H-5), 7.14 – 7.07 (4H, m, H-8 and H-9), 
6.50 (J = 1.7, 3.6 Hz, 1H, dd, H-6), 3.81 (J = 7.3, 7.3, 7.4, 7.4 Hz, 1H, dddd, H-3), 
3.58 (3H, s, H-1), 3.18 (J = 7.3 Hz, 2H, d, H-4), 2.72 (J = 7.4 Hz, 2H, d, H-2), 2.28 
(3H, s, H-10); 13C-NMR (CDCl3, 75 MHz): δ 187.3 (C=O), 172.2 (C=O), 152.6, 
146.3, 139.8, 136.3, 129.2, 127.0, 117.2, 112.2, 51.5, 44.4, 40.5, 37.0, 21.0; IR: 𝜈 
3131, 2950, 1731 (C=O), 1670 (C=O), 1567, 1466, 1435, 1393, 1363, 1275, 1223, 
1153, 1114, 1085, 1016, 883, 816, 763, 721, 595, 540, 494, 457; Melting Point: 67 
– 68 °C; Rf (1:1 petroleum ether : diethyl ether) 0.24; Mass Spectrometry: TOF 
ES+: MH+: Expected: m/z 287.1283, Observed: m/z 287.1284, Difference = −0.35 
ppm 
 
Synthesis of methyl-3-(3,4-dimethoxyphenyl)-5-(furan-2-yl)-5-oxopentanoate 
(270e) 
 
 
 
 
 
Experimental procedure followed matched that described for 270a using: 
Dimethyl-2-(1-(3,4-dimethoxyphenyl)-3-(furan-2-yl)-3-oxopropyl)malonate (271e) 
(0.600 g, 1.54 mmol, 1.00 eqv.), lithium chloride (3.31 g, 78.1 mmol, 50.7 eqv.) 
and 5:1 DMSO:water (12.0 mL). The product was a pale yellow solid. 
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Yield: 14% over 2 steps (0.0961 g, 0.289 mmol); 1H-NMR (CDCl3, 300 MHz): δ 
7.53 (J = 1.7 Hz, 1H, d, H-7), 7.13 (J = 3.6 Hz, 1H, d, H-5), 6.75 (3H, broad s, H-8, 
H-9 and H-10), 6.48 (J = 1.7, 3.6 Hz, 1H, dd, H-6), 3.83 (3H, s, H-12), 3.80 (3H, s, 
H-11), 3.78 (1H, m, H-3), 3.56 (3H, s, H-1), 3.16 (J = 7.2 Hz, 2H, d, H-4), 2.69 (J = 
7.5 Hz, 2H, d, H-2); 13C-NMR (CDCl3, 75 MHz): δ 187.3 (C=O), 172.1 (C=O), 
152.6, 148.7, 147.6, 146.3, 135.4, 118.8, 117.1, 112.2, 111.1, 110.7, 55.7, 55.7, 
51.5, 44.4, 40.6, 37.1; IR: 𝜈 3130, 3100, 3008, 2957, 2836, 1735 (C=O), 1658 
(C=O), 1519, 1465, 1425, 1397, 1281, 1254, 1230, 1142, 1039, 1019, 999, 919, 
859, 805, 776, 763, 661, 596, 520; Melting Point: 95 – 96 °C; Rf (1:1 petroleum 
ether : diethyl ether) 0.24; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 
355.1158, Observed: m/z 355.1166, Difference = 2.25 ppm 
 
Synthesis of methyl-3-(4-bromophenyl)-5-(furan-2-yl)-5-oxopentanoate (270f) 
 
 
 
 
 
Experimental procedure followed matched that described for 270a using: 
Dimethyl-2-(1-(4-bromophenyl)-3-(furan-2-yl)-3-oxopropyl)malonate (271f) (0.105 
g, 0.269 mmol, 1.00 eqv.), lithium chloride (0.464 g, 10.8 mmol, 40.1 eqv.) and 
DMSO (5.00 mL). The product was a pale yellow solid. 
 
Yield: 12% over two steps (0.0781 g, 0.222 mmol); 1H-NMR (CDCl3, 300 MHz): δ 
7.55 (J = 1.7 Hz, 1H, d, H-7), 7.40 (J = 8.5 Hz, 2H, d, H-8), 7.15 (J = 3.6 Hz, 1H, d, 
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H-5), 7.14 (J = 8.5 Hz, 2H, d, H-9), 6.51 (J = 1.7, 3.6 Hz, 1H, dd, H-6), 3.82 (J = 
7.2, 7.2, 7.5, 7.5 Hz, 1H, dddd, H-3), 3.59 (3H, s, H-1), 3.17 (J = 7.2 Hz, 2H, d, H-
4), 2.71 (J = 7.5 Hz, 2H, d, H-2); 13C-NMR (CDCl3, 75 MHz): δ 186.9 (C=O), 171.9 
(C=O), 152.6, 146.4, 141.9, 131.7, 129.1, 120.6, 117.2, 112.3, 51.7, 44.1, 40.2, 
36.8; IR: 𝜈 3124, 3097, 2951, 1722 (C=O), 1662 (C=O), 1472, 1398, 1214, 1105, 
1065, 1000, 950, 824, 769, 597, 535, 518; Melting Point: 84 – 85 °C; Rf (1:1 
petroleum ether : diethyl ether) 0.40; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 373.0051, Observed: m/z 373.0069, Difference = 4.82 ppm 
 
Synthesis of methyl-3-(4-bromophenyl)-5-(5-methylfuran-2-yl)-5-oxopentanoate 
(270h) 
 
 
 
 
 
Experimental procedure followed matched that described for 270a using: 
Dimethyl-2-(1-(4-bromophenyl)-3-(5-methylfuran-2-yl)-3-oxopropyl)malonate 
(271h) (0.507 g, 1.20 mmol, 1.00 eqv.), lithium chloride (2.09 g, 49.3 mmol, 41.1 
eqv.) and DMSO (12.0 mL). The product was a pale yellow solid. 
 
Yield: 25% (0.114 g, 0.301 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.39 (J = 8.4 Hz, 
2H, d, H-8), 7.14 (J = 8.4 Hz, 2H, d, H-9), 7.06 (J = 3.5 Hz, 1H, d, H-5), 6.12 (J = 
3.5 Hz, 1H, d, H-6), 3.85 – 3.75 (1H, m, H-3), 3.58 (3H, s, H-1), 3.11 (J = 7.3 Hz, 
2H, d, H-4), 2.71 (J = 7.5 Hz, 2H, d, H-2), 2.36 (3H, s, H-7); 13C-NMR (CDCl3, 75 
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MHz): δ 186.1 (C=O), 171.9 (C=O), 158.0, 151.3, 142.0, 131.6, 129.1, 120.6, 
119.4, 109.1, 51.7, 43.8, 40.2, 37.1, 14.1; IR: 𝜈 2952, 2916, 1735 (C=O), 1654 
(C=O), 1516, 1489, 1437, 1220, 1165, 1104, 873, 823, 792, 725, 526; Melting 
Point: 78 – 79 °C; Rf (1:1 petroleum ether : diethyl ether) 0.48; Mass 
Spectrometry: TOF ES+: MNa+: Expected: m/z 387.0208, Observed: m/z 
387.0225, Difference = 4.39 ppm 
 
Synthesis of methyl-5-(5-methylfuran-2-yl)-5-oxo-3-phenylpentanoate (270i) 
 
 
 
 
 
Experimental procedure followed matched that described for 270a using: 
Dimethyl-2-(3-(5-methylfuran-2-yl)-3-oxo-1-phenylpropyl)malonate (271i) (0.527 g, 
1.54 mmol, 1.00 eqv.), lithium chloride (2.96 g, 69.8 mmol, 45.3 eqv.) and DMSO 
(12.0 mL). The product was a pale yellow solid. 
 
Yield: 16% over 2 steps (0.106 g, 0.384 mmol); 1H-NMR (CDCl3, 400 MHz): δ 7.38 
– 7.13 (5H, m, H-8, H-9 and H-10), 7.07 (J = 3.5 Hz, 1H, d, H-5), 6.11 (J = 3.5 Hz, 
1H, d, H-6), 3.89 – 3.79 (1H, m, H-3), 3.57 (3H, s, H-1), 3.14 (J = 7.3 Hz, 2H, d, H-
4), 2.75 (J = 7.5 Hz, 2H, d, H-2), 2.34 (3H, s, H-7); 13C-NMR (CDCl3, 100 MHz): δ 
186.5 (C=O), 172.2 (C=O), 157.8, 151.5, 143.1, 128.6, 127.3, 126.8, 119.2, 109.0, 
51.5, 44.1, 40.4, 37.7, 14.0; IR: 𝜈 2952, 2896, 1730 (C=O), 1659 (C=O), 1515, 
1456, 1372, 1360, 1284, 1248, 1211, 1161, 1090, 1074, 1034, 978, 882, 796, 783, 
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761, 699, 559, 536, 469; Melting Point: 100 – 101 °C; Rf (1:1 petroleum ether : 
diethyl ether) 0.53; Mass Spectrometry: TOF ES+: MH+: Expected: m/z 287.1283, 
Observed: m/z 287.1278, Difference = 1.74 ppm 
 
Synthesis of methyl-5-(5-methylfuran-2-yl)-5-oxo-p-tolylpentanoate (270j) 
 
 
 
 
 
Experimental procedure followed matched that described for 270a using: 
Dimethyl-2-(3-(5-methylfuran-2-yl)-3-oxo-1-p-tolylpropyl)malonate (271j) (0.560 g, 
1.56 mmol, 1.00 eqv.), lithium chloride (2.74 g, 64.6 mmol, 41.4 eqv.) and DMSO 
(8.00 mL). The product was a pale yellow solid. 
 
Yield: 15% over 2 steps (0.105 g, 0.366 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.15 
– 7.05 (5H, m, H-5, H-8 and H-9), 6.10 (J = 3.5 Hz, 1H, d, H-6), 3.79 (J = 7.3, 7.3, 
7.4, 7.4 Hz, 1H, dddd, H-3), 3.56 (3H, s, H-1), 3.10 (J = 7.3 Hz, 2H, d, H-4), 2.71 
(J = 7.4 Hz, 2H, d, H-2), 2.34 (3H, s, H-7), 2.27 (3H, s, H-10); 13C-NMR (CDCl3, 75 
MHz): δ 186.4 (C=O), 172.2 (C=O), 157.7, 151.3, 139.9, 136.1, 129.1, 127.0, 
119.2, 108.8, 51.4, 44.1, 40.3, 37.2, 20.9, 13.9; IR: 𝜈 2951, 2920, 1729 (C=O), 
1659 (C=O), 1515, 1435, 1270, 1223, 1211, 1162, 1037, 873, 816, 795, 722, 528; 
Melting Point: 79 - 80 °C; Rf (1:1 petroleum ether : diethyl ether) 0.43; Mass 
Spectrometry: TOF ES+: MNa+: Expected: m/z 323.1259, Observed: m/z 
323.1248, Difference = −3.40 ppm 
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Synthesis of methyl-3-(4-chlorophenyl)-5-(5-methylfuran-2-yl)-5-oxopentanoate 
(270k) 
 
 
 
 
 
Experimental procedure followed matched that described for 270a using: 
Dimethyl-2-(1-(4-chlorophenyl)-3-(5-methylfuran-2-yl)-3-oxopropyl)malonate 
(271k) (0.510 g, 1.35 mmol, 1.00 eqv.), lithium chloride (2.31 g, 54.5 mmol, 40.4 
eqv.) and 5:1 DMSO:H2O (12.0 mL). The product was a yellow solid. 
 
Yield: 13% over 2 steps (0.0943 g, 0.293 mmol); 1H-NMR (CDCl3, 300 MHz): δ 
7.23 – 7.16 (4H, m, H-8 and H-9), 7.05 (J = 3.5 Hz, 1H, d, H-5), 6.10 (J = 3.5 Hz, 
1H, d, H-6), 3.80 (J = 7.3, 7.3, 7.3, 7.3 Hz, 1H, dddd, H-3), 3.56 (3H, s, H-1), 3.09 
(J = 7.3 Hz, 2H, d, H-4), 2.70 (J = 7.33 Hz, 2H, d, H-2), 2.34 (3H, s, H-7); 13C-NMR 
(CDCl3, 75 MHz): δ 185.9 (C=O), 171.8 (C=O), 157.8, 151.2, 141.4, 132.3, 128.6, 
128.5, 119.3, 108.9, 51.5, 43.7, 40.1, 36.9, 13.9; IR: 𝜈 3120, 2998, 2953, 2920, 
2849, 1735 (C=O), 1654 (C=O), 1514, 1492, 1423, 1369, 1271, 1220, 1209, 1164, 
1088, 1036, 873, 825, 791, 729, 711, 537, 526; Melting Point: 66 – 67 °C; Rf (1:1 
petroleum ether : diethyl ether) 0.29; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 343.0713, Observed: m/z 343.0706, Difference = −1.88 ppm 
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Synthesis of 1-(furan-2-yl)-3-phenylpentane-1,5-diol (266a) 
 
 
 
 
 
THF (12.0 mL) was added to lithium aluminium hydride (1.15 g, 30.3 mmol, 10.2 
eqv.). This was cooled to −15°C and methyl-5-(furan-2-yl)-5-oxo-3-
phenylpentanoate (270a) (0.810 g, 2.97 mmol, 1.00 eqv.) was added in THF (8 
mL). This was stirred at room temperature for 15 minutes and then it was 
quenched by adding diethyl ether (10.0 mL), followed by a 4:1 mixture of diethyl 
ether and acetone (10.0 mL). The reaction mixture was then diluted with ethyl 
acetate (40.0 mL), water (80.0 mL) and 2M sodium hydroxide solution (150 mL). 
Extraction was performed using ethyl acetate (3 × 30.0 mL) and the combined 
organic phases were washed with water (2 × 50.0 mL) and brine (50.0 mL). This 
was then dried over magnesium sulfate and concentrated under reduced pressure.  
The product was a yellow oil. 
 
Diastereomeric Ratio: 1.4:1; Yield: 99% (0.725 g, 2.94 mmol); 1H-NMR (CD3CN, 
300 MHz): δ 7.44 (J = 1.8 Hz, [1.4] 1H, d, H-8 [D-1]), 7.36 (J = 1.8 Hz, 1H, d, H-8 
[D-2]), 7.31 – 7.13 ([1.4] 5H + 5H, m, H-9 [D-1], H-9 [D-2], H-10 [D-1], H-10 [D-2], 
H-11 [D-1] and H-11 [D-2]), 6.37 (J = 1.8, 3.2 Hz, [1.4] 1H, dd, H-7 [D-1]), 6.30 (J = 
1.8, 3.2 Hz, 1H, dd, H-7 [D-2]), 6.20 (J = 3.2 Hz, [1.4] 1H, d, H-6 [D-1]), 6.14 (J = 
3.2 Hz, 1H, d, H-6 [D-2]), 4.33 (J = 7.3, 7.3 Hz, [1.4] 1H, dd, H-5 [D-1]), 4.17 (J = 
3.2, 10.0 Hz, 1H, dd, H-5 [D-2]), 3.40 – 3.17 ([1.4] 3H + 3H, m, H-1 [D-1], H-1 [D-
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2], OH [D-1] and OH [D-2]), 3.10 – 2.98 ([1.4] 1H, m, H-3 [D-1]), 2.67 – 2.57 ([1.4] 
1H + 2H, m, H-3 [D-2], OH [D-1] and OH [D-2]), 2.23 – 1.67 ([1.4] 4H + 4H, m, H-4 
[D-1], H-4 [D-2], H-2 [D-1] and H-2 [D-2]); 13C-NMR (CD3CN, 75 MHz): δ 158.9, 
157.9, 145.9, 145.5, 142.8, 142.5, 129.2, 128.7, 128.5, 127.1, 118.2, 110.9, 110.9, 
107.0, 105.9, 65.6, 65.2, 60.4, 60.2, 43.2, 43.1, 40.6, 39.9, 39.2, 39.0; IR: 𝜈 3318 
(O-H), 2921, 2850, 1494, 1453, 1145, 1043, 1009, 808, 762, 740, 701, 634, 598, 
533, 493; Rf (Diethyl ether) 0.47; Mass Spectrometry: TOF ES+: MNa+: Expected: 
m/z 269.1154, Observed: m/z 269.1445, Difference = −3.34 ppm 
 
Synthesis of 3-(4-chlorophenyl)-1-(furan-2-yl)pentan-1,5-diol (266b) 
 
 
 
 
 
Experimental procedure followed matched that described for 266a using: 
Lithium aluminium hydride (0.156 g, 4.11 mmol, 11.8 eqv.), methyl-3-(4-
chlorophenyl)-5-(furan-2-yl)-5-oxopentanoate (270b) (0.107 g, 0.349 mmol, 1.00 
eqv.) and THF (25.0 mL). The product was a pale yellow oil. 
 
Diastereomeric Ratio: 1.3:1; Yield: 99% (0.0967 g, 0.344 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.39 (J = 1.8 Hz, [1.3] 1H, d, H-8 [D-1]), 7.32 (J = 1.9 Hz, 1H, dd, H-8 
[D-2]), 7.31 – 7.26 ([1.3] 2H + 2H, m, H-10 [D-1] and H-10 [D-2]), 7.17 (J = 8.3 Hz, 
[1.3] 2H, d, H-9 [D-1]), 7.09 (J = 8.4 Hz, 2H, d, H-9 [D-2]), 6.33 (J = 1.8, 3.2 Hz, 
[1.3] 1H, dd, H-7 [D-1]), 6.29 (J = 1.9, 3.2 Hz, 1H, dd, H-7 [D-2]), 6.18 (J = 3.2 Hz, 
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[1.3] 1H, d, H-6 [D-1]), 6.15 (J = 3.2 Hz, 1H, d, H-6 [D-2]), 4.49 (J = 6.7, 7.9 Hz, 
[1.3] 1H, dd, H-5 [D-1]), 4.33 (J = 3.3, 10.4 Hz, 1H, dd, H-5 [D-2]), 3.61 – 3.36 
([1.3] 2H + 2H, m, H-1 [D-1] and H-1 [D-2]), 3.19 – 3.09 ([1.3] 1H, m, H-3 [D-1]), 
2.75 – 2.64 (1H, m, H-3 [D-2]), 2.29 – 1.64 ([1.3] 4H + 4H, m, H-4 [D-1], H-4 [D-2], 
H-2 [D-1] and H-2 [D-2]); 13C-NMR (CDCl3, 75 MHz): δ 156.7, 155.7, 142.7, 142.3, 
141.9, 141.9, 132.1, 129.2, 128.9, 128.8, 128.7, 110.2, 110.1, 106.8, 105.6, 65.7, 
65.0, 60.6, 60.5, 42.1, 41.8, 39.6, 38.9, 38.0, 37.7; IR: 𝜈 3314 (O-H), 2932, 1489, 
1412, 1146, 1090, 1043, 1012, 824, 737, 634, 598, 534, 493; Rf (Diethyl ether) 
0.38; Mass Spectrometry: TOF ES+: MH+: Expected: m/z 303.0764, Observed: m/z 
303.0748, Difference = 5.26 ppm 
 
These diastereoisomers were able to be separated into diastereomerically 
enriched mixtures with careful column chromatography in a graduated solvent 
system reaching pure diethyl ether.  
 
First Diastereoisomer 
1H-NMR (CDCl3, 300 MHz): δ 7.38 (J = 1.8 Hz, 1H, d, H-8), 7.27 (J = 8.4 Hz, 2H, 
d, H-10), 7.08 (J = 8.4 Hz, 2H, d, H-9), 6.33 (J = 1.8, 3.2 Hz, 1H, dd, H-7), 6.17 (J 
= 3.2 Hz, 1H, d, H-6), 4.49 (J = 6.2, 6.2 Hz, 1H, dd, H-5), 3.52 (1H, m, H-1), 3.39 
(1H, m, H-1), 2.71 (1H, m, H-3), 2.30 – 1.70 (4H, m, H-2 and H-4); 13C-NMR 
(CDCl3, 75 MHz): δ 155.7, 142.7, 142.2, 132.1, 128.9, 128.7, 110.2, 106.7, 65.6, 
60.5, 42.1, 38.8, 38.0; IR: 𝜈 3328 (O-H), 2938, 2885, 1490, 1412, 1147, 1091, 
1043, 1012, 909, 824, 730, 598 
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Second Diastereoisomer 
1H-NMR (CDCl3, 300 MHz): δ 7.32 (J = 1.8 Hz, 1H, d, H-8), 7.28 (J = 8.5 Hz, 2H, 
d, H-10), 7.17 (J = 8.5 Hz, 2H, d, H-9), 6.29 (J = 1.8, 3.2 Hz, 1H, dd, H-7), 6.14 (J 
= 3.2 Hz, 1H, d, H-6), 4.33 (J = 3.3, 10.5 Hz, 1H, dd, H-5), 3.65 – 3.40 (2H, m, H-
1), 3.14 (1H, m, H-3), 2.22 (J = 3.3, 10.5, 14.2 Hz, 1H, ddd, H-4), 2.05 – 1.80 (3H, 
m, H-2 and H-4); 13C-NMR (CDCl3, 75 MHz): δ 156.7, 142.3, 141.9, 132.1, 129.2, 
128.8, 110.1, 105.6, 65.1, 60.7, 41.9, 39.6, 37.8; IR: 𝜈 3332 (O-H), 2937, 2901, 
1490, 1412, 1229, 1147, 1091, 1044, 1012, 909, 824, 732, 598 
 
Synthesis of 1-(furan-2-yl)-3-(4-methoxyphenyl)pentane-1,5-diol (266c) 
 
 
 
 
 
Experimental procedure followed matched that described for 266a using: 
Lithium aluminium hydride (119 mg, 3.11 mmol, 19.8 eqv.), methyl-5-(furan-2-yl)-
3-(4-methoxyphenyl)-5-oxopentanoate (270c) (47.5 g, 0.157 mmol, 1.00 eqv.) and 
THF (5.00 mL). The product was a dark yellow oil. 
 
Diastereomeric Ratio: 1.3:1; Yield: 96% (41.7 mg, 0.151 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.39 (J = 1.7 Hz, [1.3] 1H, d, H-8 [D-1]), 7.33 (1H, m, H-8 [D-2]), 7.15 
(J = 8.5 Hz, 2H, d, H-9 [D-2]), 7.07 (J = 8.3 Hz, [1.3] 2H, d, H-9 [D-1]), 6.87 – 6.84 
([1.3] 2H + 2H, m, H-10 [D-1] and H-10 [D-2]), 6.33 (J = 1.7, 2.7 Hz, [1.3] 1H, dd, 
H-7 [D-1]), 6.29 (J = 1.6, 3.0 Hz, 1H, dd, H-7 [D-2]), 6.19 (J = 2.7 Hz, [1.3] 1H, d, 
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H-6 [D-1]), 6.15 (J = 3.0 Hz, 1H, d, H-6 [D-2]), 4.51 (J = 5.9, 11.2 Hz, [1.3] 1H, dd, 
H-5 [D-1]), 4.37 (J = 3.6, 8.8 Hz, 1H, dd, H-5 [D-2]), 3.80 ([1.3] 3H + 3H, s, H-11 
[D-1] and H-11 [D-2]), 3.62 – 3.38 ([1.3] 2H + 2H, m, H-1 [D-1] and H-1 [D-2]), 3.13 
– 3.02 (1H, m, H-3 [D-2]), 2.68 – 2.59 ([1.3] 1H, m, H-3 [D-1]), 2.29 – 1.79 ([1.3] 
4H + 4H, m, H-2 [D-1], H-1 [D-2], H-4 [D-1] and H-4 [D-2]); 13C-NMR (CDCl3, 75 
MHz): δ 158.3, 157.1, 156.0, 142.2, 141.8, 136.0, 135.6, 128.7, 128.5, 114.1, 
114.1, 110.1, 106.6, 105.4, 66.1, 65.3, 61.1, 60.9, 55.2, 42.6, 42.3, 40.0, 39.4, 
38.2, 37.7; IR: 𝜈 3347 (O-H), 2933, 1609, 1510, 1301, 1243, 1177, 1146, 1029, 
1008, 883, 830, 736, 598, 574; Rf (Diethyl ether) 0.35; Mass Spectrometry: TOF 
ES+: MNa+: Expected: m/z 299.1259, Observed: m/z 299.1273, Difference = 4.68 
ppm 
 
Synthesis of 1-(furan-2-yl)-3-p-tolylpentane-1,5-diol (266d) 
 
 
 
 
 
Experimental procedure followed matched that described for 266a using: 
Lithium aluminium hydride (16.4 mg, 0.432 mmol, 12.4 eqv.), methyl-5-(furan-2-yl)-
5-oxo-p-tolylpentanoate (270d) (10.0 mg, 0.0349 mmol, 1.00 eqv.) and THF (5.00 
mL). The product was a pale yellow oil. 
 
Diastereomeric Ratio: 1.3:1; Yield: 40% (3.60 mg, 0.0138 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.39 (J = 1.83 Hz, [1.3] 1H, d, H-8 [D-1]), 7.32 (J = 1.83 Hz, 1H, d, H-
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8 [D-2]), 7.13 – 7.03 ([1.3] 4H + 4H, m, H-9 [D-1], H-9 [D-2], H-10 [D-1] and H-10 
[D-2]), 6.33 (J = 1.8, 3.1 Hz, [1.3] 1H, dd, H-7 [D-1]), 6.28 (J = 1.8, 3.2 Hz, 1H, dd, 
H-7 [D-2]), 6.19 (J = 3.1 Hz, [1.3] 1H, d, H-6 [D-1]), 6.15 (J = 3.2 Hz, 1H, d, H-6 [D-
2]), 4.51 (J = 4.3, 7.5 Hz, [1.3] 1H, dd, H-5 [D-1]), 4.37 (J = 3.5, 7.6 Hz, 1H, dd, H-
5 [D-2]), 3.62 – 3.38 ([1.3] 2H + 2H, m, H-1 [D-1] and H-1 [D-2]), 3.13 – 3.03 (1H, 
m, H-3 [D-2]), 2.70 – 2.60 ([1.3] 1H, m, H-3 [D-1]), 2.33 ([1.3] 3H + 3H, s, H-11 [D-
1] and H-11 [D-2]), 2.29 – 1.75 ([1.3] 2H + 2H, m, H-4 [D-1] and H-4 [D-2]), 2.01 – 
1.81 ([1.3] 2H + 2H, m, H-2 [D-1] and H-2 [D-2]); 13C-NMR (CDCl3, 75 MHz): δ 
157.0, 155.9, 142.1, 141.8, 140.9, 140.5, 136.1, 136.1, 129.4, 127.6, 127.4, 110.1, 
110.1, 106.7, 105.4, 66.0, 65.2, 61.1, 60.9, 42.4, 42.0, 39.8, 39.2, 38.5, 38.0, 21.0; 
IR: 𝜈 3317 (O-H), 2924, 1512, 1145, 1042, 1008, 884, 814, 735, 598, 572; Rf 
(Diethyl ether) 0.40; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 
283.1310, Observed: m/z 283.1320, Difference = 3.53 ppm 
 
Synthesis of 3-(3,4-dimethoxyphenyl)-1-(furan-2-yl)pentane-1,5-diol (266e) 
 
 
 
 
 
Experimental procedure followed matched that described for 266a using: 
Lithium aluminium hydride (135 mg, 3.56 mmol, 12.3 eqv.), methyl-3-(3,4-
dimethoxyphenyl)-5-(furan-2-yl)-5-oxopentanoate (270e) (96.0 mg, 0.289 mmol, 
1.00 eqv.) and THF (10.0 mL). The product was a pale yellow oil. 
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Diastereomeric Ratio: 1.3:1; Yield: 41% (36.6 mg, 0.119 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.36 (J = 1.8 Hz, [1.3] 1H, d, H-8 [D-1]), 7.30 (J = 1.8 Hz, 1H, d, H-8 
[D-2]), 6.81 – 6.64 ([1.3] 3H + 3H, m, H-9 [D-1], H-9 [D-2], H-10 [D-1], H-10 [D-2], 
H-11 [D-1] and H-11 [D-2]), 6.31 (J = 1.8, 3.1 Hz, [1.3] 1H, dd, H-7 [D-1]), 6.26 (J = 
1.8, 3.2 Hz, 1H, dd, H-7 [D-2]), 6.17 (J = 3.1 Hz, [1.3] 1H, d, H-6 [D-1]), 6.12 (J = 
3.2 Hz, 1H, d, H-6 [D-2]), 4.52 (J = 7.2, 7.2 Hz, [1.3] 1H, dd, H-5 [D-1]), 4.36 (J = 
2.9, 10.3 Hz, 1H, dd, H-5 [D-2]), 3.84 ([1.3] 3H + 3H, s, H-12 [D-1] and H-12 [D-2]), 
3.83 ([1.3] 3H + 3H, s, H-13 [D-1] and H-13 [D-2]), 3.36 – 3.67 ([1.3] 2H + 2H, m, 
H-1 [D-1] and H-1 [D-2]), 3.10 – 3.00 ([1.3] 1H, m, H-3 [D-1]), 2.70 – 2.61 (1H, m, 
H-3 [D-2]), 2.26 – 1.84 ([1.3] 4H + 4H, m, H-4 [D-1], H-4 [D-2], H-2 [D-1] and H-1 
[D-2]); 13C-NMR (CDCl3, 75 MHz): δ 157.0, 156.0, 148.9, 148.9, 147.4, 142.0, 
141.7, 136.7, 136.3, 119.7, 119.4, 111.2, 111.2, 110.6, 110.5, 110.1, 110.0, 106.5, 
105.3, 65.6, 65.1, 60.7, 55.8, 55.8, 42.4, 41.8, 39.8, 38.7, 38.3, 37.8, 30.2, 29.6; 
IR: 𝜈 3344 (O-H), 2935, 2835, 1513, 1463, 1256, 1232, 1139, 1024, 912, 808, 763, 
727, 649, 599; Rf (Diethyl ether) 0.21; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 329.1365, Observed: m/z 329.1358, Difference = 2.13 ppm 
 
Synthesis of 3-(4-bromophenyl)-1-(furan-2-yl)pentane-1,5-diol (266f) 
 
 
 
 
 
Experimental procedure followed matched that described for 266a using: 
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Lithium aluminium hydride (0.141 g, 3.72 mmol, 10.9 eqv.), methyl-3-(4-
bromophenyl)-5-(furan-2-yl)-5-oxopentanoate (270f) (0.120 g, 0.342 mmol, 1.00 
eqv.) and THF (25.0 mL). The product was a milky coloured oil. 
 
Diastereomeric Ratio: 1.3:1; Yield: 91% (0.101 g, 0.311 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.46 – 7.40 ([1.3] 2H + 2H, m, H-9 [D-1] and H-9 [D-2]), 7.39 (J = 1.8 
Hz, [1.3] 1H, d, H-8 [D-1]), 7.32 (J = 1.8 Hz, 1H, d, H-8 [D-2]), 7.14 – 7.01 ([1.3] 2H 
+ 2H, m, H-10 [D-1] and H-10 [D-2]), 6.33 (J = 1.8, 3.2 Hz, [1.3] 1H, dd, H-7 [D-1]), 
6.29 (J = 1.8, 3.2 Hz, 1H, dd, H-7 [D-2]), 6.18 (J = 3.2 Hz, [1.3] 1H, d, H-6 [D-1]), 
6.15 (J = 3.2 Hz, 1H, d, H-6 [D-2]), 4.49 (J = 6.8, 7.8 Hz, [1.3] 1H, dd, H-5 [D-1]), 
4.33 (J = 3.2, 10.4 Hz, 1H, dd, H-5 [D-2]), 3.61 – 3.37 ([1.3] 2H + 2H, m, H-1 [D-1] 
and H-1 [D-2]), 3.18 – 3.08 (1H, m, H-3 [D-2]), 2.74 – 2.66 ([1.3] 1H, m, H-3 [D-1]), 
2.32 – 1.71 ([1.3] 4H + 4H, m, H-4 [D-1], H-4 [D-2], H-2 [D-1] and H-2 [D-2]); 13C-
NMR (CDCl3, 75 MHz): δ 156.7, 155.6, 143.2, 142.8, 142.3, 141.9, 131.7, 131.7, 
129.6, 129.3, 120.2, 110.2, 110.1, 106.8, 105.6, 65.7, 65.1, 60.7, 60.5, 42.1, 41.9, 
39.6, 38.9, 38.2, 37.9; IR: 𝜈 3312 (O-H), 2929, 1486, 1146, 1069, 1042, 1008, 818, 
737, 598; Rf (Diethyl ether) 0.40; Mass Spectrometry: TOF ES+: MNa+: Expected: 
m/z 347.0259, Observed: m/z 347.0245, Difference = −4.03 ppm 
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Synthesis of 3-(4-bromophenyl)-1-(5-methylfuran-2-yl)pentane-1,5-diol (266h) 
 
 
 
 
 
Experimental procedure followed matched that described for 266a using: 
Lithium aluminium hydride (32.3 mg, 0.851 mmol, 10.4 eqv.), methyl-3-(4-
bromophenyl)-5-(5-methylfuran-2-yl)-5-oxopentanoate (270h) (30.0 mg, 0.0821 
mmol, 1.00 eqv.) and THF (15.0 mL). The product was a yellow oil. 
 
Diastereomeric Ratio: 1.4:1; Yield: 28% (7.70 mg, 0.0227 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.45 – 7.40 ([1.4] 2H + 2H, m, H-9 [D-1] and H-9 [D-2]), 7.13 – 7.01 
([1.4] 2H + 2H, m, H-10 [D-1] and H-10 [D-2]), 6.04 (J = 3.0 Hz, [1.4] 1H, d, H-6 [D-
1]), 6.01 (J = 3.1 Hz, 1H, d, H-6 [D-2]), 5.89 (J = 1.0, 3.0 Hz, [1.4] 1H, dd, H-7 [D-
1]), 5.85 (J = 0.9, 3.1 Hz, 1H, dd, H-7 [D-2]), 4.43 (J = 6.8, 7.7 Hz, [1.4] 1H, dd, H-
5 [D-1]), 4.26 (J = 3.3, 10.4 Hz, 1H, dd, H-5 [D-2]), 3.61 – 3.37 ([1.4] 2H + 2H, m, 
H-1 [D-1] and H-1 [D-2]), 3.16 – 3.05 (1H, m, H-3 [D-2]), 2.77 – 2.66 ([1.4] 1H, m, 
H-3 [D-1]), 2.28 (J = 1.0 Hz, [1.4] 3H, d, H-8 [D-1]), 2.23 (J = 0.9 Hz, 3H, d, H-8 [D-
2]), 2.21 – 1.71 ([1.4] 4H + 4H, m, H-4 [D-1],  H-4 [D-2], H-2 [D-1] and H-2 [D-2]); 
13C-NMR (CDCl3, 75 MHz): δ 154.8, 153.8, 152.0, 151.7, 143.3, 142.9, 131.6, 
129.6, 129.3, 120.1, 107.7, 106.5, 106.0, 105.9, 65.7, 65.0, 60.6, 60.5, 41.9, 41.7, 
39.6, 38.8, 38.1, 37.9, 13.6, 13.5; IR: 𝜈 3309 (O-H), 2920, 1486, 1408, 1218, 1070, 
1042, 1020, 1008, 820, 784, 565; Rf (Diethyl ether) 0.43; Mass Spectrometry: TOF 
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ES+: MNa+: Expected: m/z 361.0415, Observed: m/z 361.0427, Difference = 3.32 
ppm 
 
Synthesis of 1-(5-methylfuran-2-yl)-3-phenylpentane-1,5-diol (266i) 
 
 
 
 
 
Experimental procedure followed matched that described for 266a using: 
Lithium aluminium hydride (0.144 g, 3.79 mmol, 12.3 eqv.), methyl-5-(5-
methylfuran-2-yl)-5-oxo-3-phenylpentanoate (270i) (87.9 mg, 0.307 mmol, 1.00 
eqv.) and THF (5.50 mL). The product was a yellow oil. 
 
Diastereomeric Ratio: 1.4:1; Yield: 73% (58.1 mg, 0.223 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.34 – 7.14 ([1.4] 5H + 5H, m, H-9 [D-1], H-9 [D-2], H-10 [D-1], H-10 
[D-2], H-11 [D-1] and H-11 [D-2]), 6.06 (J = 3.1 Hz, [1.4] 1H, d, H-6 [D-1]), 6.01 (J 
= 3.1 Hz, 1H, d, H-6 [D-2]), 5.90 (J = 0.9, 3.1 Hz, [1.4] 1H, dd, H-7 [D-1]), 5.85 (J = 
0.9, 3.1 Hz, 1H, dd, H-7 [D-2]), 4.44 (J = 7.2, 7.2 Hz, [1.4] 1H, dd, H-5 [D-1]), 4.29 
(J = 3.3, 10.3 Hz, 1H, dd, H-5 [D-2]), 3.61 – 3.40 ([1.4] 2H + 2H, m, H-1 [D-1] and 
H-1 [D-2]), 3.02 – 3.19 ([1.4] 1H, m, H-3 [D-1]), 2.65 – 2.79 (1H, m, H-3 [D-2]), 
2.28 (J = 0.9 Hz, [1.4] 3H, d, H-8 [D-1]), 2.23 (J = 0.9 Hz, 3H, d, H-8 [D-2]), 2.08 – 
1.77 ([1.4] 4H + 4H, m, H-4 [D-1], H-4 [D-2], H-2 [D-1] and H-2 [D-2]); 13C-NMR 
(CDCl3, 75 MHz): δ 153.9, 152.0, 144.2, 143.8, 128.6, 127.8, 127.6, 126.5, 126.5, 
107.6, 106.3, 106.0, 105.9, 65.9, 60.9, 42.2, 41.9, 39.8, 39.0, 38.9, 38.5, 13.6, 
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13.5; IR: 𝜈 3339 (O-H), 2922, 1699, 1562, 1452, 1219, 1044, 1020, 784, 762, 700; 
Rf (Diethyl ether) 0.44; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 
283.1310, Observed: m/z 283.1324, Difference = 4.94 ppm 
 
Synthesis of 1-(5-methylfuran-2-yl)-3-p-tolylpentane-1,5-diol (266j) 
 
 
 
 
 
Experimental procedure followed matched that described for 266a using: 
Lithium aluminium hydride (0.117 g, 3.08 mmol, 9.25 eqv.), methyl-5-(5-
methylfuran-2-yl)-5-oxo-p-tolylpentanoate (270j) (0.100 g, 0.333 mmol, 1.00 eqv.) 
and THF (5.00 mL). The product was a dark yellow oil. 
 
Diastereomeric Ratio: 1.4:1; Yield: >99% (90.5 mg, 0.332 mmol); 1H-NMR (CDCl3, 
400 MHz): δ 7.13 – 7.02 ([1.4] 4H + 4H, m, H-9 [D-1], H-9 [D-2], H-10 [D-1] and H-
10 [D-2]), 6.05 (J = 3.0 Hz, [1.4] 1H, d, H-6 [D-1]), 6.01 (J = 3.1 Hz, 1H, d, H-6 [D-
2]), 5.89 (J = 0.9, 3.0 Hz, [1.4] 1H, dd, H-7 [D-1]), 5.85 (J = 0.9, 3.1 Hz, 1H, dd, H-
7 [D-2]), 4.45 (J = 7.1, 7.1 Hz, [1.4] 1H, dd, H-5 [D-1]), 4.30 (J = 3.1, 10.2 Hz, 1H, 
dd, H-5 [D-2]), 3.61 – 3.39 ([1.4] 2H + 2H, m, H-1 [D-1] and H-1 [D-2]), 3.12 – 3.01 
(1H, m, H-3 [D-2]), 2.78 – 2.63 ([1.4] 1H, m, H-3 [D-1]), 2.32 ([1.4] 3H + 3H, s, H-
11 [D-1] and H-11 [D-2]), 2.28 (J = 0.9 Hz, [1.4] 3H, d, H-8 [D-1]), 2.23 (J = 0.9 Hz, 
3H, d, H-8 [D-2]), 2.16 – 1.50 ([1.4] 4H + 4H, m, H-2 [D-1], H-2 [D-2], H-4 [D-1] 
and H-4 [D-2]); 13C-NMR (CDCl3, 100 MHz): δ 155.2, 154.2, 151.9, 151.6, 141.2, 
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140.7, 136.1, 136.0, 129.4, 127.7, 127.4, 107.5, 106.3, 106.0, 105.9, 66.1, 65.2, 
61.2, 61.0, 42.4, 42.1, 39.9, 39.2, 38.7, 38.2, 21.0, 13.6, 13.5; IR: 𝜈 3314 (O-H), 
2920, 2882, 1513, 1044, 1020, 784, 668, 631, 595, 533, 495; Rf (Diethyl ether) 
0.50; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 297.1467, Observed: 
m/z 297.1477, Difference = 3.37 ppm 
 
Synthesis of 3-(4-chlorophenyl)-1-(5-methylfuran-2-yl)pentane-1,5-diol (266k) 
 
 
 
 
 
Experimental procedure followed matched that described for 266a using: 
Lithium aluminium hydride (120 mg, 3.16 mmol, 11.2 eqv.), methyl-3-(4-
chlorophenyl)-5-(5-methylfuran-2-yl)-5-oxopentanoate (270k) (90.0 mg, 0.281 
mmol, 1.00 eqv.) and THF (5.00 mL). The product was a yellow oil. 
 
Diastereomeric Ratio: 1.3:1; Yield: 69% (56.8 mg, 0.193 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.31 – 7.08 ([1.3] 4H + 4H, m, H-9 [D-1], H-9 [D-2], H-10 [D-1] and H-
10 [D-2]), 6.05 (J = 3.1 Hz, [1.3] 1H, d, H-6 [D-1]), 6.01 (J = 3.1 Hz, 1H, d, H-6 [D-
2]), 5.90 (J = 1.0, 3.1 Hz, [1.3] 1H, dd, H-7 [D-1]), 5.85 (J = 0.9, 3.1 Hz, 1H, dd, H-
7 [D-2]), 4.42 (J = 8.5, 8.5 Hz, [1.3] 1H, dd, H-5 [D-1]), 4.26 (J = 3.1, 13.1 Hz, 1H, 
dd, H-5 [D-2]), 3.60 – 3.37 ([1.3] 2H + 2H, m, H-1 [D-1] and H-1 [D-2]), 3.05 – 3.19 
(1H, m, H-3 [D-2]), 2.64 – 2.81 ([1.3] 1H, m, H-3 [D-1]), 2.28 (J = 1.0 Hz, [1.3] 3H, 
d, H-8 [D-1]), 2.23 (J = 0.9 Hz, 3H, d, H-8 [D-2]), 2.20 – 1.72 ([1.3] 4H + 4H, m, H-
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4 [D-1], H-4 [D-2], H-2 [D-1] and H-2 [D-2]); 13C-NMR (CDCl3, 75 MHz): δ 154.9, 
153.9, 151.9, 151.6, 142.9, 142.5, 131.9, 129.2, 128.9, 128.6, 107.5, 106.4, 106.0, 
105.9, 65.4, 64.9, 60.3, 60.3, 42.0, 41.4, 39.6, 38.4, 37.8, 37.5, 13.5, 13.5; IR: 𝜈 
3323 (O-H), 2922, 1489, 1219, 1090, 1043, 1013, 826, 784, 566; Rf (Diethyl ether) 
0.42; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 317.0920, Observed: 
m/z 317.0936, Difference = 5.05 ppm 
 
Synthesis of (2S, 4R)-2-(furan-2-yl)-4-phenyltetrahydro-2H-pyran (269a) 
 
 
 
 
 
 
1-(furan-2-yl)-3-phenylpentane-1,5-diol (266a) (71.9 mg, 0.292 mmol) was 
dissolved in acetonitrile (2.00 mL). Quadrapure™ polymer-supported sulfonic acid 
(11.0 mg) was then added and the reaction was stirred for 3 hours. Upon 
completion the reaction mixture was filtered and then concentrated under reduced 
pressure before being characterised. The product was a dark yellow oil. 
 
Yield: 73% (48.4 mg, 0.212 mmol); Diastereomeric Ratio: 22:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.39 (J = 1.8 Hz, 1H, d, H-1), 7.32 – 7.21 (5H, m, H-9, H-10 and H-
11), 6.34 (J = 1.8, 3.3 Hz, 1H, dd, H-2), 6.29 (J = 3.3 Hz, d, H-3), 4.56 (J = 2.6, 
11.0 Hz, 1H, dd, H-4), 4.24 (J = 1.8, 4.3, 11.6 Hz, 1H, ddd, H-5), 3.77 (J = 2.8, 
11.6, 11.6 Hz, 1H, ddd, H-5), 2.92 (J = 4.3, 4.3, 11.8, 11.8 Hz, 1H, dddd, H-8), 
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2.12 – 1.82 (4H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 154.6, 145.2, 
142.2, 128.6, 126.8, 126.5, 110.1, 106.3, 73.1, 68.6, 41.6, 37.1, 33.1; IR: 𝜈 2917, 
2846, 1724, 1452, 1252, 1122, 1078, 1012, 943, 808, 739, 698, 599, 532; Rf (9:1 
Petroleum ether : Diethyl ether) 0.30; Mass Spectrometry: TOF ES+: M+: 
Expected: m/z 228.1150, Difference: m/z 228.1142, Difference: −3.51 ppm 
 
Synthesis of (2R,4R)-2-(furan-2-yl)-4-phenyltetrahydro-2H-pyran (268a) 
 
 
 
 
 
 
1-(furan-2-yl)-3-phenylpentane-1,5-diol (266a) (268 mg, 1.09 mmol, 1.00 eqv.) was 
dissolved in tetrahydrofuran (10.0 mL) under an inert atmosphere. Sodium hydride 
(60% in mineral oil) (566 mg, 14.2 mmol, 13.0 eqv.) was then added and the 
reaction mixture was stirred for 30 minutes at room temperature. 4-toluenesulfonyl 
chloride (438 mg, 2.30 mmol, 2.11 eqv.) was then added and the reaction was 
stirred for 12 hours. After, the reaction mixture was quenched with 2M aqueous 
sodium hydroxide solution (40.0 mL). The reaction mixture was then diluted with 
ethyl acetate (30.0 mL) and water (30.0 mL). Extraction was performed using ethyl 
acetate (3 × 30.0 mL) and the combined organic phases were washed with water 
(2 × 50.0 mL) and brine (50.0 mL). This was then dried over magnesium sulfate 
and concentrated under reduced pressure. The diastereoisomer mix was then 
separated by column chromatography using a graduated solvent system reaching 
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a 19:1 mixture of petroleum ether and diethyl ether. The product was a colourless 
oil. 
 
Yield: 7% (18.6 mg, 0.0815 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.45 (J = 1.8 Hz, 
1H, d, H-1), 7.38 – 7.21 (5H, m, H-9, H-10 and H-11), 6.41 (J = 1.8, 3.2 Hz, 1H, 
dd, H-2), 6.37 (J = 3.2 Hz, d, H-3), 5.09 (J = 2.7, 5.3 Hz, 1H, dd, H-4), 3.87 (J = 
3.8, 3.9, 11.6 Hz, 1H, ddd, H-5), 3.73 (J = 2.9, 10.8, 11.6 Hz, 1H, ddd, H-5), 3.13 
(J = 4.1, 4.1, 11.0, 11.0 Hz, 1H, dddd, H-8), 2.33 (J = 2.7, 4.1, 13.7 Hz, 1H, ddd, 
H-7), 2.19 (J = 5.3, 11.0, 13.7 Hz, 1H, ddd, H-7), 1.94 (J = 4.1, 10.8, 11.1, 13.4 Hz, 
1H, dddd, H-6), 1.86 – 1.78 (1H, m, H-6); 13C-NMR (CDCl3, 75 MHz): δ 154.1, 
145.2, 142.1, 128.6, 126.9, 126.3, 110.2, 108.0, 69.1, 62.7, 36.4, 34.1, 32.9; IR: 𝜈 
2959, 2948, 2926, 2897, 2873, 1497, 1452, 1341, 1181, 1146, 1080, 1005, 768, 
761, 700, 599, 534, 443; Rf (Diethyl ether) 0.93; Mass Spectrometry: TOF ES+: 
M+: Expected: m/z 228.1150, Observed: m/z 228.1151, Difference = 0.44 ppm 
 
Synthesis of (2S,4R)-4-(4-chlorophenyl)-2-(furan-2-yl)tetrahydro-2H-pyran (269b) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 269a using: 
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3-(4-chlorophenyl)-1-(furan-2-yl)pentan-1,5-diol (266b) (25.0 mg, 0.0890 mmol), 
Quadrapure™ polymer-supported sulfonic acid (10.2 mg) and acetonitrile (2.50 
mL). The product was a pale yellow oil. 
 
Yield: 23% (5.30 mg, 0.0202 mmol); Diastereomeric Ratio: 19:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.39 (J = 1.8 Hz, 1H, d, H-1), 7.32 – 7.28 (2H, m, H-10), 7.21 – 7.17 
(2H, m, H-9), 6.34 (J = 1.8, 3.2 Hz, 1H, dd, H-2), 6.29 (J = 3.2 Hz, 1H, d, H-3), 
4.54 (J = 2.5, 11.1 Hz, 1H, dd, H-4), 4.23 (J = 2.1, 4.1, 11.6 Hz, 1H, ddd, H-5), 
3.75 (J = 3.2, 11.5, 11.6 Hz, 1H, ddd, H-5), 2.90 (J = 4.4, 4.4, 11.4, 11.4 Hz, 1H, 
dddd, H-8), 2.13 – 1.76 (4H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 154.4, 
143.6, 142.2, 132.1, 128.7, 128.1, 110.1, 106.4, 73.0, 68.4, 41.0, 37.0, 33.0; IR: 𝜈 
2917, 2844, 1491, 1169, 1078, 1012, 877, 824, 803, 736, 599, 536, 435; Rf (9:1 
Petroleum ether : Diethyl ether) 0.27; Mass Spectrometry: TOF ES+: M+: 
Expected: m/z 262.0761, Observed: m/z 262.0771, Difference = 3.82 ppm 
 
Synthesis of (2S,4R)-2-(furan-2-yl)-4-(4-methoxyphenyl)tetrahydro-2H-pyran 
(269c) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 269a using: 
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1-(furan-2-yl)-3-(4-methoxyphenyl)pentane-1,5-diol (266c) (33.0 mg, 0.119 mmol), 
Quadrapure™ polymer-supported sulfonic acid (23.8 mg) and acetonitrile (5.04 
mL). The product was a yellow oil. 
 
Yield: 59% (18.2 mg, 0.0705 mmol); Diastereomeric Ratio: 10:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.39 (J = 1.8 Hz, 1H, d, H-1), 7.21 – 7.17 (2H, m, H-9), 6.91 – 6.86 
(2H, m, H-10), 6.34 (J = 1.8, 3.3 Hz, 1H, dd, H-2), 6.29 (J = 3.3 Hz, 1H, d, H-3), 
4.55 (J = 2.4, 11.1 Hz, 1H, dd, H-4), 4.23 (J = 1.9, 4.2, 11.5 Hz, 1H, ddd, H-5), 
3.80 (3H, s, H-11), 3.76 – 3.71 (1H, m, H-5), 2.92 – 2.81 (1H, m, H-8), 2.13 – 1.80 
(4H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 158.1, 154.6, 142.2, 137.4, 
127.6, 113.9, 110.0, 106.3, 73.0, 68.6, 55.2, 40.7, 37.3, 33.3; IR: 𝜈 2919, 2837, 
1583, 1245, 1178, 1078, 1034, 1011, 828, 806, 736, 599, 547, 531; Rf (9:1 
Petroleum ether : Diethyl ether) 0.25; Mass Spectrometry: TOF ES+: M+: 
Expected: m/z 258.1256, Observed: m/z 258.1244, Difference = −4.65 ppm 
 
Synthesis of (2S,4R)-2-(furan-2-yl)-4-p-tolyltetrahydro-2H-pyran (269d) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 269a using: 
269d
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1-(furan-2-yl)-3-p-tolylpentane-1,5-diol (266d) (3.00 mg, 0.0115 mmol), 
Quadrapure™ polymer-supported sulfonic acid (10.0 mg) and acetonitrile (0.750 
mL). The product was a pale yellow oil. 
 
Yield: 83% (2.30 mg, 0.00949 mmol); Diastereomeric Ratio: 20:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.48 (J = 1.8 Hz, 1H, d, H-1), 7.26 (4H, m, H-9 and H-10), 6.43 (J = 
1.8, 3.2 Hz, 1H, dd, H-2), 6.39 (J = 3.2 Hz, 1H, d, H-3), 4.64 (J = 2.4, 11.0 Hz, 1H, 
dd, H-4), 4.33 (J = 1.4, 4.3, 11.5 Hz, 1H, ddd, H-5), 3.83 (J = 2.6, 11.5, 11.6 Hz, 
1H, ddd, H-5), 2.96 (J = 4.2, 4.2, 11.7, 11.7 Hz, 1H, dddd, H-8), 2.44 (3H, s, H-11), 
2.25 – 2.05 (2H, m, H-7), 2.04 – 1.83 (2H, m, H-6); 13C-NMR (CDCl3, 75 MHz): δ 
154.5, 142.0, 141.9, 135.7, 129.0, 126.4, 109.8, 106.0, 72.8, 68.3, 40.8, 37.0, 
33.0, 20.7; IR: 𝜈 3109, 2916, 2847, 1514, 1440, 1373, 1349, 1251, 1226, 1039, 
1011, 998, 910, 804, 734, 541, 505; Rf (Diethyl ether) 0.90; Mass Spectrometry: 
TOF EI+: M+: Expected: m/z 258.1256, Observed: m/z 258.1244, Difference: −4.65 
ppm 
 
Synthesis of (2S,4R)-4-(3,4-dimethoxyphenyl)-2-(furan-2-yl)tetrahydro-2H-pyran 
(269e) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 269a using: 
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3-(3,4-dimethoxyphenyl)-1-(furan-2-yl)pentane-1,5-diol (266e) (3.00 mg, 0.00979 
mmol), Quadrapure™ polymer-supported sulfonic acid (7.40 mg) and acetonitrile 
(0.750 mL). The product was a pale brown solid. 
 
Yield: 82% (2.30 mg, 0.00798 mmol); Diastereomeric Ratio: 15:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.39 (J = 1.8 Hz, 1H, dd, H-1), 6.86 – 6.79 (3H, m, H-9, H-10 and H-
11), 6.34 (J = 1.8, 3.3 Hz, 1H, dd, H-2), 6.29 (J = 3.3 Hz, 1H, d, H-3), 4.54 (J = 2.4, 
11.1 Hz, 1H, dd, H-4), 4.24 (J = 1.9, 4.2, 11.5 Hz, 1H, ddd, H-5), 3.89 (3H, s, H-
13), 3.87 (3H, s, H-12), 3.75 (J = 3.4, 11.5, 11.5 Hz, 1H, ddd, H-5), 2.87 (J = 4.3, 
4.3, 11.6, 11.6 Hz, 1H, dddd, H-8), 2.14 – 1.78 (4H, m, H-6 and H-7); 13C-NMR 
(CDCl3, 75 MHz): δ 154.6, 148.9, 147.5, 142.2, 137.9, 118.4, 111.2, 110.1, 110.0, 
106.3, 73.1, 68.6, 55.9, 55.8, 41.2, 37.4, 33.3; IR: 𝜈 2933, 2835, 1515, 1463, 1259, 
1242, 1142, 1120, 1078, 1026, 1013, 912, 882, 808, 764, 729, 638, 599, 541, 493, 
460; Melting Point: 88 – 89 °C; Rf (Diethyl ether) 0.85; Mass Spectrometry: TOF 
ES+: M+: Expected: m/z 288.1362, Observed: m/z 288.1359, Difference = −1.04 
ppm 
 
Synthesis of (2S,4R)-4-(4-bromophenyl)-2-(furan-2-yl)tetrahydro-2H-pyran (269f) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 269a using: 
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3-(4-bromophenyl)-1-(furan-2-yl)pentane-1,5-diol (266f) (88.4 mg, 0.272 mmol), 
Quadrapure™ polymer-supported sulfonic acid (23.9 mg) and acetonitrile (6.50 
mL). The product was a brown oil. 
 
Yield: 96% (80.1 mg, 0.261 mmol); Diastereomeric Ratio: 10:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.48 – 7.43 (2H, m, H-9), 7.40 (J = 1.8 Hz, 1H, dd, H-1), 7.16 – 7.12 
(2H, m, H-10), 6.35 (J = 1.8, 3.3 Hz, 1H, dd, H-2), 6.30 (J = 3.3 Hz, 1H, d, H-3), 
4.55 (J = 2.4, 11.0 Hz, 1H, dd, H-4), 4.24 (J = 2.0, 4.1, 11.5 Hz, 1H, ddd, H-5), 
3.75 (J = 3.7, 11.5, 11.5 Hz, 1H, ddd, H-5), 2.88 (J = 4.3, 4.3, 11.5, 11.5 Hz, 1H, 
dddd, H-8), 2.13 – 1.76 (4H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 154.4, 
144.1, 142.2, 131.6, 128.5, 120.2, 110.1, 106.4, 73.0, 68.4, 41.1, 36.9, 33.0; IR: 𝜈 
2917, 2846, 1488, 1075, 1044, 1008, 911, 820, 732, 599, 534; Rf (9:1 Petroleum 
ether : Diethyl ether) 0.27; Mass Spectrometry: TOF ES+: M+: Expected: m/z 
306.0255, Observed: m/z 306.0268, Difference = 4.25 ppm 
 
Synthesis of (2S,4R)-4-(4-bromophenyl)-2-(5-methylfuran-2-yl)tetrahydro-2H-
pyran (269h) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 269a using: 
269h
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3-(4-bromophenyl)-1-(5-methylfuran-2-yl)pentane-1,5-diol (266h) (10.0 mg, 0.0295 
mmol), Quadrapure™ polymer-supported sulfonic acid (21.0 mg) and acetonitrile 
(1.50 mL). The product was a pale yellow oil. 
 
Yield: 70% (6.60 mg, 0.0205 mmol); Diastereomeric Ratio: 22:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.47 – 7.42 (2H, m, H-9), 7.16 – 7.12 (2H, m, H-10), 6.16 (J = 3.1 Hz, 
1H, d, H-3), 5.91 (J = 0.9, 3.1 Hz, 1H, dd, H-2), 4.47 (J = 2.8, 10.7 Hz, 1H, dd, H-
4), 4.23 (J = 2.0, 4.2, 11.56 Hz, 1H, ddd, H-5), 3.74 (J = 3.5, 11.5, 11.6 Hz, ddd, H-
5), 2.87 (J = 4.6, 4.6, 11.3, 11.3 Hz, 1H, dddd, H-8), 2.29 (J = 0.9 Hz, 3H, d, H-1), 
2.08 – 1.75 (4H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 152.6, 152.1, 
144.2, 131.6, 128.5, 120.1, 107.4, 106.0, 73.0, 68.4, 41.2, 36.8, 33.0, 13.6; IR: 𝜈 
2940, 2918, 2856, 1570, 1488, 1440, 1345, 1218, 1084, 1074, 1038, 1006, 957, 
909, 808, 794, 770, 666, 556, 534, 516, 501; Rf (9:1 Petroleum ether : Diethyl 
ether) 0.24; Mass Spectrometry: TOF ES+: M+: Expected: m/z 320.0412, 
Observed: m/z 320.0403, Difference = −2.81 ppm 
 
Synthesis of (2S,4R)-2-(5-methylfuran-2-yl)-4-phenyltetrahydro-2H-pyran (269i) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 269a using: 
269i
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1-(5-methylfuran-2-yl)-3-phenylpentane-1,5-diol (266i) (53.0 mg, 0.204 mmol), 
Quadrapure™ polymer-supported sulfonic acid (14.4 mg) and acetonitrile (2.50 
mL). The product was a yellow oil. 
 
Yield: 83% (41.1 mg, 0.170 mmol); Diastereomeric Ratio: 20:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.35 – 7.18 (5H, m, H-9, H-10 and H-11), 6.15 (J = 3.1 Hz, 1H, d, H-
3), 5.89 (J = 0.9, 3.1 Hz, 1H, dd, H-2), 4.47 (J = 3.2, 10.3 Hz, 1H, dd, H-4), 4.22 (J 
= 1.7, 4.4, 11.6 Hz, 1H, ddd, H-5), 3.73 (J = 2.7, 11.6, 11.7 Hz, 1H, ddd, H-5), 2.88 
(J = 4.5, 4.5, 11.7, 11.7 Hz, 1H, dddd, H-8), 2.27 (J = 0.9 Hz, 3H, d, H-1), 2.10 – 
1.74 (4H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 152.8, 152.0, 145.3, 
128.6, 126.8, 126.5, 107.3, 105.9, 73.1, 68.5, 41.7, 36.9, 33.1, 13.6; IR: 𝜈 2920, 
2848, 1452, 1374, 1220, 1078, 1012, 907, 786, 727, 698, 647, 548, 532; Rf (9:1 
Petroleum ether : Diethyl ether) 0.33; Mass Spectrometry: TOF EI+: M+: Expected: 
m/z 242.1307, Observed: m/z 242.1297, Difference = 4.13 ppm 
 
Synthesis of (2S,4R)-2-(5-methylfurn-2-yl)-4-p-tolyltetrahydro-2H-pyran (269j) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 269a using: 
269j
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1-(5-methylfuran-2-yl)-3-p-tolylpentane-1,5-diol (266j) (35.0 mg, 0.129 mmol), 
Quadrapure™ polymer-supported sulfonic acid (25.3 mg) and acetonitrile (1.50 
mL). The product was a orange/brown oil. 
 
Yield: 85% (28.0 mg, 0.109 mmol); Diastereomeric Ratio: 15:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.19 – 7.15 (4H, m, H-9 and H-10), 6.17 (J = 3.1 Hz, 1H, d, H-3), 5.91 
(J = 1.0, 3.1 Hz, 1H, dd, H-2), 4.49 (J = 3.0, 10.5 Hz, 1H, dd, H-4), 4.24 (J = 1.7, 
4.3, 11.6 Hz, 1H, ddd, H-5), 3.75 (J = 2.8, 11.6, 11.6 Hz, 1H, ddd, H-5), 2.88 (J = 
4.5, 4.5, 11.7, 11.65 Hz, 1H, dddd, H-8), 2.35 (3H, s, H-11), 2.30 (J = 1.0 Hz, 3H, 
d, H-1), 2.09 – 1.79 (4H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 152.9, 
152.0, 142.3, 136.0, 129.2, 126.6, 107.3, 105.9, 73.1, 68.5, 41.2, 37.0, 33.2, 21.0, 
13.6; IR: 𝜈 2919, 2847, 1515, 1441, 1372, 1221, 1077, 1049, 1011, 964, 911, 814, 
781, 540; Rf (9:1 Petroleum ether : Diethyl ether) 0.32; Mass Spectrometry: TOF 
ES+: M+: Expected: m/z 256.1463, Observed: m/z 256.1457, Difference = −2.34 
ppm 
 
Synthesis of (2S,4R)-4-(4-chlorophenyl)-2-(5-methylfuran-2-yl)tetrahydro-2H-pyran 
(269k) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 269a using: 
269k
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3-(4-chlorophenyl)-1-(5-methylfuran-2-yl)pentane-1,5-diol (266k) (49.0 mg, 0.166 
mmol), Quadrapure™ polymer-supported sulfonic acid (22.0 mg) and acetonitrile 
(2.00 mL). The product was a yellow oil. 
 
Yield: 68% (31.1 mg, 0.112 mmol); Diastereomeric Ratio: 10:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.31 – 7.28 (2H, m, H-10), 7.21 – 7.17 (2H, m, H-9), 6.16 (J = 3.1 Hz, 
1H, d, H-3), 5.91 (J = 0.8, 3.1 Hz, 1H, dd, H-2), 4.48 (J = 2.9, 10.6 Hz, 1H, dd, H-
4), 4.23 (J = 1.9, 4.1, 11.5 Hz, 1H, ddd, H-5), 3.74 (J = 3.0, 11.4, 11.5 Hz, 1H, ddd, 
H-5), 2.88 (J = 4.6, 4.6, 11.4, 11.4 Hz, 1H, dddd, H-8), 2.29 (J = 0.8 Hz, 3H, d, H-
1), 2.04 – 1.79 (4H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 152.6, 152.1, 
143.7, 132.1, 128.7, 128.1, 107.4, 106.0, 73.0, 68.4, 41.1, 36.9, 33.0, 13.6; IR: 𝜈 
2942, 2917, 2842, 1492, 1221, 1124, 1084, 1050, 1012, 965, 826, 787, 635, 536, 
436; Rf (9:1 Petroleum ether : Diethyl ether) 0.26; Mass Spectrometry: TOF ES+: 
M+: Expected: m/z 276.0917, Observed: m/z 276.0905, Difference = −4.35 ppm 
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5.5. Data for Compounds Synthesised in the Formation of 
2,4,5-Trisubstituted Tetrahydropyrans 
 
Synthesis of 3-(4-chlorophenyl)-1-(furan-2-yl)-4-(hydroxymethyl)pentane-1,5-diol 
(287b) 
 
 
 
 
 
Lithium aluminium hydride (0.368 g, 9.70 mmol, 10.6 eqv.) was dissolved in 
tetrahydrofuran (15.0 mL). This was then cooled to −15°C and dimethyl-2-(1-(4-
chlorophenyl)-3-(furan-2-yl)-3-oxopropyl)malonate (271b) (0.303 g, 0.917 mmol, 
1.00 eqv.) in THF (10.0 mL) was added. The reaction was stirred at room 
temperature for 30 minutes. After this, the reaction was quenched by the addition 
of diethyl ether (20.0 mL), followed by a 4:1 mixture of diethyl ether and acetone 
(20.0 mL) at −15°C. The reaction mixture was then diluted with ethyl acetate (60.0 
mL), water (150 mL) and 2M aqueous sodium hydroxide solution (200 mL). 
Extraction was completed using ethyl acetate (3 × 60.0 mL). The combined 
organic phases were washed with water (2 × 100 mL) and brine (100 mL). This 
was then dried over magnesium sulfate, concentrated under reduced pressure and 
purified via column chromatography using a graduated solvent system reaching a 
95:5 mixture of dichloromethane and methanol. The product was analysed by 1H-
NMR and during the NMR analysis some solid crashed out. The white solid was 
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enriched in one diastereoisomer whilst the pale yellow liquid was enriched in the 
other. Data was collected on both states; however the solid didn’t dissolve in d-
chloroform and so d3-acetonitrile was used instead. 
 
Yield: 47% (94.3 mg, 0.303 mmol) 
 
anti-293b (Crystal) 
1H-NMR (CD3CN, 400 MHz): δ 7.35 (J = 1.8 Hz, 1H, d, H-9), 7.34 – 7.31 (2H, m, 
H-10), 7.24 – 7.20 (2H, m, H-11), 6.30 (J = 1.8, 3.2 Hz, 1H, dd, H-8), 6.13 (J = 3.2 
Hz, 1H, d, H-7), 4.06 (J = 2.8, 5.1, 10.7 Hz, 1H, ddd, H-6), 3.71 – 3.65 (2H, m, H-
1), 3.31 – 3.24 (2H, m, H-2), 3.11 (J = 3.5, 8.8, 12.6 Hz, 1H, ddd, H-4), 2.90 (J = 
5.1 Hz, 1H, d, OH), 2.79 (J = 5.1, 5.1 Hz, 1H, dd, OH), 2.25 (J = 3.5, 10.7, 14.2 
Hz, 1H, ddd, H-5), 1.99 (J = 2.8, 12.6, 14.2 Hz, 1H, ddd, H-5), 1.78 (1H, m, H-3); 
13C-NMR (CD3CN, 100 MHz): δ 159.0, 143.0, 142.5, 132.1, 131.2, 129.0, 110.9, 
105.8, 65.1, 62.8, 62.1, 48.4, 40.0, 39.4 
 
syn-293b (Oil) 
1H-NMR (CD3CN, 400 MHz): δ 7.42 (J = 1.8 Hz, 1H, d, H-9), 7.31 – 7.29 (2H, m, 
H-10), 7.12 – 7.07 (2H, m, H-11), 6.36 (J = 1.8, 3.2 Hz, 1H, dd, H-8), 6.18, (J = 3.2 
Hz, 1H, d, H-7), 4.15 (J = 5.1, 5.3, 9.9 Hz, 1H, ddd, H-6), 3.78 – 3.71 (2H, m, H-1), 
3.42 – 3.32 (1H, m, H-2), 3.28 (J = 5.3 Hz, 1H, d, OH), 3.14 (J = 5.1, 5.4, 14.5 Hz, 
1H, ddd, H-2), 2.90 (J = 5.1, 5.1 Hz, 1H, dd, OH), 2.69 (J = 5.1, 5.1 Hz, 1H, dd, 
OH), 2.58 (J = 4.1, 8.8, 11.1 Hz, 1H, ddd, H-4), 2.43 (J = 4.1, 9.9, 13.6 Hz, 1H, 
ddd, H-5), 2.09 (J = 5.1, 11.1, 13.6 Hz, 1H, ddd, H-5), 1.78 (1H, m, H-3); 13C-NMR 
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(CD3CN, 100 MHz): δ 157.3, 143.1, 142.9, 132.1, 130.9, 129.0, 110.9, 107.4, 66.1, 
62.4, 62.1, 48.2, 40.4, 39.4 
 
IR: 𝜈 3363 (O-H), 3212 (O-H), 2932, 2897, 1453, 1412, 1082, 1048, 1013, 996, 
966, 875, 847, 815, 739, 638, 617, 598, 543; Rf (ethyl acetate) 0.44; Mass 
Spectrometry: TOF ES+: MNa+: Expected: m/z 333.0860, Observed: m/z 
333.0870, Difference = 3.00 ppm 
 
Synthesis of 1-(furan-2-yl)-4-(hydroxymethyl)-3-(4-methoxyphenyl)pentane-1,5-diol 
(287c) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 287b using: 
Lithium aluminium hydride (0.217 g, 5.72 mmol, 9.91 eqv.), dimethyl-2-(3-(furan-2-
yl)-1-(4-methoxyphenyl)-3-oxopropyl)malonate (271c) (0.208 g, 0.577 mmol, 1.00 
eqv.) and THF (25.0 mL). The product was a pale yellow oil. 
 
Diastereomeric Ratio: 1.7:1; Yield: 33% (58.4 mg, 0.191 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.33 (J = 1.5 Hz, [1.7] 1H, d, H-9 [D-1]), 7.26 (J = 1.7 Hz, 1H, d, H-9 
[D-2]), 7.11 – 6.78 ([1.7] 4H + 4H, m, H-10 [D-1], H-10 [D-2], H-11 [D-1] and H-11 
[D-2]), 6.28 (J = 1.5, 3.2 Hz, [1.7] 1H, dd, H-8 [D-1]), 6.23 (J = 1.7, 3.2 Hz, 1H, dd, 
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H-8 [D-2]), 6.13 (J = 3.2 Hz, [1.7] 1H, d, H-7 [D-1]), 6.06 (J = 3.2 Hz, 1H, d, H-7 [D-
2]), 4.33 (J = 5.3, 8.8 Hz, [1.7] 1H, dd, H-6 [D-1]), 4.20 (J = 1.5, 10.9 Hz, 1H, dd, 
H-6 [D-2]), 3.92 – 3.71 ([1.7] 2H + 2H, m, H-2 [D-1] and H-2 [D-2]), 3.76 ([1.7] 3H + 
3H, s, H-12 [D-1] and H-12 [D-2]), 3.58 – 3.01 ([1.7] 6H + 6H, m, H-1 [D-1], H-1 [D-
2], H-4 [D-1], H-4 [D-2], OH [D-1], OH [D-2], OH [D-1], OH [D-2], OH [D-1] and OH 
[D-2]), 2.54 – 1.70 ([1.7] 3H + 3H, m, H-3 [D-1], H-3 [D-2], H-5 [D-1] and H-5 [D-
2]); 13C-NMR (CDCl3, 75 MHz): δ 158.1, 157.1, 155.4, 142.1, 141.6, 134.2, 134.2, 
129.2, 128.9, 114.0, 113.9, 110.1, 110.0, 107.1, 105.2, 66.0, 64.9, 63.8, 63.6, 
62.6, 55.2, 50.6, 46.7, 39.3, 38.7, 38.1; IR: 𝜈 3311 (O-H), 2944, 2887, 2384, 1609, 
1509, 1440, 1301, 1244, 1177, 1146, 1008, 828, 736, 598, 556; Rf (ethyl acetate) 
0.33; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 329.1365, Observed: 
m/z 329.1361, Difference = −1.22 ppm 
 
Synthesis of 1-(furan-2-yl)-4-(hydroxymethyl)-3-p-tolylpentane-1,5-diol (287d) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 287b using: 
Lithium aluminium hydride (0.340 g, 8.96 mmol, 9.18 eqv.), dimethyl-2-(3-(furan-2-
yl)-3-oxo-1-p-tolylpropyl)malonate (271d) (0.336 g, 0.976 mmol, 1.00 eqv.) and 
THF (25.0 mL). The product was a pale yellow oil. 
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Diastereomeric Ratio: 1.3:1; Yield: 27% (76.6 mg, 0.264 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.31 (J = 1.8 Hz, [1.3] 1H, d, H-9 [D-1]), 7.24 (J = 1.8 Hz, 1H, d, H-9 
[D-2]), 7.09 – 6.90 ([1.3] 4H + 4H, m, H-10 [D-1], H-10 [D-2], H-11 [D-1] and H-11 
[D-2]), 6.27 (J = 1.8, 3.1 Hz, [1.3] 1H, dd, H-8 [D-1]), 6.22 (J = 1.8, 3.2 Hz, 1H, dd, 
H-8 [D-2]), 6.12 (J = 3.1 Hz, [1.3] 1H, d, H-7 [D-1]), 6.04 (J = 3.2 Hz, 1H, d, H-7 [D-
2]), 4.33 (J = 5.4, 8.8 Hz, [1.3] 1H, dd, H-6 [D-1]), 4.18 (J = 1.4, 10.8 Hz, 1H, dd, 
H-6 [D-2]), 3.90 – 3.00 ([1.3] 7H + 7H, m, H-4 [D-1], H-4 [D-2], H-1 [D-1], H-1 [D-
2], H-2 [D-1], H-2 [D-2], OH [D-1], OH [D-2], OH [D-1] and OH [D-2]), 2.54 – 1.70 
([1.3] 4H + 4H, m, H-5 [D-1], H-5 [D-2], H-3 [D-1], H-3 [D-2], OH [D-1] and OH [D-
2]), 2.30 ([1.3] 3H + 3H, s, H-12 [D-1] and H-12 [D-2]); 13C-NMR (CDCl3, 75 MHz): 
δ 157.2, 155.4, 142.1, 141.5, 139.2, 139.1, 136.0, 135.9, 129.3, 129.2, 128.1, 
127.9, 110.0, 110.0, 107.0, 105.2, 65.9, 64.9, 63.6, 63.6, 63.4, 62.2, 46.7, 46.6, 
39.8, 38.6, 38.5, 21.0; IR: 𝜈 3317 (O-H), 2922, 2889, 1512, 1434, 1147, 1010, 909, 
814, 731, 632, 599, 533, 494; Rf (ethyl acetate) 0.32; Mass Spectrometry: TOF 
ES+: MNa+: Expected: m/z 313.1416, Observed: m/z 313.1407, Difference = −2.87 
ppm 
 
Synthesis of 3-(3,4-dimethoxyphenyl)-1-(furan-2-yl)-4-(hydroxymethyl)pentane-
1,5-diol (287e) 
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Experimental procedure followed matched that described for 287b using: 
Lithium aluminium hydride (0.246 g, 6.48 mmol, 12.2 eqv.), dimethyl-2-(1-(3,4-
dimethoxyphenyl)-3-(furan-2-yl)-3-oxopropyl)malonate (271e) (0.207 g, 0.530 
mmol, 1.00 eqv.) and THF (25.0 mL). The product was a pale yellow oil. 
 
Diastereomeric Ratio: 1:1; Yield: 15% (27.2 mg, 0.0809 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.33 (J = 1.5 Hz, 1H, d, H-9 [D-1]), 7.26 (J = 1.6 Hz, 1H, d, H-9 [D-2]), 
6.79 – 6.71 (3H, m, H-10 [D-1], H-11 [D-1] and H-12 [D-1]), 6.60 – 6.54 (3H, m, H-
10 [D-2], H-11 [D-2] and H-12 [D-2]), 6.29 (J = 1.5, 3.1 Hz, 1H, dd, H-8 [D-1]), 6.24 
(J = 1.6, 3.2 Hz, 1H, dd, H-8 [D-2]), 6.15 (J = 3.1 Hz, 1H, d, H-7 [D-1]), 6.07 (J = 
3.2 Hz, 1H, d, H-7 [D-2]), 4.36 (J = 5.3, 8.8 Hz, 1H, dd, H-6 [D-1]), 4.24 (J = 1.4, 
10.8 Hz, 1H, dd, H-6 [D-2]), 3.92 – 3.87 (2H + 2H, m, H-1 [D-1] and H-1 [D-2]). 
3.83 (3H + 3H, s, H-14 [D-1] and H-14 [D-2]), 3.81 (3H, s, H-13 [D-1]), 3.79 (3H, s, 
H-13 [D-2]), 3.65 – 3.01 (6H + 6H, m, H-2 [D-1], H-2 [D-2], H-4 [D-1], H-4 [D-2], 
OH [D-1], OH [D-2], OH [D-1], OH [D-2], OH [D-1] and OH [D-2]), 2.60 – 1.70 (3H 
+ 3H, m, H-3 [D-1], H-3 [D-2], H-5 [D-1] and H-5 [D-2]); 13C-NMR (CDCl3, 75 
MHz): δ 157.1, 155.5, 148.9, 148.7, 147.5, 142.1, 141.6, 134.9, 134.8, 120.3, 
119.9, 111.2, 111.1, 110.1, 110.0, 107.0, 105.2, 66.0, 65.0, 64.0, 63.9, 63.6, 62.6, 
55.8, 55.8, 46.8, 39.7, 38.7, 38.6; IR: 𝜈 3330 (O-H), 2934, 2835, 1590, 1511, 1463, 
1420, 1255, 1233, 1139, 1022, 914, 861, 808, 728, 646, 598; Rf (ethyl acetate) 
0.19; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 359.1471, Observed: 
m/z 359.1455, Difference = −4.46 ppm 
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Synthesis of 3-(4-bromophenyl)-1-(furan-2-yl)-4-(hydroxymethyl)pentane-1,5-diol 
(287f) 
 
 
 
 
 
Experimental procedure followed matched that described for 287b using: 
Lithium aluminium hydride (107 mg, 2.82 mmol, 10.1 eqv.), dimethyl-2-(1-(4-
bromophenyl)-3-(furan-2-yl)-3-oxopropyl)malonate (271f) (114 mg, 0.279 mmol, 
1.00 eqv.) and THF (25.0 mL). The product was a cream coloured solid. 
 
Diastereomeric Ratio: 1:1.3; Yield: 35% (34.9 mg, 0.0982 mmol); 1H-NMR 
(CD3OD, 400 MHz): δ 7.47 – 7.42 (3H + [1.3] 2H, m, H-9 [D-1], H-10 [D-1] and H-
10 [D-2]), 7.36 ([1.3] 1H, s, H-9 [D-2]), 7.19 (J = 8.3 Hz, [1.3] 2H, d, H-11 [D-2]), 
7.06 (J = 8.3 Hz, 2H, d, H-11 [D-1]), 6.35 (1H, m, H-8 [D-1]), 6.28 ([1.3] 1H, m, H-8 
[D-2]), 6.20 (J = 3.0 Hz, 1H, d, H-7 [D-1]), 6.14 (J = 3.0 Hz, [1.3] 1H, d, H-7 [D-2]), 
4.20 (J = 4.7, 10.1 Hz, 1H, dd, H-6 [D-1]), 4.13 (J = 2.5, 10.5 Hz, [1.3] 1H, H-6 [D-
2]), 3.76 (J = 4.9 Hz, [1.3] 2H, d, H-1 [D-2]), 3.70 (J = 5.1 Hz, 2H, dd, H-1 [D-1]), 
3.50 – 3.38 (1H + [1.3] 1H, d, H-2 [D-1] and H-2 [D-2]), 3.35 – 3.23 ([1.3] 1H, m, H-
2 [D-2]), 3.23 – 3.10 (1H + [1.3] 1H, m, H-2 [D-1] and H-4 [D-2]), 2.60 (1H, m, H-5 
[D-1]), 2.50 (J = 3.9, 10.3, 13.0 Hz, 1H, ddd, H-4 [D-1]), 2.33 (J = 3.4, 10.7, 13.8 
Hz, [1.3] 1H, ddd, H-5 [D-2]), 2.18 (J = 4.5, 13.0, 13.1 Hz, 1H, ddd, H-5 [D-1]), 
2.07 ([1.3] 1H, m, H-5 [D-2]), 1.90 – 1.79 (1H + [1.3] 1H, m, H-3 [D-1] and H-3 [D-
2]); 13C-NMR (CD3OD, 100 MHz): δ 159.0, 157.2, 143.4, 143.4, 143.3, 142.8, 
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132.5, 132.5, 131.8, 131.6, 121.1, 121.0, 111.1, 111.0, 108.1, 106.2, 66.7, 65.9, 
62.2, 61.9, 61.7, 61.6, 49.4, 41.3, 40.9, 39.8, 39.7; IR: 𝜈 3355 (O-H), 2933, 2895, 
1485, 1449, 1425, 1407, 1331, 1147, 1046, 1007, 964, 924, 875, 808, 736, 597, 
541; Melting Point: 129 – 130 °C; Rf (ethyl acetate) 0.36; Mass Spectrometry: 
(MNa+) Expected: m/z 377.0369, Found: m/z 377.0364, Error: 1.3 ppm 
 
Synthesis of 3-(4-bromophenyl)-4-(hydroxymethyl)-1-(5-methylfuran-2-yl)pentane-
1,5-diol (287h) 
 
 
 
 
 
Experimental procedure followed matched that described for 287b using: 
Lithium aluminium hydride (89.3 mg, 2.35 mmol, 13.8 eqv.), dimethyl-2-(1-(4-
bromophenyl)-3-(5-methylfuran-2-yl)-3-oxopropyl)malonate (271h) (72.0 mg, 0.170 
mmol, 1.00 eqv.) and THF (25.0 mL). The product was a pale yellow oil. 
 
Diastereomeric Ratio: 1.7:1; Yield: 28% (17.7 mg, 0.479 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.46 – 7.38 ([1.7] 2H + 2H, m, H-10 [D-1] and H-10 [D-2]), 7.12 – 6.94 
([1.7] 2H + 2H, m, H-11 [D-1] and H-11 [D-2]), 6.04 (J = 2.4 Hz, [1.7] 1H, d, H-7 [D-
1]), 5.96 (J = 2.4 Hz, 1H, d, H-7 [D-2]), 5.88 (J = 2.4 Hz, [1.7] 1H, d, H-8 [D-1]), 
5.83 (J = 2.4 Hz, 1H, d, H-8 [D-2]), 4.30 (J = 4.5, 8.1 Hz, [1.7] 1H, dd, H-6 [D-1]), 
4.16 – 4.10 (1H, m, H-6 [D-2]), 4.10 – 1.60 ([1.7] 11H + 11H, m, H-1 [D-1], H-1 [D-
2], H-2 [D-1], H-2 [D-2], H-3 [D-1], H-3 [D-2], H-4 [D-1], H-4 [D-2], H-5 [D-1], H-5 
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[D-2], OH [D-1], OH [D-2], OH [D-1], OH [D-2], OH [D-1] and OH [D-2]), 2.23 ([1.7] 
3H, s, H-9 [D-1]), 2.20 (3H, s, H-9 [D-2]); 13C-NMR (CDCl3, 75 MHz): δ 154.9, 
153.4, 152.1, 151.6, 141.8, 131.8, 131.6, 130.2, 129.9, 120.3, 120.3, 108.2, 106.4, 
106.1, 106.0, 66.1, 65.1, 64.7, 56.0, 56.0, 53.5, 46.5, 39.3, 38.5, 38.5, 38.4, 13.6, 
13.5; IR: 𝜈 3336 (O-H), 2920, 1486, 1408, 1218, 1008, 962, 908, 784, 727,  554; 
Rf (ethyl acetate) 0.30; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 
391.0521, Observed: m/z 391.0507, Difference = −3.58 ppm 
 
Synthesis of 4-(hydroxymethyl)-1-(5-methylfuran-2-yl)-3-phenylpentane-1,5-diol 
(287i) 
 
 
 
 
 
Experimental procedure followed matched that described for 287b using: 
Lithium aluminium hydride (112 mg, 2.95 mmol, 9.97 eqv.), dimethyl-2-(3-(5-
methylfuran-2-yl)-3-oxo-1-phenylpropyl)malonate (271i) (102 mg, 0.296 mmol, 
1.00 eqv.) and THF (15.0 mL). The product was a pale yellow oil. 
 
Diastereomeric Ratio: 2:1; Yield: 35% (30.0 mg, 0.103 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.32 – 7.06 ([2] 5H + 5H, m, H-10 [D-1], H-10 [D-2], H-11 [D-1], H-11 
[D-2], H-12 [D-1] and H-12 [D-2]), 6.04 (J = 3.1 Hz, [2] 1H, d, H-7 [D-1]), 5.95 (J = 
3.1 Hz, 1H, d, H-7 [D-2]), 5.87 (J = 0.8, 3.1 Hz, [2] 1H, dd, H-8 [D-1]), 5.82 (J = 
0.9, 3.1 Hz, 1H, dd, H-8 [D-2]), 4.30 (J = 5.4, 9.0 Hz, [2] 1H, dd, H-6 [D-1]), 4.16 (J 
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= 1.9, 10.8 Hz, 1H, dd, H-6 [D-2]), 3.93 (J = 3.3, 10.9 Hz, [2] 2H, dd, H-1 [D-1]), 
3.82 (J = 6.1, 11.0 Hz, 2H, dd, H-1 [D-2]), 3.53 (J = 3.2, 10.7 Hz, [2] 2H, dd, H-2 
[D-1]), 3.41 (J = 5.1, 11.5 Hz, 2H, dd, H-2 [D-2]), 3.15 (1H, m, H-4 [D-2]), 2.58 (J = 
4.1, 10.2, 10.6 Hz, [2] 1H, ddd, H-4 [D-1]), 2.43 (J = 4.1, 9.0, 13.1 Hz, [2] 1H, ddd, 
H-5 [D-1]), 2.33 (1H, m, H-5 [D-2]), 2.24 (J = 0.8 Hz, [2] 3H, d, H-9 [D-1]), 2.20 (J = 
0.9 Hz, 3H, d, H-9 [D-2]), 2.15 (J = 5.4, 10.6, 13.3 Hz, [2] 1H, ddd, H-5 [D-1]), 2.04 
– 1.75 ([2] 1H + 2H, m, H-5 [D-2], H-3 [D-1] and H-3 [D-2]); 13C-NMR (CDCl3, 75 
MHz): δ 155.2, 153.5, 151.9, 151.4, 142.5, 128.6, 128.5, 128.3, 128.1, 126.6, 
126.5, 108.0, 106.1, 106.0, 105.9, 66.1, 65.0, 64.1, 63.9, 46.6, 46.6, 40.1, 39.0, 
38.5, 13.6, 13.5; IR: 𝜈 3307 (O-H), 2921, 1452, 1219, 1019, 961, 909, 783, 729, 
701, 587; Rf (ethyl acetate) 0.36; Mass Spectrometry: TOF ES+: MNa+: Expected: 
m/z 313.1416, Observed: m/z 313.1411, Difference = −1.60 ppm 
 
Synthesis of 4-(hydroxymethyl)-1-(5-methylfuran-2-yl)-3-p-tolylpentane-1,5-diol 
(287j) 
 
 
 
 
 
Experimental procedure followed matched that described for 287b using: 
Lithium aluminium hydride (0.368 g, 9.70 mmol, 9.07 eqv.), dimethyl-2-(3-(5-
methylfuran-2-yl)-3-oxo-1-p-tolylpropyl)malonate (271j) (0.359 g, 1.07 mmol, 1.00 
eqv.) and THF (17.0 mL). The product was a yellow oil. 
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Diastereomeric Ratio: 1.7:1; Yield: 31% (94.9 mg, 0.312 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.10 – 6.93 ([1.7] 4H + 4H, m, H-10 [D-1], H-10 [D-2], H-11 [D-1] and 
H-11 [D-2]), 6.02 (J = 3.0 Hz, [1.7] 1H, d, H-7 [D-1]), 5.94 (J = 3.0 Hz, 1H, d, H-7 
[D-2]), 5.86 (J = 3.0 Hz, [1.7] 1H, d, H-8 [D-1]), 5.81 (J = 3.0 Hz, 1H, d, H-8 [D-2]), 
4.29 (J = 5.4, 9.0 Hz, [1.7] 1H, dd, H-6 [D-1]), 4.16 (J = 1.6, 10.7 Hz, 1H, dd, H-6 
[D-2]), 3.95 – 3.73 ([1.7] 2H + 2H, m, H-1 [D-1] and H-1 [D-2]), 3.55 – 3.25 ([1.7] 
2H + 2H, m, H-2 [D-1] and H-2 [D-2]), 3.09 (1H, m, H-4 [D-2]), 2.52 (J = 4.1, 10.4, 
10.4 Hz, [1.7] 1H, ddd, H-4 [D-1]), 2.45 – 2.05 ([1.7] 2H + 1H, m, H-5 [D-1] and H-
5 [D-2]), 2.31 ([1.7] 3H + 3H, s, H-12 [D-1] and H-12 [D-2]), 2.23 ([1.7] 3H, s, H-9 
[D-1]), 2.20 (3H, s, H-9 [D-2]), 2.02 – 1.75 ([1.7] 1H + 2H, m, H-5 [D-2], H-3 [D-1] 
and H-3 [D-2]); 13C-NMR (CDCl3, 75 MHz): δ 155.3, 153.6, 151.8, 151.3, 139.3, 
139.3, 136.0, 135.9, 129.2, 129.2, 128.1, 127.9, 107.9, 106.0, 106.0, 105.8, 66.0, 
64.9, 64.0, 63.8, 62.7, 50.5, 46.7, 46.7, 39.8, 38.7, 38.6, 38.5, 21.0, 13.5, 13.4; IR: 𝜈 3312 (O-H), 2920, 1512, 1435, 1219, 1019, 962, 909, 783, 727, 570; Rf (ethyl 
acetate) 0.42; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 327.1572, 
Observed: m/z 327.1561, Difference = −3.36 ppm 
 
Synthesis of 3-(4-chlorophenyl)-4-(hydroxymethyl)-1-(5-methylfuran-2-yl)pentane-
1,5-diol (287k) 
 
 
 
 
 
Experimental procedure followed matched that described for 287b using: 
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Lithium aluminium hydride (91.4 mg, 2.41 mmol, 11.4 eqv.), dimethyl-2-(1-(4-
chlorophenyl)-3-(5-methylfuran-2-yl)-3-oxopropyl)malonate (271k) (80.3 mg, 0.212 
mmol, 1.00 eqv.) and THF (14.0 mL). The product was a pale yellow oil. 
 
Diastereomeric Ratio: 1.7:1; Yield: 37% (25.4 mg, 0.0782 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.29 – 6.98 ([1.7] 4H + 4H, m, H-10 [D-1], H-10 [D-2], H-11 [D-1] and 
H-11 [D-2]), 6.03 (J = 3.0 Hz, [1.7] 1H, d, H-7 [D-1]), 5.95 (J = 3.1 Hz, 1H, d, H-7 
[D-2]), 5.87 (J = 0.8, 3.0 Hz, [1.7] 1H, dd, H-8 [D-1]), 5.82 (J = 0.8, 3.1 Hz, 1H, dd, 
H-8 [D-2]), 4.29 (J = 5.2, 9.0 Hz, [1.7] 1H, dd, H-6 [D-1]), 4.12 (J = 1.9, 10.9 Hz, 
1H, dd, H-6 [D-2]), 3.97 – 3.78 ([1.7] 2H + 2H, m, H-1 [D-1] and H-1 [D-2]), 3.60 – 
2.80 ([1.7] 5H + 6H, m, H-2 [D-1], H-2 [D-2], OH [D-1], OH [D-2], OH [D-1], OH [D-
2], OH [D-1], OH [D-2] and H-4 [D-2]), 2.61 (J = 4.0, 9.9, 10.2 Hz, [1.7] 1H, ddd, H-
4 [D-1]), 2.46 – 2.27 ([1.7] 1H + 1H, m, H-5 [D-1] and H-5 [D-2]), 2.23 (J = 0.8 Hz, 
[1.7] 3H, d, H-9 [D-1]), 2.20 (J = 0.8 Hz, 3H, d, H-9 [D-2]), 2.11, (J = 5.2, 10.2, 13.5 
Hz, [1.7] 1H, ddd, H-5 [D-1]), 1.93 – 1.70 ([1.7] 1H + 2H, m, H-5 [D-2], H-3 [D-1] 
and H-3 [D-2]); 13C-NMR (CDCl3, 75 MHz): δ 154.9, 153.3, 152.0, 151.5, 141.2, 
141.1, 132.1, 129.7, 129.4, 128.7, 128.6, 108.0, 106.3, 106.0, 105.9, 66.0, 64.9, 
63.9, 63.9, 63.5, 62.7, 46.6, 46.5, 39.3, 38.4, 38.4, 13.5, 13.5; IR: 𝜈 3316 (O-H), 
2921, 1489, 1411, 1219, 1089, 1012, 962, 820, 784, 723, 553; Rf (ethyl acetate) 
0.41; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 347.1026, Observed: 
m/z 347.1019, Difference = −2.02 ppm 
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Synthesis of ((3S,4S,6S)-6-(furan-2-yl)-4-phenyltetrahydro-2H-pyran-3-yl)methanol 
(288a) 
 
 
 
 
 
Lithium aluminium hydride (0.368 g, 9.70 mmol, 10.6 eqv.) was dissolved in 
tetrahydrofuran (15.0 mL). This was then cooled to −15°C and dimethyl-2-(3-
(furan-2-yl)-3-oxo-1-phenylpropyl)malonate (271a) (0.303 g, 0.917 mmol, 1.00 
eqv.) in THF (10.0 mL) was added. The reaction was stirred at room temperature 
for 30 minutes. After this, the reaction was quenched by the addition of diethyl 
ether (20.0 mL), followed by a 4:1 mixture of diethyl ether and acetone (20.0 mL) 
at −15°C. The reaction mixture was then diluted with ethyl acetate (60.0 mL), 
water (150 mL) and 2M aqueous sodium hydroxide solution (200 mL). Extraction 
was completed using ethyl acetate (3 × 60.0 mL). The combined organic phases 
were washed with water (2 × 100 mL) and brine (100 mL). This was then dried 
over magnesium sulfate and concentrated under reduced pressure. The crude 
material (50.0 mg, 0.181 mmol) was then dissolved in acetonitrile (6.00 mL) and 
Quadrapure™ polymer-supported sulfonic acid (20.3 mg) was added. This was 
stirred for 24 hours before being filtered, concentrated under reduced pressure 
and fully characterised. The product was a brown oil. 
 
Yield: 23% over 2 steps (46.4 mg, 0.180 mmol); Diastereomeric Ratio: 12:1; 1H-
NMR (CDCl3, 300 MHz): δ 7.40 (J = 1.8 Hz, 1H, d, H-1), 7.35 – 7.23 (5H, m, H-10, 
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H-11 and H-12), 6.35 (J = 1.8, 3.3 Hz, 1H, dd, H-2), 6.30 (J = 3.3 Hz, 1H, d, H-3), 
4.56 (J = 3.6, 10.1 Hz, 1H, dd, H-4), 4.38 (J = 4.4, 11.4 Hz, 1H, dd, H-5), 3.64 (J = 
11.3, 11.4, Hz, 1H, dd, H-5), 3.47 (J = 3.3, 11.1 Hz, 1H, dd, H-9), 3.31 (J = 6.9, 
11.1 Hz, 1H, dd, H-9), 2.78 (J = 5.3, 11.1, 11.2 Hz, 1H, ddd, H-8), 2.21 – 2.07 (3H, 
m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 154.3, 143.1, 142.2, 128.8, 127.4, 
126.9, 110.1, 106.5, 73.1, 71.2, 62.2, 44.0, 43.4, 37.6; IR: 𝜈 3373 (O-H), 2918, 
2862, 1494, 1452, 1352, 1336, 1228, 1066, 1040, 1009, 923, 911, 883, 759, 734, 
699, 598, 544; Rf (diethyl ether) 0.90; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 281.1154, Observed: m/z 281.1143, Difference = −3.91 ppm 
 
Synthesis of ((3S,4S,6S)-4-(4-chlorophenyl)-6-(furan-2-yl)tetrahydro-2H-pyran-3-
yl)methanol (288b) 
 
 
 
 
 
 
3-(4-chlorophenyl)-1-(furan-2-yl)-4-(hydroxymethyl)pentane-1,5-diol (287b) (18.1 
mg, 0.0582 mmol) was then dissolved in acetonitrile (6.00 mL) and Quadrapure™ 
polymer-supported sulfonic acid (11.3 mg) was added. This was stirred for 24 
hours before being filtered, concentrated under reduced pressure and fully 
characterised. The product was a colourless oil. 
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Yield: 89% (15.1 mg, 0.0516 mmol); Diastereomeric Ratio: 17:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.39 (J = 1.8 Hz, 1H, d, H-1), 7.32 – 7.29 (2H, m, H-11), 7.22 – 7.17 
(2H, m, H-10), 6.33 (J = 1.8, 3.3 Hz, 1H, dd, H-2), 6.28 (J = 3.3 Hz, 1H, d, H-3), 
4.53 (J = 4.2, 9.5 Hz, 1H, dd, H-4), 4.35 (J = 4.4, 11.5 Hz, 1H, dd, H-5), 3.64 (J = 
11.3, 11.5 Hz, 1H, dd, H-5), 3.47 (J = 3.2, 11.0 Hz, 1H, dd, H-9), 3.31 (J = 6.7, 
11.0 Hz, 1H, dd, H-9), 2.79 (J = 5.8, 8.2, 11.1 Hz, 1H, ddd, H-8), 2.14 – 2.03 (3H, 
m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 154.0, 142.3, 141.6, 132.4, 128.9, 
128.8, 110.1, 106.6, 73.0, 71.1, 61.8, 43.2, 43.1, 37.5; IR: 𝜈 3401 (O-H), 2920, 
2855, 1723, 1491, 1338, 1147, 1073, 1044, 1012, 908, 826, 731, 632, 599, 530, 
494; Rf (diethyl ether) 0.90; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 
315.0764, Observed: m/z 315.0777, Difference = 4.13 ppm 
 
Synthesis of ((3S,4S,6S)-6-(furan-2-yl)-4-(4-methoxyphenyl)tetrahydro-2H-pyran-
3-yl)methanol (288c) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 288b using: 
1-(furan-2-yl)-4-(hydroxymethyl)-3-(4-methoxyphenyl)pentane-1,5-diol (287c) (45.0 
mg, 0.147 mmol), Quadrapure™ polymer-supported sulfonic acid (19.4 mg) and 
acetonitrile (3.50 mL). The product was a yellow oil. 
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Yield: 87% (36.9 mg, 0.128 mmol); Diastereomeric Ratio: 18:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.37 (J = 1.4 Hz, 1H, d, H-1), 7.17 (J = 8.6 Hz, 2H, d, H-10), 6.87 (J = 
8.6 Hz, 2H, d, H-11), 6.32 (J = 1.4, 3.2 Hz, 1H, dd, H-2), 6.27 (J = 3.2 Hz, 1H, d, 
H-3), 4.52 (J = 4.0, 9.7 Hz, 1H, dd, H-4), 4.33 (J = 4.3, 11.4 Hz, 1H, dd, H-5), 3.79 
(3H, s, H-12), 3.60 (J = 11.3, 11.4 Hz, 1H, dd, H-5), 3.46 (J = 3.3, 11.0 Hz, 1H, dd, 
H-9), 3.29 (J = 6.7, 11.0 Hz, 1H, dd, H-9), 2.70 (J = 6.0, 11.0, 11.1 Hz, 1H, dd, H-
8), 2.09 – 2.00 (3H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 158.4, 154.3, 
142.2, 135.2, 128.3, 114.1, 110.1, 106.4, 73.1, 71.2, 62.3, 55.3, 43.6, 43.1, 37.8; 
IR: 𝜈 3390 (O-H), 2937, 2916, 2835, 1610, 1511, 1462, 1248, 1178, 1073, 1036, 
1011, 830, 732, 632, 530, 495; Rf (diethyl ether) 0.76; Mass Spectrometry: TOF 
ES+: MH+: Expected: m/z 289.1440, Observed: m/z 289.1433, Difference = −2.42 
ppm 
 
Synthesis of ((3S,4S,6S)-6-(furan-2-yl)-4-p-tolyltetrahydro-2H-pyran-3-yl)methanol 
(288d) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 288b using: 
1-(furan-2-yl)-4-(hydroxymethyl)-3-p-tolylpentane-1,5-diol (287d) (104 mg, 0.358 
mmol), Quadrapure™ polymer-supported sulfonic acid (25.7 mg) and acetonitrile 
(5.00 mL). The product was a yellow oil. 
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Yield: 95% (92.5 mg, 0.340 mmol); Diastereomeric Ratio: 13:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.38 (J = 1.8 Hz, 1H, d, H-1), 7.16 – 7.12 (4H, m, H-10 and H-11), 
6.33 (J = 1.8, 3.3 Hz, 1H, dd, H-2), 6.27 (J = 3.3 Hz, 1H, d, H-3), 4.53 (J = 3.7, 
10.1 Hz, 1H, dd, H-4), 4.35 (J = 4.4, 11.4 Hz, 1H, dd, H-5), 3.62 (J = 11.3, 11.4 Hz, 
1H, dd, H-6), 3.47 (J = 3.4, 11.0 Hz, 1H, dd, H-9), 3.31 (J = 6.8, 11.0 Hz, 1H, dd, 
H-9), 2.73 (J = 6.3, 11.2, 11.3 Hz, 1H, ddd, H-8), 2.34 (3H, s, H-12), 2.17 – 1.98 
(3H, m, H-6 and H-7); 13C-NMR (CDCl3 75 MHz): δ 154.3, 142.2, 140.0, 136.4, 
129.5, 127.3, 110.1, 106.4, 73.1, 71.2, 62.3, 43.6, 43.4, 37.7, 21.0; IR: 𝜈 3401 (O-
H), 2918, 2858, 1723, 1514, 1457, 1280, 1227, 1147, 1073, 1041, 1009, 925, 816, 
737, 586, 550, 508; Rf (diethyl ether) 0.71; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 295.1310, Observed: m/z 295.1320, Difference = 3.39 ppm 
 
Synthesis of ((3S,4S,6S)-4-(3,4-dimethoxyphenyl)-6-(furan-2-yl)tetrahydro-2H-
pyran-3-yl)methanol (288e) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 288b using: 
3-(3,4-dimethoxyphenyl)-1-(furan-2-yl)-4-(hydroxymethyl)pentane-1,5-diol (287e) 
(30.0 mg, 0.0892 mmol), Quadrapure™ polymer-supported sulfonic acid (19.4 mg) 
and acetonitrile (2.50 mL). The product was a yellow oil. 
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Yield: 89% (25.2 mg, 0.0792 mmol); Diastereomeric Ratio: 19:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.38 (J = 0.7, 1.8 Hz, 1H, dd, H-1), 6.82 – 6.78 (3H, m, H-10, H-11 
and H-12), 6.33 (J = 1.8, 2.9 Hz, 1H, dd, H-2), 6.28 (J = 0.7, 2.9 Hz, 1H, dd, H-3), 
4.53 (J = 4.6, 9.1 Hz, 1H, dd, H-4), 4.34 (J = 4.4, 11.4 Hz, 1H, dd, H-5), 3.88 (3H, 
s, H-14), 3.86 (3H, s, H-13), 3.62 (J = 11.3, 11.4 Hz, 1H, dd, H-5), 3.49 (J = 3.4, 
11.0 Hz, 1H, dd, H-9), 3.33 (J = 6.7, 11.0 Hz, 1H, dd, H-9), 2.72 (J = 6.3, 8.3, 10.8 
Hz, 1H, ddd, H-8), 2.15 – 2.04 (3H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 
154.2, 149.1, 147.8, 142.3, 135.7, 119.4, 111.3, 110.2, 110.1, 106.5, 73.2, 71.2, 
62.3, 55.9, 55.9, 43.7, 43.6, 37.8; IR: 𝜈 3345 (O-H), 2947, 2923, 2873, 2836, 1516, 
1463, 1452, 1340, 1261, 1241, 1157, 1121, 1077, 1026, 1012, 952, 921, 881, 809, 
767, 738, 701, 599, 535; Rf (diethyl ether) 0.36; Mass Spectrometry: TOF ES+: 
MH+: Expected: m/z 319.1545, Observed: m/z 319.1530, Difference = −4.70 ppm 
 
Synthesis of ((3S,4S,6S)-4-(4-bromophenyl)-6-(furan-2-yl)tetrahydro-2H-pyran-3-
yl)methanol (288f) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 288b using: 
3-(4-bromophenyl)-1-(furan-2-yl)-4-(hydroxymethyl)pentane-1,5-diol (287f) (28.0 
mg, 0.0788 mmol), Quadrapure™ polymer-supported sulfonic acid (20.7 mg) and 
acetonitrile (3.50 mL). The product was a pale yellow oil. 
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Yield: 86% (22.8 mg, 0.0676 mmol); Diastereomeric Ratio: 10:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.46 (J = 8.4 Hz, 2H, d, H-10), 7.38 (J = 1.7 Hz, 1H, d, H-1), 7.14 (J = 
8.4 Hz, 2H, d, H-11), 6.33 (J = 1.7, 3.2 Hz, 1H, dd, H-2), 6.28 (J = 3.2 Hz, 1H, d, 
H-3), 4.53 (J = 5.6, 8.2 Hz, 1H, dd, H-4), 4.34 (J = 4.5, 11.5 Hz, 1H, dd, H-5), 3.64 
(J = 11.3, 11.5 Hz, 1H, dd, H-5), 3.46 (J = 3.2, 11.0 Hz, 1H, dd, H-9), 3.30 (J = 6.7, 
11.0 Hz, 1H, dd, H-9), 2.78 (J = 5.9, 8.3, 10.8 Hz, 1H, ddd, H-8), 2.13 – 2.03 (3H, 
m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 154.0, 142.3, 142.1, 131.8, 129.2, 
120.5, 110.1, 106.6, 73.0, 71.1, 61.8, 43.2, 43.1, 37.4; IR: 𝜈 3391 (O-H), 2919, 
1488, 1148, 1072, 1044, 1009, 908, 822, 731, 648, 599, 536, 495; Rf (diethyl 
ether) 0.79; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 359.0259, 
Observed: m/z 359.0243, Difference = −4.46 ppm 
 
Synthesis of ((3S,4S,6S)-4-(4-bromophenyl)-6-(5-methylfuran-2-yl)tetrahydro-2H-
pyran-3-yl)methanol (288h) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 288b using: 
3-(4-bromophenyl)-4-(hydroxymethyl)-1-(5-methylfuran-2-yl)pentane-1,5-diol 
(287h) (13.3 mg, 0.0360 mmol), Quadrapure™ polymer-supported sulfonic acid 
(18.2 mg) and acetonitrile (2.50 mL). The product was a yellow oil. 
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Yield: 63% (8.0 mg, 0.0228 mmol); Diastereomeric Ratio: 12:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.47 – 7.44 (2H, m, H-10), 7.17 – 7.13 (2H, m, H-11), 6.15 (J = 3.1 
Hz, 1H, d, H-3), 5.90 (J = 0.9, 3.1 Hz, 1H, dd, H-2), 4.47 (J = 3.5, 10.2 Hz, 1H, dd, 
H-4), 4.35 (J = 4.4, 11.5 Hz, 1H, dd, H-5), 3.63 (J = 11.3, 11.5 Hz, 1H, dd, H-5), 
3.47 (J = 3.2, 10.9 Hz, 1H, dd, H-9), 3.31 (J = 6.7, 10.9 Hz, 1H, dd, H-9), 2.81 – 
2.71 (1H, m, H-8), 2.28 (J = 0.9 Hz, 3H, d, H-1), 2.11 – 2.01 (3H, m, H-6 and H-7); 
13C-NMR (CDCl3, 75 MHz): δ 152.2, 152.1, 142.2, 131.8, 129.2, 120.4, 107.6, 
106.0, 73.0, 71.0, 61.9, 43.3, 43.2, 37.3, 13.6; IR: 𝜈 3402 (O-H), 2919, 2360, 1712, 
1488, 1377, 1222, 1132, 1071, 1051, 1009, 909, 849, 822, 785, 730, 633, 540, 
493; Rf (diethyl ether) 0.78; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 
391.0521, Observed: m/z 391.0507, Difference = −3.58 ppm 
 
Synthesis of ((3S, 4S, 6S)-6-(5-methylfuran-2-yl)-4-phenyltetrahydro-2H-pyran-3-
yl)methanol (288i) 
 
 
 
 
 
Experimental procedure followed matched that described for 288b using: 
4-(hydroxymethyl)-1-(5-methylfuran-2-yl)-3-phenylpentane-1,5-diol (287i) (22.5 
mg, 0.0775 mmol), Quadrapure™ polymer-supported sulfonic acid (11.6 mg) and 
acetonitrile (3.00 mL). The product was a colourless oil. 
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Yield: 84% (17.7 mg, 0.0650 mmol); Diastereomeric Ratio: 12:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.33 – 7.25 (5H, m, H-10, H-11 and H-12), 6.15 (J = 3.1 Hz, 1H, d, H-
3), 5.90 (J = 0.8, 3.1 Hz, 1H, dd, H-2), 4.48 (J = 2.9, 10.8 Hz, 1H, dd, H-4), 4.36 (J 
= 4.3, 11.4 Hz, 1H, dd, H-5), 3.63 (J = 11.3, 11.4, 1H, dd, H-5), 3.47 (J = 6.8, 11.0 
Hz, 1H, dd, H-9), 3.31 (J = 6.8, 11.0 Hz, 1H, dd, H-9), 2.76 (J = 4.8, 11.4, 11.5 Hz, 
1H, ddd, H-8), 2.28 (J = 0.8 Hz, 3H, d, H-1), 2.15 – 2.03 (3H, m, H-6 and H-7); 
13C-NMR (CDCl3, 75 MHz): δ 152.4, 152.1, 143.2, 128.8, 127.4, 126.8, 107.5, 
106.0, 73.0, 71.2, 62.3, 44.1, 43.3, 37.5, 13.6; IR: ν 3402 (O-H), 2942, 2918, 2853, 
1565, 1452, 1378, 1335, 1221, 1129, 1048, 1018, 949, 782, 760, 700, 554, 493; Rf 
(diethyl ether) 0.84; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 
295.1310, Observed: m/z 295.1309, Difference = −0.34 ppm 
 
Synthesis of ((3S,4S,6S)-6-(5-methylfuran-2-yl)-4-p-tolyltetrahydr-2H-pyran-3-
yl)methanol (288j) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 288b using: 
4-(hydroxymethyl)-1-(5-methylfuran-2-yl)-3-p-tolylpentane-1,5-diol (287j) (65.0 mg, 
0.214 mmol), Quadrapure™ polymer-supported sulfonic acid (10.4 mg) and 
acetonitrile (4.00 mL). The product was a deep yellow oil. 
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Yield: 75% (46.0 mg, 0.161 mmol); Diastereomeric Ratio: 13:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.16 – 7.13 (4H, m, H-10 and H-11), 6.15 (J = 3.1 Hz, 1H, d, H-3), 
5.90 (J = 0.8, 3.1 Hz, 1H, dd, H-2), 4.47 (J = 2.9, 10.7 Hz, 1H, dd, H-4), 4.34 (J = 
4.4, 11.4 Hz, 1H, dd, H-5), 3.60 (J = 11.3, 11.4 Hz, 1H, dd, H-5), 3.46 (J = 3.4, 
11.1 1H, dd, H-9), 3.29 (J = 6.8, 11.1 Hz, 1H, dd, H-9), 2.71 (J = 4.8, 11.4, 11.4 
Hz, 1H, ddd, H-8), 2.34 (3H, s, H-12), 2.28 (J = 0.8 Hz, 3H, d, H-1), 2.18 – 2.02 
(3H, m, H-6 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 152.4, 152.0, 140.1, 136.3, 
129.4, 127.2, 107.4, 105.9, 73.1, 71.1, 62.2, 43.6, 43.3, 37.5, 21.0, 13.5; IR: 𝜈 
3402 (O-H), 2943, 2918, 2857, 1565, 1514, 1435, 1378, 1335, 1220, 1129, 1109, 
1074, 1048, 1018, 942, 816, 782, 587, 549, 508; Rf (diethyl ether) 0.79; Mass 
Spectrometry: TOF ES+: MH+: Expected: m/z 287.1647, Observed: m/z 287.1637, 
Difference = −3.48 ppm 
 
Synthesis of ((3S,4S,6S)-4-(4-chlorophenyl)-6-(5-methylfuran-2-yl)tetrahydro-2H-
pyran-3-yl)methanol (288k) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 288b using: 
3-(4-chlorophenyl)-4-(hydroxymethyl)-1-(5-methylfuran-2-yl)pentane-1,5-diol 
(287k) (19.7 mg, 0.0607 mmol), Quadrapure™ polymer-supported sulfonic acid 
(12.3 mg) and acetonitrile (2.50 mL). The product was a pale yellow oil. 
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Yield: 83% (15.4 mg, 0.0502 mmol); Diastereomeric Ratio: 10:1; 1H-NMR (CDCl3, 
300 MHz): δ 7.33 – 7.29 (2H, m, H-11), 7.22 – 7.17 (2H, m, H-10), 6.15 (J = 3.1 
Hz, 1H, d, H-3), 5.90 (J = 0.9, 3.1 Hz, 1H, dd, H-2), 4.47 (J = 3.2, 10.4 Hz, 1H, dd, 
H-4), 4.35 (J = 4.4, 11.5 Hz, 1H, dd, H-5), 3.63 (J = 11.3, 11.5 Hz, 1H, dd, H-5), 
3.45 (J = 3.3, 11.0 Hz, 1H, dd, H-9), 3.31 (J = 6.7, 11.0 Hz, 1H, dd, H-9), 2.82 – 
2.73 (1H, m, H-8), 2.28 (J = 0.9 Hz, 3H, d, H-1), 2.10 – 2.01 (3H, m, H-6 and H-7); 
13C-NMR (CDCl3, 75 MHz): δ 152.2, 152.1, 141.7, 132.4, 128.9, 128.8, 107.6, 
106.0, 73.0, 71.1, 61.9, 43.3, 43.2, 37.4, 13.6; IR: 𝜈 3391 (O-H), 2945, 2919, 2855, 
1564, 1491, 1378, 1336, 1221, 1129, 1085, 1048, 1013, 942, 909, 825, 784, 730, 
649, 634, 573, 494; Rf (diethyl ether) 0.77; Mass Spectrometry: TOF ES+: MH+: 
Expected: m/z 307.1101, Observed: m/z 307.1069, Difference = −10.42 ppm 
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5.6. Data from the Synthesis of 4-Aryl-2,6-Difuranyl 
Tetrahydropyrans 
 
Synthesis of 1,5,-di(furan-2-yl)-3-(4-methoxyphenyl)pentane-1,5-dione (294c) 
 
 
 
 
 
 
2-acetylfuran (274) (0.525 g, 4.77 mmol, 1.00 eqv.) was dissolved in methanol 
(45.0 mL). (E)-1-(furan-2-yl)-3-(4-methoxyphenyl)prop-2-en-1-one (272c) (1.10 g, 
4.82 mmol, 1.01 eqv.) was then added, followed by 5% aqueous sodium hydroxide 
solution (6.00 mL). The reaction was stirred at reflux for 5 hours. Once the reaction 
had gone to completion it was diluted with diethyl ether (50.0 mL) and ammonium 
chloride solution (100 mL). Extraction was performed using diethyl ether (4 × 40.0 
mL) and the combined organic phases were then washed with water (2 × 100 mL) 
and brine (2 × 100 mL). The organic material was then dried over magnesium 
sulfate before being concentrated under reduced pressure. The crude material 
was purified by column chromatography using a graduated solvent system 
reaching a 1:1 mixture of dichloromethane and diethyl ether. The product was a 
thick brown gum. 
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Yield: 41% (0.654 g, 1.93 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.54 (J = 1.7 Hz, 
2H, d, H-1 and H-9), 7.19 (J = 8.6 Hz, 2H, d, H-10), 7.18 (J = 3.5 Hz, 2H, d, H-3 
and H-7), 6.78 (J = 8.6 Hz, 2H, d, H-11), 6.49 (J = 1.7, 3.5 Hz, 2H, dd, H-2 and H-
8), 4.02 – 3.93 (1H, m, H-5), 3.73 (3H, s, H-12), 3.22 (J = 7.4, 7.4 Hz, 4H, dd, H-4 
and H-6); 13C-NMR (CDCl3, 75 MHz): δ 187.6 (C=O), 158.2, 152.6, 146.4, 135.1, 
128.3, 117.4, 113.9, 112.2, 55.1, 44.7, 36.4; IR: 𝜈 3129, 2933, 2835, 1664 (C=O), 
1608, 1565, 1510, 1463, 1392, 1284, 1244, 1177, 1084, 1026, 882, 829, 760, 593, 
530; Rf (dichloromethane) 0.19; Mass Spectrometry: TOF ES+: MH+: Expected: 
m/z 339.1233, Observed: m/z 339.1236, Difference = −0.88 ppm 
 
Synthesis of 1,5-di(furan-2-yl)-3-p-tolylpentane-1,5-dione (294d) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 294c using: 
2-acetylfuran (274) (0.667 g, 6.06 mmol, 1.26 eqv.), (E)-1-(furan-2-yl)-3-p-
tolylprop-2-en-1-one (272d) (1.02 g, 4.81 mmol, 1.00 eqv.), 5% aqueous sodium 
hydroxide (5.00 mL) and methanol (50.0 mL). The product was a dark brown oil. 
 
Yield: 58% (0.912 g, 2.81 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.54 (J = 1.7 Hz, 
2H, d, H-1 and H-9), 7.18 (J = 3.6 Hz, 2H, d, H-3 and H-7), 7.17 (J = 7.6 Hz, 2H, d, 
H-10), 7.07 (J = 7.6 Hz, d, H-11), 6.45 (J = 1.7, 3.6 Hz, 2H, dd, H-2 and H-8), 4.04 
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– 3.94 (1H, m, H-5), 3.31 – 3.18 (4H, m, H-4 and H-6); 13C-NMR (CDCl3, 75 MHz): 
δ 187.6 (C=O), 152.6, 146.3, 140.1, 136.3, 129.2, 127.2, 117.3, 112.2, 44.6, 36.7, 
21.0; IR: 𝜈 3130, 2921, 1732, 1666 (C=O), 1566, 1514, 1464, 1393, 1243, 1156, 
1014, 911, 883, 816, 761, 730, 594, 551, 493; Rf (dichloromethane) 0.21; Mass 
Spectrometry: TOF ES+: MH+: Expected: m/z 323.1283, Observed: m/z 323.1282, 
Difference = 0.31 ppm 
 
Synthesis of 3-(4-bromophenyl)-1.5-di(furan-2-yl)pentane-1,5-dione (294f) 
 
 
 
 
 
Experimental procedure followed matched that described for 294c using: 
2-acetylfuran (274) (0.397 g, 3.61 mmol, 1.00 eqv.), (E)-3-(4-bromophenyl)-1-
(furan-2-yl)prop-2-en-1-one (272f) (1.08 g, 3.90 mmol, 1.08 eqv.), 5% aqueous 
sodium hydroxide (5.00 mL) and methanol (45.0 mL). The product was a brown 
crystalline solid. 
 
Yield: 53% (0.740 g, 1.91 mmol); 1H-NMR (CDCl3, 300 MHz): δ 7.55 (J = 1.7 Hz, 
2H, d, H-1 and H-9), 7.38 (J = 8.5 Hz, 2H, d, H-10), 7.18 (J = 3.6 Hz, 2H, d, H-3 
and H-7), 7.17 (J = 8.5 Hz, 2H, d, H-11), 6.51 (J = 1.7, 3.6 Hz, 2H, dd, H-2 and H-
8), 4.00 (J = 7.1, 7.1, 7.2, 7.2 Hz, 1H, dddd, H-5), 3.31 – 3.16 (4H, m, H-4 and H-
6); 13C-NMR (CDCl3, 75 MHz): δ 187.1 (C=O), 152.5, 146.5, 142.2, 131.6, 129.2, 
120.5, 117.4, 112.3, 44.2, 36.3; IR: 𝜈 3129, 1667 (C=O), 1566, 1487, 1465, 1393, 
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1288, 1155, 1072, 1009, 883, 825, 761, 593, 545; Melting Point: 58 °C; Rf 
(dichloromethane) 0.26; Mass Spectrometry: TOF ES+: MH+: Expected: m/z 
387.0232, Observed: m/z 387.0230, Difference = 0.52 ppm 
 
Synthesis of 1,5,-di(furan-2-yl)-3-(4-methoxyphenyl)pentane-1,5-diol (293c) 
 
 
 
 
 
1,5-di(furan-2-yl)-3-(4-methoxyphenyl)pentane-1,5-dione (294c) (0.600 g, 1.77 
mmol, 1.00 eqv.) was dissolved in methanol (30.0 mL) and the reaction mixture 
was cooled to −10°C. Sodium borohydride (0.808 g, 21.4 mmol, 12.6 eqv.) was 
added and the reaction mixture was stirred for 20 minutes whilst being allowed to 
warm to room temperature. After, the reaction mixture was concentrated to 
approximately 5.00 mL. This was then diluted with ethyl acetate (40.0 mL) and 
water (40.0 mL) whilst stirring. Extraction was accomplished using ethyl acetate (3 
× 30.0 mL) and the combined organic phases were then washed with brine (3 × 
70.0 mL). The organic material was then dried over magnesium sulfate before 
being concentrated under reduced pressure. The crude material was purified by 
column chromatography using a graduated solvent system approaching 100% 
diethyl ether. The product was a thick yellow gum. 
 
Diastereomeric Ratio: 2:1; Yield: 56% (0.337 g, 0.984 mmol); 1H-NMR (CDCl3, 300 
MHz): δ 7.37 (J = 1.7 Hz, [2] 1H, d, H-1 [D-1]), 7.35 (J = 1.7 Hz, [2] 1H, d, H-11 [D-
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1]), 7.31 (J = 2.1 Hz, 1H, d, H-1 [D-2]), 7.30 (J = 1.9 Hz, 1H, d, H-11 [D-2]), 7.11 (J 
= 8.7 Hz, [2] 2H, d, H-12 [D-1]), 7.02 (J = 8.7 Hz, 2H, d, H-12 [D-2]), 6.85 (J = 8.7 
Hz, [2] 2H, d, H-13 [D-1]), 6.84 (J = 8.7 Hz, 2H, d, H-13 [D-2]), 6.32 (J = 1.7, 3.1 
Hz, [2] 1H, dd, H-2 [D-1]), 6.30 (J = 1.7, 3.2 Hz, [2] 1H, dd, H-10 [D-1]), 6.29 – 
6.28 (1H, m, H-2 [D-2]), 6.27 (J = 1.9, 3.2 Hz, 1H, dd, H-10 [D-2]), 6.17 (J = 3.1 
Hz, [2] 1H, d, H-3 [D-1]), 6.15 (J = 3.2 Hz, [2] 1H, d, H-9 [D-1]), 6.13 (J = 2.7 Hz, 
1H, d, H-3 [D-2]), 6.11 (J = 3.2 Hz, 1H, d, H-9 [D-2]), 4.55 – 4.46 ([2] 2H, m, H-4 
[D-1] and H-8 [D-1]), 4.38 – 4.30 (2H, m, H-4 [D-2] and H-8 [D-2]), 3.80 ([2] 3H, s, 
H-14 [D-1]), 3.79 (3H, s, H-14 [D-2]), 2.93 – 2.83 ([2] 1H, m, H-6 [D-1]), 2.53 – 
2.38 (1H, m, H-6 [D-2]), 2.30 – 1.92 ([2] 6H + 6H, m, H-5 [D-1], H-5 [D-2], H-7 [D-
1], H-7 [D-2], OH [D-1], OH [D-2], OH [D-1] and OH [D-2]); 13C-NMR (CDCl3, 75 
MHz): δ 158.2, 156.9, 155.9, 155.8, 142.1, 141.8, 135.9, 135.5, 128.7, 128.4, 
114.0, 110.1, 106.6, 105.5, 105.4, 65.9, 65.8, 65.2, 65.0, 55.2, 42.6, 42.5, 42.1, 
41.7, 38.1, 37.5; IR: 𝜈 3372 (O-H), 2934, 2835, 1609, 1509, 1462, 1296, 1243, 
1177, 1147, 1065, 1030, 1003, 914, 883, 829, 809, 733, 598, 561; Rf (1:1 
petroleum ether : diethyl ether) 0.13; Mass Spectrometry: TOF ES+: MNa+: 
Expected: m/z 365.1365, Observed: m/z 365.1352, Difference = 3.56 ppm 
 
Synthesis of 1,5-di(furan-2-yl)-3-p-tolylpentane-1,5-diol (293d) 
 
 
 
 
 
Experimental procedure followed matched that described for 293c using: 
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1,5-di(furan-2-yl)-3-p-tolylpentane-1,5-dione (294d) (0.850 g, 2.62 mmol, 1.00 
eqv.), sodium borohydride (0.619 g, 16.4 mmol, 6.26 eqv.) and methanol (45.0 
mL). The product was a yellow foam. 
 
Diastereomeric Ratio: 2.5:1; Yield: 51% (0.433 g, 1.33 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.37 (J = 1.8 Hz [2.5] 1H, d, H-1 [D-1]), 7.36 (J = 1.8 Hz, [2.5] 1H, d, 
H-11 [D-1]), 7.31 (J = 1.9 Hz, 1H, d, H-1 [D-2]), 7.30 (J = 1.8 Hz, 1H, d, H-11 [D-
2]), 7.15 – 7.10 ([2.5] 4H, m, H-12 [D-1] and H-13 [D-1]), 7.01 – 6.99 (4H, m, H-12 
[D-2] and H-13 [D-2]), 6.33 – 6.30 ([2.5] 2H, m, H-2 [D-1] and H-10 [D-1]), 6.29 – 
6.26 (2H, m, H-2 [D-2] and H-10 [D-2]), 6.18 (J = 3.2 Hz, [2.5] 1H, d, H-3 [D-1]), 
6.16 (J = 3.3 Hz, [2.5] 1H, d, H-9 [D-1]), 6.14 – 6.11 (2H, m, H-3 [D-2] and H-9 [D-
2]), 4.56 – 4.48 ([2.5] 2H, m, H-4 [D-1] and H-8 [D-1]), 4.40 – 4.31 (2H, m, H-4 [D-
2] and H-8 [D-2]), 2.96 – 2.85 ([2.5] 1H, m, H-6 [D-1]), 2.51 – 2.45 (1H, m, H-6 [D-
2]), 2.33 ([2.5] 3H, s, H-14 [D-1]), 2.33 (3H, s, H-14 [D-2]), 2.29 – 1.96 ([2.5] 6H + 
6H, m, H-5 [D-1], H-5 [D-2], H-7 [D-1], H-7 [D-2], OH [D-1], OH [D-2], OH [D-1] and 
OH [D-2]); 13C-NMR (CDCl3, 75 MHz): δ 156.9, 155.9, 155.9, 142.1, 141.8, 140.9, 
140.5, 136.2, 136.1, 129.4, 127.6, 127.4, 110.1, 106.6, 105.4, 105.4, 65.9, 65.8, 
65.2, 65.0, 42.6, 42.1, 41.6, 38.5, 37.9, 21.0; IR: 𝜈 3334 (O-H), 2921, 1512, 1228, 
1147, 1065, 1003, 912, 883, 814, 725, 598, 562; Rf (1:1 petroleum ether : diethyl 
ether) 0.09; Mass Spectrometry: TOF ES+: MNa+: Expected: m/z 349.1416, 
Observed: m/z 349.1407, Difference = 2.58 ppm 
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Synthesis of (2R,4S,6S)-2,6-di(furan-2-yl)-4-(4-methoxyphenyl)tetrahydro-2H-
pyran (292c) 
 
 
 
 
 
 
1,5-di(furan-2-yl)-3-(4-methoxyphenyl)pentane-1,5-diol (293c) (35.8 mg, 0.105 
mmol) was dissolved in acetonitrile (5.00 mL). Quadrapure™ polymer-supported 
sulfonic acid (15.0 mg) was added and the reaction was stirred gently for 5 hours. 
After, the mixture was diluted with dichloromethane (10.0 mL) and petroleum ether 
(10.0 mL). This was then passed through a silica plug and the resulting solution 
was concentrated under reduced pressure. The crude material was purified by 
column chromatography using a graduated solvent system reaching a 1:1 mixture 
of petroleum ether and diethyl ether. The product obtained was a pale brown oil. 
 
Diastereomeric Ratio: 10:1; Yield: 16% (5.4 mg, 0.0116 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.37 (J = 1.6 Hz, 2H, d, H-1 and H-11), 7.22 (J = 8.7 Hz, 2H, d, H-12), 
6.89 (J = 8.7 Hz, 2H, d, H-13), 6.34 – 6.30 (4H, m, H-2, H-3, H-9 and H-10), 4.76 
(J = 3.2, 10.4 Hz, 2H, dd, H-4 and H-8), 3.81 (3H, s, H-14), 3.02 (J = 5.1, 5.1, 10.2, 
10.2 Hz, 1H, dddd, H-6), 2.14 – 2.01 (4H, m, H-5 and H-7); 13C-NMR (CDCl3, 75 
MHz): δ 158.2, 154.1, 142.2, 136.9, 127.7, 114.0, 110.1, 107.0, 73.3, 55.3, 40.8, 
36.6; Rf (1:1 petroleum ether : diethyl ether) 0.72; Mass Spectrometry: 
Decomposed rapidly – accurate mass unable to be obtained. 
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Synthesis of (2R,4S,6S)-2,6-di(furan-2-yl)-4-p-tolyltetrahydro-2H-pyran (292d) 
 
 
 
 
 
 
Experimental procedure followed matched that described for 292c using: 
1,5-di(furan-2-yl)-3-p-tolylpentane-1,5-diol (293d) (0.163 g, 0.499 mmol), polymer-
supported sulfonic acid (23.8 mg) and acetonitrile (15.0 mL). The product obtained 
was a yellow oil. 
 
Diastereomeric Ratio: 20:1; Yield: 33% (51.3 mg, 0.166 mmol); 1H-NMR (CDCl3, 
300 MHz): δ 7.37 (J = 1.5 Hz, 2H, d, H-1 and H-11), 7.24 – 7.18 (4H, m, H-12 and 
H-13), 6.37 – 6.33 (4H, m, H-2, H-3, H-9 and H-10), 4.81 – 4.77 (2H, m, H-4 and 
H-8), 3.14 – 3.00 (1H, m, H-6), 2.37 (3H, s, H-14), 2.17 – 2.06 (4H, m, H-5 and H-
7); 13C-NMR (CDCl3, 75 MHz): δ 154.1, 142.2, 141.7, 136.2, 129.3, 126.6, 110.0, 
107.0, 73.3, 41.2, 36.4, 21.0; IR: 𝜈 2941, 2916, 2876, 1505, 1368, 1346, 1305, 
1255, 1144, 1091, 1055, 1009, 981, 921, 811, 587, 553, 513; Rf (1:1 petroleum 
ether : diethyl ether) 0.79; Mass Spectrometry: TOF ES+: MH+: Expected: m/z 
309.1491, Observed: m/z 309.1485, Difference = 1.94 ppm 
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Synthesis of (2R,4S,6S)-4-(4-bromophenyl)-2,6-di(furan-2-yl)tetrahydro-2H-pyran 
(292f) 
 
 
 
 
 
 
3-(4-bromophenyl)-1,5-di(furan-2-yl)pentane-1,5-dione (294f) (0.549 g, 1.42 mmol, 
1.00 eqv.) was dissolved in methanol (30.0 mL) and the reaction mixture was 
cooled to −10°C. Sodium borohydride (0.676 g, 17.9 mmol, 12.0 eqv.) was added 
and the reaction mixture was stirred for 20 minutes whilst being allowed to warm to 
room temperature. After, the reaction mixture was concentrated to approximately 
5.00 mL. This was then diluted with ethyl acetate (40.0 mL) and water (40.0 mL) 
whilst stirring. Extraction was accomplished using ethyl acetate (3 × 30.0 mL) and 
the combined organic phases were then washed with brine (3 × 70.0 mL). The 
organic material was then dried over magnesium sulfate before being 
concentrated under reduced pressure. The crude material was then dissolved in 
acetonitrile (25.0 mL). Quadrapure™ polymer-supported sulfonic acid (15.0 mg) 
was added and the reaction was stirred gently for 5 hours. After, the mixture was 
diluted with dichloromethane (10.0 mL) and petroleum ether (45.6 mL). This was 
then passed through a silica plug and the resulting solution was concentrated 
under reduced pressure. The crude material was purified by column 
chromatography using a graduated solvent system reaching a 1:1 mixture of 
petroleum ether and diethyl ether. The product obtained was a white solid. 
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Diastereomeric Ratio: 40:1; Yield: 19% over 2 steps (68.9 mg, 0.185 mmol); 1H-
NMR (CDCl3, 300 MHz): δ 7.48 (J = 8.5 Hz, 2H, d, H-12), 7.38 (J = 1.5 Hz, 2H, dd, 
H-1 and H-11), 7.18 (J = 8.5 Hz, 2H, d, H-13), 6.34 – 6.32 (4H, m, H-2, H-3, H-9 
and H-10), 4.78 (J = 3.3, 10.2 Hz, 2H, dd, H-4 and H-8), 3.10 – 2.98 (1H, m, H-6), 
2.17 – 2.06 (4H, m, H-5 and H-7); 13C-NMR (CDCl3, 75 MHz): δ 153.8, 143.5, 
142.2, 131.7, 128.5, 120.3, 110.1, 107.1, 73.2, 41.1, 36.2; IR: 𝜈 3143, 2943, 2921, 
2853, 1490, 1318, 1150, 1062, 1009, 984, 808, 755, 740, 649, 598, 565, 543, 520, 
436; Melting Point: 82 – 83 °C; Rf (1:1 petroleum ether : diethyl ether) 0.81; Mass 
Spectrometry: TOF ES+: MH+: Expected: m/z 373.0439, Observed: m/z 373.0438, 
Difference = 0.27 ppm 
 
Synthesis of 5,5-di(furan-2-yl)-3-p-tolylpentanal (295) 
 
 
 
 
 
 
This aldehyde is the major impurity seen during the cyclisation reaction to 
synthesise 292d. 
 
1H-NMR (CDCl3, 300 MHz): δ 9.57 (J = 2.1 Hz, 1H, t, H-1), 7.38 (J = 1.9 Hz, 1H, d, 
H-8), 7.27 (J = 2.0 Hz, 1H, d, H-11), 7.15 – 7.06 (4H, m, H-12 and H-13), 6.36 (J = 
1.9, 3.2 Hz, 1H, dd, H-7), 6.25 (J = 2.0, 3.12 Hz, 1H, dd, H-10), 6.12 (J = 3.2 Hz, 
1H, d, H-6), 5.95 (J = 3.2 Hz, 1H, d, H-9), 3.85 – 3.76 (2H, m, H-2), 3.10 – 2.98 
12
13
14
295
32 41
O
5O
8
7 6 9 10
11
O
		
Experimental	–	4-Aryl-2,6-Difuranyl	Tetrahydropyran	Synthesis	 		 	
310	
(2H, m, H-3 and H-5), 2.69 (J = 2.1, 2.8, 7.1 Hz, 2H, ddd, H-4), 2.33 (3H, s, H-14); 
13C-NMR (CDCl3, 75 MHz): δ 201.7 (C=O), 155.4, 153.8, 141.7, 141.3, 139.2, 
136.5, 129.5, 127.5, 110.2, 110.1, 106.9, 105.2, 50.6, 38.9, 37.2, 36.3, 21.0; Mass 
Spectrometry: TOF ES+: MH+: Expected: m/z 309.1491, Observed: m/z 309.1493, 
Difference = −0.65 ppm 
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5.7. Data for the Continuous-Flow Test Reactions and 
Bromination of Enaminones 	
Synthesis of (E)-methyl 2-benzylidenehydrazinecarboxylate (317) 
 
 
 
 
0.5 M methyl carbazate (316) solution in dichloromethane (0.500 mL, 0.250 mmol, 
2.00 eqv.) was added to 0.25 M benzaldehyde (56) solution in dichloromethane 
(0.500 mL, 0.125 mmol, 1.00 eqv.). To this was added 0.03 M pyridinium p-
toluenesulfonate solution in dichloromethane (0.500 mL, 0.0159 mmol, 0.127 
eqv.). The reaction was allowed to react for two minutes. After this time had 
elapsed the reaction was quenched by the addition of 1 M aqueous phosphoric 
acid (1.50 mL). This was rapidly shaken for thirty seconds and then the organic 
phase was concentrated under reduced pressure and subsequently characterised 
by 1H-NMR. 
 
Yield: 95% (0.0212 g, 0.119 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 9.03 (1H, br, 
NH), 7.91 (1H, s, H-2), 7.66 – 7.34 (5H, m, H-3, H-4 and H-5), 3.85 (3H, s, H-1); 
Data in accordance with literature values.12 
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Synthesis of 2-phenyl-1,3-dithiane (324) 
 
 
 
 
0.5 M benzaldehyde (56) solution in dichloromethane (0.500 mL, 0.250 mmol, 1.00 
eqv.) was added to solution of 0.75 M BF3·THF (0.500 mL, 0.375 mmol, 1.50 eqv.) 
and 1 M 1,2-ethanedithiol (323) in dichloromethane (0.500 mL, 0.500 mmol, 2.00 
eqv.). The reaction was allowed to react for one minute. After this time had 
elapsed the reaction was quenched by the addition of 2 M aqueous sodium 
hydroxide solution (1.00 mL). This was rapidly shaken for thirty seconds and then 
the organic phase was concentrated under reduced pressure and subsequently 
characterised by 1H-NMR. 
 
1H-NMR: (CDCl3, 300 MHz) δ 7.54 – 7.27 (5H, m, H-1, H-2 and H-3), 5.64 (1H, s, 
H-4), 3.57 – 3.50 (2H, m, H-5 and H-6), 3.41 – 3.31 (2H, m, H-5’ and H-6’); Data in 
accordance with literature values.13 
 
Synthesis of 2-methyl-2-phenyl-1,3-dithiolane (326) 
 
 
 
 
1 M acetophenone (325) solution in dichloromethane (0.500 mL, 0.500 mmol, 1.00 
eqv.) was added to solution of 3 M BF3·THF (0.500 mL, 1.50 mmol, 3.00 eqv.) and 
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4 M 1,2-ethanedithiol (323) in dichloromethane (0.500 mL, 2.00 mmol, 4.00 eqv.). 
The reaction was allowed to react for two minutes. After this time had elapsed the 
reaction was quenched by the addition of 2 M aqueous sodium hydroxide solution 
(4.00 mL). This was rapidly shaken for thirty seconds and then the organic phase 
was concentrated under reduced pressure and subsequently characterised by 1H-
NMR. 
 
1H-NMR: (CDCl3, 300 MHz) δ 7.80 – 7.22 (5H, m, H-1, H-2 and H-3), 3.54 – 3.32 
(4H, m, H-5 and H-6), 2.18 (3H, s, H-4); Data in accordance with literature 
values.14 
 
Synthesis of 3-[(4-chlorobenzyl)amino]cyclohex-2-enone (331a)15 
 
 
 
 
 
Cyclohexanedione (329b) (1.55 g, 13.8 mmol, 1.00 eqv.) and 4-chlorobenzylamine 
(1.80 mL, 14.8 mmol, 1.07 eqv.) were added to a flask under nitrogen. To this was 
added toluene (50.0 mL) and ethanol (2.50 mL) and the reaction was stirred at 
reflux for three hours. Solvent was then removed under concentrated pressure and 
the product was recrystallised in toluene. The product a yellow crystalline material. 
 
Yield: 71% (2.31 g, 9.80 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 7.32 – 7.26 (2H, m, 
H-7), 7.18 (J = 8.5 Hz, 2H, m, H-6), 5.34 (1H, s, NH), 5.07 (1H, s, H-4), 4.18 (J = 
1
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5.4 Hz, 2H, d, H-5), 2.38 (J = 6.2 Hz, 2H, t, H-1), 2.27 (J = 6.5 Hz, 2H, t, H-3), 1.99 
– 1.91 (2H, m, H-2); Melting Point: 167 – 168 °C (Literature value: 170 – 172 °C); 
Data in accordance with literature values.15 
 
Synthesis of 3-(4-chlorobenzylamino)-5,5-dimethylcyclohex-2-enone (331b) 
 
 
 
 
 
Experimental procedure followed matched that described for 331a using: 
Dimedone (329a) (1.51 g, 10.8 mmol, 1.00 eqv.), 4-chlorobenzylamine (1.60 mL, 
13.2 mmol, 1.22 eqv.), ethanol (2.50 mL) and toluene (50.0 mL). The product was 
a pale yellow crystalline solid. 
 
Yield: 88% (2.50 g, 9.48 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 7.30 – 7.26 (2H, m, 
H-8), 7.17 (J = 8.3 Hz, 2H, d, H-7), 5.42 (1H, s, NH), 5.04 (1H, s, H-5), 4.19 (J = 
5.4 Hz, 2H, d, H-6), 2.22 (2H, s, H-1), 2.12 (2H, s, H-4), 1.04 (6H, s, H-2 and H-3); 
Melting Point: 157 – 159 °C (Literature Value: 159 – 169 °C); Data in accordance 
with literature values.15 
 
Synthesis of (Z)-4-(4-chlorobenzylamino)pent-3-en-2-one (331c) 
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The procedure followed matched that described for 331a using: 
2,4-pentanedione (329c) (1.60 mL, 15.6 mmol, 1.00 eqv.), 4-chlorobenzylamine 
(2.20 mL, 18.1 mmol, 1.16 eqv.), ethanol (2.50 mL) and toluene (50.0 mL). The 
product was an off-white crystalline solid. 
 
Yield: 50% (1.74 g, 7.78 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 11.12 (1H, s, NH), 
7.27 (J = 8.1 Hz, 2H, d, H-6), 7.15 (J = 8.1 Hz, 2H, d, H-5), 5.03 (1H, s, H-2), 4.39 
(J = 6.2 Hz, 2H, d, H-4), 2.01 (3H, s, H-3), 1.86 (3H, s, H-1); Melting Point: 81 – 82 
°C; Data in accordance with literature values.16 
 
Synthesis of 3-(cyclohexylamino)cyclohex-2-enone (331d) 
  
 
 
 
The procedure followed matched that described for 331a using: 
Cyclohexanedione (329b) (1.52 g, 13.6 mmol, 1.00 eqv.), cyclohexylamine (2.00 
mL, 17.5 mmol, 1.29 eqv.), ethanol (3.00 mL) and toluene (50.0 mL). The product 
was a yellow crystalline solid. 
 
Yield: 91% (2.39 g, 12.4 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 5.89 (J = 7.3 Hz, 
1H, d, NH), 5.00 (1H, s, H-4), 3.14 – 3.05 (1H, m, H-5), 2.26 (J = 6.2 Hz, 2H, t, H-
1), 2.16 (J = 6.4 Hz, 2H, t, H-3), 1.88 – 0.97 (12H, m, H-2, H-6, H-7, H-8, H-9 and 
H-10); Melting Point: 152 – 154 °C (Literature Value: 155 – 156 °C); Data in 
accordance with literature values.17 
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Synthesis of 3-(cyclohexylamino)-5,5-dimethylcyclohex-2-enone (331e) 
 
 
 
 
The procedure followed matched that described for 331a using: 
Dimedone (329a) (1.62 g, 11.6 mmol, 1.00 eqv.), cyclohexylamine (1.60 mL, 14.1 
mmol, 1.22 eqv.), ethanol (2.50 mL) and toluene (50.0 mL). The product was a 
yellow crystalline material. 
 
Yield: 96% (2.46 g, 11.1 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 5.52 (1H, s, NH), 
5.04 (1H, s, H-5), 3.15 (1H, s, H-6), 2.13 (2H, s, H-1), 2.08 (2H, s, H-4), 1.93 – 
1.11 (10H, m, H-7, H-8, H-9, H-10 and H-11), 0.97 (6H, s, H-2 and H-3); Melting 
Point: 173 – 174 °C (Literature Value: 170 – 172 °C); Data in accordance with 
literature values.18 
 
Synthesis of 3-(benzylamino)cyclohex-2-enone (331f) 
 
 
 
 
The procedure followed matched that described for 331a using: 
Cyclohexandione (329b) (1.51 g, 13.5 mmol, 1.00 eqv.), benzylamine (319) (1.80 
mL, 16.5 mmol, 1.22 eqv.), ethanol (2.50 mL) and toluene (50.0 mL). The product 
was a yellow solid. 
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Yield: 81% (2.21 g, 11.0 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 7.35 – 7.19 (5H, m, 
H-6, H-7 and H-8), 6.31 (1H, s, NH), 5.06 (1H, s, H-4), 4.17 (2H, s, H-5), 2.38 (J = 
6.1 Hz, 2H, t, H-1), 2.21 (J = 5.7 Hz, 2H, t, H-3), 1.98 – 1.83 (2H, m, H-2); Melting 
Point: 124 – 126 °C; Data in accordance with literature values.19 
 
Synthesis of 3-(benzylamino)-5,5-dimethylcyclohex-2-enone (331g) 
 
 
 
 
The procedure followed matched that described for 331a using: 
Dimedone (329a) (1.52 g, 10.8 mmol, 1.00 eqv.), benzylamine (319) (1.40 mL, 
12.8 mmol, 1.19 eqv.), ethanol (2.50 mL) and toluene (50.0 mL). The product was 
an orange solid. 
 
Yield: 90% (2.22 g, 9.68 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 7.38 – 7.24 (5H, m, 
H-7, H-8 and H-9), 5.58 (1H, s, NH), 5.12 (1H, s, H-5), 4.22 (2H, s, H-6), 2.24 (2H, 
s, H-1), 2.13 (2H, s, H-4), 1.06 (6H, s, H-2 and H-3); Melting Point: 130 – 131 °C 
(Literature Value: 127 – 128 °C); Data in accordance with literature values.20 
 
Synthesis of (Z)-4-(benzylamino)pent-3-en-2-one (331h) 
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The procedure followed matched that described for 331a using: 
2,4-pentanedione (329c) (1.60 mL, 15.6 mmol, 1.00 eqv.), benzylamine (319) 
(2.00 mL, 18.3 mmol, 1.17 eqv.), ethanol (3.00 mL) and toluene (50.0 mL). The 
product was an amber oil. 
 
Yield: 88% (2.60 g, 13.7 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 11.17 (1H, s, NH), 
7.31 – 7.19 (5H, m, H-5, H-6 and H-7), 5.02 (1H, s, H-2), 4.35 (J = 6.4 Hz, 2H, d, 
H-4), 2.00 (3H, s, H-3), 1.84 (3H, s, H-1); Data in accordance with literature 
values.21 
 
Synthesis of 3-(sec-butylamino)-5,5-dimethylcyclohex-2-enone (331i) 
 
 
 
 
The procedure followed matched that described for 331a using: 
Dimedone (329a) (1.56 g, 11.1 mmol, 1.00 eqv.), sec-butylamine (1.80 mL, 17.8 
mmol, 1.60 eqv.), ethanol (2.50 mL) and toluene (50.0 mL). The product was a 
yellow solid. 
 
Yield: 93% (2.02 g, 10.3 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 5.09 – 5.00 (2H, m, 
H-5 and NH), 3.40 – 3.28 (1H, m, H-6), 2.15 (2H, s, H-1), 2.13 (2H, s, H-4), 1.57 – 
1.51 (1H, m, H-8), 1.51 – 1.37 (1H, m, H-8’), 1.13 (J = 5.8 Hz, 3H, d, H-7), 1.02 
(6H, s, H-2 and H-3), 0.87 (J = 6.9 Hz, 3H, t, H-9); 13C-NMR: (CDCl3, 100 MHz) δ 
196.5 (C=O), 162.6, 95.1, 50.0, 49.7, 43.8, 32.7, 28.9, 28.2, 28.1, 19.5, 10.2; IR: 𝜈 
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3246 (N-H), 3078, 2963, 2924, 2873, 1525 (C=O), 1449, 1385, 1364, 1345, 1271, 
1253, 1223, 1148, 731, 604, 547; Melting Point: 113 – 115 °C; Rf (ethyl acetate) 
0.37; Mass Spectrometry: TOF ES+: MH+: Expected: m/z 196.1701, Observed: m/z 
196.1701, Difference = 0.00 ppm 
 
Synthesis 3-(2-bromobenzylamino)-5,5-dimethylcyclohex-2-enone (331j) 
 
 
 
 
Experimental procedure followed matched that described for 331a using: 
Dimedone (329a) (1.52 g, 10.8 mmol, 1.00 eqv.), 2-bromobenzylamine (1.80 mL, 
14.3 mmol, 1.32 eqv.), ethanol (2.00 mL) and toluene (50.0 mL). The product was 
a yellow solid. 
 
Yield: 87% (2.91 g, 9.44 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 7.55 (J = 7.5 Hz, 
1H, d, H-10), 7.30 – 7.24 (2H, m, H-7 and H-8), 7.16 (J = 7.5 Hz, 1H, t, H-9), 5.21 
(1H, s, NH), 5.09 (1H, s, H-5), 4.32 (J = 4.0 Hz, 2H, d, H-6), 2.24 (2H, s, H-1), 2.15 
(2H, s, H-4), 1.06 (6H, s, H-2 and H-3); 13C-NMR: (CDCl3, 100 MHz) δ 196.9 
(C=O), 162.3, 135.7, 133.1, 129.4, 129.4, 127.7, 123.5, 96.5, 50.3, 47.4, 43.4, 
32.9, 28.2; IR: 𝜈 3219 (N-H), 3010, 2936, 2900, 2867, 1576, 1552, 1429, 1364, 
1281, 1241, 1172, 1154, 1128, 1026, 1005, 811, 775, 750, 741, 638, 614, 571, 
553; Melting Point: 171 – 172 °C; Rf (ethyl acetate) 0.31; Mass Spectrometry: TOF 
ES+: MH+: Expected: m/z 308.0650, Observed: m/z 308.0651, Difference = −0.32 
ppm 
331j
1
4
5
O
2
3
N
H
6
7
8
9
10
Br
		
Experimental	–	Continuous-Flow	Test	Reactions	and	Bromination	of	Enaminones	 		 	
320	
Synthesis of 3-(furan-2-ylmethylamino)cyclohex-2-enone (331k) 
 
 
 
 
The procedure followed matched that described for compound 331a using: 
Dimedone (329a) (1.66 g, 11.8 mmol, 1.00 eqv.), furfurylamine (1.40 mL, 15.8 
mmol, 1.34 eqv.), ethanol (2.50 mL) and toluene (50.0 mL). The product was an 
off-white crystalline material. 
 
Yield: 83% (2.14 g, 9.76 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 7.35 (J = 1.9 Hz, 
1H, d, H-9), 6.32 (J = 1.9, 3.2 Hz, 1H, dd, H-8), 6.25 (J = 3.2 Hz, 1H, d, H-7), 5.18 
(1H, s, H-5), 5.05 (1H, s, NH), 4.23 (J = 5.1 Hz, 2H, d, H-6), 2.19 (2H, s, H-1), 2.16 
(2H, s, H-4), 1.05 (6H, s, H-2 and H-3); Melting Point: 153 – 154 °C (Literature 
Value: 148 – 150 °C); Data in accordance with literature values.22 
 
Synthesis of 3-(pyridine-2-ylmethylamino)cyclohex-2-enone (331l) 
 
 
 
 
The procedure followed matched that described for 331a using: 
Dimedone (329a) (1.59 g, 11.3 mmol, 1.00 eqv.), 2-picolylamine (1.60 mL, 15.5 
mmol, 1.37 eqv.), ethanol (2.50 mL) and toluene (50.0 mL). The product was a 
yellow crystalline solid. 
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Yield: 86% (2.24 g, 9.73 mmol); 1H-NMR: (CDCl3, 300 MHz) δ 8.48 (J = 4.5 Hz, 
1H, d, H-10), 7.63 (J = 7.7, 7.7 Hz, 1H, dd, H-8), 7.20 – 7.15 (2H, m, H-7 and H-9), 
6.42 (1H, s, NH), 5.06 (1H, s, H-5), 4.30 (J = 4.6 Hz, 2H, d, H-6), 2.28 (2H, s, H-1), 
2.12 (2H, s, H-4), 1.02 (6H, s, H-2 and H-3); Melting Point: 121 – 122 °C 
(Literature Value: 160 – 161 °C); Data in accordance with literature values.22 
 
Synthesis of 3-(sec-butylamino)cyclohex-2-enone (331m) 
 
 
 
 
The procedure followed matched that described for 331a using: 
Cyclohexanedione (329b) (1.56 g, 13.9 mmol, 1.00 eqv.), sec-butylamine (1.80 
mL, 17.8 mmol, 1.28 eqv.), ethanol (2.50 mL) and toluene (50.0 mL). The product 
was an orange/brown solid. 
 
Yield: 35% (0.811 g, 4.84 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 5.07 (1H, s, H-4), 
4.92 (1H, s, NH), 3.37 – 3.28 (1H, m, H-5), 2.32 (J = 6.7 Hz, 2H, d, H-1), 2.26 (J = 
5.8 Hz, 2H, d, H-3), 1.96 – 1.87 (2H, m, H-2), 1.64 – 1.49 (1H, m, H-7), 1.49 – 1.39 
(1H, m, H-7’) 1.12 (J = 6.2 Hz, 3H, d, H-6), 0.87 (J = 7.2 Hz, 3H, t, H-8); 13C-NMR: 
(CDCl3, 100 MHz) δ 197.0 (C=O), 163.7, 96.5, 49.6, 36.3, 30.0, 28.9, 21.9, 19.4, 
10.2; IR: 𝜈 3253 (N-H), 3086, 2966, 2935, 2874, 1532 (C=O), 1455, 1428, 1369, 
1300, 1252, 1189, 1147, 1108, 1003, 799, 785, 729, 671, 607, 599; Melting Point: 
74 – 756 °C; Rf (ethyl acetate) 0.19; Mass Spectrometry: TOF ES+: MH+: 
Expected: m/z 168.1388, Observed: m/z 168.1391, Difference = −1.78 ppm 
331m
1
2
3
4
O
N
H
5
7
6
8
		
Experimental	–	Continuous-Flow	Test	Reactions	and	Bromination	of	Enaminones	 		 	
322	
Synthesis of 2-bromo-3-(4-chlorobenzylamino)cyclohex-2-enone (332a) 
 
 
 
 
3-[(4-chlorobenzyl)amino]cyclohex-2-enone (331a) (0.100 M) was passed through 
a 3.00 mL loop to reach a reaction loop of 4.70 mL at 1.10 mL min-1. Here it was 
combined with N-bromosuccinimide (NBS) (0.105 M), which had been passed 
through a 4.10 mL loop at 0.900 mL min-1 beginning 20 seconds prior to the 
enaminone flow. Upon reaching the end of the reaction loop the organic reaction 
mixture joined with an aqueous stream of 0.1 M sodium thiosulfate/potassium 
carbonate, flowing at 4.00 mL min-1. This passed through a mixing chamber where 
the two phases were mixed using several magnetic stirrer bars above a stirrer 
hotplate. After this the solutions reached a separation chamber where the phases 
were separately collected. The organic phase was concentrated under reduced 
pressure yielding a brown solid. 
 
Yield: 93% (87.5 mg, 0.278 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 7.32 (J = 7.6 Hz, 
2H, d, H-6), 7.18 (J = 7.6 Hz, 2H, d, H-5), 6.12 (1H, s, NH), 4.49 (J = 5.2 Hz, 2H, 
d, H-4), 2.51 (J = 6.3 Hz, 2H, t, H-1), 2.45 (J = 6.0 Hz, 2H, t, H-3), 1.98 – 1.84 (2H, 
m, H-2); 13C-NMR: (CDCl3, 100 MHz) δ 187.8 (C=O), 161.0, 135.6, 133.7, 129.2, 
128.0, 96.6, 46.5, 36.6, 26.7, 20.7; IR: 𝜈 3260 (N-H), 2988, 2955, 2939, 2901, 
2884, 1584, 1573, 1520, 1489, 1440, 1390, 1313, 1294, 1255, 1194, 1176, 1102, 
1086, 1009, 910, 800, 715, 659, 587, 571; Melting Point: 122 °C; Rf (ethyl acetate) 
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0.65; Mass Spectrometry: TOF ES+: MH+: Expected: m/z 313.9947, Observed: m/z 
313.9939, Difference = 2.55 ppm 
 
Synthesis of 2-bromo-3-(4-chlorobenzylamino)-5,5-dimethylcyclohex-2-enone 
(332b) 
 
 
 
 
The procedure followed matched that described for 332a using: 
3-(4-chlorobenzylamino)-5,5-dimethylcyclohex-2-enone (331b) (0.100 M) was 
passed through a 3.00 mL loop to reach a reaction loop of 4.70 mL at 0.900 mL 
min-1 and N-bromosuccinimide (NBS) (0.106 M), which was passed through a 4.10 
mL loop at 0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The 
product was a cream solid. 
 
Yield: 85% (87.5 mg, 0.255 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 7.35 (J = 7.6 Hz, 
2H, d, H-7), 7.18 (J = 7.6 Hz, 2H, d, H-6), 6.04 (1H, s, NH), 4.49 (J = 5.4 Hz, 2H, 
d, H-5), 2.36 (4H, s, H-1 and H-4), 1.03 (6H, s, H-2 and H-3); 13C-NMR: (CDCl3, 
100 MHz) δ 187.4 (C=O), 159.0, 135.8, 133.8, 129.2, 127.9, 95.5, 50.3, 46.4, 40.1, 
32.2, 28.2; IR: 𝜈 3221 (N-H), 2956, 2935, 2865, 1526 (C=O), 1447, 1388, 1313, 
1294, 1240, 1152, 1090, 1014, 928, 904, 886, 795, 734, 640, 554; Melting Point: 
178 – 179 °C; Rf (ethyl acetate) 0.83; Mass Spectrometry: TOF ES+: MH+: 
Expected: m/z 342.0260, Observed: m/z 342.0275, Difference = 4.39 ppm 
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Synthesis of (E)-3-bromo-4-(4-chlorobenzylamino)pent-3-en-2-one (332c) 
 
 
 
 
The procedure followed matched that described for 332a using: 
(Z)-4-(4-chlorobenzylamino)pent-3-en-2-one (331c) (0.101 M) was passed through 
a 3.00 mL loop to reach a reaction loop of 4.70 mL at 1.10 mL min-1  and N-
bromosuccinimide (NBS) (0.105 M), which was passed through a 4.10 mL loop at 
0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The product 
was an off-white solid. 
 
Yield: 89% (81.8 mg, 0.270 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 11.90 (1H, s, 
NH), 7.31 (J = 7.8 Hz, 2H, d, H-5), 7.17 (J = 7.8 Hz, 2H, d, H-4), 4.47 (J = 5.6 Hz, 
2H, d, H-3), 2.38 (3H, s, H-1), 2.18 (3H, s, H-2); 13C-NMR: (CDCl3, 100 MHz) δ 
194.3 (C=O), 162.1, 136.0, 133.5, 129.0, 128.1, 92.4, 47.4, 30.4, 19.5; IR: 𝜈 3666 
(N-H), 2988, 2901, 1561 (C=O), 1488, 1454, 1406, 1353, 1258, 1239, 1090, 1013, 
954, 934, 802, 731, 667, 657, 563; Melting Point: 77 °C; Rf (ethyl acetate) 0.76; 
Mass Spectrometry: TOF ES+: MH+: Expected: m/z 301.9947, Observed: m/z 
301.9937, Difference = 3.31 ppm 
 
Synthesis of 2-bromo-3-(cyclohexylamino)cyclohex-2-enone (332d) 	
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The procedure followed matched that described for 332a using: 
3-(cyclohexylamino)cyclohex-2-enone (331d) (0.099 M) was passed through a 
3.00 mL loop to reach a reaction loop of 4.70 mL at 1.20 mL min-1 and N-
bromosuccinimide (NBS) (0.106 M), which was passed through a 4.10 mL loop at 
0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The product 
was a yellow oil. 
 
Yield: 78% (63.2 mg, 0.232 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 5.62 (J = 6.3 Hz, 
1H, d, NH), 3.43 – 3.27 (1H, m, H-4), 2.58 (J = 5.5 Hz, 2H, t, H-1), 2.50 (J = 6.0 
Hz, 2H, t, H-3), 1.95 – 1.18 (12H, m, H-2, H-5, H-6, H-7, H-8 and H-9); 13C-NMR: 
(CDCl3, 100 MHz) δ 187.3 (C=O), 160.2, 95.6, 52.0, 36.7, 34.0, 26.6, 25.0, 24.4, 
20.9; IR: 𝜈 3363 (N-H), 2920, 2848, 1627, 1553, 1446, 1405, 1322, 1187, 1143, 
1103, 980, 915, 804, 725, 682, 528; Rf (ethyl acetate) 0.57; Mass Spectrometry: 
TOF ES+: MH+: Expected: m/z 272.0650, Observed: m/z 272.0652, Difference = 
−0.74 ppm 
 
Synthesis of 2-bromo-3-(cyclohexylamino)-5,5-dimethylcyclohex-2-enone (332e) 
 
 
 
 
The procedure followed matched that described for compound 332a using: 
3-(cyclohexylamino)-5,5-dimethylcyclohex-2-enone (331e) (0.102 M) was passed 
through a 3.00 mL loop to reach a reaction loop of 4.70 mL at 1.10 mL min-1 and 
N-bromosuccinimide (NBS) (0.105 M), which was passed through a 4.10 mL loop 
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at 0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The product 
was a yellow crystalline material. 
 
Yield: 89% (112 mg, 0.274 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 5.61 (J = 6.7 Hz, 
1H, d, NH), 3.39 – 3.31 (1H, m, H-5), 2.41 (2H, s, H-1), 2.35 (2H, s, H-4), 1.90 – 
1.19 (10H, m, H-6, H-7, H-8, H-9 and H-10), 1.07 (6H, s, H-2 and H-3); Melting 
Point: 138 – 140 °C; Data in accordance with literature values.23 
 
Synthesis of 3-(benzylamino)-2-bromocyclohex-2-enone (332f) 	
 
 
 
The procedure followed matched that described for 332a using: 
3-(benzylamino)cyclohex-2-enone (331f) (0.102 M) was passed through a 3.00 mL 
loop to reach a reaction loop of 4.70 mL at 1.00 mL min-1 and N-bromosuccinimide 
(NBS) (0.105 M), which was passed through a 4.10 mL loop at 0.900 mL min-1 
beginning 20 seconds prior to the enaminone flow. The product was a cream solid. 
 
Yield: 91% (77.8 mg, 0.278 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 7.42 – 7.20 (5H, 
m, H-5, H-6 and H-7), 6.15 (1H, s, NH), 4.53 (J = 4.9 Hz, 2H, d, H-4), 2.57 (J = 6.5 
Hz, 2H, t, H-1), 2.49 (J = 6.7 Hz, 2H, t, H-3), 1.99 – 1.90 (2H, m, H-2); Melting 
Point: 128 – 130 °C (Literature Value: 128 – 130 °C); Data in accordance with 
literature values.24 
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Synthesis of 3-(benzylamino)-2-bromo-5,5-dimethylcyclohex-2-enone (332g) 
 
 
 
 
The procedure followed matched that described for 332a using: 
3-(benzylamino)-5,5-dimethylcyclohex-2-enone (331g) (0.101 M) was passed 
through a 3.00 mL loop to reach a reaction loop of 4.70 mL at 1.00 mL min-1 and 
N-bromosuccinimide (NBS) (0.105 M), which was passed through a 4.10 mL loop 
at 0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The product 
was a cream solid. 
 
Yield: 96% (89.9 mg, 0.292 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 7.41 – 7.25 (5H, 
m, H-6, H-7 and H-8), 6.13 (1H, s, NH), 4.53 (J = 5.5 Hz, 2H, d, H-5), 2.41 (2H, s, 
H-1), 2.37 (2H, s, H-4), 1.04 (6H, s, H-2 and H-3); Melting Point: 177 – 178 °C 
(Literature Value: 183 – 185 °C); Data in accordance with literature values.24 
 
Synthesis of (E)-4-(benzylamino)-3-bromopent-3-en-2-one (332h) 
 
 
 
 
The procedure followed matched that described for 332a using: 
(Z)-4-(benzylamino)pent-3-en-one (331h) (0.104 M) was passed through a 3.00 
mL loop to reach a reaction loop of 4.70 mL at 1.15 mL min-1 and N-
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bromosuccinimide (NBS) (0.105 M), which was passed through a 4.10 mL loop at 
0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The product 
was a cream coloured solid. 
 
Yield: 82% (68.9 mg, 0.257 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 11.94 (1H, s, 
NH), 7.39 – 7.21 (5H, m, H-4, H-5 and H-6), 4.50 (J = 4.9 Hz, 2H, d, H-3), 2.38 
(3H, s, H-1), 2.21 (3H, s, H-2); Melting Point: 82 °C; Data in accordance with 
literature values.25 
	
Synthesis of 2-bromo-3-(sec-butylamino)-5,5-dimethylcyclohex-2-enone (332i) 	
 
 
 
The procedure followed matched that described for 332a using: 
3-(sec-butylamino)-5,5-dimethylcyclohex-2-enone (331i) (0.098 M) was passed 
through a 3.00 mL loop to reach a reaction loop of 4.70 mL at 1.00 mL min-1 and 
N-bromosuccinimide (NBS) (0.106 M), which was passed through a 4.10 mL loop 
at 0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The product 
was a yellow solid. 
 
Yield: 76% (61.4 mg, 0.224 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 5.49 (J = 6.6 Hz, 
1H, d, NH), 3.60 – 3.49 (1H, m, H-5), 2.40 (2H, s, H-1), 2.36 (2H, s, H-4), 1.59 – 
1.49 (2H, m, H-7), 1.21 (J = 5.9 Hz, 3H, d, H-6), 1.07 (6H, s, H-2 and H-3), 0.93 (J 
= 7.0 Hz, 3H, t, H-8); 13C-NMR: (CDCl3, 100 MHz) δ 186.8 (C=O), 158.7, 94.4, 
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50.6, 50.3, 40.3, 32.2, 30.7, 28.2, 28.2, 21.8, 10.2; IR: 𝜈 3345 (N-H), 2958, 2932, 
2872, 1627, 1563, 1557, 1459, 1404, 1311, 1268, 1140, 1123, 1044, 993, 934, 
909, 887, 780, 728, 640, 563; Melting Point: 67 – 68 °C; Rf (ethyl acetate) 0.71; 
Mass Spectrometry: TOF ES+: MH+: Expected: m/z 274.0807, Observed: m/z 
274.0802, Difference = 1.82 ppm 
 
Synthesis of 2-bromo-3-(2-bromobenzylamino)-5,5-dimethylcyclohex-2-enone 
(332j) 		
 
 
The procedure followed matched that described for 332a using: 
3-(2-bromobenzylamino)-5,5-dimethylcyclohex-2-enone (331j) (0.102 M) was 
passed through a 3.00 mL loop to reach a reaction loop of 4.70 mL at 1.00 mL 
min-1 and N-bromosuccinimide (NBS) (0.105 M), which was passed through a 4.10 
mL loop at 0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The 
product was a cream solid. 
 
Yield: 85% (101 mg, 0.261 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 7.60 (J = 7.5 Hz, 
1H, d, H-9), 7.35 (J = 7.1, 7.1 Hz, 1H, dd, H-7), 7.25 – 7.20 (2H, m, H-6 and H-8), 
6.11 (1H, s, NH), 4.54 (J = 6.0 Hz, 2H, d, H-5), 2.38 (4H, s, H-1 and H-4), 1.04 
(6H, s, H-2 and H-3); 13C-NMR: (CDCl3, 100 MHz) δ 187.4 (C=O), 159.0, 136.4, 
133.2, 129.6, 128.2, 128.0, 122.8, 95.6, 50.4, 47.4, 39.9, 32.2, 28.2; IR: 𝜈 3262 (N-
H), 3064, 2957, 2901, 2883, 1574, 1531, 1394, 1385, 1313, 1295, 1254, 1193, 
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1101, 1086, 1025, 908, 800, 752, 660, 584, 567; Melting Point: 175 – 177 °C; Rf 
(ethyl acetate) 0.84; Mass Spectrometry: TOF ES+: MH+: Expected: m/z 385.9755, 
Observed: m/z 385.9744, Difference = 2.85 ppm 
	
Synthesis of 2-bromo-3-(furan-2-ylmethylamino)-5,5-dimethylcyclohex-2-enone 
(332k) 			
 
The procedure followed matched that described for 332a using: 
3-(furan-2-ylmethylamino)-5,5-dimethylcyclohex-2-enone (331k) (0.100 M) was 
passed through a 3.00 mL loop to reach a reaction loop of 4.70 mL at 1.00 mL 
min-1 and N-bromosuccinimide (NBS) (0.105 M), which was passed through a 4.10 
mL loop at 0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The 
product was a yellow solid. 
 
Yield: 84% (75.4 mg, 0.253 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 7.38 (1H, s, H-
8), 6.33 (1H, s, H-7), 6.23 (1H, s, H-6), 5.98 (1H, s, NH), 4.45 (J = 5.9 Hz, 2H, d, 
H-5), 2.50 (2H, s, H-1), 2.36 (2H, s, H-4), 1.07 (6H, s, H-2 and H-3); 13C-NMR: 
(CDCl3, 100 MHz) δ 187.4 (C=O), 158.9, 150.2, 142.7, 110.5, 107.7, 95.4, 50.3, 
40.4, 39.8, 32.1, 28.2; IR: 𝜈 3290 (N-H), 2959, 2929, 2890, 1618, 1581, 1525, 
1444, 1406, 1308, 1276, 1254, 1147, 1103, 1069, 1005, 927, 916, 900, 884, 812, 
733, 703, 619, 598, 565, 548; Melting Point: 138 – 139 °C; Rf (ethyl acetate) 0.77; 
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Mass Spectrometry: TOF ES+: MH+: Expected: m/z 298.0443, Observed: m/z 
298.0449, Difference = −2.01 ppm 
 
Synthesis of -2-bromo-5,5-dimethyl-3-(pyridin-2-tlmethylamino)cyclohex-2-enone 
(332l) 	
 
 
 
The procedure followed matched that described for 332a using: 
3-(pyridine-2-ylmethylamino)cyclohex-2-enone (331l) (0.103 M) was passed 
through a 3.00 mL loop to reach a reaction loop of 4.70 mL at 0.850 mL min-1 and 
N-bromosuccinimide (NBS) (0.105 M), which was passed through a 4.10 mL loop 
at 0.900 mL min-1 beginning 20 seconds prior to the enaminone flow. The product 
was brown coloured solid. 
 
Yield: 90% (89.1 mg, 0.277 mmol); 1H-NMR: (CDCl3, 400 MHz) δ 8.61 (1H, s, H-
9), 7.76 (J = 7.4, 7.4 Hz, 1H, dd, H-7), 7.32 – 7.25 (2H, m, H-6 and H-8), 7.03 (1H, 
s, NH), 4.66 (J = 3.9 Hz, 2H, d, H-5), 2.50 (2H, s, H-1), 2.39 (2H, s, H-4), 1.08 (6H, 
s, H-2 and H-3); 13C-NMR: (CDCl3, 100 MHz) δ 187.2 (C=O), 159.2, 155.2, 149.1, 
137.2, 122.8, 121.3, 94.9, 50.3, 47.6, 40.6, 32.1, 28.2; IR: 𝜈 3293 (N-H), 3047, 
2958, 2928, 2900, 1713, 1558, 1476, 1454, 1403, 1305, 1275, 1226, 1211, 1176, 
1151, 1106, 1078, 997, 924, 901, 886, 831, 771, 751, 727, 630, 602, 566, 545; 
Melting Point: 123 – 124 °C; Rf (ethyl acetate) 0.88; Mass Spectrometry: TOF ES+: 
MH+: Expected: m/z 309.0602, Observed: m/z 309.0602, Difference = 0.00 ppm 
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 Appendix A – X-ray Crystal Data 
X-ray data for 269e 
Empirical formula   C17H20O4 
Formula weight    288.33 
Temperature    100(2) K 
Wavelength     0.71075 Å 
Crystal system    Monoclinic 
Space group    P121/c1  
Unit cell dimensions   a = 8.6678(17) Å  α = 90°  
b = 19.551(3) Å  β = 111.010(3)° 
c = 9.4202(17) Å  γ  = 90° 
Volume     1490.3(5) Å3 
Z      4 
Density (calculated)   1.285 Mg / m3 
Absorption coefficient   0.091 mm-1 
F(000)     616 
Crystal     Block; Colourless 
Crystal size     0.16 × 0.13 × 0.07 mm3 
θ range for data collection   2.517 - 27.545° 
Index ranges    -11 ≤ h ≤ 11, -25 ≤ k ≤ 24, -12 ≤ l ≤ 10 
Reflections collected   10597 
Independent reflections   3410 [Rint = 0.0448] 
Completeness to θ = 25.242°  99.9 %  
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Absorption correction   Semi-empirical from equivalents 
Max. and min. transmission  1.000 and 0.606 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  3410 / 0 / 192 
Goodness-of-fit on F2   1.053 
Final R indices [F2 > 2σ(F2)]  R1 = 0.0417, wR2 = 0.1106 
R indices (all data)    R1 = 0.0499, wR2 = 0.1156 
Extinction coefficient   N/A 
Largest diff. peak and hole  0.285 and -0.191 e Å-3  
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Atom x y z Ueq S.o.f. 
O1 2282(1) 4834(1) 4706(1) 28(1) 1 
O2 3882(1) 3517(1) 5097(1) 32(1) 1 
O3 533(1) 6743(1) 11945(1) 28(1) 1 
O4 − 1446(1) 5989(1) 9823(1) 28(1) 1 
C1 3334(2) 4580(1) 6164(1) 25(1) 1 
C2 2828(2) 4862(1) 7444(1) 26(1) 1 
C3 2760(2) 5648(1) 7413(1) 25(1) 1 
C4 1672(2) 5883(1) 5810(1) 28(1) 1 
C5 2292(2) 5567(1) 4641(2) 29(1) 1 
C6 3223(2) 3820(1) 6072(1) 26(1) 1 
C7 2554(2) 3342(1) 6712(2) 31(1) 1 
C8 2797(2) 2695(1) 6093(2) 37(1) 1 
C9 3588(2) 2830(1) 5136(2) 38(1) 1 
C10 2215(2) 5933(1) 8655(1) 24(1) 1 
C11 3304(2) 6302(1) 9858(1) 26(1) 1 
C12 2790(2) 6581(1) 10989(1) 26(1) 1 
C13 1182(2) 6485(1) 10926(1) 24(1) 1 
C14 85(2) 6085(1) 9744(1) 24(1) 1 
C15 594(2) 5826(1) 8612(1) 25(1) 1 
C16 1506(2) 7246(1) 12987(2) 33(1) 1 
C17 − 2539(2) 5541(1) 8710(1) 29(1) 1 
 
X-ray Data for 269g 
Empirical formula    C18H22O5 
Formula weight    318.35 
Temperature    100(2) K 
Wavelength     0.71075 Å 
Crystal system    Triclinic 
Space group    P-1  
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Unit cell dimensions   a = 6.9484(11) Å  α = 80.017(6)° 
b = 9.9740(15) Å  β = 86.243(8)° 
c = 11.9674(18) Å  γ  = 86.393(8)° 
Volume     813.9(2) Å3 
Z      2 
Density (calculated)   1.299 Mg / m3 
Absorption coefficient   0.094 mm-1 
F(000)     340 
Crystal     Block; Colourless 
Crystal size     0.17 × 0.17 × 0.12 mm3 
θ range for data collection   2.467 - 27.514° 
Index ranges    -9 ≤ h ≤ 9, -12 ≤ k ≤ 12, -12 ≤ l ≤ 15 
Reflections collected   10756 
Independent reflections   3643 [Rint = 0.0337] 
Completeness to q = 25.242°  98.6 %  
Absorption correction   Semi-empirical from equivalents 
Max. and min. transmission  1.000 and 0.716 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  3643 / 0 / 211 
Goodness-of-fit on F2   1.122 
Final R indices [F2 > 2σ(F2)]  R1 = 0.0388, wR2 = 0.1076 
R indices (all data)    R1 = 0.0440, wR2 = 0.1114 
Extinction coefficient   N/A 
Largest diff. peak and hole  0.312 and -0.248 e Å-3 
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Atom x y z Ueq S.o.f. 
O1 6663(1) 1637(1) 10686(1) 23(1) 1 
O2 3281(1) 1330(1) 12330(1) 24(1) 1 
O3 906(1) 703(1) 6021(1) 22(1) 1 
O4 − 1493(1) 2807(1) 5660(1) 24(1) 1 
O5 1870(1) 5028(1) 8237(1) 22(1) 1 
C1 5159(2) 2673(1) 10792(1) 21(1) 1 
C2 3590(2) 2651(1) 9951(1) 21(1) 1 
C3 4470(2) 2821(1) 8722(1) 19(1) 1 
C4 6093(2) 1717(1) 8673(1) 22(1) 1 
C5 7550(2) 1806(1) 9556(1) 24(1) 1 
C6 4368(2) 2449(1) 11993(1) 20(1) 1 
C7 4434(2) 3146(1) 12864(1) 22(1) 1 
C8 3322(2) 2430(1) 13806(1) 23(1) 1 
C9 2666(2) 1342(1) 13444(1) 24(1) 1 
C10 2907(2) 2837(1) 7887(1) 19(1) 1 
C11 2676(2) 1729(1) 7337(1) 20(1) 1 
C12 1205(2) 1741(1) 6598(1) 19(1) 1 
C13 − 85(2) 2885(1) 6397(1) 19(1) 1 
C14 106(2) 3995(1) 6934(1) 20(1) 1 
C15 1601(2) 3966(1) 7674(1) 18(1) 1 
C16 2218(2) − 466(1) 6211(1) 26(1) 1 
C17 − 2920(2) 3904(1) 5498(1) 26(1) 1 
C18 611(2) 6216(1) 8001(1) 29(1) 1 
 
X-ray Data for 293b 
Empirical formula    C16H19ClO4 
Formula weight    310.76 
Temperature    100(2) K 
Wavelength     0.71075 Å 
Crystal system    Monoclinic 
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Space group    P121/c1  
Unit cell dimensions   a = 14.243(3) Å  α = 90° 
b = 8.5982(19) Å  β = 105.996(3)°  
c = 12.723(3) Å  γ  = 90° 
Volume     1497.8(6) Å3 
Z      4 
Density (calculated)   1.378 Mg / m3 
Absorption coefficient   0.268 mm-1 
F(000)     656 
Crystal     Plate; Colorless 
Crystal size     0.1 × 0.1 × 0.02 mm3 
θ range for data collection   2.797 - 27.536° 
Index ranges    -12 ≤ h ≤ 18, -11 ≤ k ≤ 11, -16 ≤ l ≤ 16 
Reflections collected   10350 
Independent reflections   3392 [Rint = 0.0446] 
Completeness to θ = 25.242°  99.4 %  
Absorption correction   Semi-empirical from equivalents 
Max. and min. transmission  1.000 and 0.600 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  3392 / 0 / 193 
Goodness-of-fit on F2   1.041 
Final R indices [F2 > 2σ(F2)]  R1 = 0.0438, wR2 = 0.1167 
R indices (all data)    R1 = 0.0539, wR2 = 0.1238 
Extinction coefficient   N/A 
Largest diff. peak and hole  0.363 and -0.312 e Å-3 
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Atom x y z Ueq S.o.f. 
Cl1 5582(1) 4543(1) 3309(1) 36(1) 1 
O1 7737(1) 6070(1) 10649(1) 22(1) 1 
O2 8284(1) 6922(1) 8697(1) 20(1) 1 
O3 10279(1) 2776(1) 9409(1) 24(1) 1 
O4 10249(1) 2691(1) 7284(1) 24(1) 1 
C1 7172(1) 6277(2) 11356(1) 23(1) 1 
C2 6221(1) 6323(2) 10801(1) 26(1) 1 
C3 6173(1) 6151(2) 9664(1) 26(1) 1 
C4 7102(1) 6008(2) 9611(1) 19(1) 1 
C5 7559(1) 5751(2) 8699(1) 18(1) 1 
C6 7993(1) 4112(2) 8757(1) 20(1) 1 
C7 8425(1) 3727(2) 7806(1) 18(1) 1 
C8 8844(1) 2043(2) 7902(1) 19(1) 1 
C9 9504(1) 1661(2) 9044(1) 21(1) 1 
C10 9385(1) 1725(2) 7046(1) 22(1) 1 
C11 7695(1) 3959(2) 6690(1) 18(1) 1 
C12 7929(1) 4883(2) 5902(1) 21(1) 1 
C13 7292(1) 5067(2) 4860(1) 22(1) 1 
C14 6396(1) 4326(2) 4616(1) 24(1) 1 
C15 6130(1) 3423(2) 5383(2) 33(1) 1 
C16 6780(1) 3231(2) 6412(1) 28(1) 1 
 
 
X-ray Data for 294g 
Empirical formula    C19H24O6 
Formula weight    348.38 
Temperature    100(2) K 
Wavelength     0.71075 Å 
Crystal system    Monoclinic 
Space group    P121/c1  
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Unit cell dimensions   a = 17.481(6) Å  α = 90°  
b = 7.270(2) Å  β = 114.170(5)° 
c = 14.959(4) Å  γ  = 90° 
Volume     1734.4(9) Å3 
Z      4 
Density (calculated)   1.334 Mg / m3 
Absorption coefficient   0.099 mm-1 
F(000)    744 
Crystal     Plate; Colourless 
Crystal size     0.08 × 0.06 × 0.01 mm3 
θ range for data collection   2.554 - 27.550° 
Index ranges    -22 ≤ h ≤ 22, -9 ≤ k ≤ 9, -19 ≤ l ≤ 14 
Reflections collected   11956 
Independent reflections   3974 [Rint = 0.0480] 
Completeness to θ = 25.242°  99.8 %  
Absorption correction   Semi-empirical from equivalents 
Max. and min. transmission  1.000 and 0.632 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  3974 / 1 / 232 
Goodness-of-fit on F2   1.026 
Final R indices [F2 > 2σs(F2)]  R1 = 0.0416, wR2 = 0.1036 
R indices (all data)    R1 = 0.0565, wR2 = 0.1120 
Extinction coefficient   N/A 
Largest diff. peak and hole  0.320 and -0.252 e Å-3 
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Atom x y z Ueq S.o.f. 
O1 1545(1) 6381(1) − 960(1) 18(1) 1 
O2 74(1) 4131(1) − 1653(1) 20(1) 1 
O3 4381(1) 5952(1) 4004(1) 20(1) 1 
O4 4223(1) 8733(1) 4987(1) 20(1) 1 
O5 1928(1) 11134(1) 2074(1) 22(1) 1 
O6 3277(1) 10813(1) − 234(1) 24(1) 1 
C1 1059(1) 6091(2) − 397(1) 17(1) 1 
C2 1619(1) 6231(2) 698(1) 17(1) 1 
C3 2042(1) 8133(2) 935(1) 17(1) 1 
C4 2508(1) 8490(2) 267(1) 18(1) 1 
C5 1907(1) 8185(2) − 804(1) 18(1) 1 
C6 643(1) 4269(2) − 688(1) 17(1) 1 
C7 692(1) 2650(2) − 225(1) 19(1) 1 
C8 125(1) 1413(2) − 940(1) 20(1) 1 
C9 − 226(1) 2365(2) − 1783(1) 20(1) 1 
C10 2611(1) 8362(2) 2016(1) 17(1) 1 
C11 3243(1) 7059(2) 2491(1) 18(1) 1 
C12 3774(1) 7215(2) 3474(1) 18(1) 1 
C13 3693(1) 8734(2) 4007(1) 17(1) 1 
C14 3089(1) 10070(2) 3551(1) 17(1) 1 
C15 2545(1) 9861(2) 2561(1) 17(1) 1 
C16 4452(1) 4351(2) 3491(1) 26(1) 1 
C17 4200(1) 10307(2) 5548(1) 22(1) 1 
C18 1731(1) 12458(2) 2659(1) 23(1) 1 
C19 2879(1) 10418(2) 407(1) 21(1) 1 
 
